Anda di halaman 1dari 338

No Bulan Tanggal Identitas

OBSTETRIC OUTPATIENT REPORT


1 Januari 08/01/21 Mrs. YEN/ 41 YO/ 1196489/ PALEMBANG/ DPR-EZA/ HE
2 Januari
3 Januari Mrs. MAY/ 29 YO/ 421622/ PALEMBANG/ BAN-AB
4 Januari 11/01/21 Mrs. YUL/ 28 YO/ 1183473/ PALEMBANG/ API-EZA/A
5 Januari Mrs. YUN/ 25 YO/ 711010/ PALEMBANG/ API-EZA/IS
6 Januari 13/2/21 Mrs. FIT/ 33 YO/ 1194714/ PALEMBAG/ API-EZA/ IS
7 Januari Mrs. YAN/ 31 YO/ 1194839/ PALEMBANG/ API-EZA/N
8 Januari 14/1/21 Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ API-EZA/
9 Januari Mrs. USM/ 33 YO/ 879476/ PALEMBANG/ KOM/ AB-HI
10 Januari Mrs. AYU/ 26 YO/ 1193653/ PALEMBANG/ KOM/ HI-F
11 Februari 02/02/21 Mrs. YEN/ 41 YO/ 1196489/ PALEMBANG/ DPR-EZA/ HE
12 Februari 03/02/21 Mrs. FER/ 30 YO/ 1193973/ PALEMBANG/ DPR-EZA/ PB
13 Februari 04/02/21 Mrs. MEI/ 24 YO/ 1194928/ PALEMBANG/ DPR-EZA/ NS
14 Februari 04/02/21 Mrs. MAR/ 32 YO/ 1194077/BANYUASIN/ DPR-EZA/ NS
15 Februari 04/02/21 Mrs. MAR/ 27 YO/ 1193236/ PALEMBANG/ DPR-EZA/ NS
16 Februari 15/02/21 Mrs. KUR/ 23 YO/ 1197676/ PALEMBANG/ IKY-TIA/ FB
17 Februari 15/02/21 Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ IKY-TIA/ AW
18 Februari 15/02/21 Mrs. MAR/ 32 YO/ 1194077/BANYUASIN/ IKY-TIA/ NS
19 Februari 15/02/21 Mrs. ELI/ 28 YO/ 1074132/ PALEMBANG/ IKY-TIA/ FB
20 Februari 16/02/21 Mrs. TRI/ 32 YO/ 1197740/ OGAN ILIR/ IKY-TIA/ AB
21 Februari 16/02/21 Mrs. DIA/ 760419/ PALEMBANG/ IKY-TIA/ HI
22 Februari 16/02/21 Mrs. NUR/ 30 YO/ 1192648/ PALEMBANG/ IKY-TIA/AB
23 Februari 16/02/21 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-TIA/ AB
24 Februari 17/02/21 Mrs. INT/ 41 YO/ 1197820/ MUARA ENIM/ IKY-TIA/ AB
25 Februari 18/02/21 Mrs. MAR/ 27 YO/ 1193236/ PALEMBANG/ IKY-TIA/ NS
26 Februari 18/02/21 Mrs. PUP/ 39 YO/ 1168684/ PALEMBANG/ IKY-TIA AB
27 Februari 18/02/21 Mrs. DEW/ 27 YO/ 857301/ MUARA ENIM/ IKY-TIA/ NS
28 Februari 18/02/21 Mrs. MER/ 19 YO/ 1196532/ PALEMBANG/ IKY-TIA/ NS.
29 Februari 18/02/21 Mrs. LID/ 36 YO/ 188136/ OGAN ILIR/ IKY-TIA/ HD
FAMILY PLANNING OUTPATIENT REPORT
30 Februari 03/02/21 Mrs. NUR/ 32 YO/ 1196506/ BANYUASIN/ CIA/FB
LACTATION AND PUERPERAL OUTPATIENT REPORT
31 Februari 01/02/21 Mrs. YUL/ 28 YO/ 1183473/ PALEMBANG/ CIA/AB-HI
32 Februari 02/02/21 Mrs.INE / 28 YO/ 1195396/ PALEMBANG/ CIA/AB-FY
33 Februari 04/02/21 Mrs. RAN/ 27 YO/ 1035800/ Palembang/ CIA-FY
34 Februari 15/02/21 Mrs. WID/ 30 YO/ 1196994/ OKI/ CIA/HI
35 Februari 16/02/21 Mrs. WUL/31YO/1195842/PALEMBANG/CIA/FY
36 Februari 16/02/21 Mrs. PUR/ 35 YO/ 1196179/ Palembang/ CIA-FY
37 Februari 17/02/21 Mrs.MUR/35YO/1197946/BANYUASIN/CIA-FB
38 Februari 17/02/21 Mrs. SUL/ 33 YO/ 1196624/ PALEMBANG/FB
39 Februari 17/02/21 Mrs.YUL/34YO/1196523/PALEMBANG/STI-IZY/FB
40 Februari 18/02/21 Mrs. RES/ 26 YO/ 919026/PALEMBANG/CIA/FB
41 Februari 18/02/21 Mrs. ROS/ 31 YO/ 1196975/PALEMBANG/ CIA/ FB
OBSTETRIC OUTPATIENT REPORT
42 Maret 05.03.2021 Mrs. EKA/ 27 YO/ 1196859/ PALEMBANG/ IKY-HAD/A
43 Maret 05.03.2021 Mrs. MAY/ 37 YO/ 421622/ PALEMBANG/ IKY-HAD/AB
44 Maret 05.03.2021 Mrs. DES/ 25 YO/ 1198402/ MUSI BANYUSIN/ IKY-DAV
45 Maret 08.03.2021 Mrs. ANG/ 25 YO/ 1194665/ PALEMBANG/ IKY-DAV/ PB
46 Maret 08.03.2021 Mrs. NOV/ 24 YO/ 1199702/ MUSI BANYUASIN/ IKY-DA
47 Maret 08.03.2021 Mrs. KHO/ 35 YO/ 936625/ OGAN ILIR/ IKY-DAV/PB - N
48 Maret 09.03.2021 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-MUT/ AW
49 Maret 09.03.2021 Mrs. ELI/ 28 YO/ 1074132/ PALEMBANG/ IKY-MUT/ FB
50 Maret 09.03.2021 Mrs. LES/ 28 YO/ 936625/ OGAN ILIR/ IKY-DAV/ NS
51 Maret 09.03.2021 Mrs. YOC/ 26 YO/ 1199340/ PALEMBANG/ IKY-MUT/N
52 Maret 09.03.2021 Mrs. EVI/ 25 YO/ 401844/ PALEMBANG/ IKY-MUT/ PB
53 Maret 09.03.2021 Mrs. LEN/ 39 YO/ 1199283/ PALEMBANG/ IKY-MUT/ IS
54 Maret 09.03.2021 Mrs. RIT/ 28 YO/ 1199840/ PALEMBANG/ IKY-MUT/AA
55 Maret 10.03.2021 Mrs. SEP/ 28 YO/1 1192117/ PRABUMULIH/ IKY-MUT/
56 Maret 10.03.2021 Mrs. NIN/ 21 YO/ 1198027/ OGAN KOMERING ILIR/ IK
57 Maret 10.03.2021 Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ IKY-MUT/ A
58 Maret 10.03.2021 Mrs. LIA/ 24 YO/ 1070439/ PALEMBANG/ IKY-MUT/ NS
59 Maret 10.03.2021 Mrs. MUN/ 38 YO/ 1200075/ BANYUASIN/ IKY-MUT/
60 Maret 12.03.2021 Mrs. IND/ 29 YO/ 845134/ PALEMBANG/ IKY-MUT/FB-
61 Maret 12.03.2021 Mrs. SUS/ 28 YO/ 1200204/ PALEMBANG/ IKY-MUT/ N
62 Maret 15.03.2021 Mrs. INT/ 41 YO/ 1197820/ MUARA ENIM/ IKY-DAV/ N
63 Maret 15.03.2021 Mrs. FER/ 32 YO/ 1199277/ OGAN ILIR/IKY-DAV/NS -A
64 Maret 15.03.2021 Mrs. RIN/ 33 YO/ 1199409/ PALEMBANG/ IKY-DAV/NS
65 Maret 15.03.2021 Mrs. FAT/ 24 YO/ 1200385/ PALEMBANG/ IKY-DAV/NS
66 Maret 16.03.2021 MRS.IST/36YO/1200520/ BANYU ASIN/ / IKY-MUT/HD
67 Maret 16.03.2021 MRS. MEL/35YO/ 1200504/LUBUKLINGGAU/ IKY-MUT
68 Maret 16.03.2021 MRS. NUR/30YO/ 1192648/PALEMBANG/ IKY-MUT/HD
69 Maret 17.03.2021 Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ IKY-DAV/
PALEMBANG/
70 Maret 17.03.2021 IKY-DAV/HE
71 Maret 18.03.2021 Mrs.SOR/31YO/ 1199137/BANGKA/IKY-MUT/NS
72 Maret 18.03.2022 Mrs.YUL/38YO/1140898/PALEMBANG/IKY-MUT/NS
73 Maret 18.03.2023 Mrs.VIN/30YO/1200785/MUBA/IKY-MUT/NS
74 Maret 18.03.2024 Mrs. NIN/ 21 YO/ 1198027/ OGAN KOMERING ILIR/ IK
75 Maret 18.03.2025 Mrs. MER/ 19 YO/ 1196532/PALEMBANG/IKY-TIA/ NS
76 Maret 18.03.2026 MRS. MEL/35YO/ 1200504/LUBUKLINGGAU/ IKY-MUT
77 Maret 18.03.2027 Mrs. SAP/ 37 YO/ 1191922/ LUBUK LINGGAU/ IKY-MUT
78 Maret 18.03.2028 Mrs.ANG/25YO/828394/PALEMBANG/IKY-MUT/NS
79 Maret 18.03.2029 Mrs. DEW/ 27 YO/ 857301/ MUARA ENIM/ DPR-EZA/ N
80 Maret 19.03.2021 Mrs. IND/ 29 YO/ 845134/ PALEMBANG/ IKY-DAV/AB
81 Maret 19.03.2022 Mrs. EKA/ 27 YO/ 1196859/ PALEMBANG/ IKY-DAV/A
82 Maret 19.03.2023 Mrs. YEN/ 35 YO/ 1022131/ PALEMBANG/ IKY-DAV/IS
83 Maret 22.03.2021 Mrs. INT/ 41 YO/ 1197820/ MUARA ENIM/ IKY-MUT/ K
84 Maret 22.03.2022 Mrs. ANG/ 25 YO/ 1194665/ PALEMBANG/IKY-MUT/ KY
85 Maret 23.03.2021 Mrs. DEL/ 25 YO/ 1184450/PALEMBANG/ IKY-DAV/ FU
86 Maret 23.03.2021 MRS.IST/36 YO/ 1200520/ BANYU ASIN/ / IKY-DAV/FU
87 Maret 24.03.2021 MRS.IGA/ 22 YO/ 981072/ LAHAT/ IKY-MUT/ IS-AB
88 Maret 24.03.2021 MRS.MUN/ 38 YO / 1200088/ BANYU ASIN/ /IKY-MUT/
89 Maret 24.03.2021 MRS.SRI/ 33 YO/ 783752/ PALEMBANG/ IKY-MUT/ IS
90 Maret 24.03.2021 MRS. ROH/ 31 YO/ 1199052/ BANYUASIN/ IKY-MUT/ I
91 Maret 24.03.2021 MRS. MEI/ 24 YO/ 1200515/ PALEMBANG/ IKY-MUT/ I
92 Maret 24.03.2022 MRS.NEL/ 31 YO /1201338/ PRABUMULIH/ IKY-MUT/ I
93 Maret 24.03.2023 MRS.DIA/ 33 YO/ 891675/ PALEMBANG/ IKY-MUT/ IS-
94 Maret 25.03.2021 MRS.LES/ 28 YO/ 793399/ MUARAENIM/IKY-MUT/NS
95 Maret 25.03.2022 MRS.NOV/ 21 YO/ 1201575/ PALEMBANG/IKY-DAV/A
96 April 05.04.21 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-PIT/ AB
97 April 05.04.21 Mrs.MEI/ 31 YO/ 1024319/ PALEMBANG/ IKY-PIT/ AB
98 April 05.04.21 Mrs. LND/ 34 YO/ 686810/ PALEMBANG/ IKY-IAN/ NS
99 April 05.04.21 Mrs. LIN/ 30 YO/ 968918/ PALEMBANG/ IKY-IAN/ AF
100 April 06.04.21 Mrs.FER/ 30 YO/ 11939973/ PALEMBANG/ IKY-PIT/PB
101 April 06.04.21 Mrs. ULT/ 43 YO/ 1159799/ PALEMBANG/ IKY-IAN/ AB
102 April 08.04.21 Mrs.ANG/25 YO/ 828394/ PALEMBANG/ IKY-PIT/PM-NS
103 April 08.04.21 Mrs. NET/38YO/ 1202967/ PALEMBANG/ IKY-IAN/PM-IS
104 April 08.04.21 Mrs. ENA/ 46 YO/ 1201996/ PALEMBANG/ ZAN/ FY
105 April 08.04.21 Mrs. RIA/ 40 YO/ 1201810/ OGAN ILIR/ ZAN/ FY
106 April 08.04.21 Mrs. ERM/ 31 YO/ 1201810/ OGAN ILIR/ ZAN/ FY
107 April 09.04.21 Mrs. NAI/ 59 YO/ 1202861/ PALEMBANG/ P6A0/ MIQ-IS
108 April 09.04.21 Mrs. SUG/ 62 YO/ 1185872/ OKU TIMUR/ P3A0/ MIQ-AT
109 April 09.04.21 Mrs. ERM/ 45 YO/ 1201908/ MUARA ENIM/ P4A0/ MIQ-IS
110 April 09.04.21 Mrs. DEW/ 48 YO/ 1135664/ PAGAR ALAM/P0A0/ MIQ-IS
111 April 09.04.21 Mrs. GUS/ 48 YO/ 1182780/ PALEMBANG/ P3A0/ MIQ-IS
112 April 09.04.21 Mrs. SRI/ 67 YO/ 1176549/ OGAN KOMERING ULU/ P8A1
113 April 09.04.21 Mrs. DES/ 29 YO/ 1158791/ PALEMBANG/ P0A0/ MIQ-AT
114 April 09.04.21 Mrs. KUR/ 38 YO/ 1179808/ PALEMBANG/ P1A1/ MIQ-IS
115 April 09.04.21 Mrs. WIW/ 34 YO/ 835176/ PALEMBANG/ P2A2/ MIQ-AT
116 April 09.04.21 Mrs. HEL/ 54 YO/ 31527/ PALEMBANG/ P1A2/ MIQ-IS
117 April 13.04.21 Mrs. EMM/ 47 YO/ 1203286/ BANGKA BELITUNG/ P1A0/ UT
118 April 13.04.21 Miss. DEL/ 24 YO/ 1192294/ PALEMBANG/ P0A0/ ZAN-IS
119 April 13.04.21 Mrs. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ ZAN-AT
120 April 13.04.21 Mrs. KOM/ 47 YO/ 1203439/ BANYUASIN/ P5A0/ UTI-RS
121 April 19.04.21 Mrs. ZAN/ 34 YO/ 1201569/ PALEMBANG/ IKY-IAN/AF
122 April 19.04.21 Mrs. MER/ 19 YO/ 1196532 / PALEMBANG/IKY-PIT/ NS
123 April 19.04.21 Mrs. ENT/ 32 YO/ 1202351/ PALEMBANG/ OGL/FB
124 April 19.04.21 Mrs. AND/ 36 YO/ 1199137/ BANYUASIN/ OGL/NS
125 April 20.04.21 Mrs. ANG/ 25 YO/ 1194665/ PALEMBANG/ OGL/HI
126 April 20.04.21 Mrs. RIK/ 38 YO/ 1202765/ PALEMBANG/ OGL/IS
No Bulan Tanggal Identitas
127 May 31.05.21 IND, 29 tahun, Palembang

128 May 31.05.21 FER, 30 tahun , Palembang

No Bulan Tanggal Identitas


129 Juni 02.06.21 BER, 28 tahun, Palembang

130 Juni 03.06.21 TEN, 45 tahun, Ogan Komering Ilir

131 Juni 03.06.21 NOV, 41 tahun, Muara Enim

132 Juni 07.06.21 PEB, 34 tahun, Kayuagung

133 Juni 08.06.21 FER, 30 tahun, Palembang

134 Juni 08.06.21 ULT, 43 tahun, Palembang

135 Juni 09.06.21 SEL, 25 tahun, Palembang


136 Juni 09.06.21 EKA, 35 tahun, Palembang

137 Juni 10.06.21 HEN, 31 tahun, Palembang

138 Juni 10.06.21 ANI, 31 tahun, Palembang

no bulan tanggal identitas


139 Agustus 13.07.21 Mrs. Hal / 21 YO / 1213225 / Muara Dua
140 Agustus Mrs. RAH/ 41 YO/ 727989/ Palembang
141 Agustus Mrs. ANG/ 30 YO/ 1217915/ Palembang
142 Agustus Mrs. MAR/ 37 YO/ 1217954/ Banyuasin
143 Agustus Mrs. ADI/ 18 YO/ 1178404/ Musi Banyuasin
144 Agustus Mrs. ADE/ 26 YO/ 1218263/ Palembang
145 Agustus Mrs. AIN/ 18 YO/ 1216198/ PALEMBANG
146 Agustus Mrs. YUN/ 35 YO/ 1216175/ PALEMBANG
147 Agustus Mrs. Hal / 21 YO / 1213225 / Muara Dua
148 Agustus Mrs. RAH/ 41 YO/ 727989/ Palembang/
149 Agustus Mrs. ANG/ 30 YO/ 1217915/ Palembang
150 Agustus Mrs. MAR/ 37 YO/ 1217954/ Banyuasin
151 Agustus Mrs. ADI/ 18 YO/ 1178404/ Musi Banyuasin
152 Agustus Mrs. ADE/ 26 YO/ 1218263/ Palembang
153 September 27.7.21 Mrs. YUN/ 33 YO/ 1219306
154 September Mrs. TRI/ 22 YO/ 681518/ Palembang
155 September Mrs. THE/ 34 YO/ 1219623
156 September Mrs. YET/ 33 YO/ 1219705
157 September Mrs. LIA/ 29 YO/ 1219705
158 September Mrs. SRI/ 39 YO/ 1161818/ OGAN ILIR
159 September Mrs. JUM/ 22 YO/ 1160358
160 September Mrs. RET/ 26 YO/ 1218729/ Palembang
161 September Mrs. YUL/ 38 YO/ 1215585/ Palembang
162 September Mrs. WITA WINATI/ 30 YO/ 1218376/ OGAN ILIR
163 September Mrs. AST/ 39 YO/ 1216112/ PALEMBANG
164 September Mrs. NOV / 43 YO/ 1219095/ PALEMBANG
165 September Mrs. YUN/ 33 YO/ 1219306
166 September Mrs. TRI/ 22 YO/ 681518/ Palembang
167 September Mrs. THE/ 34 YO/ 1219623
168 September Mrs. YET/ 33 YO/ 1219705/
169 September Mrs. WITA WINATI/ 30 YO/ 1218376/ OGAN ILIR

170 NOV 29.10.2021 Mrs. NUR/ 29 YO/ 1228288/ PALEMBANG/AYI-CYN/ R


171 NOV 29.10.2021 Mrs. DEV/ 27 YO/ 960298/ PALEMBANG/AYI-CYN/ PB
172 NOV 29.10.2021 Mrs. AIN/ 36 YO/ 1111137/ PALEMBANG/AYI-CYN/ PB
173 NOV 2.11.2021 Mrs. LAH / 34 YO/ 1128278/ Ogan Ilir/ AYI-ARM/ IS
174 NOV 3.11.2021 Mrs. SRI/ 31 YO/ 1161818/OGAN ILIR/ GIO-NAL/PM
175 NOV 3.11.2021 SITI NURHALIMAH/ 25 YO/ 1226392/ PALEMBANG/
176 NOV 3.11.2021 Mrs. RAC/ 33 YO/ 825043/ MCD-ARM-NS
177 NOV 3.11.2021 Mrs. Okta Vianti/24 YO/1120916/PALEMBANG/MCD AR
178 NOV 3.11.2021 MRS.MAY/29YO/ 1187279/ BANYUASIN/ ASR-DPR/FY
179 NOV 5.11.2021 Mrs. YUN/ 32YO/ 1179675/ BETUNG/ MCD-CYN/AB
180 NOV 8.11.2021 Mrs. MAY/ 25 YO/ 977136/ Palembang/ AYI-ARM/AB
181 NOV 8.11.2021 Mrs. APR/ 38 YO/ 1211046/ Palembang/ AYI-ARM
182 NOV 9.11.2021 Mrs. ROM/ 33 YO/ 1101422/ Ogan Komering Ulu/ GIO-NA
183 NOV 9.11.2021 Mrs. LAH/ 34 YO/ 1128278/ Ogan Ilir/ GIO-NAL/IS
184 NOV 10.11.2021 Mrs. YUL/ 25 YO/ 1222480/ Palembang/ GIO-MIQ/ PM
185 NOV 10.11.2021 Mrs. FIT/ 39 YO/ 1230112/ Palembang/ GIO-MIQ/ AB
186 NOV 11.11.2021 Mrs. ANN/ 30 YO/ 1230349 PRABUMULIH/ AYI-ARM/ N
187 NOV 11.11.2021 Mrs. FEB/ 30 YO/ 1230349 PRABUMULIH/ AYI-ARM/ N
188 NOV 11.11.2021 MRS. SAR/ 26YO/ 1222048/ PALEMBANG/ BER-FB
189 NOV 11.11.2021 Mrs. FIT/ 1230009/ PALEMBANG/ AF – BER
190 NOV 11.11.2021 Mrs. DIA/ 28 YO/ 1227864/ Palembang/ P1A0/ BER-HI
191 NOV 11.11.2021 Mrs. ULA/ 26 YO/ 1227988/ Palembang/ BER-NS
192 OKT 01.10.2021 Mrs.ELL / 30 YO/ 460476/ OganKomering Ilir/ EDA-SAR/
193 OKT 01.10.2021 Mrs. IGA/ 22 YO/ 981072/ Lahat/ ANE-CYN/ AB
194 OKT 01.10.2021 Mrs. BELL/ 23 YO/ 1186965/ Lahat/ ANE-CYN/ NS
195 OKT 01.10.2021 Mrs. NOV / 33 YO/ 1220200/ Prabumulih/ ANE-CYN/ AB
196 OKT 01.10.2021 Mrs. YUN/ 32YO/ 1179675/ BETUNG/ ANE-CYN/AB
197 OKT 01.10.2021 Mrs. MER/ 26 YO/ 1222056/ Palembang/ ANE-CYN/ AF
198 OKT 01.10.2021 Mrs. SAR/ 29 YO/ 1191335/ BANYUASIN/ ANE-CYN/ A
199 OKT 01.10.2021 Mrs. SRI/ 40 YO/ 981072/ Kayu Agung/ EDA-CYN/ IS
200 OKT 01.10.2021 Mrs. FEB/ 28 YO/ 1084328/ Palembang/ EDA-CYN/ NS
201 OKT 01.10.2021 Mrs. SRI/ 39 YO/ 1161818/OGAN ILIR/ EDA-CYN/PM
202 OKT 01.10.2021 Mrs. YUL/ 25 YO/ 1222480/ Palembang/ ANE-SAR/ PM
203 OKT 01.10.2021 Mrs. NUR/ 40 YO/ 107450/ Palembang/ ANE-FES/NS
204 OKT 01.10.2021 Mrs. MER/ 32 YO/ 747199/ PALEMBANG/ANE-FES/ NS
205 OKT 01.10.2021 Mrs. SIS/ 28 YO/ 1220156/ Palembang/ ANE-FES/ NS
206 OKT 01.10.2021 Mrs. RAD/ 39 YO/ 1217290/ Palembang/ ANE-FES/ AW
207 OKT 01.10.2021 Mrs. RIS/ 28 YO/ 535733/ Palembang/ ANE-FES/ NS
208 OKT 01.10.2021 Mrs. DIN/ 19 YO/ 935116/ Palembang/ ANE-FES/ NS
209 OKT 01.10.2021 Mrs. JUM/ 19 YO/ 1160358/ Palembang/ ANE-FES/ NS
210 OKT 08.10.2021 Mrs.ELL / 30 YO/ 460476/ OganKomering Ilir/ EDA-SAR/ AF
211 OKT 08.10.2021 Mrs. IGA/ 22 YO/ 981072/ Lahat/ ANE-CYN/ AB
212 OKT 08.10.2021 Mrs. BELL/ 23 YO/ 1186965/ Lahat/ ANE-CYN/ NS
213 OKT 08.10.2021 Mrs. NOV / 33 YO/ 1220200/ Prabumulih/ ANE-CYN/ AB
214 OKT 08.10.2021 Mrs. YUN/ 32YO/ 1179675/ BETUNG/ ANE-CYN/AB
215 OKT 08.10.2021 Mrs. MER/ 26 YO/ 1222056/ Palembang/ ANE-CYN/ AF
216 OKT 08.10.2021 Mrs. SAR/ 29 YO/ 1191335/ BANYUASIN/ ANE-CYN/ A
217 OKT 08.10.2021 Mrs. SRI/ 40 YO/ 981072/ Kayu Agung/ EDA-CYN/ IS
218 OKT 08.10.2021 Mrs. FEB/ 28 YO/ 1084328/ Palembang/ EDA-CYN/ NS
219 OKT 08.10.2021 Mrs. SRI/ 39 YO/ 1161818/OGAN ILIR/ EDA-CYN/PM
220 OKT 08.10.2021 Mrs. YUL/ 25 YO/ 1222480/ Palembang/ ANE-SAR/ PM
221 OKT 08.10.2021 Mrs. NUR/ 40 YO/ 107450/ Palembang/ ANE-FES/NS
222 OKT 08.10.2021 Mrs. MER/ 32 YO/ 747199/ PALEMBANG/ANE-FES/ NS
223 OKT 08.10.2021 Mrs. SIS/ 28 YO/ 1220156/ Palembang/ ANE-FES/ NS
224 OKT 08.10.2021 Mrs. RAD/ 39 YO/ 1217290/ Palembang/ ANE-FES/ AW
225 OKT 08.10.2021 Mrs. RIS/ 28 YO/ 535733/ Palembang/ ANE-FES/ NS
226 OKT 08.10.2021 Mrs. DIN/ 19 YO/ 935116/ Palembang/ ANE-FES/ NS
227 OKT 08.10.2021 Mrs. JUM/ 19 YO/ 1160358/ Palembang/ ANE-FES/ NS
228 OKT 15.10.2021 Mrs. APR/ 38 YO/ 1211046/ Palembang/ GAR- RS
229 OKT 15.10.2021 Mrs. NOV/ 33 YO/ 1220200/ Prabumuih/GAR-AB
230 OKT 15.10.2021 Mrs. MEJ/ 32 YO/ 1217277/ OKU Timur/ GAR-AB
231 OKT 15.10.2021 Mrs, ECA/ 38 YO/ 1225217/ Palembang/ GAR- AB
232 OKT 15.10.2021 Mrs. YUN/ 28 YO/ 1225236/ Palembanh/ GAR-AB
233 OKT 15.10.2021 Mrs. SAR/ 25 YO/ 1222648/ Palembang/ GAR-AF
234 OKT 15.10.2021 Mrs. LAH / 40 YO/ 1128278/ Ogan Ilir/ EDA-CYN/ IS
235 OKT 15.10.2021 Mrs. FEB/ 28 YO/ 1084328/ Palembang/ EDA-CYN/ NS
236 OKT 15.10.2021 Mrs. UTA/ 33 YO/ 863084/ Palembang/ EDA-CYN/ PB
237 OKT 15.10.2021 Mrs. FET/ 38 YO/ 913596/ Palembang/ EDA-CYN/ AF
238 OKT 15.10.2021 Mrs. MIT/ 31 YO/ 859418 Palembang/ EDA-CYN/ AF
239 OKT 15.10.2021 Mrs. Put/ 25 YO/ 1223863/ Palembang/ GAR-HI
240 OKT 15.10.2021 MRS. JUL / 23 YO/ 889447/ PALEMBANG/ GAR- AW
241 OKT 15.10.2021 MRS. SUM/ 38 YO/ 1188902/ PALEMBANG/ GAR-NS
242 OKT 15.10.2021 MRS. NEI/ 24 YO/ 909661/ PALEMBANG/ GAR-NS
243 OKT 15.10.2021 MR. OKT/ 20 YO/ 756180/ PALEMBANG/ GAR-NS
244 OKT 15.10.2021 MRS. NUR/25 YO/ 1222205/ PALEMBANG/ GAR-HI
245 OKT 15.10.2021 MRS. PUTI/ 27 YO/ 12464/ PALEMBANG/ GAR-PM
246 OKT 15.10.2021 MRS. MER/ 32 YO/ 747199/ PALEMBANG/ GAR-NS
247 OKT 22.10.2021 Mrs. DEV/ 27 YO/ 960298/ PALEMBANG/ANE-CYN/ NS
248 OKT 22.10.2021 Mrs. JUM/ 26 YO/ 1213225/ OKI/ GIO-CYN-PB
249 OKT 22.10.2021 Mrs. NOV/ 33 YO/ 1220200/ Prabumulih/ GIO-CYN-AB
250 OKT 22.10.2022 Mrs. SIT/ 25 YO/ 1226392/ GIO-CYN-AB
251 OKT 22.10.2022 Mrs. AGU/ 28 YO/ 1226410/PALEMBANG / MCD-CYN/
252 OKT 22.10.2022 Mrs. IND/ 31 YO/ 1112529/ PALEMBANG / MCD-CYN/H
253 OKT 22.10.2022 Mrs. ISN/ 25 YO/ 1225413/ PALEMBANG / MCD-CYN/A
254 OKT 22.10.2022 Mrs. JUL/ 28 YO/ 889447/ PALEMBANG / MCD-CYN/NS
255 OKT 22.10.2022 Mrs. WID/ 34 YO/ 1226864/ MUSI BANYUASIN / MCD-
256 OKT 22.10.2022 Mrs. HOS/ 26 YO/ 1221060/ OGAN ILIR / MCD-CYN
257 OKT 29.10.2021 Mrs. TUT/ 36 YO/ 855433/ PALEMBANG / AYI-FES-NS
258 OKT 29.10.2021 Mrs. NOV/ 33 YO/ 1220200/ Prabumulih/ AYI-FES-AB
259 OKT 29.10.2021 Mrs. LAH / 34 YO/ 1128278/ Ogan Ilir/ GIO-CYN/ IS
260 OKT 29.10.2021 Mrs. AST/ 29 YO/ 1222279/ Palembang/ GIO-FES/PB
261 OKT 29.10.2021 MAY/ 28 YO/ 999811/PALEMBANG/ MCD-CYN/ PM
262 OKT 29.10.2021 Mrs. Sari Bunga/ 25 YO/ 1222648/ Palembang/ MCD-FES-
263 OKT 29.10.2021 Mrs. Yuliana BtMamat/ 25 YO/ 1222480/ Palembang/ MC
264 OKT 29.10.2021 Mrs. Ririn Oktarina/ 28 YO/ 1045515/ Palembang/ MCD -F
265 OKT 29.10.2021 Mrs. Silvy Oktarina/ 27 YO/ 1200659/ Palembang/ MCD -F
266 OKT 29.10.2021 LIL/ 33 YO/ 1161828/Muara Enim/ MCD-FES/ AB
267 OKT 29.10.2021 Mrs. LikaHaryani/ 47 YO/ 1228109/ PagarAlam/ MCD-FES
268 OKT 29.10.2021 Mrs. TriaAgustina/ 22 YO/ 681518/ Palembang/ MCD-CYN
269 Mrs. KIK/35 YO/1238840/Palembang
270 DESEMBER 24.12.21 Mrs. YEN/34 YO/645858/Palembang
271 DESEMBER Mrs. PUT/20 YO/1198752/PALEMBANG
272 DESEMBER Mrs. UTA/33 YO/863084/PALEMBANG
273 DESEMBER Mrs. DEV/28 YO/960298/PALEMBANG
274 DESEMBER Mrs. KHA/30 YO/1002029/PALEMBANG
275 DESEMBER Mrs. NUR/24 YO/1230382/Palembang
276 DESEMBER Mrs. DIN/29 YO/11216070/PALEMBANG
277 DESEMBER Mrs. SUM/39 YO/1188902/PALEMBANG
278 DESEMBER Mrs. SIL/28 YO/1200659/PALEMBANG
279 DESEMBER Mrs. DIN/19 YO/935116/PALEMBANG
280 DESEMBER Mrs. SUS/32 YO/1200552/PALEMBANG
281 DESEMBER
Diagnosa
• Single life fetus intrauterine
• Multiple congenital anomaly
Polyhydramnios
• Single life fetus intrauterine
• Fetal tend to be small
• Oligohydramnios
• Single life fetus cephalic presentation
• Plan for abdominal termination and tubal ligation (Monday, January 18th 2021)
• Single life fetus intrauterine
• Post tubectomy pomeroy

P1A0
• Single post
lifeLSCS on indication antepartum eclampsia was suspected.( D-15)
fetus intrauterine
•• Multiple congenital anomaly
Single life fetus intrauterine
•• Umbilical cord cyst
Hydrocephalus was suspected
ec bilateral ventriculomegaly
•• AEDV Meningocele
•• Dolichocephalic
Single life fetus transverse lie
•• Meningoencephalocele
Covid-19 confirmed

• G5P3A1 Single life
32fetus
weekscephalic presentation
gestational age not in labor
•• Meningocele
Single life fetus cephalic presentation
• Dolichocephalic
••G1P0A0 Placenta4accrete
weeks gestational age Intrauterine
spectrum disorder was suspected
•• Single life
Prior CS 2x fetus cephalic presentation
• G2P1A0• Single life
16fetus
weekscephalic presentation
gestational age
•• Single life fetus
HSV I Infection intrauterine
•• Single life fetus
Hiperthiroid on intrauterine
therapy
•• Single
Single life
life fetus
fetus transverse
cephalic presentation
lie
•• Meningoencephalocele
Systemic lupus erythematous
•• Single lifelupus
Systemic fetus erythematous
cephalic presentation
•• Single life fetus intrauterine
ß-thalassemia
•• Single
Single life
life fetus
fetus intrauterine
cephalic presentation
• IUGR was suspected
• P3A0 post spontaneous delivery ( 44 hours outside)
• History of Early post partum hemorrhagic caused by perineal laceration
horner syndrome + intrauterine infection+ IUGR +
Fetal Post
P1A1 hypoperfusion
LSCS o.i fetal distress and
P1A0 post LSCS on12indication
history of PROM hours
cephalo-pelvic disproportion Day 8th
P1A0 Post LSCS on indication impending eclampsia day 7th
P1A0
• P2A0Post spontaneous
post deliveryprior
LSCS on indication withCS
history of PROMprevia
1x + placenta 18 hours day 4th
marginal (day 13th )
• Post IUD insertion
P3A0 with controlled Diabetes Mellitus Type II
• Post tubal ligation
• P3A0 Post SSTP on indication fetal distress
P1A0 post LSCS on indication cephalopelvic disproportion caused by hydrocephalus day 9
P2A0 post caesarean hysterectomy o.i uterine atony + Impending eclampsia + Prior CS 1x
• Nephrotic syndrome caused by GNAPS was suspected dd/ lupus nephritis ( M32.9)
•(I10)
Single life fetus intrauterine
• Sigle life fetus
Moderate anemia intrauterine
caused by(Z37.0)
iron deficiency
• SLF cephalic presentation (Z37.0)
Single life fetus cephalic presentation presentation ( Z37.0)
• Fetal tend to be (small
Hydrocephalus Q89.9) ( P06.9)
• Anhydramnios
HIV infection ( (B20) O41.1)
••G3P2A0
Single life 16fetus
weeks cephalic presentation
gestational age ( Z37.0)
• Single life fetus intrauterine
••G1P0A0
Single life 7 weeks gestational (age
fetus intrauterine Intrauterine
Z37.0)
Anhydramnios
• SLF intrauterine
• Endometriosis
Ventricel septalcyst defect
• Intrauterine
Moderate anemia restriction
growth
• SLF cephalic presentation
Bad obstetric history
• Twin death fetus
Single life fetus cephalic presentation ( Z37.0)
Meningoencephalocele
• Dermoid ( Q89.9) unilateral salpingo-oophorectomy) (D27.9)
cyst ( post laparotomy
••G5P3A1
Single life 35fetus
weeks intrauterine
gestational(Z37.0)
age not in labor (Z3A.35)
Single lifelupus
• Systemic fetuserythematous
cephalic presentation ( Z37.0)
with arthritis manifestation ( M32.9)
Single life fetuspreeclampsia
• Superimposed intrauterine (onZ37.0)
chronic hypertension (O14.03)
•(N18.9)
Single life fetus intrauterine ( Z37.0)
Single life fetus(O41.0)
Anhydramnios intrauterine (Z37.0)
IUGR was suspected (P059)
(O43.21)
Single life fetuscaused
Anhydramnios cephalic bypresentation (Z37.0)
renal agenesis + lung hypoplasia + cardiomegaly
(Q89.9)
Single life fetus cephalic presentation
(Z37.0)
G1P1A0
Placenta 18 weeks
accreta wasgestational
suspectedage with syphilis infection SLF intrauterine
Single life
Thyroid nodule fetus cephalic presentation
Single life
G2P1A0 20fetus
weeks intrauterine
gestational ag
Single life fetus intrauterine
cephalic presentation ( Z37.0)
Umbilical cord
Hepatitis B infection entanglement 2x
Single life
Myoma fetus
uteri cephalic
cystic presentation
degeneration
Single
HIV life fetus(B.20)
infection cephalic presentation
Singlelife
Twin lifefetus
fetusintra
cephalic presentation
uterine
TTTSlaparatomy
post was suspected salphyngooophorectomy sinistra on indication dermoid cyst
Single life fetus intrauterine
cephalic presentation
Asymmetric IUGR
Single life fetus intrauterine
Subchorionic
Single life fetus bleeding
cephalic presentation (Z37.0)
Meningo-encephalocele
prior CS 1x (Q89.9)
Single lifelupus
Systemic fetuserythematous
cephalic presentation
(M32.9)
Single dead fetus intrauterine
•G3P2A0 19 weeks gestational age (Z3A.16)
•Prior histerotomy
•G4P2A1 1x (O34.21)age (Z3A.28)
26 weeks gestational
•Prior CS72x
•G3P2A0 (O34.22)
weeks gestational age (Z3A.7)
•Prior CS33
·G3P2A0 2xweeks
(O34.22)
gestational age not in labor ( Z3A.30)
·Prior CS 2x ( O34.21)
·G1P0A0 37 weeks gestational age not in labor (Z3A.35)
·Single life
•G1P0A0 fetus cephalic
9 weeks presentation
gestational age (Z3A.9)presentation ( Z37.0)
•SLE mild
•G4P2A1 activity
36-37 weekswith arthritis and
gestational agemucocutaneous
( Z3A.30) manifestation (M32.9)
•Prior CS81x
·G2P1A0 (on indication
weeks gestationalpost
ageterm) (O34.21)
(Z3A.8)
·Systemic28lupus
·G1P0A0 weeks erythematosus
gestational age (M32.9)
(Z3A.28)
·Superimposed
·G4P3A0 preeclampsia
37 weeks not in labor(O11.9)
(Z3A.37)
·Single life
·G2P1A0 22 fetus
weekscephalic presentation
gestational age (Z3A.18)
·Latent syphilis infection (M32.9)
·G3P0A2 8 weeks gestational age (Z3A.8)
·Bad obstetric
·G1P0A0 history
12 weeks (O09.299)
gestational age (Z3A.12)
·Dermoid cyst was suspected (D279)
·G1P0A0 12 weeks gestational age (Z3A.8)
·Systemic29lupus
·G1P0A0 weeks erythematosus
gestational age (M32.9)
(Z3A.8)
·Single life
·G1P0A0 31 fetus
weekscephalic presentation
gestational age (Z3A.31)
·Single life
G3P2A0 fetus cephalic
20 weeks presentation
gestational (Z37.0)
age (Z3A.20)
HSV I infection
G4P3A0 24 weeks(B00.9)
gestational age (Z3A.24)
SLE arthrititis manifestation
G2P1A0 14 weeks gestational (M32.9)
age (Z3A.14)
Prior CS37
G3P2A0 1x weeks
(034.21)gestational age (Z3A.37)
Prior CS30
G1P0A0 2x weeks
(034.21)gestational age (Z3A.30)
Single life fetus breech
G3P2A0 18 weeks gestational presentation (Z37.0)
age (Z3A.18)
Single life
G2P1A0 37fetus
weeksintrauterine (Z37.0)
gestational age not in labor (Z3A.37)
Prior CS38
G3P2A0 1x weeks
(O34.21)gestational age not in labor (Z3A.38)
Uterine
P5A0 myom
post LSCS (D25.9)
on indication anhydramnion (day 9th) (34.21)
P2A3 post LSCS on indicationon
Superimposed preeclampsia chronic
prior CS 1xhypertension
+ transverse(O14.13)
lie (day 9th) (O34.21)
P2A0 post spontaneous delivery (outside) (day 9th) (650)
Post curettage
Cervical Canceron indication
Stage early
IIIB was hemorrhagic
suspected post partum caused by rest of placentae (O73.1) LPP
( C53.9)
Cervical Cancer Stage IIIB ( C53.9) on radiotherapy
Moderate
Cervical anemia
Cancer ( D64.9)
Stage IIIB ( C53.9)
Moderate anemia ( D64.9)
Cervical Cancer Stage IIIB ( C53.9)
Ovarian Cancer Stage IIIC ( C56.9) complete therapy complete response
Ovarian Cancer Stage IIIC ( C56.9) complete therapy complete response
Ovarian Cancer Inadequate staging ( C56.9)
GTN Stage I FIGO Score 3 ( O01.9)
Right solid ovarian neoplasm ( C56)
Left cystic
Cystic ovarian
ovarian neoplasm
neoplasm ( N83.02) was suspected ( C56.9)
with malignancy
Ovarian cancer Inadequate staging ( C56)
Ovarian cancer Stage IA ( C56)
Leucopenia
Ovarian cancer( C72.819)
Stage IVA ( C56)
Hydatidiform mole was suspected ( O01.9)
•G4P2A1 39 weeks gestational age (Z3A.39)
•Prior CS35
•G1P0A0 1Xweeks
(O34.21)
gestational age (Z3A.35)
•Beta thalassemia intermediate (D56.1)
•P6A1 post SSTP oi Superimposed preeclampsia + PPHD NYHA IV (days 10th)
•Post post
•P1A0 tuba spontaneous
ligation (daysdelivery
10th) (O34.21)
with history of rupture of membrane (day 20th) (O34.21
•P3A0 post LSCS oi placentae previa with prior cs 1x (days 8th ) (O34.21)
•Post pomeroy tubectomy (days 8th)
Diagnosa
G3P2A0 29 weeks gestational age (Z3A.29)
Prior histerotomy 1x (O34.21)
CKD stage V on HD (N18.9)
Single life fetus transverse lie (032.2)

G1P0A0 37 weeks gestational age not in labor (Z3A.34)


Single life fetus cephalic presentation (Z37.0)

Diagnosa
G2P1A0 35 weeks gestational age (Z3A.31)
SLE mild activity with arthritis manifestation (M32.9)
Single life fetus cephalic presentation (Z37.0)
Intrauterine growth restriction (Z36.4 )
G4P2A1 31 weeks gestational age (Z3A.31)
Single life fetus cephalic presentation (Z37.0)
Teratoma sacrococcygeal (Q76.428)

G4P3A0 37 weeks gestational age not in labor (Z3A.10)


History of coronary artery disease (C58)
Single life fetus cephalic
G2P1A0 36 weeks gestational age
Neoplasm ovarian cyst with serosum type (N83.20)
Single life fetus cephalic presentation (Z37.0)
G1P0A0 39 weeks gestational age not in labor (Z3A.34)
Single life fetus cephalic presentation (Z37.0)
G3P2A0 26 weeks gestational age (Z3A.22)
Single life fetus intrauterine (Z37.0)

G2P1A0 29 weeks gestational age not in labor (Z3A.34)


SLE with arthritis manifestation
Single life fetus cephalic presentation (Z37.0)
G3P2A0 37 weeks gestational age
Single life fetus cephalic presentation

G2P1A0 24 weeks gestational age (Z3A.34)


Single life fetus intrauterine (Z37.0)

G3P2A0 29 weeks gestational age (Z3A.25)


HSV I infection (B00.9)
Single life fetus intrauterine (Z37.0)

diagnosa
Single life fetus intrauterine
SLF cephalic presentation
Multiple congenital syndrome
Polyhydramnios
SLF intrauterine
Anhydramnios
P1A0 post LSCS on indication hydrocephalus (Z37.A) Day 13
Post IUD insertion postpartum
Single life fetus intrauterine
SLF cephalic presentation
Multiple congenital syndrome
Polyhydramnios
SLF intrauterine
Anhydramnios
IUGR
SLF intrauterine
G5P3A1 27 weeks gestational age single life fetus intrauterine (Z3A.27)
SLF cephalic presentation
Polyhydramnios (O40)
SLF intrauterine
SLF fetus intrautereine
SLF cephalic presentation
Hydrocephalic caused by holoprocenphaly semi lobaris (O35)
Wound dehiscene on perineal suture (recovery)
P4A1 post LSCS o.i conjoint twins omphalo-thoracophagus + post tubectomy pomeroy (days 10th)
P4A0 post spontaneous delivery preterm with superimposed preeclampsia IUFD(days 10th)
IUGR
SLF intrauterine
G5P3A1 27 weeks gestational age single life fetus intrauterine
SLF cephalic presentation
Wound dehiscene on perineal suture (recovery)

SLF cephalic presentation (Z37.0)


SLF intrauterine (O00.01)
Intrauterine (O00.01)
SLF cephalic presentation (Z37.0)
SLF intrauterine (O69.2)
Tend to be small (has improvement) (O36.59)
SLF cephalic presentation (O69.2)
Fetus
Singletend to be cephalic
life fetus small (O36. 5990)
presentation
History of PROM
SLF Intrauterine
Single life fetus cephalic presentation (Z37.0)
SLF transverse lie (O32.2)
SLF intrauterine (Z37.0)
SLF cephalic presentation (Z37.0)
SLF transverse lie (Z37.0)
Polyhydramnios (O40)
Congenital
Hypercoillinganomaly (duodenal
of umbillical cordatresia was suspected) (Q89. 9)
Polyhydramnios
IUGR (P05.9) (O40)

P2A0minilaparatomy
Post post LSCS oi Anhidramnios
tubectomy with history PROM 1 day (days 10)
Fistula recto-vaginal
Sub involusi uteri

•G2P1A0 35 weeks gestational age not in a labor (Z3A.3)


•Systemic35
•G2P1A0 Lupus
weeksErythematous Mucocutaneous
gestational age not in a laborManifestation
(Z3A.3) Mild Degree (M32.10)
•Systemic Lupus Erythematous Mild
•G2P1A0 24 weeks gestational age (Z3A.3) Degree (Arthritis Manifestation) (M32.10)
•Systemic
•G3P1A1 30 Lupus
weeksErythematosus
gestational ageMild(Z3A.3)
Degree Mucocutaneous Manifestation (M32.10)
•Complete
•G1P0A0 20 placenta previa (O44.0)
weeks gestational age (Z3A.2)
•Systemic
•G2P1A0 34 weeks gestational age notdegree
lupus erythematous severe with(Z3A.3)
in a labor manifestation lupus nephritic (M32.9)
•Cervival funneling
•G2P1A0 37 weeks(Y type)
gestational age not in a labor (Z3A.3)
•Systemic37
•G1P0A0 Lupus
weeksErythematous Mildnot
gestational age Degree (Mucocutaneous
in a labor (Z3A.3) Manifestation) (M32.10)
•Intramural28uterine
•G2P1A0 weeksmyoma (D26.7)
gestational age not in a labor (Z3A.2)
•Prior CS 1x (on indication HIV)
•G4P3A0 24 weeks gestational age (O34.21)
(Z3A.2)
•Chronic
•G3P0A2 25 weeks gestational age not in(C92)
Myelogenous Leukemia (CML) labor (Z3A.2)
•Secondary
•G3P2A0 38 weeks gestational age not in laborec
Antiphospholipid Syndrome (APS) SLE (O99.1)
(Z3A.3)
•Gallbladder
•G2P1A0 37 stone
weeks,(K08)
not in labor (Z3A.3)
•SLF cephalic
•G3P1A1 presentation
23 weeks (Z37.0)
gestational age
•Prior CS 23
•G5P3A1 1x oi anhydramnion
weeks gestational(O34.1)
age (Z3A.2)
•Right dermoid cyst was suspected, dd/ Cystic ovarium neoplasm with solid part (N83.1)
•G3P1A1 34 weeks gestational age not in labor (Z3A.3)
•Prior
•G3P1A1CS 23
1x oi malposition
weeks (O34.1)
gestational age (Z3A.2)
•Prior CS 1x oi HIV infection (O34.1)
•G3P2A0 24 weeks gestational age (Z3A.2)
•Shypillis
•G2P1A0 infection
35 weeks(O98.1)gestational age not in a labor (Z3A.3)
•Systemic35
•G2P1A0 Lupus
weeks Erythematous
gestational ageMucocutaneous
not in a laborManifestation
(Z3A.3) Mild Degree (M32.10)
•Systemic24
•G2P1A0 Lupus
weeks Erythematous
gestational ageMild(Z3A.3)
Degree (Arthritis Manifestation) (M32.10)
•Systemic30
•G3P1A1 Lupus
weeks Erythematosus
gestational age Mild(Z3A.3)
Degree Mucocutaneous Manifestation (M32.10)
•Complete20
•G1P0A0 placenta previa (O44.0)
weeks gestational age (Z3A.2)
•Systemic
•G2P1A0 34 weeks gestational age notdegree
lupus erythematous severe with(Z3A.3)
in a labor manifestation lupus nephritic (M32.9)
•Cervival
•G2P1A0 funneling
37 weeks(Y type)
gestational age not in a labor (Z3A.3)
•Systemic Lupus Erythematous
•G1P0A0 37 weeks gestational age Mildnot
Degree (Mucocutaneous
in a labor (Z3A.3) Manifestation) (M32.10)
•Intramural
•G2P1A0 28uterine
weeksmyoma (D26.7)
gestational age not in a labor (Z3A.2)
•Prior CS 24
•G4P3A0 1x (on
weeksindication HIV) age
gestational (O34.21)
(Z3A.2)
•Chronic Myelogenous
•G3P0A2 Leukemia
25 weeks gestational age(CML)
not in(C92)
labor (Z3A.2)
•Secondary
•G3P2A0 38Antiphospholipid
weeks gestational Syndrome
age not in (APS)
laborec SLE (O99.1)
(Z3A.3)
•Gallbladder stone (K08)
•G2P1A0 37 weeks, not in labor (Z3A.3)
•SLF cephalic
•G3P1A1 presentation
23 weeks (Z37.0)
gestational age
•Prior CS 1x oi anhydramnion (O34.1)
•G5P3A1 23 weeks gestational age (Z3A.2)
•Right
•G3P1A1 dermoid cyst was
34 weeks suspected,
gestational dd/ in
age not Cystic
laborovarium
(Z3A.3) neoplasm with solid part (N83.1)
•Prior
•G3P1A1CS 23
1x oi malposition
weeks (O34.1)
gestational age (Z3A.2)
•Prior CS 24
•G3P2A0 1x oi HIV infection
weeks gestational(O34.1)
age (Z3A.2)
•Shypillis infection
•G5P4A0 28 weeks(O98.1)gestational age (P07.3)
•SLF breech
•G4P2A1 presentation
31 weeks (O32.1)
gestational age (Z34.92)
•Prior CS 1x (on indication
•G2P1A0 35 weeks gestational age post term)not(082)
in labor (Z34.92)
•Prior CS 1x (on indication transverse
•G5P0A4 19 weeks gestational age (Z34.92) lie) (O34.21)
•Chronic
•G1P0A0hypertension
15 weeks, SLF O13.9
intrauterine (Z34.92)
•Hydrops fetalis (O36.2)
•G3P2A0 28 weeks gestational (Z34.92)
•SLF intrauterine
•G2P1A0 37 weeks (Z37.0)
gestational age not in a labor (Z34.92)
•Ovarian cancer
•G2P1A0 29 weeks stage IC complete
gestational age therapy
not in a complete response (O34.8)
labor (Z34.92)
•Prior CS 7
•G6P3A2 1xweeks
(on indication HIV)age
gestational (O34.21)
(Z34.91)
•Secondary
•G4P1A2 34Antiphospolid
weeks gestational Syndromeage not(APS)
in a caused by SLE (M32.9)
labor (Z34.92)
•Prior CS 1X (on indication failed induction)
•G4P3A0 34 weeks gestational age not in a labor (Z34.92) (O34.21)
•SLF cephalic
•G4P3A0 presentation
34 weeks (Z37.0)
gestational age not in labor (Z34.92)
•Prior CS 3x (O34.21)
•G4P2A1 34 weeks gestational age (Z34.92)
•Systemic
•G4P1A2 16 lupus erythematous
weeks gestationalwithage mild manifestation (M32.9)
(Z34.92)
•Superimposed
•G1P0A0 16 weekspreeclampsia
gestational(O11)
age (Z34.92)
•SLE with 37
•G1P0A0 mild manifestation
weeks gestational (M32.9)
age not in labor (Z34.93)
•Congenital
•G1P0A0 30Heart
weeksDisease suspected
gestational age not(ASD dd/ (Z34.92)
in labor valvular heart disease) (Q24.9)
•Post cerclage on indication cervical
•G4P2A1 13 weeks gestational age (Z34.92) insufficient (O34.3)
•Osteoma
•G2P1A0 36 was suspected
weeks (D16.4)
gestational age not in labor (Z34.93)
•SLF cephalic presentation (Z37.0)
•G3P2A0 14 weeks gestational age (Z34.92)
•Chronic
•G1P0A0Hypertension (I12.9) age (Z34.92)
19 weeks gestational
•Thalassemia
•G4P2A1 Alpha gestational
32 weeks (D56.0) age not in labor (Z3A.29)
•Prior CS 29-30
•G3P1A1 1x ( onweeks
indication post term)
gestational age(O34.21)
not in labor (Z3A.29)
•Threatened Preterm Labor (O47.0)
•G2P0A1 24 weeks gestational age (Z34.92)
•Moderate
•G2P1A0 37 anemia
weeksnormocytic
gestationalnormochrome
age not in labor (D64.9)
(Z3A.25)
•Prior CS 1x (O34.21)
•G2P1A0 29 weeks gestational age not in labor (Z3A.25)
•Prior
•G1P0A0 CS 371x (O34.21)
weeks gestational age not in labor (Z3A.25)
•Systemic36
•G1P0A0 lupus erythematous
weeks gestational(M32.9)
age not in labor (Z3A.25)
•Myoma Subserous
•G4P3A0 (D25.2)
24 weeks gestational age (Z34.92)
•Cervical Shortening
•G2P1A0 (O26.872) age not in labor (Z3A.25)
34 weeks gestational
•SLF cephalic
•G4P2A1 presentation
33 weeks (Z21.0)
gestational age not in labor (Z3A.29)
•Prior CS 1x ( on indication
•G2P1A0 36 weeks gestational age post term) not(O34.21)
in a labor (Z34.92)
•Ca Ovarium Complete Therapy Complete
•G2P1A0 27 weeks gestational age not in labor Respones (C56.9)
(Z3A.1)
•SLF
•G2P1A0intrauterine
28 weeks (Z37.0)
gestational age (Z34.92)
•Thalassemia beta major
•G3P2A0 32 weeks gestational (D56.0)age (Z3A.2)
•Low lying32
•G3P0A2 plasenta
weeks (O44.4)
gestational age not in labor (Z3A.2)
•Secondary
•G5P4A0 13Antiphospholipid
weeks gestational Syndrome
age (Z3A.2) (APS) ec SLE (O99.1)
•Hiperthyroid
•G3P2A0 ec Grave
8 weeks Disease
gestational age(O99.2)
(Z3A.1)
•Hyperthyroid (O99.2)
•G3P2A0 15 weeks gestational age (Z3A.2)
•Carcinoma
•G5P3A1 29ductal weeksmammae
gestational dextra
age stage
(Z3A.2) IIB (C50.9)
•Chronic
•G1P0A0
G5P3A1
G4P3A0 36hypertension
36 15
weeks
weeksweeks (K76.6)
gestational
gestational
gestational age notage
age not in (Z3A.2)
in labor
labor ((Z3A.36)
Z3A.36)
Prior
•SLE CS 3x (O34.21)
with moderate
Preeclampsia ( O14.10) activity AIHA manifestation (M32)
G1P0A0 33 week
Single life3xfetus gestational age not in labor (Z3A.33)
cephalic presentation (032.1XXO)
Prior CS
Systemic ( O34.21)
lupus erythematous arthritis manifestation (O99.119)
G6P3A2
SLF
G3P2A0 18
cephalic
24 week gestational
presentation
week gestational age
age (Z3A.18)
(032.1XXO)
(Z3A.24)
Single
Systemiclife fetus cephalic
lupus disease
erythematouspresentation
with (032.1XXO)
arthritis manifestation
Chronic
Asymmetric kidney
IUGR stage
(compensated) V on hemodyalisis
(036.5990) (N18.5) (O99.19)
Hypothyroid (controlled)
Chronic hypertension (R03.0) (E03.9)
Single
Single life
life33fetus
fetus intrauterine
intrauterine (O00.01)
(O00.01)
G1P0A0 weeks gestational age not in labor (Z3A.33)
Polyhydramnios
Single life fetus (040.3XX0)
reech presentation
G1P0A0
G3P2A0 12
36 weeks gestationalnot
weekteratoma
gestational agein(O32.1)
(Z3A.12)
labor (Z3A.36)
Sacrococcygeal
Osteosarcoma of right ulna (M53.3)
1/3 distal (C41.9)
Prior
G4P1A2 CS 2x
27 (034.21)
weeks gestational age (Z3A.27)
Single
Single life fetus intrauterine
life fetus cephalic (O00.01)
presentation (032.1XXO)
Controlled
G3P2A0 18diabetes mellitus
weeks gestational (E11.9)
age (Z3A.18)
Meningoencephalocele
Superimposed (Q05.OXXO)
preeclampsia on chronic hypertension (O11.2)
Hyperthyroid
G2P1A0 35 (E05.90)
week gestational age not in labor (Z3A.35)
Single
Right life fetus
dermoid(O98.7)intrauterine
cyst (N.83.20)(O00.01)
HIV infection
Single
Single life
life14fetus
fetus intrauterine
cephalic (O001.1) (O32.1XXO)
presentation
G5P3A1 week gestational age not in labor (Z3A.14)
Asymmetric
History of GTN IUGR (O36.5990)
(C58)
Single life fetus intrauterine (O001.1)
Prosedur
FeSO4 1x1
Control 1 weeks later ( January, 15th 2021)
Control 2 weeks later ( January, 22nd 2021)
• Control 2 weeks later ( January, 26th 2021)
• Ass
Planneurology and internist
for abdominal termination on Sunday, Jan 17th 2021
• CaCo3 1 tab/12 hours
• Plan for abdominal termination and tubal ligation (Monday, January 18th 2021)
US evaluation
High protein diet

DNA Folickaryotype
acid 1x1 examination
FeSO4 1x1 avidity test
Toxoplasma
•BPP evaluation
CaCo3 1x1
•• Folic CaCo3 1x11x1
acid
•Laboratory
Folic acid examination
1x1
LSCS
CaCO3 1x1
Folic acid
Folic acid 1x1
1x1
Plan
Folic acid 1x1 CS (22/2/21)
for elective
•FeSO4 1x1
Tocolytic
•• Multidiscipline
CaCO3 1x1 team
•• FolicCaCO3 acid
1x11x1
•• Folic
CaCO3 acid
1x11x1
•• Control
Internal (16/3/21)
medicine assesment
•• CaCo3
Pro cystoscopy
1x1
•• Folic
Folic acid
acid 1x1
1x1
•• CaCo3 2x1
FeSO4 1x1
Vitamin
CaCO3 3x1 D 1x4
•FeSO4 1x1
Hospitalized
Plan for LSCS
• Contraception counselling
• IUD Insertion
Counseling for contraception choice à
patient toilet
Wound agreed for IUD interval
CIE
Wound care
CIE
• Wound care à removal wound dressing.
•Family
CIE planning counselling
•CIEHigh protein
Diet
• Family planning counselling
•• IUD
HighInsertion
protein
•Diet
High protein
•Diet
High protein
Diet
• High protein
Diet
Furosemide 1x40 mg
Multivitamin
Metyldopa 3x250mg
• Multivitamin
ARV drug ( 99.21)
• Plan
Folicfor
acidLSCS
1x1 (74.1)
• CaCO3
Laboratory1x1examination (TORCH) ( V72.62)
••Control
Plan for( LSCS
March,( 74.1)
22nd 2021)
Continued
• FeSO4 1x1ARV therapy ( 99.21)
Laboratory
• Folic examination
acid 1x1
••Control
FeSO4 1x1
•( March,
Folic acid16th
1x12021)
• FeSO4 1x1
• Control April 6th 2021
••Hospitalized
Laboratory examination
• Plan for LSCS (March 12th 2021)
• Plan for DnC
Elective CS ( March, 15th 2021) ( 74.1)
Laboratory
• Folic examination and anesthesia consult ( March, 11th 2021) (V72.62; 89.09)
acid 1x1
• FeSO4 1x1
Control ( March,
• Folic acid 1x1 17th 2021)
FeSO4 1x110mg 1x1
• Nifedipine
•Low
Aspirin 80mg 1x1
salt diet
HD
Lungasmaturation
scheduled (dexamethason 12mg twice every 24 hr) (659.8)
Ultrasound
Fe tablet 1x1 confirmation (88.7)
Folic acid
CaCO3 tab 1x400mcg
3x500mg
Fe tabfor3x1
Plan C-Section with TAH
Stable in VK
Control
Laboratory
Fe tablet 1x1 exam
Folic acid tab 1x400mcg
Control on 18.03.2021
Laboratory
Vit D 1000 examination
2x1
Folic acid tab
Fe tablet 1x300mg1x400mcg
Plan for LSCS
Fe tablet 1x300mgon March 29th 2021
Plan for LSCS on March 31st 2021
Control on April 1st 2021
Control on April 1st 2021
Referred to Harapan Kita Hoespital for fetal therapy
Control on April 15th 2021
Control
Consulton to April 1st 2021
oncology surgery
Control on April 15th
Control ( March, 25th 2021) 2021
Plan for LSCS
Control on April 1st 2021
Plan for curretage à patient refused
•Control
on March, 26th 2021
•Control
on April, 16th 2021
•Control
on April, 16th 2021
•Hospitalized
•Plan for LSCS
•Control
on March, 29th 2021
•Control
on April,
•Plan for 20th 2021
Elective caesarean section in 38 weeks gestational age
•Control
In 4 weeks
•Control
on March, 31st 2021
•Control
on March, 31st 2021
•Control
in a 4 weeks
•Control
in a 4 weeks
•Control
In 3 weeks
•Control
in a 4 weeks
•Control
in a 2 weeks
•Control
in a 2 weeks
Control on the next 4 weeks
Evaluation ofHospitalized
Suggestion: HSV I IgG IgM leveltranfusion
for PRC
Folic acid
Control on 3x1
the next 4 weeks
Education : Plan for PRC tranfusion
Hospitalized
Plan foron
Control elective
the nextLSCS after general condition improvement
4 weeks
Education
Control on the next 4 weeks
USGfor
Plan evaluation in 1 month
elective LSCS on April 22nd 2021 (74.1)
Consult
Plan to anesthesia
for elective LSCS department
on April 15th 2021 (74.1)
Consult to anesthesia
Wound Care (96.5) department
Antihypertension
Family (E94.2) (V65.40)
planning counselling
Woundplanning
Family Care (96.5)
counselling (V65.40)
Plan for Clinical staging
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 1st course ( 99.25)
Plan for radiotherapy ( June,
Tumor marker evaluation ( V72.4) 29th 2021) ( 92.29)
Tumor marker evaluation ( V72.4)
Laparoscopy conservative surgical staging ( 54.21)
MR Chemotherapy 14th course ( 99.25)
Laparotomy VC ( 54.1)
Laparotomy VC ( 54.1)
Laparotomy surgical staging ( 54.1)
Hsoptialized
Leucogen
BEP injection 2nd
Chemotherapy ( 99.21)
course ( 99.25)
Hospitalized
Laboratory examination ( V72.62)
•Hospitalized
•Controlfor
•Plan inelective
1 week cesarean section (20.04.2021)
•Education
•CIE(E94.2)
•CIE
•Plan for consult Internal Medicine department
•CIE(E94.2)
•Antibiotic
•CIE
Procedure
Control in 1 week
Medication (99.21)
- CaCO3 3x500mg
- Folid acid 1x400mg
- Sulfas ferrous 1x1
Nifedipine 1x10mg
Heparin 5000/12 hours (SC Injection)
Education :
- Water intake
restriction
- Low salt diet
- HD as scheduled
Control in 1 weeks
FeSO4 tab 1x300mg
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Procedure
Hospitalized
Laboratory examination
Lung maturation
US confirmation
Control in 2 weeks
Education
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Sulfas ferrous 1 x 1 tab
Control in 1 week
Cardiologist and Anasthesia consultant

Control in 1 weeks
Planning for C-Section and Laparotomy FS on June 14th 2021

Planning for termination (induction of labour)


Plan for vaginal delivery 🡪 failed of induction 🡪 LSCS
Control on the next 4 weeks
Medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 2 weeks
medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1tab/24 hours (PO)
Metylprednisolone 4 mg / 24 hours (PO)
Imuran 50 mg/ 24 hours (PO)
Control on the next 1 week
medications
-CaCO3 500mg/ 8 hours (PO)
- Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 4 weeks
Medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 4 weeks
Medication (99.21)
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1tab/24 hours (PO)
procedure
Medicinalis
CaCO3 3x1
Informed consent for discussed at joint conference
Elective abdominal termination
Folic acid 1x400 mg
Abdominal termination
High protein diet
ASI on demand
Medicinalis
CaCO3 3x1
Informed consent for discussed at joint conference
Expectative management
US confirmation
Folic acid 1x400 (mgAugust, 18th 2021)
Abdominal termination
LSCS
PRC transfusion until Hb > 10 g/dL
Folid acid 1 x 1
Plan for elective sectio secarea and tubectomy

Calc 1x1
Calc 1x1
roborantia
Elective CS and tuba ligation on Monday September 6th. 2021
ASI on demand
ASI on demand
Antihypertension
LSCS
PRC transfusion until Hb > 10 g/dL
Folid acid 1 x 1
Plan for elective sectio secarea and tubectomy
ASI on demand

FeSO4 1 x 300 mg peroral


Hemodialysis
Terconazole supp 1x1 pv 10 days
FeSO4 1x 300 mg
FeSO4 1 x 300 mg PO
Folid acid 1 x 400
High calory low protein intake
FeSO4 1 x 300 mg PO
Counseling for contraception ~ plan for IUD Interval
Vit D3 1X 5000 IU
PRC Transfusion
CaCO3 3x500 mg po
Thromboaspilet 1 x 100 mg
FeSO4 1x 300 mg po
CaCO3 3x 500 mg
Anti Hypertension
Assessment Anesthesia department
ARV 1 tab/24 hours po
Counseling contraception and lactation

Mini laparotomy
Repair Tubectomy
fistula ( 3 months post partum)
USG confirmation

ree (M32.10)

ation (M32.10)

nephritic (M32.9)

ation) (M32.10)

olid part (N83.1)


ree (M32.10)

ation (M32.10)

nephritic (M32.9)

ation) (M32.10)

olid part (N83.1)


Hospitalized
Stabilization
Antihypertension (99.21)
Anticonvulsant (99.21)
Internal medicine assessment
Anesthesia
Methyldopa and internal
250/mg medicine
12 hours assessemnt
( 99.21)
Plan
LSCS for elective LSCS
andultrasound
tubal ligation (January,
(74.21) 06th 2021)
Obstetric
Obstetric ultrasound examination
examination
Obstetric
Evaluation ultrasound
1 week examination
later
Control
Laboratory1 month later
examination
Medication
Control 2 weeks later
Medication
Control
Obstetric2 ultrasound
weeks laterexamination
medication
Laboratory exam
Control 1 weeks
Plan for join conference
Plan for elective CS
Consult to 4preoperative
Control in weeks clinic
Medication
Medication
Control
Control 4
1 weeks
weeks
Diet high carbo and low proteins
Control 4 weeks
18th 2021)
Rekap data OK 2021
LSCS : 117
Laparotomy : 90
Laparoscopy : 45
Total : 252
No Bulan Tanggal Identitas
1 Januari 8/1/2021 Mrs. RAH/25 YO/1194377/PAGAR ALAM/DEV-HIL

2 Januari 9/1/2021 Mrs. SUS/34 YO/1194028/PALEMBANG/DEV–HIL

3 Januari 9/1/2021 Mrs. SUS/39 YO/1194474/PALEMBANG/DEV–HIL/

4 Januari 9/1/2021 Mrs. RAR/32 YO/1194487/PALEMBANG/OGL–AR

5 Januari 9/1/2020 Mrs. HER/ 20 YO/ 1194490/ PALEMBANG/ OGL-

6 Januari 9/1/2021 Mrs. FIT/ 25 YO/ 1194489/ PALEMBANG/ OGL-A

7 Januari 9/1/2021 Mrs. FIT/ 24 YO/1194492/ OI/ OGL-ARM/ AF


8 Januari 9/1/2021 Mrs. KAR/ 20 YO/ 1199445/ BANYUASIN/OGL- A

9 Januari 9/1/2021 Mrs. NEL/ 30 YO/ 1194504/ OKU TIMUR/ DID-IZY

10 Januari 9/1/2021 Mrs. RUS/ 23 YO/ 1194510/ BANYUASIN/ DID-IZY

11 Januari 9/1/2021 Mrs. MAR/ 31 YO/ 1194511/ PALEMBANG/ DID-W

SUNDAY JANUARI 10th 2021


12 Januari 1/10/2021 Mrs. DES/ 35 YO/ 865932/ BANYUASIN/ STI-UFA
13 Januari 1/11/2021 Mrs. ANG/25YO/1194665/PALEMBANG/ DID-NAL

14 Januari 1/11/2021 Mrs.SRI/44YO/1193376/PALEMBANG/DID-NAL/H

15 Januari 1/11/2021 Mrs.MAR/20YO/9224067/PALEMBANG/DID-NAL/

16 Januari 1/11/2021 Mrs.DAR/29YO/1194662/PALEMBANG/DID-NAL/

17 Januari 1/12/2021 Mrs. AME/ 27 YO/ 1194757/ PALEMBANG/ STI-HI

18 Januari 1/12/2021 Mrs. YUN/ 37 YO/ 1194753/ OGAN KOMERING ILIR

19 Januari 1/13/2021 Mrs. NUR/ 30 YO/ 1194873/ PALEMBANG/ DID-H

20 Januari 1/13/2021 Mrs. ROD/ 30 YO/ 1194875/ BANYUASIN/ DEV-W


21 Januari 1/13/2021 Mrs. WIN/ 40 YO/ 1193387/ PALEMBANG/ DEV-W

22 Januari 1/14/2021 Mrs. DEM/ 123YO/ 1194885/ OGAN ILIR/ DEV-W

23 Januari 1/14/2021 Mrs. SAN/ 27 YO/ 1194895/ OGAN KOMERING U

24 Februari 01/02/21 Mrs.YUL/34YO/1196523/PALEMBANG/STI-IZY/F


25 Februari 01/02/21 Mrs. MER/19YO/119532/OKI/STI-IZY/FU
26 Februari 01/02/21 Mrs. DEW/ 58 YO/ 1196563/ PALEMBANG/ DID-H
27 Februari 02/02/21 Mrs. SUL/ 43 YO/ 1196624/ PALEMBANG/ DID-W
28 Februari 02/02/21 Mrs. NUR/ 30 YO/ 1196621/ PALEMBANG/ DID-W
29 Februari 02/02/21 Mrs. LAE/ 19 YO/ 1196635/ OGAN KOMERING IL
30 Februari 03/02/21 Mrs. NIN/ 32 YO/ 1196726/ BANYUASIN/ DEV-UF
31 Februari 13/02/21 Mrs. JUI/30YO/1197525/BANYUASIN/URI-ARM/H
32 Februari 13/02/21 Mrs. MEI/24 YO/1194928/PALEMBANG/URI-ARM
33 Februari 13/02/21 Mrs.NAN/38YO/1197541/PALEMBANG//DEV-IZY
34 Februari 14/02/21 Mrs. NEN/ 35 YO/ 1197558/ OGAN KOMERING UL
35 Februari 14/02/21 Mrs. MIR / 21 YO/ 1197579/ BANYUASIN/ STI-WIS
36 Februari 15/02/21 Mrs. SRI/ 30 YO/ 1197728/ BANYUASIN/ DEV-HIL
37 Februari 15/02/21 Mrs. MON/28 YO/1197638/Palembang
38 Februari 16/02/21 Mrs. RAG/ 27 YO/ 1197849/ BANYUASIN/ STI-UFA
39 Februari 16/02/21 Mrs. YUL/ 38 YO/ 1197852/ PAGAR ALAM/ STI-U
40 Februari 16/02/21 Mrs. ULI/ 31 YO/ 822619/ PALEMBANG/ STI-UFA/
41 Februari 16/02/21 Mrs. MAR/ 32 YO/ 1194077/ BANYUASIN/ STI-UF
42 Februari 16/02/21 Mrs. TRI/ 32 YO/ 1197740/ OGAN ILIR/ IKY-TIA/
43 Februari 16/02/21 Mrs. NUR/ 29 YO/ 1197973/ BANYUASIN/ STI-DA
44 Februari 17/02/21 Mrs. YEP /30 YO/ PALEMBANG/ DID-ARM/FY
45 Februari 17/02/21 Mrs. MEL/37 YO/ PALEMBANG/ DID-ARM/AB
46 Februari 17/02/21 Mrs. REN /35 YO/ PALEMBANG/ DID-ARM/HD
47 Februari 17/02/21 Mrs.AIS/37 YO/ PALEMBANG/ DID-ARM/HD
48 Februari 17/02/21 Mrs. LIT/ 28 YO/ 1198000/ PALEMBANG/DID-AR
49 Februari 17/02/21 Mrs. WAR/ 30 YO/ 1198004/ PALEMBANG/DID-A
50 Februari 17/02/21 Mrs. YUL/ 21 YO/ 1197896/ PALEMBANG/ STI-D
51 Februari 01/02/21 Mrs. NUR/ 32 YO/ 1196506/ BANYUASIN/ DID-IA
52 Februari 02/02/21 Mrs. DEW/ 58 YO/ 1196563/ PALEMBANG/ DID-H
53 Februari 04/02/21 Mrs. ALF/ 35 YO/ 1196823/ PALEMBANG/ DID-H
54 Februari 15/02/21 Mrs.PUS/31YO/1197618/JAKABARING/STI-DAV-
55 Februari 15/02/21 Mrs. MON/28 YO /1197638/ PALEMBANG/ STI-
56 Februari 17/02/21 Mrs. NUR/ 29 YO/ 1197973/ BANYUASIN/ STI-DA
57 Februari 17/02/21 Mrs. YUL/ 21 YO/ 1197896/ PALEMBANG/ STI-D
58 Februari 17/02/21 Mrs. MAR/ 32 YO/ 1194077/ BANYUASIN/ STI-UF
59 Februari 18/02/21 Mrs. MEL/37 YO/ PALEMBANG/ DID-ARM/AB
60 Februari 19/02/21 Mrs. IKA/ 32 YO/ 1198130/ PAGAR ALAM/ STI -
61 Februari 22/02/21 Mrs. OOM/ 42 YO/ 1198283/ PALEMBANG/ STI-D
62 Februari 22/02/21 Mrs. SIT/ 39 YO/ 1197077/ PRABUMULIH/ STI-WA
63 Februari 22/02/21 Mrs. NAN/ 23 YO/ 1198506 / PALEMBANG/ STI-
64 Februari 24/02/21 Mrs. MAR/ 32 YO/ 1194077/ BANYUASIN/ STI-D
65 Februari 24/02/21 Mrs. OKT/ 28 YO/ 1198595/ BANYUASIN/ STI-D
66 Februari 25/02/21 Mrs. NOV/ 27 YO/ MUSIRAWAS / STI-DAV-MUT/
67 Februari 25/02/21 Mrs. SUY/ 31 YO/ 1198689/ BANYUASIN / STI-DA
68 Februari 25/02/21 Mrs. FAT/ 34 YO/ OKU / STI-DAV-MUT/ NS
69 Februari 25/02/21 Mrs. ASN/ 26 YO/ 1198736/ PALEMBANG/ STI-DA
no bulan tanggal identitas

Mrs.SISKA
70 Maret 12.03.2021 WIDARSIH / 35 YO/ 1200191/PALEMBANG/STI-HAD/HE

Mrs.
71 Maret 16.03.2021 YOSI YUNITA/ 25 YO/ 1200410/BENGKULU/ STI-HAD/ HE

Mrs.
Maret 16.03.2021 MAYANG TARI/ 29 YO/ 1200455/PALEMBANG/STI-HAD/AB

71

Mrs.
Maret 17.03.2021 KHO/ 25 YO/ 1200625/ BANYUASIN/ STI-HAD/ NS
Mrs.
Maret 17.03.2021 KHO/ 25 YO/ 1200625/ BANYUASIN/ STI-HAD/ NS

72

Mrs.
Maret 17.03.2021 NOV/ 31 YO/ 1200589/PALEMBANG/ STI-HAD/ NS-HD

72
73

Maret 17.03.2021 NOV/40


Mrs. LET/ 25YO/
YO/716375/
101659/PALEMBANG/
PALEMBANG/STI-HAD/
STI-HA
Maret 17.03.2021 NS
Mrs.ROD/39YO/1200859/Palembang/STI-ARM/NS
Maret 18.03.2021 Mrs. DES / 24 YO / 1024135 / PALEMBANG / DID – WIS / HD
Maret 17.03.2021 Mrs. HAN/ 29 YO/ PALEMBANG/ STI-NAL/ AF
Maret 12.03.2021 Mrs. MAI/ 16/YO/ PALEMBANG/ DID-WAH/HD
Maret Mrs. LEL/ 23 YO/ PALEMBANG/ DID-WAH/ AW
Maret Mrs. NUR / 19 YO / 1200252 / STI – HIL / AW
Maret 13.03.2021 MRS. MIS/43 YO/1198216 BANYUASIN STI-HAD-FB
Maret Mrs. BAI/ 23 YO/1200307/ PALEMBANG/ DEV-WAH/ HI
Maret 14.03.2021 Mrs. MEL/ 32 YO/PALEMBANG/ STI-OSP/ AB
Maret 15.03.2021 Mrs. RIN / 35 YO / 1200448 / Ogan Ilir / STI – OSP / FU
Maret Mrs. RIN / 33 YO / 1199409 / PALEMBANG / IKY – DAV / NS
Maret Mrs. SIS / 35 YO / 1200191 / PALEMBANG/ DEV – HUD / HE
Maret Mrs. EST / 30 YO / 827986 / PALEMBANG / DEV – HIL / IS
Maret 16.03.2021 Mrs. KHO / 26 YO / 1199065 / PALEMBANG/ DEV – HIL / PB
Maret Mrs. KIK/ 16 YO/ 1200701/ PALEMBANG/ DID-WIS/AF
Maret 17.03.2021 Mrs. AFI / 19 YO / 1200716 / MUARA ENIM / DID – WIS / AF
Maret Mrs. DES / 24 YO / 1024135 / PALEMBANG / DID – WIS / HD
Maret Mrs. NOV / 25 YO / 101659 / PALEMBANG / STI – HAD / NS
Maret Mrs. CIK/ 29 YO/ PALEMBANG/ DID-UFA/ HE
Maret Mrs. IND/ 29 YO/ 845134/ PALEMBANG/ IKY-MUT/FB-AB
Maret 12.03.2021 Mrs. SUS/ 28 YO/ 1200204/ PALEMBANG/ IKY-MUT/ NS
Maret Mrs. INT/ 41 YO/ 1197820/ MUARA ENIM/ IKY-DAV/ NS-AB
Maret 15.03.2021 Mrs. FER/ 32 YO/ 1199277/ OGAN ILIR/IKY-DAV/NS -AB
Maret Mrs. RIN/ 33 YO/ 1199409/ PALEMBANG/ IKY-DAV/NS
Maret Mrs. FAT/ 24 YO/ 1200385/ PALEMBANG/ IKY-DAV/NS
Maret MRS.IST/36YO/1200520/ BANYU ASIN/ / IKY-MUT/HD-PB
Maret 16.03.2021
MRS. MEL/35YO/ 1200504/LUBUKLINGGAU/ IKY-MUT/HD-NS
Maret MRS. NUR/30YO/ 1192648/PALEMBANG/ IKY-MUT/HD-AB
Maret Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ IKY-DAV/ AW
Maret 17.03.2021 IKY-DAV/HE
Maret Mrs.SOR/31YO/ 1199137/BANGKA/IKY-MUT/NS
Maret 18.03.2021 Mrs.YUL/38YO/1140898/PALEMBANG/IKY-MUT/NS
Maret Mrs.VIN/30YO/1200785/MUBA/IKY-MUT/NS
Maret Mrs. NIN/ 21 YO/ 1198027/ OGAN KOMERING ILIR/ IKY-MUT/ NS
Maret
Maret Mrs. MER/
MRS. 19 YO/ 1200504/LUBUKLINGGAU/
MEL/35YO/ 1196532/PALEMBANG/IKY-TIA IKY-MUT/HD-NS
Maret Mrs. SAP/ 37 YO/ 1191922/ LUBUK LINGGAU/ IKY-MUT/ NS
Maret Mrs.ANG/25YO/828394/PALEMBANG/IKY-MUT/NS
Maret  
Maret Mrs. DEW/ 40 YO/ 1196563/ PALEMBANG/ ZAN/ FY/ P3A0
Maret 16.03.2021 Mrs. SIT/ 35 YO/ 1199282/ PALEMBANG/ ZAN/ FY/ P3A0
Maret Mrs. NOV/ 24 YO/ 1199702/ MUSI BANYUASIN/ ZAN/ FY/ P4A1
Maret Mrs. DEV/ 25 YO/ 1199577/ PALEMBANG/ ZAN/ FY/ P2A0
Maret Mrs. FAU/ 27 YO/ 1199412/ PALEMBANG/ ZAN/ FY/ P1A0
Maret Mrs. LEN/ 38 YO/ 1199283/ Palembang/ Op IS VAI URI
Maret IJA
Maret 15.03.2021 IJA
Maret 16.03.2021 Mrs. MIS/ 43 YO/ 1198216/ BANYUASIN/ INO-OGL-ZAN/ FB/ P3A0
Maret 15.03.2021 Mrs. LEN/ 42 YO/ 1200463/ PALEMBANG/ URI-ZAN/ AF/ P4A0
Maret 17.03.2021 Mrs. PUT/ 35 YO/ 1200469/ PALEMBANG/ URI-ZAN/ AF/ P4A0
Maret
Maret 05.03.2021 Mrs. EKA/ 27 YO/ 1196859/ PALEMBANG/ IKY-HAD/AB
Maret Mrs. MAY/ 37 YO/ 421622/ PALEMBANG/ IKY-HAD/AB
Maret Mrs. DES/ 25 YO/ 1198402/ MUSI BANYUSIN/ IKY-DAV/ NS
Maret 08.03.2021 Mrs. ANG/ 25 YO/ 1194665/ PALEMBANG/ IKY-DAV/ PB - HI
Maret Mrs. NOV/ 24 YO/ 1199702/ MUSI BANYUASIN/ IKY-DAV/ PB - HD
Maret Mrs. KHO/ 35 YO/ 936625/ OGAN ILIR/ IKY-DAV/PB - NS
Maret 09.03.2021 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-MUT/ AW Pregnancy contr
Maret Mrs. ELI/ 28 YO/ 1074132/ PALEMBANG/ IKY-MUT/ FB Pregnancy contro
Maret Mrs. LES/ 28 YO/ 936625/ OGAN ILIR/ IKY-DAV/ NS
Maret Mrs. YOC/ 26 YO/ 1199340/ PALEMBANG/ IKY-MUT/NS
Maret Mrs. EVI/ 25 YO/ 401844/ PALEMBANG/ IKY-MUT/ PB
Maret Mrs. LEN/ 39 YO/ 1199283/ PALEMBANG/ IKY-MUT/ IS
Maret Mrs. RIT/ 28 YO/ 1199840/ PALEMBANG/ IKY-MUT/AA
Maret 10.03.2021 Mrs. SEP/
NIN/ 28
21 YO/1 1192117/OGAN
YO/ 1198027/ PRABUMULIH/
KOMERING IKY
ILIR/ IKY-MUT/ NS
Maret
Maret Mrs. HEV/ 38 YO/ 1059347/ PALEMBANG/ IKY-M
Maret Mrs. LIA/ 24 YO/ 1070439/ PALEMBANG/ IKY-MU
Maret Mrs. MUN/ 38 YO/ 1200075/ BANYUASIN/ IKY-MU
Maret 10.03.2021 Mrs. ELI/ 31 YO/ 1004572/ PALEMBANG/ ZAN/ FB
Maret Mrs. REN/ 38 YO/ 1199933/ PALEMBANG/ ZAN/ F
Mrs. KAS/ 39 YO/ 1199508/ BANYUASIN/ STI-DAV-MUT/ AW
Maret 05.03.2021  
Maret Mrs. TIT /30 YO/ 1054338/ TALANG UBI/ STI-HAD/AA
Maret MRS. FAT/ 36 YO/623135/PALEMBANG/ STI-WIS/ FU
Maret Mrs. LUP/ 17 YO/ 1199818/ OKU/ DEV-IY/ HI
Maret Mrs. DIA/ 26 YO/ 1199489/ OGAN ILIR/ STI-MUT-DAV/ AW
Maret Mrs. KHO/ 45 YO/ 1196882/ PALEMBANG/ P2A1/ STI-DAV-MUT/AT
Maret Mrs. KIK/ 26 YO/ 1199689/ KERTAPATI/ STI-HAD/AA
Maret
Maret 05.03.2021 Mrs. KAS/ 39 YO/ 1199508/ BANYUASIN/ STI-D
Maret Mrs. SAN/ 34 YO/ 1192210/ BANGKA BELITUNG/
Maret Mrs. AYU/ 27 YO/ 1199526/ BANYUASIN/ STI-IZ
Maret 06.03.2021 Mrs. MIS
BEL // 40
22 YO
YO // 1199550
681479 / /PALEMBANG
PALEMBANG/ /ZAN-UFA
ZAN- / AB
Maret DEV-ARM-WAH/AC
Maret /DEV-ARM-WAH/NS
Maret Mrs. DEW / 37YO / 1199576 / Palembang / DEV-ARM-WAH / AC
Maret Mrs. ROS / 33 YO / 833395 / PALEMBANG / STI-DAV-MUT / HD-AB
Maret Mrs. AMA / 24YO / 1199587 / Palembang / DEV-ARM-WAH/ AC  
Maret Mrs. ZUR / 38 YO / 1199593 / BANYUASIN / DID-OSP / NS
Maret 07.03.2021 Mrs. ENI / 37th YO / 1199608 / Banyuasin / STI-WIS/HE
Maret Mrs. WID / 38 YO/ 1199612 / PALEMBANG / STI-WIS / FB
Maret Mrs. Eka / 30 YO / 1199614 / BANYUASIN / STI-NAL / FB
Maret Mrs. FAT / 36 YO / 623135 / Palembang / STI-WIS / FU
Maret Mrs. NOV / 24 YO / 1199702 / MUSI BANYUASIN / IKY-MUT / HD
Maret 08.03.2021 Mrs. TIT / 22 YO / 1054338 / Muara Enim / STI-HAD / AA
Maret Mrs. LUP / 17 YO / 99818 / OKU / DEV-IZY / HI
Maret Mrs. REN / 35 YO / 1199831 / PALEMBANG / DEV-IZY / HI
Maret
Maret 09.03.2021 Mrs. DES
ASN // 23
26 YO
YO // 1199964
1198736 // BANYUASIN
PALEMBANG/ /STI-
STI-ARM / IS
Maret Mrs. ANI / 45 YO / 1199951 / MUSI BANYUASIN / STI-ARM / HE
Maret Mrs. FIT / 18 YO / 1199976 / BANYUASIN / STI-ARM / RK
Maret Mrs. SAP / 38 YO / 1199975 / OGAN ILIR / STI-ARM / RK
Maret Mrs. RIN / 28 YO / 1199974 / BANYUASIN / STI-ARM / RK
Maret Mrs. DEV / 36 YO / OKI / DEV-WIS / NS
Maret 10.03.2021 Mrs. JUI / 28 YO / Empat Lawang / DEV-WIS / NS
Maret Mrs. HAN/ 29 YO/ PALEMBANG/ STI-NAL/ AF
Maret 11.03.2021 Mrs. RES/ 34 YO/ OGAN ILIR/ STI-NAL/ AB
Maret Mrs. MUN/ 38 YO/ 1200075/ BANYUASIN/ IKY-MUT/
Maret Mrs. ELI/ 31 YO/ 1004572/ PALEMBANG/ ZAN/ FB
Maret Mrs. REN/ 38 YO/ 1199933/ PALEMBANG/ ZAN/ FY
Maret Mrs.JUI/28YO /EMPAT LAWANG/ DEV-WIS/NS
Maret 10.03.2021 Mrs. LUD /25 YO /PALEMBANG/ DID-OSP/HD
Maret 11.03.2021 Mrs.MSY/32 YO /PALEMBANG/ DID-OSP/HD
Maret 11.03.2021 Mrs.RIZ /24YO/ MUSI BANYUASIN/ DID-OSP/AA-HE
Maret 11.03.2021
WIS
Maret 08.03.2021 TIA
Maret WIS
Maret
Maret Mrs. DES
09.03.2021 URI
Maret 19.03.2021 25 YO
Maret Mrs. RIN
Maret 33 YO
Mrs. SRI
Maret 27 YO
22.03.2021 Mrs. NOV
Maret 25 YO
24.03.2021 Mrs. INT
Maret 41 YO
25.03.2021 Mrs. YOS
Maret 25 YO
Mrs. NUR FB
DEV-IZY/
Maret 27 YO
19.03.2021 DEV-IZY/FB
Maret Mrs. DWI/ 35 YO/ PALEMBANG/ STI-HAD/ AB
Maret 20.03.2021 Mrs. YUH / 28 YO / PALEMBANG / INO – OSP / AW
Maret 21.03.2021 Mrs. ANG / 25 YO / PALEMBANG / IYA – DID – ARM / FY
Maret Mrs. FAT / 36 YO/ BANYUASIN/ DEV – IZY / FU
Maret Mrs. MAR / 35 YO / PALEMBANG/ DEV – HIL / FU
Maret AB
Maret 22.03.2021 Mrs. SUH / 30 YO / 1201199 / STI – WAH / AB
Maret Mrs. REN / 30 YO /
Maret 1120198
Mrs. KHO / STI
/ 26–YO
WAH / AB / PALEMBANG / DEV – HIL / PB
/ 1199065
Maret HE
Maret 23.03.2021 Mrs. LEN/ 27 YO/ 1201209/ LUBUK LINGGAU/ DEV-NAL/ HI
Maret Mrs. SET/20 YO/ 1201514/ MUSI BANYUASIN/ STI-UFA/HE
Maret 24.03.2021 Mrs. SIT/ 36 YO/ 1201517/ BANYUASIN/ STI-UFA/ FB
Maret Mrs. SUG/ 30 YO/ 1201519/ PALEMBANG/ STI-UFA/ FB
Maret Mrs. AFI/ 19 YO/ 1200716/ PALEMBANG/ STI-UFA/ AF
Maret Mrs. YOS/ 25 YO/ 1200410/BENGKULU/ STI-HAD/ HE
Maret
No Bulan Tanggal Identitas
1 April 02.04.21 Mrs. Feni Marseptiani/ 27 YO/653999/Palembang
2 April 02.04.21 Mrs. NAB/ 19 YO/ 1202372/ PALEMBANG/ DEV-ARM/ AC
3 April 02.04.21 Mrs. RIZ/ 21 YO/ 1202367/ BANYUASIN/ DEV-ARM/ HD
4 April 02.04.21 Mrs. RAN/ 25 YO/ 1031439/ PALEMBANG/ DEV-ARM/ FY
5 April 02.04.21 Ms. NAB/ 21 YO/ 1202332/ PALEMBANG/ STI-NAL/ HI
6 April 02.04.21 Mrs. FIT/ 45 YO/ 1202383/ BANYUASIN/ DID-WIS/ HE
7 April 02.04.21 Mrs. END/ 24 YO/ 1202396/ PALEMBANG/ DID-WIS/ HD
8 April 03.04.21 Mrs. IST/37 YO/1200520/OKU Timur/STI-OSP/PB
9 April 03.04.21 Mrs. SRI/34 YO/1202412/Palembang/STI-OSP/HD
10 April 03.04.21 Mrs. NOVI REZA/ 21 YO/ 1202432/ PALEMBANG/ DEV-HIL/ AB
11 April 03.04.21 Mrs.ERM/39 YO/750655/ PALEMBANG/STI-OSP/NS
12 April 03.04.21 Mrs. INTAN OKTRIANI/ 41YO/1197820/PALEMBANG/DEV-WAH/AB
13 April 04.04.21 Mrs.EKA/30 YO/1178052/ OKI/API-UFA/HE
14 April 04.04.21 Mrs. SUS/27YO/1202441/BANYUASIN/IYA-UFA/HE
15 April 04.04.21 Mrs.IND/22YO/1202465/DID-IZY-HUD/HD
16 April 04.04.21 Mrs.DEV/28 YO/1202467/DID-IZY-HUD/HD
17 April 04.04.21 Mrs.EKA/30 YO/1178052/ /API-UFA/HE
18 April 05.04.21 Mrs. HAN/ 25 YO/ 1202586/ BANYUASIN/ STI-TIA/ AB
19 April 05.04.21 Mrs. SAR/ 25 YO/ 1202613/ OGAN KOMERING ILIR/ STI-NAL/ KY
20 April 05.04.21 Mrs. Maya Wulan Sari/ 36 YO/ 12017176/ PALEMBANG/ STI-TIA-VAI/ FY
21 April 05.04.21 Mrs. PAR/33 YO/1200521/Palembang/P3A2/MUT-IJA/HE
22 April 05.04.21 Mrs. KHO/ 32 YO/ 1192019/ BANYUASIN/ ZAN/ NS
23 April 05.04.21 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-PIT/ AB
24 April 05.04.21 Mrs.MEI/ 31 YO/ 1024319/ PALEMBANG/ IKY-PIT
25 April 05.04.21 Mrs. LND/ 34 YO/ 686810/ PALEMBANG/ IKY-IAN
26 April 05.04.21 Mrs. LIN/ 30 YO/ 968918/ PALEMBANG/ IKY-IAN/
27 April 06.04.21 Mrs.FER/ 30 YO/ 11939973/ PALEMBANG/ IKY-PI
28 April 06.04.21 Mrs. ULT/ 43 YO/ 1159799/ PALEMBANG/ IKY-IA
29 April 06.04.21 Mrs. SOR/31 YO/1199137/Palembang/NS-AT/MUT
30 April 06.04.21 Mrs. EST/30 YO/827966/Palembang/HIL-OGL/IS
31 April 06.04.21 Mrs. MAY/ 36 YO/ 12017176/ Palembang/ MUT-OG
32 April 06.04.21 Mrs. UMI/ 19 YO/ 1202717/ PALEMBANG/DEV-WAH/AW
33 April 06.04.21  Mrs. RIK/ 37 YO/ 1202765/ MUSI BANYUASIN/ DEV-WAH/ IS
34 April 06.04.21 Mrs. RIR/ 27 YO/ 570721/ PALEMBANG/ DEV-WAH/ AF
35 April 07.04.21 Mrs. Betaria Sitanggang/ 22 YO/ 1202812/ PALEM
36 April 07.04.21 Mrs. Desi Repila/ 34 YO/ 1202850/ PALEMBANG/ STI-TIA-VAI/ NS
37 April 07.04.21 Mrs. ENA DEFIAN / 30 YO/ 1015996/ PALEMBANG
38 April 07.04.21 Mrs. ING/ 38 YO/1202904/Palembang/DID-OSP-KAR/NS
39 April 07.04.21 Mrs. SUS/ 41 YO/ 1202903/ OGAN ILIR/ DID-OSP/ NS
40 April 07.04.21 Mrs. YUL/ 24 YO/ 1102273/ PALEMBANG/ DID-OSP/ HD
41 April 07.04.21 Mrs. SEK/ 32 YO/ 1051479/ YOGYAKARTA/ DID-OSP/ NS
42 April 07.04.21 Mrs. TIK/ 26 YO/ 1202920/ Banyuasin/ DID-OSP/ HD
43 April 07.04.21 Mrs. RIZ/ 29 YO/ 1202926/ Palembang/ DID-OSP/ NS
44 April 07.04.21 Mrs. KHO/ 27 YO/ 1202925/ Banyuasin/ DID-OSP/ HD
45 April 07.04.21 Mrs. NUR/ 19 YO/ 1199132/ BANYUASIN/ STI-TIA/ NS
46 April 07.04.21 MRS. MAS/ 21 YO/ PALEMBANG/ 1202894/STI-TIA-VAI/ RK
47 April 08.04.21 Mrs. DES/ 34 YO/ 1202850/ Palembang/ P1A1/ MUT-RAM/ NS
48 April 08.04.21 Mrs. ANDI NUR FITRIANI/35 YO/1203048/ BAN
49 April 08.04.21 Mrs. LINDA SARI/34 YO/1203050/ PALEMBANG/
50 April 08.04.21 Mrs. Meilisa Binti Amir Hamzah/ 20 YO/1203054
51 April 08.04.21 Mrs. MARIDA BINTI DUL/35 YO/1203031/ BANY
52 April 08.04.21 Mrs. LANASARI BINTI SYAFIK/ 34 YO/ OGAN ILIR/ KOM/ PM
53 April 08.04.21 Mrs.ANG/25 YO/ 828394/ PALEMBANG/ IKY-PIT/PM-NS
54 April 08.04.21 Mrs. NET/38YO/ 1202967/ PALEMBANG/ IKY-IAN
55 April 08.04.21 Mrs. ENA/ 46 YO/ 1201996/ PALEMBANG/ ZAN/ F
56 April 08.04.21 Mrs. RIA/ 40 YO/ 1201810/ OGAN ILIR/ ZAN/ FY
57 April 08.04.21 Mrs. ERM/ 31 YO/ 1201810/ OGAN ILIR/ ZAN/ FY
58 April 09.04.21 Mrs. SRI / 27 YO/ 1129774/ PALEMBANG/ STI-TIA-VAI/ FY
59 April 09.04.21 Mrs.NUR/23YO/ 1203174/
Mrs. NOV/ 37 YO/ Banyuasin/
Palembang / P2A0 /STI-WIS-PIT/FU
AF/ UTI-RAM
60 April 09.04.21 Mrs. SUR/30 YO/ 1203264/ BANYUASIN/ STI-WAH/ FB
61 April 11.04.21 Mrs. WAY/ 31 YO/ 1203425/ OGAN KOMERING ULU TIMUR/ API-WIS/ A
62 April 12.04.21 Mrs.RIK/39YO/ 1203298/ Palembang/ API-WIS-TIA/AB
63 April 12.04.21 Mrs. DIN/ 28 YO/ 1203295/ PALEMBANG/ JAY-API -WIS-VAI-TIA/ AB
64 April 12.04.21 Mrs. FER/ 32 YO/ 1199277/ OGAN ILIR/ IKY-PIT/AB
65 April 12.04.21 Mrs. DIN/ 28 YO/ 1203295/ PALEMBANG/ JAY-API -WIS-VAI-TIA/ AB
66 April 12.04.21 Mrs. SHE/ 26 YO/ 1203404/ PALEMBANG/ JAY-API-VAI-TIA/KY
67 April 12.04.21 Mrs. HAN/ 25 YO/ 1202586/ BANYUASIN/ STI-TIA/ AB
68 April 12.04.21 Mrs. MAY/ 34 YO/ 1202070/ OGAN KOMERING ILIR/ JAY-VAI/ NS
69 April 13.04.21 Mrs. HER/ 29 YO/ 1157316/ BANYUASIN/ API-WIS/ AF
70 April 13.04.21 Mrs. LEN/ 27 YO/ 1201209/ Lubuk Linggau/ ASR-ARM/ HI
71 April 14.04.21 Mrs. HEN/ 31 YO/ 1037523/ Banyuasin/ ASR-ARM/ AB
72 April 14.04.21 Mrs. RAN/ 30 YO/ 427296/ PALEMBANG/ JAY-API/TIA-VAI/ NS
73 April 14.04.21 Mrs. JAM/ 28 YO/ 1203560/ PALEMBANG/ JAY-API/ TIA-VAI/ PM
74 April 14.04.21
75 April 14.04.21 MEY/19
Mrs. BEL/ 30YO/
YO/1203645/
1089101/Palembang/
MUARA ENIM/ JAY-AP
ASR-ARM/ AB
76 April 14.04.21 Mrs. NUN/ 31 YO/ 1203642/ PALEMBANG/ ASR-ARM/ AB
77 April 14.04.21 Mrs. RUS/ 36 YO/ 1203620/ BANYUASIN/ JAY-API/ TIA-VAI/ NS
78 April 15.04.21
79 April 15.04.21 Mrs. NET/ 38 YO/ 1202967/ OGAN ILIR/ IKY-IS
80 April 15.04.21 MRS.SUS/28 YO/1200204/
Mrs. IIS/ 29 YO/ PALEMBANG /IKY-IANTIA-VAI/ FB
1203731/ PALEMBANG/JAY-API/
81 April 15.04.21
82 April 15.04.21 Mrs. RAD/ 22 YO/ 1203688/ BANYUASIN/ API-JAY
No Bulan Tanggal Identitas
1 May 31.05.21 IND, 29 tahun, Palembang

2 May 31.05.21 FER, 30 tahun , Palembang

No Bulan Tanggal Identitas


1 Juni 02.06.21 BER, 28 tahun, Palembang
1 Juni 02.06.21 BER, 28 tahun, Palembang

2 Juni 03.06.21 TEN, 45 tahun, Ogan Komering Ilir

3 Juni 03.06.21 NOV, 41 tahun, Muara Enim

4 Juni 04.06.21 AND, 28 tahun, Palembang

5 Juni 04.06.21 RIT, 18 tahun, Ogan Ilir

6 Juni 04.06.21 SRI, 23 tahun, Palembang

7 Juni 04.06.21 JUM, 30 tahun, Palembang

8 Juni 07.06.21 FIK, 37 tahun, Banyuasin


8 Juni 07.06.21 FIK, 37 tahun, Banyuasin

9 Juni 08.06.21 KUR, 30 tahun, Ogan Komering Ilir

10 Juni 09.06.21 FER, 30 tahun, Palembang

11 Juni 10.06.21 RACH, 20 tahun, Banyuasin

12 Juni 10.06.21 REK, 24 tahun, Banyuasin

13 Juni 07.06.21 MEI, 31 tahun, Kayuagung


14 Juni 07.06.21 PEB, 34 tahun, Kayuagung

15 Juni 08.06.21 FER, 30 tahun, Palembang

16 Juni 08.06.21 ULT, 43 tahun, Palembang

17 Juni 09.06.21 SEL, 25 tahun, Palembang

18 Juni 09.06.21 EKA, 35 tahun, Palembang

19 Juni 10.06.21 HEN, 31 tahun, Palembang

20 Juni 10.06.21 ANI, 31 tahun, Palembang

No Bulan Tanggal Identitas


MIR, 29 tahun, Palembang

1 Agustus 5
2 Agustus 5 CAR, 45 tahun, Palembang

3 Agustus 5 AGU, 35 tahun, Palembang

4 Agustus 5 SUSILAWATI BT SOBORIN, 32 tahun, Palembang

5 Agusutus 5 OKTAVIA YULIANA, 32 tahun, Palembang


6 Mrs. TIN/ 36 YO/ 1217626/PALEMBANG
7 Mrs. SUM/ 21 YO/ 1088789/ PALEMBANG
8 Mrs. HER/ 26 YO/ 121773/ PALEMBANG
9 Mrs. PER/ 25 YO/ 1217816/ Ogan Komering Ilir
10 Mrs. LEL/ 27 YO/ 1217817/ PALEMBANG
11 MRS. AIS/ 29 YO/ 1217803/ PALEMBANG/
12 Mrs. DEL/ 26 YO/ 946749/ Palembang
13 Mrs. ZAL/ 31 YO/ 1217587/ PALEMBANG
14 Mrs. NUR/ 36 YO/ 1217833/ Lampung
15 Mrs. HER/ 45 YO/ 1217874/ PAGAR ALAM
16 Mrs. Bai/27YO/OKI/1218027
17 Mrs. JUN/ 22 YO/ 1218209/BANYUASIN
18 Mrs. JUN/ 22 YO/ 1218209/BANYUASIN

No Bulan Tanggal Identitas


1 Oktober 1-7/10/21 Mrs. MER/ 26 YO/ 1222056/ Palembang/ ANE-CYN/

2 Oktober Mrs. SAR/ 29 YO/ 1191335/ BANYUASIN/ ANE-C

3 OKtober Mrs. SRI/ 40 YO/ 981072/ Kayu Agung/ EDA-CYN/

4 OKtober Mrs. FEB/ 28 YO/ 1084328/ Palembang/ EDA-CYN/

5 Oktober Mrs. SRI/ 39 YO/ 1161818/OGAN ILIR/ EDA-CYN

6 Oktober Mrs. YUL/ 25 YO/ 1222480/ Palembang/ ANE-SAR/

7 Oktober Mrs. NUR/ 40 YO/ 107450/ Palembang/ ANE-FES/N

8 Oktober Mrs. MER/ 32 YO/ 747199/ PALEMBANG/ANE-FES

9 Oktober Mrs. SIS/ 28 YO/ 1220156/ Palembang/ ANE-FES/ N


10 Oktober Mrs. RAD/ 39 YO/ 1217290/ Palembang/ ANE-FES/

11 Oktober Mrs. RIS/ 28 YO/ 535733/ Palembang/ ANE-FES/ NS

12 Oktober Mrs. DIN/ 19 YO/ 935116/ Palembang/ ANE-FES/ NS

13 Oktober Mrs. JUM/ 19 YO/ 1160358/ Palembang/ ANE-FES/

32 Oktober 08/10/21 Mrs. TRI /20 YO/ 1225048/Palembang/JAY/OGL/AB

33 Oktober Mrs. YUL/41YO/1225059J/AY / OGL /FY

34 Oktober 09/10/21 Mrs. CIC/27 YO/1225074/PALEMBANG/IKY/ CIA /

35 Oktober Mrs. WIK/26 YO/1225101/INDRALAYA/IKY/CIA /


36 Oktober Mrs. BET/37YO/1155984/Palembang/BER/URI/AB

37 Oktober Mrs. WEL/23YO/1225136/Palembang/BER/URI/AB

38 Oktober 10/10/21 Mrs. SAL/ 27 YO/690125/PALEMBANG/JAY/RAM

39 Oktober 11/10/21 Mrs. RYS/29YO/122536/PRABUMULIH/ASR/INO/

40 Oktober Mrs. RYS/29 YO/122536/PRABUMULIH/ ASR /INO


41 Oktober 11/10/21 Mrs. IND/21YO/Palembang/1225379

42 Oktober 12/10/21 Mrs. TUT/36YO/Palembang /855433/ASR/INO/NS

43 Oktober Mrs. MER/25YO/OKI/1225409/ASR/INO/RK

44 Oktober Mrs. RES/23YO/PALEMBANG/1225410/ASR/INO/

45 Oktober Mrs. DIA/30YO/1224520 /OGANILIR/API/SAR/AB


46 Oktober Mrs. YUN/37 YO/ PALEMBANG/12225599/API/K

47 Oktober Mrs. AST /28 YO/122539/PALEMBANG/API/KOM/

48 Oktober 13/10/21 Mrs. DIA/38YO/1225794/PALEMBANG/BER/RAM

49 Oktober 25/10/21 Mrs. IND/ 31YO/1215464/Palembang/JAY/UFA/ NS

50 Oktober 26/10/21 Mrs.MAY/29YO 1187279 Banyuasin JAY/SAR/ FY


51 Oktober 27/10/21 Mrs.ULA/26YO 1227986/Ogan Ilir/ JAY/SAR/NS

52 Oktober 28/10/21 Mrs. HOS/ 27 YO/ 1220160/ Ogan Ilir/ JAY/UFA/HD

53 Oktober Mrs. TIN/ 23 YO/ 1228188/ Palembang/ JAY/UFA/

No. Bulan tanggal identitas


03/12/2021 Mrs. FIT/35 YO/1234965/Palembang/CAY-ZAN/HD

1 Desember
03/12/2021 Mrs. MAR/ 37 th/ 785223/ PALEMBANG/ CAY-ZAN

2 Desember
09/12/2021 Mrs.RANI ANGGRAINI / 31YO / 1236288 / PALE

3 Desember
09/12/2021 Mrs.NI LUH PUTU SUKERTI / 38YO / 1236293 /
4 Desember
09/12/2021 Mrs. FITRI HANDAYANI/ 21 YO/ 1236324/BANY

5 Desember
03/12/2021 Mrs. DES/ 21 YO/ 1237129/ Banyuasin/ BER-THR/

6 Desember
10/12/2021 Mrs. HEN/ 26 YO/ 1236426/ Palembang/ BER-MIQ/

7 Desember
8 Desember 10/12/2021 Mrs. NYI/ 27 YO/ 1236379/ Palembang/ BER-MIQ/

10/12/2021 Mrs. NOV / 27YO / 1237834 / PALEMBANG / IKY

9 Desember
03/12/2021 Mrs. SIK/ 37YO 1229812
PALEMBANG
CAY-ZAN-UFA/ HI

10 Desember
03/12/2021 Mrs. SIH/ 29YO 1229802

59 Desember Mrs. SIH/ 29YO 1229802


62 Desember 03/12/2021 PALEMBANG
CAY-ZAN-UFA / AB

63 Desember
63 Desember
03/12/2021 Mrs. NOV / 32 YO
808444
PALEMBANG
CAY-ZAN-SAR / HI

70 Desember
03/12/2021 Mrs. IRM/ 33 YO/ 1233875/ Palembang/ DPR-CIA-U

76 Desember
27.11.2021 Mrs. MAI/ 30 YO/ 1233948/ OGAN ILIR/ DPR-CIA
06.30 PM 27.11.2021

83 Desember
03/12/2021 Mrs. ANG/ 22 YO / 706277/ Palembang/ DPR-CIA-U

93 Desember
28.11.2021 Mrs. ROY/ 32 YO/ 1233993/ Ogan Ilir/ ASR-RAM-

98 Desember
28.11.2021 TUT/ 25 YO/ 915283/ Musi Banyuasin/ 915283/ JAY

104 Desember
29.11.2021 Mrs.MUN/ 45 YO/ 123407/ Banyuasin/ BAN-KOM-
110 Desember
29.11.2021 Mrs. IRA/ 31 YO/ 1234081/ Palembang/ BAN-KOM

115 Desember
30.11.2021 Mrs. FEB/42 YO/ 1234339/ PALEMBANG/ JAY-O

122 Desember
30.11.2021 Mrs. ISR/ 28 YO/ 1122713/ Ogan Komering Ilir/ C

127 Desember
03/12/2021 Mrs. SIM/ 45 YO/ 1234558/ Banyuasin/ BER-INO-SA

135 Desember
30.11.2021 Mrs. LOM/ 37 YO/ 1234460/ Palembang/ GIO-OSP/
02.10 PM

140 Desember
01.12.2021 Mrs. NUR/ 27 YO/ 1234780/ Banyuasin / IYA-CIA
09.00 PM

147 Desember
02.12.2021 Mrs. DIN/ 19 YO/ 935116/ Palembang/ IYA-CIA-SA
02.10 AM

151 Desember
151 Desember
03.12.2021 Mrs. YUS/ 34 YO/ 998580/ Palembang/ GAS-IZY-OS

158 Desember
03/12/2021 Mrs. TRI/ 24 YO/ 1235065/ Palembang/ CAY-MIQ/

166 Desember
03/12/2021 Mrs. MAY/ 33 YO/ 525542/ Palembang/ CAY-THR/

171 Desember
06/12/2021 Mrs. DIA/ 24 YO/ 1235463/ Palembang/ BER-MIQ/

175 Desember
06/12/2021 Mrs. ROS/ 42 YO/ 388712/ Batam/ P0A1/ BER-MIQ/

179 Desember
08/12/2021 Mrs. VER/ 34 YO/ 1236021/ Riau/ BER-THR/AB

188 Desember
09/12/2021 Mrs. MUS/ 27 YO/ 1075896/ Ogan Ilir/ BER-THR/ N

195 Desember
195 Desember
03.12.2021 Mrs. AMA/30 YO/749065/Palembang/KOM-KIS/AF

201 Desember
03.12.2021 Mrs. RIZ/29 YO/704796/Palembang/G4PA1

209 Desember
06.12.2021 Mrs. YES/34 YO/9999580/Palembang/G3P2AO/KIS

215 Desember
07/12/2021 Mrs. UMM/32 YO/1234641/Palembang/G4P2A1

223 Desember
07/12/2021 Mrs. FIT/35 YO/Palembang/G4PA0

229 Desember
OBSTETRIC INPATIENT
Diagnosa
G2P1A0 39 weeks gestational age not in labor
COVID-19 was suspected
Single life fetus transverse lie

G3P2A0 37 weeks gestational age not in labor


Prior CS 1x (on indication failed of induction)
Premature rupture of membrane 2 hours
Hepatitis B infection
COVID-19 was suspected
Single life fetus breech presentation
Oligohydramnios
G1P0A0 35 weeks gestational age not in labor
PPROM 6 hours
Impending eclampsia
Single life fetus cephalic presentation
Anhydramnios

G3P2A0 38 weeks gestational age not inlabor


Placenta accreta was suspected
Prior CS 2x
Complete placenta previa
Moderate anemia c.b iron deficiency
Single life fetus tranverse lie
G1P0A0 37 weeks gestational age not in labor
Premature rupture of Membrane 15 hours
Single life fetus cephalic presentation
Anhydramnios
G1P0A0 37 weeks gestational age not in labor
Impending eclampsia
Single life fetus cephalic presentation

G5P0A4 37 weeks gestational age in labor first stage latent phase


Covid 19 was suspected
Single life fetus cephalic presentation
G2P1A0 39 weeks gestational age inlabor
Prolonged second stage (8 hours outside)
Severe preeclampsia
Threatened uterine rupture
Single life fetus cephalic presentation
Fetal distress

P1A0 post LSCS on indication impending eclampsia ( 4 days outside)


HELLP Syndrome
AKI Stage III
Moderate anemia
Leucocytosis
Thrombocytopenia
Hypoalbumin
Hypocalemia

G3P2A0 25 weeks gestational age not in labor


Eclampsia antepartum
Prior CS 2x
Asymptomatic urinary tract infection
Obesity grade II
Single life fetus intrauterine

P2A0 post spontaneous delivery ( 7 days outside)


Late post partum hemorrhagic caused by rest of placentae
Mild anemia

G3P2A0 40 weeks gestational age in labor first stage latent phase


Severe preeclampsia
Prior CS 2x
Single life fetus cephalic presentation
G1P0A0 27 weeks gestational age
Threatened preterm labor
Single life fetus cephalic presentation

G5P3A1 35 weeks gestational age not in labor


Antepartum hemorrhage caused by marginal placenta previa with reccurent bleeding
COVID-19 was suspected
Single life fetus cephalic presentation
G1P0A0 30 weeks gestational age
Threatened preterm labor
Moderate Anemia (hypocrhromic microcytic)
IUGR was suspected
AEDV

P2A0 post spontaneous delivery ( 5 hours outside)


early post partum hemorrhage caused by rest of placenta and vaginal laceration
Severe anemia
·
·

G1P0A0 37 weeks gestational age not in labor


Premature rupture of membrane 12 hours
Single life fetus cephalic presentation
Anhydramnios
G3P2A0 37 weeks gestational age not in labor
Severe preeclampsia
Covid-19 was suspected ( pneumonia)
Single life fetus cephalic presentation

G4P3A0 38 weeks gestational age inlabor first stage latent phase


Prior CS 2x
COVID -19 was suspected (Ig G reactive)
Single life fetus cephalic presentation

P1A0 post spontaneous delivery


Early post partum hemorrhagic caused by perineal rupture grade IV
Covid-19 was suspected
G3P2A0 35 weeks gestational age
Threatened preterm labor
Complete placenta previa
Asymptomatic urinary tract infection
Single life fetus cephalic presentation

G2P1A0 38 weeks gestational age second stage labor


Single life fetus breech presentation
G1P0A0 30 weeks gestational age in labor first stage active phase
Preterm Premature rupture of membrane 2 hours
Twin life fetus cephalic presentation breech presentation
• Mild anemia (normocytic normochrom) OBSTETRIC INPATIENT
Twin life
• Severe fetus (cephalic
anemia presentation
microcytic hypochrom – transverse
) lie
Single lifemellitus
• Diabetes fetus intrauterine
type II uncontrolled
• Single life fetus cephalic presentation
Hydrocephalus
• Severe preeclampsia
• Single
Eclampsia fetus
life cephalic presentation
antepartum
• Single
Perineallife fetus cephalic
laceration grade presentation
III A
• Mild anemia
Intrauterine infection
• Single life
death fetus cephalic
fetus presentation
cephalic presentation
•· Threatened
Multiple congenital anomaly
preterm labor
•· Single
Covid 19lifewas
fetus transverse
suspected lie reactive)
(IgG
Single lifeanemia
• Moderate fetus cephalic presentation
(microcytic hypochrome)
• Single live fetus
Severe preeclampsia cephalic presentation
•Post
Single life fetus
operative cephalic presentation
diagnosis
•P2A0 post
Single lifeLSCS
fetus oi post-term
Cephalic pregnancy
presentation
• Anhydramnios
Moderate anemia
Single lifewas
• Covid-19 fetussuspected
cephalic presentation
cephalicpresentation
• Single life fetus breech presentation
Severe bilateral
• Cervical cancer ventriculomegaly
was suspected + meningocele + dolicocephali
breech presentation
• Single life fetus cephalic presentation
•· Asymptomatic
Fetal tend to beUTI small
· Single
PROMlife fetus cephalic presentation
1 days
· Syphylis infection was suspected
UTI asymptomatics
· Single life fetus cephalic presentation
Polyhydramnios
Atresia Esofaghial
· Covid-19 was supeted
was suspected
· Single life fetus Cephalic presentation
G2P1A0 37 weeks
• Single life gestational
fetus breech age second stage of labor with Retention of second baby ( 3
presentation
• Oligohydramnions
IGD
• Early postpartum haemorrhagic caused by obstetric laceration of cervix
• Severe
Diabetes Anemia
mellitus type II uncontrolled
• Single life fetus cephalic presentation
Macrosomia
• Late postpartum washemorrhage
suspected cb rest of placenta
••G2P1A0
Severe anemia
42 weeks gestational not in labor
•Asymptomatic
Single life fetus cephalic
urinary presentation
infection
•Single
Singlelife
lifefetus
fetuscephalic
breech presentation
• Oligohydramnions
Dolicocephali
•· PROM
Meningocele
1 days
•· Single
Covid-19lifewas
fetussuspected
cephalic (presentation
IgG and IgM reactive)
Single -19
• Covid life was
fetussuspected
cephalic presentation
(U07.2)
life fetus
• Single death breech
fetus presentation
cephalic (O32.1
presentation )
(O34.6)
Congenital
• Covid 19 was anomaly (Q79.2)
suspected (U07.2)
•Diabetes
Single life fetus cephalic presentation (Z37.0)
mellitus type II ( E11.9)
Surgical
Covid-19sitewasinfection
suspected( L08.9)
( U07.2)
Single life fetus cephalic
· Asymptomatic urinary tract presentation
infection (O23)
· Single life fetus cephalic presentation
• G5P4A0 26 weeks gestational age in labor first stage active phase ( Z3A.26 )
•· Prior
SingleCSlife1xfetus intrauterine (O34.12)
(oi anhidramnion
•· Single
Covid 19lifewas
fetus cephalic (U07.0)
confirmed presentation
• Single life fetus breech presentation (O32.1 )
diagnosa

• G3P2A0 38 weeks gestational age not inlabor ( Z3A.38)


• Antepartum haemorrhage c.b total placenta previa was suspected (O44. 03)
• Covid 19 was confirmed (U07.2)
• Single life fetus cephalic presentation
Recent diagnosis
• P3A0 post SLCS o.i partial placenta previa
• Covid 19 was confirmed

• G2P0A1 32 weeks gestational age (Z3A.32)


• ASD (Q21.1)
• Eisenmenger syndrome was suspected (I27. 83)
• Severe preeclampsia (O42.10 )
• SLF cephalic presentation

• G2P0A1 38 weeks gestational age inlabor first stage laten phase ( Z3A.38)
• Single life fetus breech presentation (O32.1)
• Umbilical cord Entanglement twice

Recent diagnosis
• P1A1 post SLCS o.i breech presentation + umbilical cord Entanglement twice

• G1P0A0 31 weeks gestational age inlabor first stage latent phase ( Z3A.31)
• Antepartum hemorrhagic caused by placenta abruption (O45)
• Single dead fetus transverse lie ( O32.2)

Recent diagnosis
P1A0 post LSCS on indication placenta abruption + post ß-lynch modification
• G1P0A0 31 weeks gestational age inlabor first stage latent phase ( Z3A.31)
• Antepartum hemorrhagic caused by placenta abruption (O45)
• Single dead fetus transverse lie ( O32.2)

Recent diagnosis
P1A0 post LSCS on indication placenta abruption + post ß-lynch modification
• G1P0A0 39 weeks gestational age inlabor first stage laten phase ( Z3A.39)
• Covid -19 was suspected (U07.2)
• Single life fetus transverse lie (O32.2XX0)

Recent diagnosis

P1A0 post SLCS o.i transverse lie

• G3P1A1 35 weeks gestational age (Z3A.35)


• Threatened preterm labor (O47)
• Prior CS 1x ( on indication fetal distress) (O34.21)
• Placenta accreta spectrum disorder was suspected (O43.21)
• Asymptomatic urinary tract infection (023.40)
• Moderate anemia (O99.019)
• Single life fetus cephalic presentation
• P3A1 post SLCS o.i prior CS
P4A0 post spontaneous bracht ( O32.1 )
P1A0 post spontaneous delivery (O32.1)
Status : Discharge
Single life fetus cephalic presentation (Z34.0)

Single life fetus cephalic presentation ( Z37.0)


Single life fetus cephalic presentation (Z37.0)
P2A0 post spontaneous delivery with moderate anemia caused by iron deficiency, morbid obesity
Multiple congenial anomaly was suspected (Q89.9)
- Covid 19 not confirmed
(Z37.0)
Status : Stable in ward
Status : Stable in ward
Twin life-death fetus cephalic – cephalic presentation O30.0
 
Single life fetus intrauterine (O32.1)
G1P0A0 42 weeks gestational age not in laborZ3A.42 Single life fetus cephalic presentation (O32.1)
Single life fetus cephalic presentation
Covid-19 was suspected (U07.2)
Single life fetus intrauterine (Z37.0)
IUGR was suspected (P059) 
Single life fetus cephalic presentation (Z37.0)
(Q89.9)
(Z37.0)
G1P1A0 18 weeks gestational age with syphilis infection SLF intrauterine
Single life fetus cephalic presentation
Single life fetus intrauterine
Single life fetus intrauterine
Umbilical cord entanglement 2x
Single life fetus cephalic presentation
Single life fetus cephalic presentation
Single life fetus cephalic presentation
TTTS was suspected
Single life fetus intrauterine
Asymmetric IUGR
Subchorionic bleeding
Meningo-encephalocele (Q89.9)
Single life fetus cephalic presentation
Single dead fetus intrauterine
P3A0 post LSCS on indication maternal distress (day 40th) (34.21)
Post
P3A0laparotomy
post LSCSrepair wound dehiscence
on indication + adhesiolysis
HIV infection + Post tubal+ligation
subtotal(day
hysterectomy (day 22th
8th) (34.21)
P4A1 post LSCS on indication hydrocephalus and anhydramnion (day 8th) (34.21)
P2A0 post LSCS on indication impending eclampsia + prior cs 2x (day 9th) (34.21)
P1A0 post LSCS on indication cephalopelvic disproportion (day 11th) (34.21)
Single life fetus cephalic presentation
G2P1A0 37 weeks gestational age not in single life fetus cephalic presentation with meningoencephalocele
Utero Placental hypoperfusion
Post Minilaparatomy Tubectomy Pomeroy
Post Minilaparatomy Tubectomy Pomeroy
Post Minilaparatomy Tubectomy Pomeroy
• Single life fetus intrauterine
• Sigle life fetus intrauterine (Z37.0)
• SLF cephalic presentation (Z37.0)
• Fetal tend to be small ( P06.9)
• Anhydramnios ( O41.1)
• Single life fetus cephalic presentation ( Z37.0)
• Single life fetus intrauterine

• G1P0A0 7 weeks gestational age Intrauterine


Anhydramnios
• Endometriosis cyst
• Intrauterine growth restriction
• SLF cephalic presentation
• Bad obstetric history
• Twin death fetus
Meningoencephalocele ( Q89.9)
• Single life fetus intrauterine (Z37.0)
• Single life fetus cephalic presentation ( Z37.0)
• Single life fetus intrauterine ( Z37.0)
• Single life fetus intrauterine ( Z37.0)
• subfascial hematoma (O90.2)

IUD dislocation (T83.32)


·G3P2A0 38 weeks gestational age in labor first stage active phase ( Z3A.38)
·Severe preeclampsia
·G3P2A0 (O42.10 )age ( Z3A.32)
32 weeks gestational
·Threatened
·G4P3A0 24 preterm labor (O60.0)
weeks gestational age not in labor ( Z3A.24)
·Antepartum eclampsia (O15.03)
·G4P3A0 39 weeks gestational age in labor first stage latent phase (Z3A.38)
·Prior CS 38
·G1P0A0 3x weeks
(O34.21)
gestational age inlabor first stage latent phase (Z3A.38)
·Thrombocytopenia
Incomplete Abortion (D69.6)
(O02.9)
Urinary
GTN tract
stage infection
II FIGO (N39.0)
Score 9 (C58)
Dehydration
Death
Recentconceptuslow intake
Diagnosis(O02.10 ) (E86.0)
P3A0 post LSCS on indication severe preeclampsia with breech presentation + post pomeroy tubectomy
10.03.2021
28 weeks
P2A0 postgestational
spontaneous agedelivery
with complete
14 daysplacenta
outside previa + placenta accrete was suspected ( PAI Score 8), SLF cephal
Endometriosis
Recent diagnosiswas suspected
P1A1
Post affpost LSCS on indication anhydramnios, intrauterine infection
cerclage

Severe anemia ( post PRC transfusion 800 cc)


P4A0 Post LSCS on indication severe preeclampsia + prior CS 1x + history of ROM and oligohydramnios ( O82.1 )
Confirmed COVID-19
Severe anemia (microcytic hypochrome) caused by iron deficiency anemia ( D64.9 )
P2A0 post LSCS on indication prior CS 1x + history of ROM 2 days + congenital anomaly
Severe Anemia ( D 64.9 )
P3A0 post spontaneous delivery with syphilis infection
Severe anemia
Post tubectomy poomeroy
P3A2 post LSCS o.i anhydramnios + multiple congenital anomaly + BOH
Recent Diagnosis
P4A0 post LSCS
P1A0 hysterotomy o.i eclampsia
on indication antepartum
fetal distress + HELLP
+ PROM 1 day syndrome + prior CS 1x (o.i severe
+ anhydramnios
P3A0 post LSCS o.i breech presentation + hepatitis B infection
Recent diagnosis
P1A0
P1A1 post LSCS on indication transverse lie + breech presentation
uterine myoma
Post tubectomy pomeroy
Post curettage on indication retained placenta
Severe anemia
P2A0 post spontaneous delivery with preterm with history of ROM 1 day
P2A0 post LSCS o.i severe preeclampsia + partial HELLP Syndrome + hyperglycemia
 
Status : Discharge
Covid 19 was suspected (IgM reactive) (U07.1)

·G1P0A0 25 weeks gestational age (Z3A.25)


·Superimposed
·P3A0 post LSCSpreeclampsia onfetal
on indication chronic hypertension
distress (O14.03)
with severe preeclampsia and complete HELLP syndrome (day 10) (34.
·subfascial hematoma
IUD dislocation
P1A0 post LSCS(T83.32)(O90.2)
on indication severe preeclampsia with CHF FC NYHA IV and IUGR 
Single life fetus cephalic presentation (Z34.0)
P3A0 Post LSCS oi transverse lie
 
G3P2A0 37 weeks gestational age not in labor with HIV infection + multiple keloid single life fetus cephalic presenta
single life fetus cephalic presentation with AEDV and IUGR was suspected
single life fetus cephalic presentation

•G2P1A0
Single life38 weeks
fetus gestational
cephalic age not in labor (Z3A.38)
presentation
•HIV infection (O98.7)
G3P2A0 34 weeks gestational age not in labor (Z3A.37)
Prior CS
P2A1 post2x (O34.21)
LSCS on indication marginalis placenta previa with prior CS 1x with breech presentation (outside) (14th d
G3P1A1 35 weekswas
Placenta percrete suspected
gestational agewith placenta in situ (043.23)
(Z3A.37)33 weeks gestational age not inlabor (D26)
G3P2A0
Prior CS 32
G2P0A1 2x weeks gestational age not inlabor (Z3A.32)
ASD + Eisenmenger
G3P2A0 syndromeage
38 weeks gestational wasnotsuspected (Q21.1)
in labor (Z3A.38)
Prior CS
·P2A1 post
Asymptomatic 2xspontaneous
(O34.21) delivery
urinary tract (2 hours outside) (O80.0)
infection
·Early postpartum hemorrhage caused by vaginal laceration (O72.1)
·G5P1A3
P4A0 37 weeks34 weeks gestational
gestational age age not in
in labor labor
first ( Z3A.33)
stage latent phase
·PROM 1 day (O42.10)
P1A0 Post spontaneous delivery (O80), mild anemia (D64.9)
 
 
P1A0 Post LSCS on indication fetal distress, intrauterine infection, history of ROM 1 day, an hydramnios
P5A0 Post spontaneous delivery with severe preeclampsia
Severe Anemia
P1A0 Post LSCS on indication Twin life-death fetus, intrauterine infection, severe oligohydramnios O31.0

•G3P2A0 38 weeks gestational age not in labor


•Antepartum
•G2P1A0 hemorrhagic
weeks gestationalcaused
age notbyinlabor
totalis placenta previa posterior
•Acute leukemia
G2P1A0 38 weeksdd/ AML age not in labor ( Z3A.38)
gestational
Premature
G5P4A0 33rupture
weeks of membrane
gestational age10not
hours ( O44.013)
in labor (Z3A.35)
Preterm premature rupture of membrane 6
G2P1A0 37 weeks gestational age not in labor (Z3A.37)hours ( O44.02)
Preterm premature
G1P0A0 rupture of membrane
34 weeks gestational age in labor6 first
hoursstage
( O44.02)
latent phase (Z3A.37)
Single life fetus
•Observation cephalic
of vital presentation
signs, contractions, (Z34.0)
and FHR
•O2 10L/m (NRM)
Diagnosa
G2P0A1 39 weeks gestational not inlabor
Single
G1P0A0 life38
fetus cephalic
weeks presentation
gestational age inlabor first stage latent phase (Z3A.38)
Premature rupture of membrane
G1P0A0 33 weeks gestational age 4 hours
(Z3A.33)(O44.012)
Threatened
G2P1A0 39preterm labor ( O47)
weeks gestational age not in labor (Z3A.39)
Prior CS 1x
G1P0A0 38 (on
weeksindication fetalage
gestational distress)
not in (O34.21)
labor (Z3A.37)
PROM 8 35
G2P0A1 hours (O42.10)
weeks gestational age not in labor (Z3A.35)
Severe preeclampsia
G2P0A1 (O14.1) age in labor with prolonged second stage (Z3A.38)
38 weeks gestational
Cephalopelvic
G4P2A1 disproportion
38 weeks gestationalwasagesuspected ( O65.4)
in labor 1st stage latent phase ( Z3A.38)
Prior CS 1x (o.i postterm) (O34.21)
G1P0A0 38 weeks gestational age not in labor ( Z3A.38)
Severe
G1P0A0 preeclampsia (O14.13) age in labor second stage (Z3A.40)
40 weeks gestational
Severe
G8P2A5 preeclampsia (O14. 1) age in labor 1st stage latent phase (Z3A.38)
38 weeks gestational
Prior CS 2xterderness
Abdominal (O34.21) due to peritoneum distension caused by ascites (R10.810)
Ascites caused
G3P2A0 by? gestational
38 weeks (DD/ hemoperitoneum)
age not in labor ( Z3A.38)
Severe Preeclampsia
G1P0A0 ( O14.1) age in labor second stage (Z3A.36)
36 weeks gestational
Severe anemia caused by Fe deficiency( D64.9)
G1P0A0 38 weeks gestational age not in labor ( Z3A.38)
PROM
G3P2A03 35 Hours
weeks gestational Age in labor second stage ( Z3A.38)
Single life
G3P2A0 38 weeks fetus breech presentation
gestational age not(O32.0)
in labor ( Z3A.38)
Severe Preeclampsia (O14)
G2P1A0 35 weeks gestational age not in labor
Prior CS 1x
G1P0A0 ( on indication
37 weeks failed
gestational induction)
in labor first stage latent phase (ZA3A.37)
Premature38rupture
G3P2A0 weeksof membraneage
gestational 6 hours
not in(O42.10)
labor ( Z3A.38)
Prior CS 2x
G6P3A2 38 (weeks
O34.21)gestational age not in labor (Z3A.38) with Hepatitis B infection (070.20)
Single life fetus cephalic
P3A0 post spontaneous expulsion persentation
(O03.9)
History of ROM 3 days (O42.0)
G3P2A0 20 weeks gestational age (Z3A.20)
HSV
G4P3A0 I infection
24 weeks (B00.9)
gestational age (Z3A.24)
SLE
G2P1A0 14 weeks gestational(M32.9)
arthrititis manifestation age (Z3A.14)
Prior CS 1x
G3P2A0 37 (034.21)
weeks gestational age (Z3A.37)
Prior CS 2x
G1P0A0 30 (034.21)
weeks gestational age (Z3A.30)
Single life18fetus
G3P2A0 weeksbreech presentation
gestational (Z37.0)
age (Z3A.18)
Single life38fetus
G1P0A0 weeksintrauterine (Z37.0)
gestational age not in labor (Z3A.38)
Cephalopelvic disproportion
G2P1A0 26 weeks gestational age (Z3A.26)(O33.9)
Preterm
G3P2A0premature 38 weeks rupture of membrane
gestational age (Z3A.38)23 days (O42.10)
Prior
G1P0A0 CS 2x 40 (O34.21)
weeks gestational age not in labor (Z3A.40)
Premature
G3P2A0 39 weeksof rupture membraneage
gestational 1 day ( O44.012)
inlabor first stage latent phase (Z3A.39)
Complete24
G1P0A0 placenta
weeks previa (O44.10)
gestational age (Z3A.24)
•Epilepticus
G1P0A0 status (G40)
39-40 weeks gestational age inlabor first stage active phase
• Severe anemia
G3P1A1 38 weeksc.b iron deficiency
gestational age not in labor
•· Arythmia ( PAC)
G2P1A0 39 weeks gestational age not in labor ( Z3A.39)
·G5P3A1 PROM 1 daysgestational
38 weeks (O42.10) age inlabor 1st stage active phase ( Z3A.38)
Prior
G5P4A0 CS 3x 33 (O34.21)
weeks gestational age not in labor (Z3A.33)
Antepartum
G3P2A0 36 weeks hemorrhagic caused
gestational ageby(Z3A.36)
complete placenta previa (O44.10)
Threatened
G2P1A0 38preterm labor (644.0)
weeks gestational age inlabor first stage active phase (Z3A.38)
Moderate39
G2P1A0 anemia
weeks(285.9)
gestational age inlabor second stage (Z3A.39)
Severe preeclampsia
G2P1A0 (O14.1) age inlabor second stage (Z3A.38)
38 weeks gestational
Covid post
P2A0 19 (confirmed)
spontaneous(U07.1)
delivery (8 hours outside) (Z3A.38)
Early post partum hemorrhagic
G1P0A0 38 weeks gestational age caused bylabor
not in retained placenta (O73.0)
(Z3A.38)
Single
G3P1A1 life35fetus
weekscephalic presentation
gestational age not(inZ37.0)
labor ( Z3A.35)
PROM 6 hours (O42.10)
G3P1A1 38 weeks gestational age not in labor with mitral stenosis Prior CS 1x
Single
· life fetus34
G7P5A1 cephalic presentationage not inlabor
weeks gestational
Severe
· G4P2A1 37Preeclampsia
weeks gestational age inlabor second stage
··G1P0A0
Covid 1927 was suspected
weeks gestational age not inlabor
·· Severe
G1P0A0Preeclampsia
35 weeks gestational age not inlabor
·
G4P2A1 Severe preeclampsia
37 weeks gestational age inlabor second stage
Covid 19 was suspected
G2P1A0 37 weeks gestational age not in labor (Z3A.37)
Prior
G3P2A0 CS 1x 38 (O34.21)
weeks gestational age not in labor (Z3A.38)
Uterine myom
P5A0 post LSCS (D25.9)
on indication anhydramnion (day 9th) (34.21)
Superimposed preeclampsia
P2A3 post LSCS on indication on prior
chronicCShypertension
1x + transverse (O14.13)
lie (day 9th) (O34.21)
P2A0 post spontaneous delivery (outside) (day 9th) (650)
Post curettage
·G3P1A1 on indication
41 weeks early
gestational agehemorrhagic post partum caused by rest of placentae (O73.1) LPP
not in labor(ZA.41)
·Bad obstetric history (O09. 299)
Recent Condition:
Discharge
Recent Diagnosis
P3A1 post
history LSCS1day
of ROM on indication retinal detachment
Recent diagnosis
•P4A0 postwas
COVID1-9 LSCS o.i Prior CS 3x
suspected
•Anhydramnios
•IUGR
P3A0 post spontaneous preterm delivery with multiple congenital anomaly
IUGR

DISCHARGED
Passed Away
On ICU at 06.00
•Covid-19 AM Monday,
was suspected April 12th, 2021
( U07.2)
•Single
P1A1 lifeLSCS
post fetus o.i
cephalic presentation (Z37.0)
malposition
P2A0 post preterm spontaneous delivery with acute myeloid leukemia
Covid 19 Was suspected (U07.1)
Single
G2P1A0 life22fetus intrauterine
weeks (Z21.0
gestational age, SLF intrauterine
Post cerclage on indication cervical
•P1A2 post LSCS of indication Cephalopelvicincompetence
disporpotion
•History of PROM 6 hours
•G2P1A0 41 weeks gestational age not in labor (Z3A.41)
•Singlelife
Single lifefetus
fetusintrauterine
cephalic presentation
( Z26.0) (Z37.0)
Anhydramnios
Single life fetus(O41.1)
cephalic presentation (Z37.0)
•Complete placenta previa with PASD was suspected (O44.1)
•Single life
Multiple fetus breech
intramural presentation
uterine myoma (O32.2)
Anhydramnion (041.0)
Asymmetric
•G2P1A0 6 weeks IUGRgestational
(P05.9) age ( Z3A.6)
•Hyperemesis
•Late post partum gravidarum gradecaused
hemorrhagic II (O21.1)
by retained placenta ( O73.1)
•Covid-19 was suspected ( IgG reactive) ( U07.2)
Diagnosa
G3P2A0 29 weeks gestational age (Z3A.29)
Prior histerotomy 1x (O34.21)
CKD stage V on HD (N18.9)
Single life fetus transverse lie (032.2)

G1P0A0 37 weeks gestational age not in labor (Z3A.34)


Single life fetus cephalic presentation (Z37.0)

Diagnosa
G2P1A0 35 weeks gestational age (Z3A.31)
SLE mild activity with arthritis manifestation (M32.9)
Single life fetus cephalic presentation (Z37.0)
Intrauterine growth restriction (Z36.4 )
G4P2A1 31 weeks gestational age (Z3A.31)
Single life fetus cephalic presentation (Z37.0)
Teratoma sacrococcygeal (Q76.428)

G4P3A0 37 weeks gestational age not in labor (Z3A.10)


History of coronary artery disease (C58)
Single life fetus cephalic
G1P0A0 37 weeks gestational age not in labor ( Z3A.37)
Premature rupture of membrane 12 hours ( O44.012)
Single life fetus breech presentation ( O32.2)
Anhydramnios ( O41.1)

Recent diagnosis
P1A0 post LSCS on indication breech presentation with anhydramnios

G1P0A0 34 weeks gestational age not in labor (Z3A.34)


Preterm premature rupture of membrane 4 days ( O44.9)
Single life fetus cephalic presentation ( Z37.0)
Oligohydramnios ( O41.1)
Tend to be small (P05.10)

Recent diagnosis
P1A0 post LSCS o.i oligohydramnios + Intrauterine infection

G1P0A0 40 weeks gestational age not in labor (Z3A.40)


Single life fetus cephalic presentation ( Z37.0)

Recent condition
P1A0 post LSCS of indication malposition + inertia uterine

G1P0A0 37 weeks gestational age not in labor (Z3A.40)


Single life fetus cephalic presentation ( Z37.0)
G4P3A0 33 weeks gestational age not in labor ( Z3A.33)
Premature rupture of membrane 12 hours ( O44.012)
Prior CS 2x (O34.21)
Single life fetus breech presentation ( O32.2)

G3P2A0 37 weeks gestational age not in labor (Z3A.37)


Imoending eclampsia ( O14.03)
Single life fetus cephalic presentation ( Z37.0)

Recent Diagnosis
P3A0 post LSCS o.i impending eclampsia

G1P0A0 39 weeks gestational age not in labor (Z3A.39)


Failed induction of labor (O61.9)
Single life fetus cephalic presentation ( Z37.0)

Recent diagnosis
P1A0 post LSCS on indication failed of induction

G1P0A0 36 weeks gestational age not in labor (Z3A.36)


PPROM 1 day (O42.10)
Covid 19 was suspected (U07.02)
Moderate anemia (D64.9)
Single life fetus cephalic presentation

G3P1A1 37 weeks gestational age in labor first stage active phase ( Z3A.37)
Prior CS 1x on indication anhydramnios (O34.21)
Single life fetus cephalic presentation

Recent diagnosis
P2A1 post spontaneous delivery with prior CS 1 x

G4P3A0 31 weeks gestational age (Z3A.30)


Prior sc 3 x
SLE with arthritis manifestation
Single life fetus breech presentation
Oligohydramnion (O.41.0)
G2P1A0 36 weeks gestational age
Neoplasm ovarian cyst with serosum type (N83.20)
Single life fetus cephalic presentation (Z37.0)
G1P0A0 39 weeks gestational age not in labor (Z3A.34)
Single life fetus cephalic presentation (Z37.0)
G3P2A0 26 weeks gestational age (Z3A.22)
Single life fetus intrauterine (Z37.0)

G2P1A0 29 weeks gestational age not in labor (Z3A.34)


SLE with arthritis manifestation
Single life fetus cephalic presentation (Z37.0)

G3P2A0 37 weeks gestational age


Single life fetus cephalic presentation

G2P1A0 24 weeks gestational age (Z3A.34)


Single life fetus intrauterine (Z37.0)

G3P2A0 29 weeks gestational age (Z3A.25)


HSV I infection (B00.9)
Single life fetus intrauterine (Z37.0)

Diagnosa
G2P1A0 40 weeks gestational age (Z3A.40)
Prior CS 1x (O34.21)
Covid 19 was suspected (U07.2)
SLF cephalic presentation (Z37.0)

Recent diagnosis:
G2P1A0 40 weeks gestational age (Z3A.40)
Prior CS 1x (O34.21)
G2P1A0 34 weeks gestational age not in labor (Z3A.34)
Antepartum hemorrhagic caused by complete palcenta previa ( O44.03)
Severe preeclampsia ( O14.03)
Moderate anemia (hypochromic microcytic) (D64.9)
SLF cephalic presentation ( Z37.0)
IUGR was suspected

Recent diagnosis :
P2A0 Post LSCS on indication Antepartum hemorrhagic caused by complete palcenta prev

Severe preeclampsia

G2P0A1 27 weeks gestational age (Z3A.27)


Eclampsia antepartum
Complete HELLP syndrome
SLF cephalic intrauterine (Z37.0)

Recent diagnosis:
P1A1 post LSCS on indication Eclampsia antepartum
Complete HELLP syndrome

G4P2A1 27 weeks gestational age (Z3A.27)


Observation dyspneu (covid 19 was suspected)
SLF cephalic intrauterine (Z37.0)
G3P2A0 38 weeks gestational age inlabor first stage active phase (Z3A.27)
Prior CS 2X (O34. 21)
COVID-19 confirmed (U07.1)
Single life fetus cephalic presentation

Recent diagnosis :
P3A0 post spontaneous delivery
Prior CS 2X
COVID-19
Covid confirmed(U07.1)
19 confirmed
Post Tubectomy
Covid-19 pomeroy
infection (66.1)
was suspected
Covid 19 Confirmed
Post curettage on indication rest of placenta
Post brand Andrew manuver on indication incarcerated of placentae
Multiple uterine myoma
Recent diagnosis
P2A0 post LSCS on indication prior CS 1x + interdelivery <18 months
Covid-19 confirmed (U07.1)
Post curettage on indication rest of placenta (O73.0)
Probable Covid 19 confirmed (U07.1)
Covid-19 was confirmed
Covid 19 was suspected
Covid 19 was suspected

Diagnosa
•G2P1A0 34 weeks gestational age not in a labor (Z3A.3)
•Cervival funneling (Y type)
•Cervical shortening 0,42 cm (O34.3)
•TLF transverse lie -breech presentation (Z37.0)
•G2P1A0 37 weeks gestational age not in a labor (Z3A.3)
•Systemic Lupus Erythematous Mild Degree (Mucocutaneous Manifestation) (M32.10)
•SLF cephalic presentation (Z37.0)
•G1P0A0 37 weeks gestational age not in a labor (Z3A.3)
•Intramural uterine myoma (D26.7)
•SLF cephalic presentation (Z37.0)
•G2P1A0 28 weeks gestational age not in a labor (Z3A.2)
•Prior CS 1x (on indication HIV) (O34.21)
•HIV infection (B 20.3)
•SLF cephalic presentation (Z37.0)
•G4P3A0 24 weeks gestational age (Z3A.2)
•Chronic Myelogenous Leukemia (CML) (C92)
•SLF intrauterine complicated by nuchal cord (O69.2)
•G3P0A2 25 weeks gestational age not in labor (Z3A.2)
•Secondary Antiphospholipid Syndrome (APS) ec SLE (O99.1)
•Hipothyroidism (O99.2)
•SLF intrauterine (Z37.0)
•G3P2A0 38 weeks gestational age not in labor (Z3A.3)
•Gallbladder stone (K08)
•SLF cephalic presentation (Z37.0)
•G2P1A0 37 weeks, not in labor (Z3A.3)
•SLF cephalic presentation (Z37.0)
•Fetal growth restriction (O36. 59)
•Umbilical cord cirfumference 1x (O43.123)
•G3P1A1 23 weeks gestational age
•Prior CS 1x oi anhydramnion (O34.1)
•TLF cephalic presentation (O30.029)
•Conjoined twin with dicephalic paraphagus (O30.029)
•G5P3A1 23 weeks gestational age (Z3A.2)
•Right dermoid cyst was suspected, dd/ Cystic ovarium neoplasm with solid part (N83.1)
•SLF intrauterine (Z37.0)
•G3P1A1 34 weeks gestational age not in labor (Z3A.3)
•Prior CS 1x oi malposition (O34.1)
•Post cerclage on indication cervical shortening + funelling (O26. 872.)
•SLF cephalic presentation (Z37.0)
•G3P1A1 23 weeks gestational age (Z3A.2)
•Prior CS 1x oi HIV infection (O34.1)
•HIV infection (O98.7)
•SLF intrauterine (Z37.0)
•G3P2A0 24 weeks gestational age (Z3A.2)
•Shypillis infection (O98.1)
•SLF intrauterine (Z37.0)
•G1P0A0 29 weeks gestational age not in labor (Z3A.29)
•Preterm premature rupture of membrane 3 days (O42.02)
•Asymptomatic urinary tract infection (O86.20)
•Moderate anemia caused by iron deficiency (D50.0)
•Single life fetus cephalic presentation (O32.2)
Oligohydramnios (O41.1)

•G7P5A1 38 weeks gestational age in labor first stage latent phase (O37)
•Prior CS 1x (oi anhydramnios) (O34.21)
•Single life fetus cephalic presentation (O32.2)
Recent diagnosis
P6A1 post spontaneous delivery with prior CS 1x
Post mini-laparotomy tubectomy (Pomeroy tubectomy)
•G5P2A2 30 weeks gestational age not in labor (Z3A.30)
•Single life fetus breech presentation (O32.1)
•Anhydramnios (O41.0)
•Lower urinary tract obstruction was suspected
•Umbilical cord loop 2x (O69.82X0)
Recent Diagnosis
•P3A2 Pos LSCS oi anhydramnios with congenital anomaly

•G1P0A0 35 weeks gestational age in labor second stage (Z34.35)


•Twin life fetus cephalic presentation-cephalic presentation (O30.04)
Recent Diagnosis
P1A0 post spontaneous twin delivery
•G2P1A0 36 weeks gestational age not in labor (Z3A.34)
•Preterm premature rupture of membrane 1 day (O42.02)
•Prior CS 1x (on indication failed of induction) (O34.21)
•Single life fetus cephalic presentation (O32.2)
•Labiopalatoschisis was suspected (Q36)
Recent Diagnosis
P2A0 post LSCS on indication intrauterine infection with PPROM 3 days
•G1P0A0 24 weeks gestational age (Z3A.24)
•Superimposed preeclampsia (O14.13)
•Moderate anemia) caused by iron deficiency (D64.9)
•Single life fetus intrauterine (Z37.0)
Recent Diagnosis
•G1P0A0 24 weeks gestational age (Z3A.24)
•Superimposed preeclampsia (O14.13)
•Moderate anemia caused by iron deficiency (D64.9)
•Single life fetus intrauterine (Z37.0)

•G1P0A0 39 weeks gestational age in labor first stage latent phase (Z3A.39)
•Moderate Anemia caused by iron deficiency (D64.9)
•Single life fetus cephalic presentation (Z37.0)
Recent diagnosis
qP1A0 Post spontaneous delivery
qIron deficiency anemia
•G2P1A0 35 weeks gestational age not in labor (O35)
•Prior CS 1x (oi total placenta previa) (O34.21)
•Total placenta previa (O44.10)
•Tumor previa caused by cervical myoma
•Uterine myoma (D26.0)
•Single death fetus cephalic presentation (O36.4)
•IUGR (03.59)
Recent diagnosis
•P2A0 Post LSCS on indication total placenta previa
•Post myomectomy o.i multiple intramural uterine myoma , subserous uterine myoma
•Post adenomyosis resection on indication uterine adenomyosis
•Post B-lynch suture on indication uterine hypotonia
•G2P1A0 35 weeks gestational age not in labor (O35)
•Prior CS 1x (oi total placenta previa) (O34.21)
•Total placenta previa (O44.10)
•Tumor previa caused by cervical myoma
•Uterine myoma (D26.0)
•Single death fetus cephalic presentation (O36.4)
•IUGR (03.59)
Recent diagnosis
•P2A0 Post LSCS on indication total placenta previa
•Post myomectomy o.i multiple intramural uterine myoma , subserous uterine myoma
•Post adenomyosis resection on indication uterine adenomyosis
•Post B-lynch suture on indication uterine hypotonia
•G1P0A0 34 weeks gestational age in labor first stage active phase (O34)
•Single life fetus cephalic presentation (O32.2)
Recent diagnosis
P1A0 post spontaneous preterm delivery

•G3P2A0 32 weeks gestational age not in labor (O33)


•PPROM 6 hours (O.42)
•Moderate anemia caused by iron deficiency (O99.01)
•Single life fetus transverse lie (O32)
Recent diagnosis
•G3P2A0 32 weeks gestational age not in labor
•PPROM 3 days
•Moderate anemia caused by iron deficiency (O99.01)
•Single life fetus transverse lie
•G1P0A0 40 weeks gestational age in labor (O40)
•Prolonged second stage (O63.1)
•Impending eclampsia (O15)
•COVID-19 was suspected
•Single life fetus cephalic presentation (32.2)
Recent diagnosis
•P1A0 post LSCS oi prolonged second stage with impending eclampsia

•P1A0 post spontaneous delivery 6 hours (outside) with post partum haemorrhage caused by
•Moderate anemia (D64)

•G1P0A0 23 weeks gestational age


•Preterm premature rupture of membrane 11 days
•Single life fetus intrauterine
•Intrauterine infection
•Anhydramnios
Recent diagnosis
•P1A0 post hysterotomy on indication intrauterine infection
•History of PROM 11 days
•Anhydramnios
•G6P5A0 38 weeks gestational age in labor first stage latent phase (Z3A.38)
•Severe preeclampsia (O14.13)
•Single life fetus cephalic presentation
Recent diagnosis
P6A0 post spontaneous delivery with severe preeclampsia

•G3P2A0 39 weeks gestational age first stage in labor latent phase (Z3A.39)
•Prior CS 2x inter-delivery interval 11 months (O34.21)
•Moderate anemia (O99.01)
•Twin life fetus breech-breech presentation
Recent Diagnosis
P2A0 post LSCS on indication prior CS 2x inter-delivery interval 11 months and twin pre
Moderate anemia

•G5P3A1 38 weeks gestational age in labor second stage ( Z3A.38)


•Severe preeclampsia (O14.10)
•Threatened uterine rupture ( O71.1)
•Retained of 2nd baby ( O31.1)
•Moderate anemia (D64.9)
•Single life fetus breech presentation (O32.2)
Recent diagnosis
•P4A1 post cesarean section oi threatened uterine rupture + retained of 2nd baby + severe
•Post Pomeroy tubectomy
•G5P3A1 40 weeks gestational age inlabor first stage latent phase (Z3A.40)
•Premature rupture of membrane 3 days
(O44.02)
•SLF cephalic presentation
•Congenital anomaly (colon dilatation)
(Q89.9)
Recent diagnosis
P4A1 post spontaneous labor with congenital anomaly

•G2P1A0 39 weeks gestational age inlabor first stage latent phase (Z3A.39)
•Premature rupture of membrane 16 hours (O44.021)
•SLF cephalic presentation
Recent diagnosis
P2A0 post SSTP oi non reassure fetal status (low variability fetal heart rate) (O76)

•P1A2 post LSCS on indication prolonged second stage (outside) (O34.21)


•Post ß-Lynch suture after LSCS on indication uterine atonia (Z.48.02)
•Post Uterine artery ligation (T81.719A)
•Hypovolemic shock grade II (R57.1)
•Severe anemia
(D64.9)
•G4P3A0 25 weeks gestational age inlabor first stage latent phase (Z3A.25)
•Prior CS 1x on indication transverse lie (O34.21)
•Post cervical cerclage (27 days)
•Asymptomatic UTI
•SLF intrauterine (Z37.0)
Recent diagnosis
P4A0 post preterm spontaneous delivery with prior CS 1x + post cervical cerclage removal
•G1P0A0 37 weeks gestational age not in labor (Z3A.37)
•Premature rupture of membrane 3 hours (O44.02)
•Hepatitis B Infection (B18.9)
•SLF cephalic presentation
Recent diagnosis
P1A0 post LSCS on indication ROM 9 hours
Hepatitis B infection
diagnosa
• G4P3A0 36 weeks gestational age not in labor (Z34.36)
• Prior CS 3x (O34.21)
• PASD was suspected ( PAI score 5.25 ~ 65%) (O43.21)
• Threatened preterm labor (O60.00)
• Single life fetus cephalic presentation (Z37.0)

• G4P3A0 36 weeks gestational age not in labor (Z34.36)


• Prior CS 3x (O34.21)
• PASD was suspected ( PAI score 5.25 ~ 65%) (O43.21)
• Threatened preterm labor (O60.00)
• Single life fetus cephalic presentation (Z37.0)

· G1P0A0 35 weeks gestational age not in labor with blunt abdominal trauma
SLF cephalic presentation

· G3P2A0 38 weeks gestational age not in labor


· Grave disease – Subclinical hyperthroidism
· Thrombocytopenia
SLF transverse lie

G1P0A0 31 weeks gestational age in labor second stage with PPROM 1 day
SLF cephalic presentation

•G1P0A0 34 weeks gestational age ( Z3A.32)


•Threatened preterm labor (O60.0)
•SLF cephalic presentation

•G1P0A0 37 weeks gestational age not in labor ( Z3A.37)


•Severe preeclampsia (O14.10)
•SLF cephalic presentation

•Pelvic pain caused by cystic ovarian neoplasm was suspected dd/ Endometriosis cyst was

•G2P1A0 26-27 weeks gestational age in labor second stage (Z3A.37)


•SLF footling Presentation

G3P2A0 40 weeks gestational age in labor second stage (Z3A .39)


SLF cephalic presentation (Z37.0)
Fetal Distress (O.68.0)
Umbilical cord prolapse
(O.69. 0XX0)

G5P1A3 30 weeks gestational age not in labor


Prior CS1x (on indication anhydramnios)
Interdelivery 16 months (O.34.21)
SLF Breech Presentation
(O.32.1)
Asymmetrical IUGR (P.05.9)
AREDV (O.77.9)

G6P4A1 39 weeks gestational age in labor first stage latent phase (Z3A .39)
Moderate Anemia (D64.9)
SLF cephalic presentation (Z37.0)

•G5P3A1 32 weeks gestational age not in labor (Z3A.32)


•Antepartum hemorrhagic caused by complete placenta previa (O44.013)
•Severe preeclampsia (O14.1)
•Hypoalbuminemia (E88.0)
•Mild anemia microcytic hypochrome (D64.9)
•SLF cephalic presentation (O32.1)

•G3P1A1 37 weeks gestational age inlabor first stage latent phase (Z3A.37)
•Antepartum hemorrhage caused by complete placenta previa (O44.10)
•Severe anemia microcytic hypochrome (D64.9)
•Single life fetus cephalic presentation (Z37.0)
•Fetal distress (O77.9)

•G1P0A0 37 weeks gestational age not in labor (Z3A.37)


•Mild anemia hypochromic microcyter (O99.01)
•SLF transverse lie (O32.2)

·G3P2A0 38 weeks gestational age inlabor prolonged second stage (Z3A.38)


·Severe preeclampsia (O14.1)
·Premature rupture of membrane 16 hours (O42.02)
·Moderate microcytic hypochrome anemia (D64.9)
·SLF cephalic presentation

G1P0A0 37 weeks gestational age not in labor (O37)


Premature rupture of membrane 2 hours
Anemia cb iron deficiency (D50)
Asymptomatic UTI (N39)
Single life fetus cephalic presentation (O32.2)

•G4P3A0 34 weeks gestational age inlabor second stage (Z3A.34)


•Single life fetus cephalic presentation (O32.1 )

•G3P2A0 39 weeks gestational age not in labor ((Z3A.39)


•Prior CS 2x (O34.21)
•Hemorragic antepartum cb Complete placenta previa (O44.10)
•PASD was suspected (O42.10)
•Moderarte anemia (hypocrom microcytic) (D16.4)
•SLF cephalic presentation (O32.1)

•G2P1A0 38 weeks gestational age in labor first stage latent phase (Z3A.38)
•Prior CS 1x o.i failed of induction (034.21)
•LUS thickness 1.2 mm
•Single life fetus cephalic presentation (Z37.0)

•G2P1A0 36 weeks gestational age ( Z3A.36)


•Threatened preterm labor ( O66.10)
•Prior CS 1x on indication breech presentation ( O34.21)
•Mild anemia (D16.4)
•SLF cephalic presentation (O32.9)

G6P5A0 37 weeks gestational age in labor first stage latent phase


Decrease of consciousness cb SOL
SLF cephalic presentation

•G2P1A0 38 weeks gestational age not in labor (Z3A.38)


•Severe preeclampsia (O14.10)
•Prior CS 1x (O34.21)
•SLF cephalic presentation (O32.9)

•G1P0A0 34 weeks gestational age not in labor (Z3A.34)


•SLF breech presentation (O32.2)
•Symmetrical IUGR was suspected (P06.9)

•G2P1A0 31 weeks gestational age not in labor (Z3A.31)


•Prior CS 1x on indication HIV (O34.21)
•Interdelivery 10 months
•HIV infection (B20)
•Moderate anemia (D64.9)
•SLF cephalic presentation

·G3P2A0 36 weeks gestational age (P07.3)


·Prior SC 2x o.i (CPD) (O34.21)
·Moderate anemia (O99)
·PASD was suspected (O43.21)
·SLF cephalic presentation (O32)

•G1P0A0 39 weeks gestational age inlabor first stage latent phase (Z3A.39)
•Premature rupture of membrane 3 hours (O44.20)
•Mild anemia cb iron deficiency (D64.0)
•SLF cephalic presentation

•Disturbance of Ectopic pregnancy (O00.9)


•Primary infertile 8 years (N97.9)
•Moderate anemia (D64.9)

•G2P0A1 38 weeks gestational age inlabor first stage active phase ( Z3A.38)
•Syphilis infection ( A53.9)
•SLF cephalic presentation

•Cervical cancer stage IVA ( C53.9)


•Gross hematuria ( R31.0)
•Severe anemia ( D64.9)
•Hypoalbuminemia ( E88)
•Leukocytosis ( D72.819)
•Thrombocytosis ( D75.83)
•Hyperkalemia (E87.5)
•AKI stage III dd/ CKD stage V ( N18.5)

•G4P2A1 17 weeks gestational age ( Z3A.17)


•Threatened abortion ( O66.10)
•Cervical incompetence ( O34.3)
•Incomplete longitudinal vaginal septum (Q52.129)
•SLF intrauterine

•G3P2A0 31 weeks gestational age ( Z3A.31)


•Threatened preterm labor ( O66)
•Prior CS 1x on indication hydrocephalus ( O34.21)
•SLF breech presentation ( O32.2)
•Hydrocephalus (caused by holoprocenphaly semilobar) (Q89.9)

•G2P1A0 39 weeks gestational age not in labor (Z3A.39)


•Prior CS 1x (O34.21)
•Single life fetus transverse lie (O32.2)

•G4P2A1 37 weeks gestational age not in labor (Z3A.37)


•Prior CS 2x (O34.21)
•Single life fetus cephalic presentation

•G3P2A0 37 weeks gestational age not in labor (Z3A.37)


•Prior CS 2x (O34.21)
•Single life fetus cephalic presentation

•Adhesiolysis
•Cesarean hysterectomy (68.3)
•Double J stent insertion
•Stab wound drain

•G4P3A0 36 weeks gestational age not in labor (Z3A.36)


•Prior CS 3x (O34.21)
•Single life fetus cephalic presentation
•Oligohydramnios (O36.29)
Prosedur
Laboratory examination (complete blood count and Anti-SARS-CoV-2)
Chest X-ray
Anesthesia assesment
EID assesment
LSCS

Laboratory examination (complete blood count, Hepatitis B marker)


Anesthesia assessment
EID assessment
LSCS
Tubectomy Pomeroy

Stabilization 1-3 hours


Oxygenation
Anticonvulsant
Antihypertension
Laboratory examination
Internal medicine assessment assesment
Anesthesia assessment
LSCS
Laboratory examination
US confirmation
Plan for LSCS after US confirmation

Antibiotics
Anesthesia assessment
LSCS

Stabilization
Lateroposition
O2 3L/m
Urine catheter
Anticonvulsant
Antihypertension
Anesthesia assessment
LSCS
Laboratory examination
Chest-X-ray
EID assessment
Vaginal delivery
Stabilization
Lateroposition
O2 5L/m
Anticonvulsant
Antibiotic
Anesthesia assessment
LSCS
Stabilization
O2
Laboratory examination
Antihypertension
Anticonvulsant
ECG
Internal medicine assessment
Transfusion PRC
Medicinalis
Join care with renal divison
Stabilization
Lateroposition
O2
Plan for ICU treatment
Chest X ray
EID assessment
Antihypertension
Anticonvulsant
Internal medicine assessment
Hysterotomy
IUD Insertion
Laboratory examination
Anesthesiology assessment
Curettage

Stabilization 3 hours
Anticonvulsant
Antihypertension
Laboratory examination
Internal medicine assesment
Anesthesia assessment
LSCS
Conservative management
Laboratory examination
Lung maturation Dexamethasone 12 mg/24 hr IM (2 days)
Tocolytic: nifedipin 10 mg/6 hr PO
Plan for US confirmation
Laboratory examination
PIE assessment
Lung maturation
Plan for abdominal termination
Conservative management
Laboratory examination
Lung maturation Dexamethasone 12 mg/24 hr IM (2 days)
Tocolytic: nifedipin 10 mg/6 hr PO
PRC Transfussion
Plan for US confirmation
Laboratory examination
PRC Transfussion
Anesthesiology assessment
laceration suturing
Plan for curettage

LSCS

Stabilization
Laboratory examination
Internal medicine, EID and anesthesia assessment
Antihypertension
Anticovulsant
LSCS

Laboratory examination
Chest X-ray
Anestesia assessment
EID Assesment
LSCS
Perineal rupture repair
Laboratory examination
Conservative management
Tocolytic
US confirmation

Laboratory examination
Vaginal delivery
Laboratory examination
Inj. Dexametason 12mg (im)
Vaginal delivery
• Vaginal swab
Plan for US obstetric
• Hemoglobin electrophoresis
• PRC Transfussion
LSCS + tubectomy
Plan for pomeroy
LSCS 05.02.2021
Transfusion
Internal PRC until
medicine Hb >10gr/dl
and anesthesia assessment
LSCS
Internal medicine, neurology, P1 and anesthesia assessment
•LSCS
Brandt Andrew Manuver
• Perineal laceration suturing
Lung maturation
•· EID
Obstetric US examination
assessment
•· Vaginal delivery assessment
internal department
Ultrasound examination
• cystoscopy
LSCS
• Moderate anemia (microcytic hypochrome)
• Single live fetus cephalic
Cervical Ripening presentation
(misoprostol 25mcg/6 hours pv)
• Plan for vaginal deliveryà failed à plan for LSCS
LSCS
• Laboratory examination
• LSCS
PCR Swab
PRC transfusion
• Chest-X-Ray
••Laboratory
LSCS examination
LSCS
• Assesment vascular surgeon division
Plan for sectio secarea at February 19th 2021
• Antibiotic
• US confirmation
Anesthesia, EID assessment
•· PRC
LSCStransfussion
· Sectio
Plan forsecarea + hysterectomy
abdominal termination
· Antibiotic
Vaginal Delivery
· EID asessment
··Laboratory
LSCS examination
· Partial extraction
Transfusion PRC
Plan for LSCS
Tamponade
PRC transfusion
Internal medicine assessment
Vaginal delivery
Laboratory à failed à LSCS
examination
•LSCS
PRC transfusion
••Plan
Curettage
for vaginal delivery (Induction of labor ) à patient refused
• Plan for LSCS
Antibiotic
• US confirmation
Transfusion PRC
LSCS
LSCS
· Cesarean section
•· Hysterectomy
EID assessment
•· EID
Plan and
for LSCS
Anasthesia Assesment (89.09)
•· LSCS (74.1 ) tubectomy
EID assessment (89.09) (V25.2)
•· PTU
Vaginal
200delivery (650
mg/ 8 hours
·Internal
LSCS (74.1 )
medicine assessment ( 89.09)
High protein diet ( V67)
Plan vaginal delivery( 75.0)à failed
LSCS
· Lung maturation
··Observation
Antibiotics of vital sign , contraction and FHR
Plan for vaginal delivery
· Tocolitics
Lungassessment
· EID maturation(89.09)
· Plan for termination perabdominal (74.1)
procedure

· EID assessment (88.78)


· LSCS (74.1)

• Observation of vital signs, contractions, and FHR


• O2 10L/m (NRM)
• Lung maturation (99.1)
• Antihypertension
• Joint care Internal Medicine
• Obstetric US examination (88.7)

· LSCS (74.1)

Laboratory examination ( V72.62)


LSCS ( 74.1)
Laboratory examination ( V72.62)
LSCS ( 74.1)

Laboratory examination ( V72.62)


LSCS ( 74.1)
• Laboratory examination (V72.62)
• Bed rest
• Tocolytic ( 99.21)
• Antibiotics ( 99.21)
• PRC transfusion (V58.2)
• MRI (88.95)
• Urology and vascular surgery assessment (89.9)
• Plan for termination perabdominal ( 74.1)
Informed choice --> LSCS ( 74.1)
Vaginal delivery (650)
Vaginal delivery (650)
Cervical ripening
Vaginal delivery (650
LSCS (74.1)
Conservative Management  Fetal distress  LSCS 
Dermatovenereology assessment
Vaginal delivery (650)
Transfusion of blood and blood component (99.0)
Pomeroy Tubectomy (66.32)
Pomeroy Tubectomy (66.32)
Stable in VK
LSCS (741)
An hydramnios
Cutis oedema on fetal A (life)
US Examination 88.78
Vaginal
88.78 delivery
: US 644.21 for gravid women
examination
88.78 : US examination for gravid women
Plan for termination per abdominal ( 74.1)
CPR
Low salt diet
HD as scheduled
Ultrasound confirmation (88.7)
Folic acid tab 1x400mcg
Fe tab 3x1
Stable in VK
Laboratory exam
Folic acid tab 1x400mcg
Laboratory examination
Folic acid tab 1x400mcg
Plan for LSCS on March 29th 2021
Plan for LSCS on March 31st 2021
Control on April 1st 2021
Control on April 1st 2021
Referred to Harapan Kita Hoespital for fetal therapy
Control on April 15th 2021
Control on April 1st 2021
Control on April 15th 2021
Plan for LSCS
Control on April 1st 2021
Plan for curretage  patient refused
Plastic surgery and endocrinology assessment

Wound Care (96.5)


Wound Care (96.5)
Antihypertension (796.2)
 

LSCS
LSCS
Tubectomy Pomeroy
Tubectomy Pomeroy
tubectomy Pomeroy
Multivitamin
• Multivitamin ( 99.21)
• Plan for LSCS (74.1)
• CaCO3 1x1
• Plan for LSCS ( 74.1)
• Continued ARV therapy ( 99.21)
• Laboratory examination
• FeSO4 1x1
( March, 16th 2021)
• Folic acid 1x1
• FeSO4 1x1 examination
Laboratory
• Plan for LSCS (March 12th 2021)

• Plan for DnC


Laboratory examination and anesthesia consult ( March, 11th 2021) (V72.62; 89.09)
• Folic acid 1x1
• FeSO4 1x1
•Control ( March,
FeSO4 1x1 17th 2021)
• Aspirin 80mg 1x1
• Antihypertension (796.2)

Hysteroscopy D&C (68.12)


·Stabilization
·Laboratory examination
·Expectative management ( V72.62)
·Laboratory examination
·Observation of vital signs( V72.62)
·Anticonvulsan
·LSCS (74.1) (99.2)
·Adhesiolisis
LSCS
·
·Laboratory examination( V72.62)
·Antibiotic (99.2)
Rehydration with crystalloid 1600 cc in 4 hours (99.1)
Leucogen
·Observation Injection
of vital
Internal medicine, 300
signmg ( 99.21)
anesthesia assessment( 89.09)
·D n Cand
LSCS (69.02)
pomeroy
Multidisciplinary tubectomy
approach (74.1) Vascular and urology surgery department assessment ( 89.09)
– Radiology,
PRC for
Plan transfusion
curettage( (69.02)
99.04) (24 hours free of fever or no sign of infection)
Febrile
Z79. evaluation
2 antibiotics
 74.1 Low segment cesarean section

Pelvic MRI ( 88.11 )


LSCS
 
 
US confirmation (88.97)
-36 examination
US weeks gestational age, SLF cephalic presentation with congenital anomal
(88.79)
Plan for vaginal delivery (650)
Anesthesia assessment
Anesthesia Assessment
Plan for LSCS ( 74.1)
Hysterotomy (68.0)
·Plan for LSCS (74.2)
Plan for LSCS (74.2)
LSCS ( 74.1)
LSCS ( 74.1)
LSCS and tubectomy pomeroy ( 74.1; 66)
 
 
Vaginal delivery ( 650)
LSCS (74.1)
LSCS (74.1)

Vaginal delivery (650)

·Hospitalized
·Expectative
•Family management
planning counselling (V25.09)
•Wound
Tubal Care
Hysteroscopy (96.5)
LigationD&C (68.12)
(V26.51)
Plan for vaginal delivery (650)
IUD insertion (69.7)
US Confirmation
Tubal ligation

Caesarean section

LSCS (669.7)
Tubectomy Pomeroy (66.62)
IUD insertion (69.7)
·LSCS (74.1)
·Total abdominal
Laprotomy hysterectomy (68.4)
exploration:
•Total abdominal
·LSCS (74.1) hysterectomy (68.4)
·Total abdominal
·Cesarean hysterectomy (68.4)
section (74)
·Hysterectomy(68.4)
·LSCS (74.1)
LSCS (74.1) Pomeroy (66.62)
·Tubectomy
Total abdominal
·Laboratory
LSCS hysterectomy
(74.1)examination (68.4)
(V72.62)
·Antibiotic (99.21)
·Laboratory examination
Plan for vaginal delivery (V72.62)
·Antibiotic
Ferrous (99.21)
sulfat 300 mg/ 24 hours
Plan for curettage after general condition improvement (69.0)
EID assessment (89.0)
EID Assessment

LSCS (74.1)

•Laboratory examination
•MRI pelvic of vital sign, contraction and FHR
•Observation
•US confirmation
Laboratory ( in working
examination hours)
( V72.62)
EID assessment
Laboratory ( 89.09)( V72.62)
examination
Antibiotic (examination
Laboratory 99.21) ( V72.62)
Anaesthesiaexamination
Laboratory and EID assessment
( V72.62)( 89.09)
Plan for
P1A1 vaginal
post LSCS delivery
c.b ASD (Q21.1)
Severe
forpreeclampsia
Procedure
Plan (O42.10 )
vaginal delivery

Laboratory examination ( V72.62)


PRC transfusion
Laboratory (99.04) (V72.62)
examination
Lung maturation
Laboratory (99.21)(V72.62)
examination
EID and anaesthesia
Observation assessment
vital sign, contraction and FHR
Laboratory examination
Observation (V72.62) and FHR
vital sign, contraction,
Stabilization
Observation of vital sign, contraction and FHR
Laboratory examination
Observation of vital sign,(V72.62)
contraction, FHR
Laboratory examination. (V72.62)
Observation of vital sign, contraction, FHR
Laboratory
Observationexamination
of vital sign,(V72.62)
contraction and FHR
Laboratory examination (V72.62)
Observation of vital sign, contraction, FHR
Laboratory
Observationexamination.
of vital sign,(V72.62)
bleeding and acites
Laboratory examination (V72.62)
Stabilization
Observationexamination
Laboratory of vital sign,(V72.62)
contraction, FHR
EID assessment ( 89.09)
Stabilization
Observation of vital sign, contraction, FHR
Vaginal breech delivery (652.2)
Stabilization
Observation of vital
vital sign,
sign, contraction,
contraction andFHR
FHR
O2 10L/minute
Observation vital(NRM) ( 99.31) and FHR
sign, contraction
Laboratory examination (V72.62)
Plan elective
LSCS (74.1) LSCS + tubectomy pomeroy
Tubectomy pomeroy
Mini laparotomy (66.62) Pomeroy (66.63)
Tubectomy
Control on the next 4 weeks
Evaluation
Suggestion:ofHospitalized
HSV I IgG for IgMPRC
leveltranfusion
Folic acid
Control on3x1
the next 4 weeks
Education
Hospitalized : Plan for PRC tranfusion
Plan for on
Control elective LSCS
the next after general condition improvement
4 weeks
Education
Control on the next 4 weeks
USG evaluation
LSCS (74.1) in 1 month
Myomectomy (68.29)
Hysterotomy (68.0)
LSCS (74.1)
Tubectomy pomeroy (66.62)
Laboratory examination (. V72.62)
Anesthesia assessment
Laboratory examination (. ( 89.09)
V72.62)
Anesthesia
US assessment
confirmation ( 89.09)
( 88.78)
Joint care with
Observation of neurology department and FHR
vital sign, contraction
Vaginal delivery
Observaiton of vital sign, contraction anf FHR
EID, internal
Observation of medicine ( cardiology)
vital signs, assessment
contractions, and FHR
Antibiotic
Observation of vital sign, contraction, FHR
Laboratory examination. (V72.62)
examination (V72.62)
Anesthesia
Laboratory assessment
examination( (V72.62)
89.09)
Consservative management
Laboratory examination (V72.62)
EID assessment (89.09)
Stabilization
Laboratory examination (V72.62)
EID assessment
Laboratory (89.09) (V72.62)
examination
Manual placenta
Observation of vital (75.4)
sign, contraction and FHR
Laboratory examination
Observation of vital signs, (V72.62)
contractions, and FHR
Expectative
LSCS management
Tubal ligation
· Observation of vital signs, contractions, and FHR
·· Chest X-ray
Stabilization 1-3 hour
· Observation of
Stabilization 1-3vital
hoursigns, contractions, and FHR
· Observation
Observation of vitalofsigns,
vital signs, contractions,
contractions, and FHR
and FHR
Chest X-ray
Plan for elective LSCS on April 22nd 2021 (74.1)
Consult
Plan for to anesthesia
elective LSCSdepartment
on April 15th 2021 (74.1)
Consult to anesthesia
Wound Care (96.5) department
Antihypertension (E94.2) (V65.40)
Family planning counselling
Wound Care (96.5)
Family planning counselling (V65.40)
·Observation vital sign, contraction and FHR
·EID assessment (V65.9)
Curettage report
Curettage was performed, there were tissue and blood for 150 cc
LSCS (74.1)assessment (89.09)
Anesthesia
LSCS ( 74.1)
LSCS + tubectomy
US confirmation ( 88.78)
Lung
On maturation
April, : dexamethasone
13th 2021; 00.30 AM -> 12TI 8mg/24 hours to
-> decided ( 99.21)
vaginal delivery
Joint conference results : conservative management
Laboratory examination ( V72.62)
Tocolytic ( 99.21)
CPR

Swab (74.2)
LSCS result à the result has not out yet
Plan for vaginal delivery ( 650.0)
Antibiotic ( 99.2)
Cerclage (67.51)
Tocolytic ( 99.21)
TOL – Failed - LSCS

Cervical Ripening plan for Vaginal delivery (650.0)


Evaluation of intrauterine infection marker
Vascular surgery assessment ( 89.09)
Lung maturation
Myomectomy : dexamethasone 12 mg/24 hours ( 99.21)
(68.29)
Informed choice -> patient choose for pregnancy termination 
Laboratory examination ( V72.62)
IVFD RL : D5 1;1
EID assessment drips xx/minute ( 99.21)
( 89.09)
Chest-X-Ray ( 87.4)
Procedure
Control in 1 week
Medication (99.21)
- CaCO3 3x500mg
- Folid acid 1x400mg
- Sulfas ferrous 1x1
Nifedipine 1x10mg
Heparin 5000/12 hours (SC Injection)
Education :
- Water intake
restriction
- Low salt diet
- HD as scheduled
Control in 1 weeks
FeSO4 tab 1x300mg
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Procedure
Hospitalized
Laboratory examination
Lung maturation
US confirmation
Control in 2 weeks
Education
Folic acid 1x400mcg
CaCO3 tab 3x500mg
Sulfas ferrous 1 x 1 tab
Control in 1 week
Cardiologist and Anasthesia consultant

Antibiotic ( 99.2)
LSCS ( 74.1)

OUTCOME
11.00 PM Life neonatus was born, female, weight 2500 gram, length 45 cm, A/S 8/9 FT AGA followed Placenta was
Lung maturation ( 99.21)
Antibiotic ( 99.2)
LSCS (74.1)

06.21 AM Life neonatus was born, female, weight 1600 gram, length 44 cm, HC 32 cm A/S 8/9 PT SGA

Recent condition
Stable in ward
Laboratory examination ( V72.62)
Cervical Ripening with misoprostol 25 mcg/6 hours (734)
Plan For Vaginal delivery (650) 🡪 Failure
LSCS (74.1)

Outcome
11.50 AM Life neonatus was born, male, weight 2750 gram, length 48 cm, HC 32 cm A/S 8/9 FT AGA
11.55 AM Placenta was delivered completely, weight 480 gram, umbilical cord length 46 cm, diameter 18x17 cm
Laboratory examination ( V72.62)
Vaginal delivery
Conservative management
Lung maturation
Tocolytic
Antibiotic

Recent condition
Stable in ward
Stabilization
Antihypertension and anticonvulsant ( 99.21)
Ophtalmology assesment
LSCS (74.1)

OUTCOME
02.00 PM Life neonatus was born, female, weight 3500 gram, length 48 cm, A/S 8/9 FT AGA followed Placenta was
Laboratory examination
Cervical ripening 🡪 misoprostol 25 mcg pervaginam 🡪 failed
LSCS

Outcome
04.20 PM Life neonates was born, male, weigh 3200 gram, length 48 cm, HC 32 cm, A/S 8/9

04.25 PM Placenta was delivered completely, weight 510 gram, umbilical cord length 43 cm, diameter 19x18 cm
Observation of vital sign, contraction and FHR
Conservative management
Antibiotics
Tocolitics
Lung maturation
PRC Transfusion
X-ray Thorax
EID assessment
Observation vital sign, contraction and FHR
Plan for TOLAC

Outcomes :
02.15 AM Life neonates was born, male, weight 2600 gram, length 46 cm, A/S 8/9
02.25 AM Placenta was delivered completely
Hospitalized
Lung Maturation
Dexamethasone 10 mg/ 24 hours for 2 days
Antibiotic
Ampicilin 1 gram / 6 hours Intravenous
Gentamycin 80 mg / 12 hours interavenous
Tocolytic:
Nifedipine 10 mg/ 6 hours (PO)
Plan for pregnancy termination
Control in 1 weeks
Planning for C-Section and Laparotomy FS on June 14th 2021

Planning for termination (induction of labour)


Plan for vaginal delivery 🡪 failed of induction 🡪 LSCS
Control on the next 4 weeks
Medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 2 weeks
medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1tab/24 hours (PO)
Metylprednisolone 4 mg / 24 hours (PO)
Imuran 50 mg/ 24 hours (PO)
Control on the next 1 week
medications
-CaCO3 500mg/ 8 hours (PO)
- Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 4 weeks
Medications
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
Sulfas ferrous 1 tab/24 hours (PO)
Control on the next 4 weeks
Medication (99.21)
-CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
- Sulfas ferrous 1tab/24 hours (PO)
Procedure
Observation of vital sign, contraction, and FHR
EID assessment
LSCS(74.1)

Outcome :
07.35 PM Male live neonatus was born, BW 2800 g, BL 47 cm, A/S 8/9 FT AGA
07.40 PM Complete placenta was born cpmpletely ,
Observation vital sign, FHR and contraction
Lung maturation 🡪 finished
Anticonvulsant : MgSO4 ~ protocol
Antihypertension
Urine catheter
PRC transfusion
LSCS

Outcomes
00.40 AM Life neonates was born, female, weight 1400 gram, length 37 cm, HC 29 cm APGAS
Score 8/9 FT AGA
00.45 AM Placenta was delivered completely,
Observation of vital sign, contraction, and FHR
Stabilization :
- Oxygen
- Antihypertension
- Anticonvulsant
Laboratory exam (V72.62)
LSCS

Outcomes : 06.08.2021 : 02.20 AM Life neonates was born, male, weight 1100 gram, length 37 cm, HC 29 cm APGA
00.45 AM Placenta was delivered completely,
Observation of vital sign, contraction, and FHR
Stabilization
Conservative management
Observation of vital sign, contraction, and FHR
PIE assessment
LSCS 🡪 no operative room 🡪 Vaginal delivery

Outcomes
03.45 AM Life neonates was born, female, weight 2650 gram, length 45 cm, A/S 8/9
03.50 AM Placenta
Conservative was delivered
management completely
🡪 maternal distress 🡪 LSCS
07.20 PM placenta delivered completely, weight 90 gram, umbilical cord length 29 cm, diameter 12x11 cm
Internal medicine Assesment
Vaginal delivery 🡪 rest of placenta 🡪 curettage
Brand Andrew manuver
Anasthesia assessment
LSCS (34.21)

Observation of vital sign, and bleeding


curettage (69.02)
Tubectomy
Vaginal delivery
LSCS
LSCS

Prosedur
•Observation of vital sign, contraction and FHR
•Laboratory examination
•Expectant management
•Maternal rehydration
•Lung maturation
•Antibiotic
•Iron supplementation
•Obstetric ultrasound examination
•Observation of clinical sign of infection and laboratory findings
•Observation of vital sign, contraction and FHR
•Laboratory examination (V72.62)
•Vaginal delivery (650)
•Mini-laparotomy tubectomy (66.1)

Observation of vital sign, contraction and FHR


Laboratory examination
Lung Maturation
LSCS (74)
Outcome
04.05 PM Life neonatus born, male, weight 1600 gram, length 39 cm,
HC 27 cm A/S 5/6/8 PTSGA
Congenital anomaly:
Potter’s face ,Low set ear, micrognathia, club foot, megalourethra
04.10 PM Placenta was delivered completely,
Observation of vital sign, contraction and FHR
Laboratory examination
Vaginal delivery (650)
Outcome
04.05 PM Life neonates was born, male, weight 1740 gram, length 41 cm, HC 29 cm A/S 8/9
04.10 PM Life neonates was born, male, weight 2240 gram, length 44 cm, HC 31 cm A/S 8/9
Placenta: monochorionic-diamniotic
•Observation of vital sign, contraction and FHR
•Antibiotics
•Lung maturation (99.2)
•Obstetric ultrasound examination (88.78)
•LSCS
Recent Diagnosis
Stable in ward
•Observation of vital sign, contraction and FHR
•Stabilization
•Expectant management
•Lung maturation (99.2)
•Anticonvulsant
•Antihypertension
•Internal medicine
•Obstetric ultrasound examination (88.78)
Recent Diagnosis
Stable in ward
•Observation of Vital signs, contraction, FHR
•PRC transfusion (99.04)
•Vaginal delivery (65.0)
Outcomes :

11.35 PM life neonate was born spontaneously, female weight 3250 g, length 51 cm HC 31 cm
•Observation of vital sign, contraction
•Laboratory examination
•Observation of vital sign, contraction
•Laboratory examination
•Cesarean section
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
•B-Lynch
Outcome
10.05 AM death neonate was born, female, 1800 gram, body length 42 cm, maceration grade III
10.08 AM placenta was born completely, weight 400 gram, umbilival cord length 40 cm diameter 16x15 cm
•Observation of vital sign, contraction
•Laboratory examination
•Observation of vital sign, contraction
•Laboratory examination
•Cesarean section
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
B-Lynch

•Observation of vital sign, contraction and FHR


•Laboratory examination
•Vaginal delivery
Outcome
08.10 PM Life neonates was born, male, weight 2300 gram, length 45 cm, A/S 8/9 PT AGA
08.15 PM Placenta was delivered completely
•Observation of vital sign, contraction
•Laboratory examination
•Lung maturation
•Tocolitic
•Antibiotic
•Iron supplementation
•Obstetric ultrasound examination

Observation of vital sign, contraction


Laboratory examination
Stabilization
Anticonvulsant
Antihypertension
LSCS
Outcomes :
530,335,648
07.49 AM live neonatus was born, male, weight 3000 gram, length 49 cm, HC 35 cm A/S 7/9 PTAGA
07.55 AM Placenta was delivered completely
Observation of vital signs, contraction, bleeding
Laboratory examination
Plan for PRC Tranfusion
Plan for Curettage
•Observation of vital sign, FHR, contraction
•Expectant management (failed)
•Rehydration
•Antibiotic
•Evaluation of intrauterine infection (clinical symptom and laboratory)
•Informed choice
•Pregnancy termination: labor induction (after 12 hours à no progress of labor) à decided to abdominal termination
Outcomes
12.15 PM Life neonates born, female, weight 700 gram, length 30 cm, HC 22 cm A/S 1/1/3 PT AGA
12.20 PM Placenta was delivered completely, weight 198 gram, umbilical cord length 28 cm, dimeter 10x12 cm
Stabilization 3 hours
Anticonvulsion
Antihypertension
Observation of vital sign, FHR
Laboratory examination
Internal medicine assessment
Labor acceleration
Vaginal delivery
Outcome :
10.55 PM Life neonates born, female, weight 3670 gram, length 48 cm, HC 34 cm A/S 8/9 FT AGA
11.00 PM Placenta was delivered completely, weight 600 gram, umbilical cord length 45 cm, diameter 20x21 cm
Observation of vital sign, contraction, fetal heart rate
Laboratory examination
Anasthesia assessment
LSCS
06.00 PM Operation started. Amniotic fluid is sufficient. Baby was delivered with cephalic extraction
06.17 PM male live baby was delivered, body weight 2900 g, body length 47 cm, head circumference 31 cm APGAR
06.20 PM male live baby was delivered, body weight 2500 g, body length 45 cm, head circumference 3 cm APGAR S
07.30 Operation finished

•Laboratory examination (V72.62)


•Stabilization
•Antihypertension (99.21)
•Anticonvulsant (99.21)
•Internal medicine and anesthesia assessment (89.09)
•PRC transfusion
•Cesarean section and Pomeroy tubectomy ( 74.21)
Outcomes
05.25 AM male, weight 3000 g, length 47 cm, HC 34 cm A/S 8/9 FTAGA
•Observation of vital sign, and FHR
•Drip acceleration
•Laboratory examination
(V72.62)
•Antibiotic
•Vaginal delivery (650.0)
Outcome
08.00 PM Life neonates was born, male, weight 3600 gram, length 50 cm, A/S 8/9 FT AGA , Imperforate anus
08.15 PM Placenta was delivered completely, weight 575 gram, umbilical cord length 48 cm, diameter 20x21 cm
Recent condition
Stable in ward
•Laboratory examination (V72.62)
•Antibiotic (99.2)
•Vaginal delivery (650.0)
Outcomes
00.05 AM life neonates was born, female, weight 3200 gram, length 47 cm, HC 34 cm A/S 8/9 FTAGA
00.15 AM Placenta was delivered completely, weight 580 gram, umbilical cord length 32 cm, diameter 22x19 cm
•General condition improvement
•PRC transfusion
•Laboratory examination
•P1 Assement

•Laboratory examination ( V72.62)


•Cervical cerclage removal
•Antibiotic
•Vaginal delivery (650.0)
Outcomes
04.40 PM Life neonates was born, female, weight 660 gram, length 29 cm, HC 22 cm, A/S 0/1/1
04.45 PM Placenta was delivered completely, weight 105 gram, umbilical cord length 27 cm, diameter 14x15 cm
•Laboratory examination (V72.62)
•LSCS ( 74.21)
Outcomes
08.10 PM Life neonates was born, female, weight 3200 gram, length 49 cm, HC 34 cm, APGAR Score 7/9
08.15 PM Placenta was delivered completely, weight 500 gram, umbilical cord length 47 cm, diameter 17x18 cm

procedure
• Observation of vital sign, contraction and FHR (V71.09)
• Laboratory examination (V72.62)
• Lung maturation (659.8)
• Tocolytic (644.03)
• Obstetric ultrasound (75.99)

• Observation of vital sign, contraction and FHR (V71.09)


• Laboratory examination (V72.62)
• Lung maturation (659.8)
• Tocolytic (644.03)
• Obstetric ultrasound (75.99)

· Observation of vital sign, contraction and FHR


· CTG
· Tocolytic
· Evaluation 2x 4 hours
Discharge

Observation of vital sign, contraction and FHR


Laboratory examination
ECG
CTG
TC/TF transfusion
Asssesment of Internal medicine
Plan for Elective CS + Tubectomy after general condition improvement

Observation of vital sign, FHR


Laboratory examination
Antibiotics
Vaginal delivery

•Laboratory examination (V72.62)


•US examination (88.78)
•Vaginal swab (V76.2)
•Lung Maturation (Z36.84)
•Tocolytic

•Laboratory examination ( V72.62)


•Stabilization
•MgSO4 ~ protocol ( 99.21)
•Antihypertension ( 99.21)
•Internal medicine assessment ( 89.09)
•Cervical ripening with misoprostol
•Vaginal delivery
Exploration laparotomy (Monday, December 20th 2021)

•P1A0 post LSCS on indication fetal tachycardia + Asthma attack with moderate degree

Oxygenation NRM 15l/m


Intrauterine resuscitation
Trendelenburg position
Filler urinary catheterization
Anasthesia assessment
LSCS
Pomeroy tubectomy
Hayman suture

•Observation of vital sign, contraction and FHR


•Laboratory examination (V72.62)
•Conduct of labor
•Observation of Vital signs, contraction, FHR
•PRC transfusion (99.04)
•Plan for vaginal delivery (65.0)
•Portio laceration suture (71.09)

•Stabilization (99.6)
•Laboratory examination (V72.62)
•Internal medicine and anesthesia assessment (89.09)
•Albumin 20 % every 24 hr
•LSCS (74.1)

•Observation of vital sign, contraction, and FHR (Z04.9)


•Resuscitation (93.0)
A : clear
B : O210/l NRM
C : fluid resuscitation
•Laboratory examination (V72.62)
•PRC transfusion (99.04)
•Anesthesia assesment
•LSCS (74.1)

•Observation of vital sign, contraction, FHR (Z04.9)


•Laboratory examination (V72.62)
•Anesthesia assessment (18.2)
•Plan for elective LSCS (74.1)

•Stabilization
•Laboratory examination (V72.62)
•CTG
•LSCS (741)

Observation of vital sign, contraction, fetal heart rate


Laboratory examination
Antibiotic
Cervical ripening
Plan for vaginal delivery

•Observation Vital signs, contraction, FHR


•Laboratoris Examination ( V72.62)
•Vaginal delivery (75.82)
•Plan to tubectomy Pomeroy (November , 30th 2021) (66.29)

•Observation of vital sign, contraction and bleeding


•Laboratory examination (V72.62)
•PRC transfusion (99.04)
•US confirmation (88.78)
•MRI
•Urology and vascular surgery assessment
•Plan for cesarean hysterectomy
•Observation of vital sign, contraction, and FHR
•Laboratory examination (V72.62)
•Anesthesia assmnt (89.09)
•LSCS (74.1)

•Laboratory examination ( V72.62)


•CTG
•US Obstetrical examination ( 88.77)
•Tocolytic ( 99.2)
•Lung maturation ( 99.2)
•Antibiotic (99.21)
Plan for LCS

P1 ward
Observation of vital sign, contraction and FHR
Laboratory examination
Plan for LCSC

•Stabilization
•Internal medicine and anesthesia assessment (89.09)
•Laboratory examination (V72.62)
•Antihypertension (99.21)
•Anticonvulsant (99.21)
•Plan for LSCS

•Laboratory examination (V72.62)


•Lung maturation (99.21)
•US confirmation (88.78)

•Laboratory examination (V72.62)


•PRC transfusion (99.04)
•US confirmation (88.78)
•Vaginal delivery ( 650.0)

•Exploration laparotomy (54.1)

•Vaginal delivery ( 650.0)


•Dermato-venerology assessment ( 89.09)

•Cervical biopsy (67.12)


•Chest-X-Ray ( 87.4)
•US confirmation ( 88.79)
•BNO-IVP ( 87)
•Clinical staging
•Urology assessment ( 89.09)
•Internal medicine assessment ( 89.09)
•General condition improvement
•PRC Tranfusion
•Laboratory examination ( v72.62)
•Tocolytic
•US confirmation ( 88.79)
•Vaginal Swab
•Bed Rest
•Plan for Cerclage

•Conservative Management
•US Confirmation ( 88.78)
•Bedrest
•Tocolytic
•Lung Maturation

•LSCS (74.1)

•LSCS (74.1)
•Tubal ligation (66.39)

•Cesarean section (74.1)


•Pomeroy tubectomy (66.39)

•P3A1 post cesarean hysterectomy on indication placenta accreta spectrum disorder


•Post Double J stent indertion
•Post Stab Wound Drain

•LSCS (74.1)
•Pomeroy tubectomy (66.39)
ent ( 89.09)
GA followed Placenta was delivered completely

A/S 8/9 PT SGA

/9 FT AGA
m, diameter 18x17 cm
GA followed Placenta was delivered completely

3 cm, diameter 19x18 cm


h 37 cm, HC 29 cm APGAR Score 0/0/3/7 PT AGA

meter 12x11 cm

Curettage after general condition improvement (69.02)


PRC transfusion( 99.00)
meter 16x15 cm
/9 PTAGA

abdominal termination

m, dimeter 10x12 cm
m, diameter 20x21 cm

umference 31 cm APGAR Score 8/9 FTAGA


umference 3 cm APGAR Score 8/9 FTAGA

GA , Imperforate anus
8 cm, diameter 20x21 cm
A/S 8/9 FTAGA
32 cm, diameter 22x19 cm

7 cm, diameter 14x15 cm

APGAR Score 7/9


7 cm, diameter 17x18 cm
GYNECOLOGY OUTPATIENT REPORT
No. Bulan Tanggal
1 Januari 08 Januari 2021

2 08 Januari 2021

3 08 Januari 2021

No. Bulan Tanggal


1 Januari 12 Januari 2021
2 12 Januari 2021
3 12 Januari 2021

4 12 Januari 2021
FERTILITY AND ENDOCRINOLOGY OUTPATIENT REPORT
Friday, January 08th 2021
No. Bulan Tanggal
1 Januari 08 Januari 2021

2 08 Januari 2021
3 08 Januari 2021

4 08 Januari 2021

No. Bulan Tanggal


1 Januari 11 Januari 2021

2 11 Januari 2021

No. Bulan Tanggal


1 Januari 12 Januari 2021
2 12 Januari 2021

No. Bulan Tanggal


1 Januari 13 Januari 2021
2 13 Januari 2021

3 13 Januari 2021

No. Bulan Tanggal


1 Januari 14 Januari 2021

2 14 Januari 2021

No. Bulan Tanggal


1 Januari 12 Januari 2021

No. Bulan Tanggal


1 Januari 14 Januari 2021

No. Bulan Tanggal


1 Januari 22/01/2021
2 Januari 22/01/2021
3 Januari 22/01/2021
4 Januari 22/01/2021
5 Januari 22/01/2021
6 Januari 22/01/2021
7 Januari 22/01/2021
8 Januari 25/01/2021
9 Januari 25/01/2021
10 Januari 25/01/2021
11 Januari 25/01/2021
12 Januari 25/01/2021
13 Januari 25/01/2021
14 Januari 25/01/2021
15 Januari 25/01/2021
16 Januari 26/01/2021
17 Januari 26/01/2021
18 Januari 26/01/2021
19 Januari 26/01/2021
20 Januari 26/01/2021
21 Januari 26/01/2021
no bulan tanggal

1 February 01st 2021


2 February 01st 2021

3 February 01st 2021


4 February 01st 2021

5 February 01st 2021


6 February 01st 2021
7 February 01st 2021
8 February 01st 2021

9 February 01st 2021

10 February 01st 2021

11 February 01st 2021

12 February 02nd 2021

13 February 02nd 2021


14 February 02nd 2021

15 February 02nd 2021

16 February 02nd 2021

17 February 02nd 2021

18 February 02nd 2021


19 February 02nd 2021

20 February 02nd 2021


21 February 02nd 2021

22 February 03rd 2021

23 February 03rd 2021


24 February 03rd 2021
25 February 03rd 2021

26 February 03rd 2021

27 February 03rd 2021

28 February 03rd 2021


29 February 03rd 2021
30 February 03rd 2021

31 February 03rd 2021


32 February 04th 2021

33 February 04th 2021


34 February 04th 2021
35 February 04th 2021
36 February 04th 2021

37 February 04th 2021

38 February 04th 2021

39 February 04th 2021

40 February 15th 2021

41 February 15th 2021

42 February 15th 2021

43 February 15th 2021

44 February 15th 2021

45 February 15th 2021


46 February 15th 2021

47 February 15th 2021


48 February 16th 2021

49 February 16th 2021

50 February 16th 2021


51 February 16th 2021

52 February 16th 2021

53 February 16th 2021


54 February 16th 2021
55 February 16th 2021
56 February 16th 2021

57 February 16th 2021

58 February 17th 2021

59 February 17th 2021


60 February 17th 2021

61 February 17th 2021


62 February 17th 2021
63 February 17th 2021

64 February 17th 2021

65 February 17th 2021

66 February 17th 2021

67 February 17th 2021

68 February 17th 2021

69 February 18th 2021

70 February 18th 2021

71 February 18th 2021


72 February 18th 2021
73 February 18th 2021
74 February 18th 2021

75 February 21th 2021

76 February 21th 2021

77 February 21th 2021


78 February 21th 2021

79 February 21th 2021

80 February 21th 2021


81 February 21th 2021

82 February 21th 2021


83 February 21th 2021

84 February 21th 2021


85 February 21th 2021

86 February 21th 2021

87 February 21th 2021

88 February 21th 2021


89 February 21th 2021
90 February 21th 2021
91 February 21th 2021
92 February 21th 2021

93 February 21th 2021


94 February 21th 2021

95 February 21th 2021

96 February 22th 2021

97 February 22th 2021


98 February 22th 2021

99 February 22th 2021

100 February 22th 2021


101 February 22th 2021
102 February 22th 2021

103 February 22th 2021

104 February 22th 2021

No. Bulan Tanggal


105 Maret 05.03.2021
106 Maret 05.03.2021
107 Maret 05.03.2021
108 Maret 05.03.2021
109 Maret 05.03.2021
110 Maret 05.03.2021
111 Maret 05.03.2021
112 Maret 05.03.2021
113 Maret 05.03.2021
114 Maret 05.03.2021
115 Maret 05.03.2021
116 Maret 08.03.2021
117 Maret 08.03.2021
118 Maret 08.03.2021
119 Maret 08.03.2021
120 Maret 08.03.2021
121 Maret 08.03.2021
122 Maret 08.03.2021
123 Maret 09.03.2021
124 Maret 09.03.2021
125 Maret 09.03.2021
126 Maret 09.03.2021
127 Maret 09.03.2021
128 Maret 09.03.2021
129 Maret 09.03.2021
130 Maret 09.03.2021
131 Maret 09.03.2021
132 Maret 10.03.2021
133 Maret 10.03.2021
134 Maret 10.03.2021
135 Maret 10.03.2021
136 Maret 10.03.2021
137 Maret 10.03.2021
138 Maret 10.03.2021
139 Maret 10.03.2021
140 Maret 10.03.2021
141 Maret 10.03.2021
142 Maret 05.03.2021
143 Maret 05.03.2021
144 Maret 05.03.2021
145 Maret 08.03.2021
146 Maret 08.03.2021
147 Maret 09.03.2021
148 Maret 09.03.2021
149 Maret 10.03.2021
150 Maret 10.03.2021
151 Maret 09.03.2021
152 Maret 05.03.2021
153 Maret 12.03.2021
154 Maret 12.03.2021
155 Maret 12.03.2021
156 Maret 12.03.2021
157 Maret 12.03.2021
158 Maret 12.03.2021
No. Bulan Tanggal
159 April 05.04.21
160 April 06.04.21
161 April 07.04.21
162 April 07.04.21
163 April 08.04.21
164 April 08.04.21
165 April 14.04.21
166 April 14.04.21
167 April 14.04.21
168 April 14.04.21
169 April 14.04.21
170 April 14.04.21
171 April 14.04.21
172 April 14.04.21
173 April 14.04.21
174 April 16.04.21
175 April 16.04.21
176 April 16.04.21
177 April 16.04.21
178 April 16.04.21
179 April 16.04.21
180 April 16.04.21
181 April 16.04.21
182 April 16.04.21
183 April 16.04.21
184 April 19.04.21
185 April 19.04.21
186 April 19.04.21
187 April 19.04.21
188 April 20.04.21
189 April 20.04.21
No. Bulan Tanggal
190 Juli
191 Juli
192 Juli
193 Juli 10 Juli 2021
194 Juli
195 Juli
196 Juli
197 Juli
198 Juli
199 Juli
200 Juli
201 Juli
202 Juli
203 Juli
204 Juli
205 Juli
206 Juli
207 Juli
208 Juli
209 Juli
210 Juli
211 Juli
212 Juli 14 Juli 2021
213 Juli
214 Juli
215 Juli
216 Juli 15 Juli 2021
217 Juli
218 Juli
219 16 Agustus 2021
220
221
222
223
224 18 Agustus 2021
225
226
227
228
229
230
231
232
233
234
235 OKT 01/10/2021
236 OKT
237 OKT
238 OKT
239 OKT
240 OKT
241 OKT
242 OKT
243 OKT
244 OKT
245 OKT
246 OKT
247 OKT
248 OKT
249 OKT
250 OKT
251 OKT
252 OKT
253 OKT
254 OKT
255 OKT
256 OKT
257 OKT
258 OKT
259 OKT
260 OKT
261 OKT
262 OKT
263 OKT
264 OKT
265 OKT
266 OKT
267 OKT
268 OKT
269 OKT
270 OKT
271 OKT
272 OKT 08/10/2021
273 OKT
274 OKT
275 OKT
276 OKT
277 OKT
278 OKT
279 OKT
280 OKT
281 OKT
282 OKT
283 OKT
284 OKT
285 OKT
286 OKT
287 OKT
288 OKT
289 OKT
290 OKT
291 OKT
292 OKT
293 OKT
294 OKT
295 OKT
296 OKT
297 OKT
298 OKT
299 OKT
300 OKT
301 OKT
302 OKT
303 OKT
304 OKT
305 OKT
306 OKT
307 OKT
308 OKT
309 OKT
310 OKT
311 OKT
312 OKT
313 OKT 15/10/2021
314 OKT
315 OKT
316 OKT
317 OKT
318 OKT
319 OKT
320 OKT
321 OKT
322 OKT
323 OKT
324 OKT
325 OKT
326 OKT
327 OKT
328 OKT
329 OKT
330 OKT
331 OKT
332 OKT
333 OKT
334 OKT
335 OKT
336 OKT
337 OKT
338 OKT
339 OKT
340 OKT
341 OKT
342 OKT 15/10/2021
343 OKT
344 OKT
345 OKT
346 OKT
347 OKT
348 OKT
349 OKT
350 OKT
351 OKT
352 OKT
353 OKT
354 OKT
355 OKT
356 OKT 18/10/2021
357 OKT
358 OKT
359 OKT
360 OKT
361 OKT
362 OKT
363 OKT
364 OKT 19/10/2021
365 OKT
366 OKT
367 OKT
368 OKT
369 OKT
370 OKT
371 OKT
372 OKT
373 OKT
374 OKT 21/10/2021
375 OKT
376 OKT
377 OKT
378 OKT
379 OKT
380 OKT
381 OKT
382 OKT 22/10/2021
383 OKT
384 OKT
385 OKT
386 OKT
387 OKT
388 OKT
389 OKT
390 OKT
391 OKT
392 OKT 25/10/2021
393 OKT
394 OKT
395 OKT
396 OKT
397 OKT
398 OKT
399 OKT
400 OKT
401 OKT
402 OKT
403 OKT
404 OKT
405 OKT 26/10/2021
406 OKT
407 OKT
408 OKT
409 OKT
410 OKT
411 OKT
412 OKT
413 OKT 27/10/2021
414 OKT
415 OKT
416 OKT
417 OKT
418 OKT
419 OKT
420 OKT
421 OKT
422 OKT
423 OKT
424 OKT
425 OKT
426 OKT
427 OKT
428 OKT
429 OKT
430 OKT
431 Bulan Tanggal
432 DESEMBER 06/12/2021
433 DESEMBER
434 DESEMBER
435 DESEMBER
436 DESEMBER
437 DESEMBER
438 DESEMBER
439 DESEMBER
440 DESEMBER
441 DESEMBER
442 DESEMBER 07/12/2021
443 DESEMBER
444 DESEMBER
445 DESEMBER
446 DESEMBER
447 DESEMBER
448 DESEMBER
449 DESEMBER
450 DESEMBER
451 DESEMBER
452 DESEMBER
453 DESEMBER
454 DESEMBER
455 DESEMBER
456 DESEMBER
457 DESEMBER
458 DESEMBER
459 DESEMBER 08/12/2021
460 DESEMBER
461 DESEMBER
462 DESEMBER
463 DESEMBER
464 DESEMBER
465 DESEMBER
466 DESEMBER
467 DESEMBER
468 DESEMBER 09/12/2021
469 DESEMBER
470 DESEMBER
471 DESEMBER
472 DESEMBER
473 DESEMBER
474 DESEMBER 03/12/2021
475 DESEMBER 06/12/2021
476 DESEMBER 06/12/2021
477 DESEMBER 07/12/2021
478 DESEMBER
479 DESEMBER
480 DESEMBER 08/12/2021
481 DESEMBER
482 DESEMBER
483 DESEMBER
484 DESEMBER 09/12/2021
485 DESEMBER
486 DESEMBER
487 DESEMBER
488 DESEMBER 03/12/2021
489 DESEMBER 06/12/2021
490 DESEMBER
491 DESEMBER 08/12/2021
492 DESEMBER
493 DESEMBER
494 DESEMBER
495 DESEMBER
496 DESEMBER
497 DESEMBER
498 DESEMBER 09/12/2021
Identitas
Mrs. LIS/ 33 YO/ 1184883/ Banyuasin/ P1A0/ IJA – IS

Mrs. SUL/ 41 YO / P3A0/ 1194321/ Baturaja/ IJA-IS

Mrs. MAR / 50 YO/ P3A1/ 1125886/ Palembang/ IJA – RS

Identitas
Mrs.EVI/48 yo/1194635/P2A0/ PRABUMULIH/ IJA-IS
Mrs. SIT/55 yo/1194636/ P1A0/PALEMBANG/IJA-IS
Ms. SHA/17 yo/1194676/ P0A0/ PALEMBANG/ IJA-HE

Ms.SEP /20 yo/1194593/ P0A0/PALEMBANG/ IJA-AW


T

Identitas
Mrs. WUL/ 32 YO/ 1194326/ PALEMBANG/ P0A3/ ARM-AC

Mrs. YEL/ 27 YO/ 1093186/ MUARA ENIM/ P0A0/ ARM-KY


Mrs. DWI/ 40 YO/ 1194309/ OGAN KOMERING ILIR/ P0A1/ ARM-AC

Mrs. FEB/ 26 YO/ 1190904/ BANYUASIN/ P1A0/ ARM-AA

Identitas
Mrs. NET/ 38 yo/ 1191709/ BANYUASIN/WAH-RS P1A1

Mrs. ULY /33 yo/1179714/ PALEMBANG/P0A0/WAH-NS

Identitas
Mrs. WIN/ 22 YO/ 1161537/ BANYUASIN/ P0A0/ ARM-AW
Mrs. NOP/ 36 YO/ 1095043/ P0A0/ PALEMBANG/ ARM-AC

Identitas
Mrs. FIT/ 37 YO/ 1144485/ PALEMBANG/ ARM-AW
Mrs. NIN/25yo/0941540/P0A/Banyuasin/WAH-AA

Mrs.EFI/29 yo/1194698/ P0A0/ BENGKULU/ HE-WAH

Identitas
Mrs.NYA /33 yo/774236/ P2A0/PALEMBANG/ARM

Mrs ERM /39 yo/1061619/ PALEMBANG/ARM

Identitas
Mrs. RUS/ 62 YO/ 1194700/ OGAN ILIR / P6A0/ IZY-RK

Identitas
Mrs.PON/ 58 YO/ 1194934/ KALIDONI / P8A0/ IZY-DES-HD

Identitas
Mrs. LES/ 41 YO/ 1194557/ PRABUMULIH/ P3A0/ FES-AT
Mrs. JUM/ 50 YO/ 1190062/ MUARA ENIM/ P0A0/ FES-IS
Mrs. IRM/ 40 YO/ 1070701/ PALEMBANG/P1A0/ FES-IS
Mrs. PRI/ 29 YO/ 720006/ PALEMBANG/ P3A0/ FES-RS
Mrs. RUB/ 69 YO/ 1195492/ PAGAR ALAM/ P3A0/ FES-RS
Mrs. ERL/ 61 YO/ 1038549/ INDRALAYA/ P2A0/ FES-RS
Mrs. ELL/ 69 YO/ 1186237/ PALEMBANG/ P6A1/ CYN-IS
Mrs. PON/ 50 YO/ 1193031/ OGAN KOMERING ULU/ P4A0/ FES-AT
Mrs. SUY/ 61 YO/ 1192314/ PALEMBANG P6A0/ FES-IS
Mrs. SUW/ 44 YO/ 1195476/ BANYUASIN P4A1/ FES-RS
Mrs. PAT/ 38 YO/ 1157081/ MUSI RAWAS/ P2A1/ FES-AT
Mrs. MAS/ 43 YO/ 1188488/ OGAN ILIR/ P3A1/ CYN-IS
Mrs . LIN/ 47 YO/ 1190432/ BANYUASIN/ P2A0/ FES-IS
Mrs. ROO/ 76 YO/ 1183709/ PALEMBANG/ P3A0/ FES-IS
Mrs. NUR/ 32 YO/ 1194679/ OKU TIMUR/ P2A0/ FES-IS
Mrs. HEN/ 43 YO/ 1189670/ OGAN KOMERING ILIR/ P3A0/ FES-RS
Mrs. RUM/ 42 YO/ 1189719/ PALEMBANG/ P4A1/ FES-RS
Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/P0A0/ FES-IS
Mrs. WAR/ 53 YO/ 1189178/ LUBUK LINGGAU/ P3A0/ FES-IS
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ FES-IS
Mrs. SAR/ 56 YO/ 1107553/ PALEMBANG/ P3A1/ FES-IS
Identitas

Mrs. RUS/ 56 YO/ 1194731/ OGAN KOMERING ILIR/ P7A1/ FES-AT


Mrs. IRA/ 40 YO/ 1193029/ BANGKA BELITUNG/ P2A1/ FES-AT

Mrs. MUG/ 52 YO/ 1190193/ BANGKA BELITUNG/ P2A0/ FES-IS


Mrs. PAT/ 38 YO/ 1157081/ MUSI RAWAS/ P2A1/ FES-AT

Miss. AIS/ 59 YO/ 792347/ PALEMBANG/ P0A0/ FES-IS


Mrs. YUS/ 55 YO/ 1188840/ MUARA ENIM/ P3A0/ FES-IS
Mrs. SUR/ 34 YO/ 1185061/ PAGAR ALAM/P4A1/ FES-RS
Mrs. TRI/ 37 YO/ 1192253/ OGAN ILIR/ P1A1/ FES-IS

Mrs. ALM/ 45 YO/ 1195696/ PALEMBANG/P3A3/ FES-RS

Miss. MAR/ 40 YO/ 1185109/ BENGKULU/ P0A0/ FES-RS

Mrs. SRI/ 26 YO/ 1193506/ OGAN KOMERING ILIR/ P1A0/ FES-RS

Mrs. HAN/ 43 YO/ 1195022/ PRABUMULIH/ P5A2/ FES-AT

Mrs. IDA/ 43 YO/ 1169046/ MUARA ENIM/ P2A0/FES-IS


Mrs. LEL/ 43 YO/ 1185808/ OGAN KOMERING ILIR/P2A0/ FES-AT
Mrs. LIN/ 36 YO/ 1195472/ MUSI RAWAS/ P3A1/ FES-RS

Mrs. LIN/ 36 YO/ 1195472/ MUSI RAWAS/ P3A1/ FES-RS

Mrs. YUS/ 52 YO/ 1192268/ BANGKA BELITUNG/ P3A0/ FES-IS

Miss. KUS/ 55 YO/ 1047242/ OGAN ILIR/ P0A0/ FES-AT

Miss. SRI/ 47 Yo/ 1190702/ PALEMBANG/P0A0/ FES-IS


Mrs. EMI/ 54 YO/ 1173623/ PALEMBANG/ P5A0/ FES-RS

Mrs. HAP/ 61 YO/ 1185221/ PALEMBANG/P1A2/ FES-IS


Mrs. ANI/ 17 YO/ 1174287/ PALEMBANG/ P0A1/ FES-RS

Mrs. AIN/ 71 YO/ 1182526/ BANGKA BELITUNG/ P7A0/FES-RS

Mrs. TUT/ 45 YO/ 1190199/ LAMPUNG/ P1A3/ FES-IS


Miss. MAR/ 43 YO/ 1160934/ PALEMBANG/ P0A0/ FES-AT
Mrs. SOI/ 55 YO/ 1154976/ PALEMBANG/ P0A0/ FES-RS

Mrs. MAR/ 57 YO/ 1180539/ PALEMBANG/ P5A0/ FES-IS

Mrs. SAN/ 46 YO/ 1066777/ PALEMBANG/ P2A1/ FES-RS

Mrs. SUM/ 54 YO/ 1194175/ MUSI RAWAS/ P6A0/ FES-IS


Mrs. YUL/ 36 YO/ 1194420/ PALEMBANG/ P5A0/ FES-AT
Mrs. SUL/ 24 YO/ 1196576/ PALEMBANG/P2A0/ FES-AT

Mrs. MER/ 57 YO/ 960618/ PALEMBANG/ P3A0/ FES-AT


Mrs. SIT/ 50 YO/ 1182507/ PRABUMULIH/P2A0/ FES-RS

Mrs. PAR/ 36 YO/ 1147653/ PALEMBANG/ P3A0/ FES-RS


Mrs. TIA/ 24 YO/ 1184535/ OGAN ILIR/ P0A1/ FES-IS
Mrs. DES/ 40 YO/ 1181573/ OGAN KOMERING ULU/ P2A2/ FES-RS
Mrs. SUK/ 18 YO/ 1196600/ PALEMBANG/ P0A1/ FES-AT

Mrs. MAR/ 51 YO/ 1196754/ OGAN KOMERING ULU/ P3A0/ FES-AT

Mrs. SIT/ 35 YO/ 1195661/ BANYUASIN/ P0A0/ FES-AT

Mrs. ERN/ 58 YO/ 1196554/ PALEMBANG/ P2A1/ FES-AT

Mrs. HEN/ 43 YO/ 1189670/ OGAN KOMERING ILIR/ P3A0/ SAR-RS

Mrs. AIS/ 33 YO/ 1184298/ MUARA ENIM/P3A0/ IJA-AT

Mrs. PON/ 50 YO/ 1193031/ OGAN KOMERING ULU/ P4A0/ SAR-AT

Mrs. MIS/ 56 YO/ 1103440/ PALEMBANG/ P3A0/ IJA-IS

Mrs. NUR/ 53 YO/ 1180434/ PALEMBANG/ P2A0/ SAR-IS

Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ IJA-IS


Mrs. FAT/ 52 YO/ 1185932/ BANYUASIN/ P3A1/ SAR-AT

Mrs. SUW/ 51 YO/ 1197126/ PALEMBANG/ P4A3/IJA-RS

Mrs. SAR/ 38 YO/ 1161822/ BENGKULU/ P2A0/ IJA-AT

Mrs. RUH/ 60 YO/ 1196750/ JAMBI/ P2A0/ SAR-AT


Miss. SUK/ 13 YO/ 1184905/ PALEMBANG/ P0A0/ SAR-IS

Miss. SHE/ 17 YO/ 1056255/ PALEMBANG/ P0A0/ IJA-IS

Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ IJA-AT


Mrs. SHE/ 29 YO/ 1192096/ PALEMBANG/ P3A1/ SAR-AT
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ IJA-IS
Mrs. DEW/ 21 YO/ 1197704/ MUARA ENIM/ P1A0/ SAR-IS

Mrs. DAR/ 38 YO/ 1197642/ PALEMBANG/ P0A0/ IJA-AT

Mrs. YAN/ 46 YO/ 1197929/ BANGKA BELITUNG/ P2A0/ IJA-IS

Mrs. ROS/ 50 YO/ 1197016/ BANGKA BELITUNG/ P4A0/ SAR-RS


Mrs. DEW/ 57 YO/ 1155825/ MUARA ENIM/P4A0/ SAR-RS

Mrs. SUM/ 48 YO/ 1184894/ MUSI RAWAS/ P3A0/ SAR-RS


Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/P0A0/ SAR-IS
Mrs. END/ 39 YO/ 904720/ PALEMBANG/ P3A0/ IJA-AT

Mrs . JUM/ 26 YO/ 1160938/ PALEMBANG/ P2A0/ IJA-AT

Mrs. MAS/ 54 YO/ 1197749/ PALEMBANG/ P2A2/ SAR-IS

Mrs. FIT/ 40 YO/ 199774/ PALEMBANG/P1A0/ IJA-IS

Mrs. MER/ 57 YO/ 960618/ PALEMBANG/ P3A0/ IJA-AT

Mrs. VIR/ 24 YO/ 1197691/ PAGAR ALAM/ P1A0/ SAR-IS

Mrs. SIT/ 62 YO/ 1196873/ MUARA ENIM/P3A0/ SAR-RS

Miss. ANG/ 22 YO/ 1177593/ MUSI BANYUASIN/ P0A0/ IJA-IS

Mrs. IDA/ 47 YO/ 1182016/ LAHAT/ P0A0/ SAR-IS


Mrs. YUL/ 36 YO/ 1194420/ PALEMBANG/ P5A0/ SAR-AT
Mrs. RIS/ 22 YO/ 1141398/ PALEMBANG/P0A1/ IJA-RS
Mrs. YAN/ 31 YO/ 1183800/ OGAN KOMERING ILIR/ P2A2/ IJA-IS

Mrs. SAK/ 40 YO/ 1189339/ OGAN KOMERING ILIR/ P2A0/ IJA-AT

Mrs. NIL/ 47 YO/ 1197176/ PALEMBANG/ P3A0/ IJA-RS

Mrs. DEP/ 33 YO/ 1197795/ MUSI RAWAS/ P3A0/ IJA-IS

Mrs. WIS/ 37 YO/ 9395618/ BANYUASIN/ P2A1/ IJA-AT

Mrs. REP/ 51 YO. 1191495/ PALEMBANG/ P3A0/ SAR-RS


Mrs. AKH/ 51 YO/ 1187313/ OGAN ILIR/ P1A1/ SAR-IS

Mrs. HER/ 52 YO/ 1196302/ EMPAT LAWANG/ P3A0/IJA-IS


Miss. JUL/ 14 YO/ 1198125/ EMPAT LAWANG/ P0A0/ SAR-IS

Mrs. WAY/ 66 YO/ 1193666/ OGAN KOMERING ULU TIMUR/ P2A0/


Mrs. HAN/ 43 YO/ 1195022/ PRABUMULIH/ P5A2/ SAR-AT

Mrs. ERN/ 43 YO/ 176021/ PALEMBANG/ P3A0/ SAR-RS

Miss. MEI/ 36 YO/ 1188301/ PALEMBANG/ P0A0/ IJA-AT

Miss. SRI/ 47 YO/ 1190702/ PALEMBANG/ P0A0/ SAR-IS


Mrs. NUR/ 52 YO/ 1173179/ MUSI BANYUASIN/ P5A0/ SAR-RS
Mrs. SUK/ 18 YO/ 1196600/ PALEMBANG/ P0A0/ SAR-AT
Mrs. KUR/ 36 YO/ 1179808/ PALEMBANG/ P1A1/ SAR-IS
Mrs. DES/ 41 YO/ 1181573/ LAHAT/ P2A2/ IJA-RS

Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ IJA-AT


Mrs. SEL/ 38 YO/ 1111743/ MUARA ENIM/ IJA-IS

Mrs. ISN/ 42 YO/ 1198477/ PALEMBANG/ P3A0/ IJA-AT

Mrs. AGU/ 43 YO/ 1186285/ BANGKA BELITUNG/ P3A1/ IJA-RS

Miss. KUS/ 55 YO/ 1047242/ OGAN ILIR/ P0A0/ IJA – AT

Mrs. HIL/ 42 YO/ 1184822/ PALEMBANG/ P0A0/IJA-IS


Mrs. RUN/ 64 YO/ 1029392/ PALEMBANG/ P4A0/ IJA-AT
Miss. TIA/ 25 YO/ 1184535/ OGAN ILIR/ P0A1/ IJA-AT

Mrs. LIN/ 47 YO/ / 1109432/ BANYUASIN/ P2A0/ SAR-IS

Mrs. ROS/ 64 YO/ 1197395/ LAHAT/ P4A0/ SAR-RS

Mrs. NUR/ 50 YO/ 1198295/ BANGKA BELITUNG/ P0A0/ IJA-AT


Identitas
Mrs. LEN/ 32 YO/ 1185134/ MUSI RAWAS/ P2A1/ SAR-RS
Mrs. HAT/ 74 YO/ 1050372/ PALEMBANG/ P6A6/ IJA-RS
Mrs. RAT/ 41 YO/ 1197693/ OGAN KOMERING ILIR/ P3A2/ IJA-RS
Mrs. ELM/ 47 YO/ 980694/ BANGKA BELITUNG/ P1A0/ SAR-IS
Mrs. FAR/ 55 YO/ 1189543/ BANGKA BELITUNG/ P5A0/ SAR-RS
Miss. SIT/ 13 YO/ 1160300/ PALEMBANG/ P0A0/ IJA-AT
Mrs. JUM/ 27 YO/ 1199252/ PALEMBANG/ P2A1/ SAR-RS
Mrs. HER/ 52 YO/ 1196302/ EMPAT LAWANG/ P3A0/ SAR-IS
Mrs. AYU/ 25 YO/ 1198203/ PALEMBANG/ P0A2/ IJA-IS
Mrs. YUL/ 36 YO/ 874601/ PALEMBANG/ P2A0/ SAR-RS
Mrs. MAR/48 YO/ 1198959/ LAHAT/ P0A0/ IJA-IS
Mrs PON/ 50 YO/ 1193031/ LAHAT/ P4A0/ IJA-AT
Mrs. NOR/ 55 YO/ 1198795/ JAMBI/ P3A0/ IJA-AT
Mrs. MAH/ 46 YO/ 1186648/ BANGKA BELITUNG/ P2A1/ IJA-AT
Mrs. WAI/ 38 YO/ 1199757/ BANYUASIN/ P2A0/ SAR-RS
Mrs. ETI/ 36 YO/ 1199627/ PALEMBANG/ P1A0/ SAR-IS
Mrs. NUR/ 48 YO/ 1199485/ PALEMBANG/ P1A1/ SAR-RS
Mrs. CIK/ 61 YO/ 1199325/ MUSI RAWAS/ P4A1/IJA-RS
Mrs. MIS/ 58 YO/ 1103440/ PALEMBANG/ P3A0/ SAR-AT
Mrs. NUR/ 53 YO/ 1180434/ PALEMBANG/ P2A0/ IJA-IS
Mrs. SUJ/ 56 YO/ 985389/ PALEMBANG/ P7A0/ IJA-RS
Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/ P0A0/ IJA-IS
Mrs. KUR/ 39 YO/ 1179808/ PALEMBANG/ P1A1/ SAR-IS
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ SAR-IS
Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ IJA-AT
Mrs. SAN/ 43 YO/ 1195363/ BANYUASIN/ P3A0/ IJA-RS
Mrs. SUT/ 44 YO/ 1197080/ OGAN KOMERING ILIR/ P1A1/ SAR-IS
Mrs. ISA/ 47 YO/ 1199753/ MUSI RAWAS/ P2A0/ SAR-IS
Mrs. NUR/ 63 YO/ 1198547/ PALEMBANG/ P4A2/ IJA-AT
Mrs. SRI/ 53 YO/ 1197302/ RIAU/ P3A0/ IJA-RS
Mrs. SUM/ 48 YO/ 1184894/ MUSI RAWAS/ P3A0/ SAR-RS
Mrs. PON/ 53 YO/ 1199899/ PALEMBANG/ P4A1/ SAR-AT
Mrs. END/ 50 YO/ 1174789/ PALEMBANG/ IJA-RS
Mrs. LIN/ 48 YO/ 1190432/ PALEMBANG/ P2A0/ SAR-IS
Mrs. SUK/ 18 YO/ 1196600/ PALEMBANG/ P0A1/ DES-AT
Mrs. NUR/ 64 YO/ 1102751/ PALEMBANG/ P5A2/ IJA-RS
Mrs. SIT/ 25 YO/ 1082767/ PAGAR ALAM/ IJA-RS
Mrs. IND/ 30 YO/ 1194937/ Banyuasin/ P0A3/ CYN-FU/ AC
Mrs. END/ 49 YO/ 702775/ Palembang/ P4A3/ CYN-RS/AC
Mrs. DES/ 40 YO/ 1143159/ Palembang/ P0A0/ CYN-KY/AC
Miss. RIS/ 19 YO/ 1198946/ MUARA ENIM/ P0A0/ OSP-AW
Miss. SIT/ 22 YO/ 733958/ PALEMBANG/ P0A0/ OSP-AA
Mrs. YUN/22 YO/ 1199481/ OKI/ P0A0/ CYN-AC/ KY
Mrs. ETI/ 44 YO/ 1199749/ Ogan Komering Ilir/ P0A0/ OSP-AW/KY
Mrs. NAD/36 YO/ 1199886/ Palembang/ P0A0/ CYN-HE/HE
Mrs. Siti Aina bt M. Rum/ 33 YO/ 1199903/ Palembang/ P0A0/ CYN-HE/HE
Mrs. Irmawati Binti Agin/ 46 YO/ 1183676/ MUARA ENIM/ RK-THR
Ms. FAU/ 34 YO/ 890677/ Palembnag/ P0A0/ IZY-AT/ HI
Mrs. ELI/ 51 YO/ 1158879/ MUSI RAWAS/ P0A1/SAR-AT
Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ SAR-AT
Mrs. SAR/ 58 YO/ 1198813/ OKU TIMUR/ P0A1/ SAR-RS
Miss. ALA/ 48 YO/ 1104499/ PALEMBANG/ P0A0/ SAR-RS
Mrs. RUK/ 41 YO/ 1189789/ PRABUMULIIH/ P2A0/ IJA-IS
Mrs. LIN/ 48 YO/ 1190432/ PALEMBANG/ P2A0/ SAR-IS
Identitas
Mrs. DIA/ 53 YO/ 1197151/ PALEMBANG/ P3A0/ OSP/ KY
Mrs. RIT/ 44 YO/ 865235/ BANYUASIN/ P2A1/ OSP-RS
Miss. LIL/ 39 YO/ 1201331/ Palembang/ P0A0/ HE – HIL
MRS. YUL/ 43 YO/ 1202309/ Palembang/ P2A0/ HE – HIL
Miss. DIA/ 17 YO/ 1134439/ PALEMBANG/ HIL-PM
Miss. ZAH/ 32 YO/ 1090862/ PALEMBANG/ HIL-RS
Mrs. RIT/ 54 YO/ 1175933/ MUSI RAWAS/ P5A0/ UTI-RS
Mrs. MUL/ 49 YO/ 1200391/ EMPAT LAWANG/ P3A0/ZAN-AT
Mrs. YEN/ 45 YO/1 201410/ PALEMBANG/ P4A0/ ZAN-RS
Miss. SRI/ 47 YO/ 1190702/ PALEMBANG/ P0A0/ ZAN-IS
Mrs. HEN/ 67 YO/ 881475/ MUSI BANYUASIN/ P1A0/ ZAN-RS
Miss. BIN/ 48 YO/ 1042820/ PALEMBANG/ P0A0/ UTI-RS
Mrs. FAR/ 55 YO/ 1189543/ BANGKA BELITUNG/ P5A0/ UTI-RS
Mrs. PAR/ 36 YO/ 1147653/ PALEMBANG/ P3A0/ UTI-RS
Miss. RAN/ 34 YO/ 1203488/ PALEMBANG/ P0A0/ ZAN-RS
Mrs. DEW/ 51 YO/ 1199682/ PALEMBANG/ P0A0/ ZAN-AT
Mrs. MAH/ 53 YO/ 1110168/ OGAN ILIR/ P0A7/ UTI-AT
Mrs. ERM/ 44 YO/ 1194216/ PALEMBANG/ P0A0/ UTI-IS
Mrs. ELI/ 41 YO/ 1059843/ PALEMBANG/ P3A1/ ZAN-RS
Mrs. SRI/ 46 YO/ 1125525/ PALEMBANG/ ZAN-RS
Mrs. KHA/24 YO/ 1200690/LAMPUNG/ P0A0/UTI-IS
Mrs. KHO/ 45 YO/ 1196882/ PALEMBANG/ P2A1/ UTI-AT
Mrs. TRI/ 37 YO/ 1192253/ OGAN ILIR/ P1A1/ UTI-IS
Mrs. DEV/ 26 YO/ 1202633/ PALEMBANG/ P2A0/ ZAN-AT
Mrs. SRI/ 37 YO/ 1203762/ PALEMBANG/ P4A1/ ZAN-AT
Mrs. ZAN/ 34 YO/ 1201569/ PALEMBANG/ IKY-IAN/AF
Mrs. MER/ 19 YO/ 1196532 / PALEMBANG/IKY-PIT/ NS
Mrs. ENT/ 32 YO/ 1202351/ PALEMBANG/ OGL/FB
Mrs. AND/ 36 YO/ 1199137/ BANYUASIN/ OGL/NS
Mrs. ANG/ 25 YO/ 1194665/ PALEMBANG/ OGL/HI
Mrs. RIK/ 38 YO/ 1202765/ PALEMBANG/ OGL/IS
Identitas
Mrs. AMI / 81 YO / 1209878 / PALEMBANG
Mrs. SUG / 62 YO / 1193704 / PALEMBANG

Mrs. ERL/ 42 YO/ 1190734/ Ogan Komering Ilir


Mrs. SUY/ 59 YO/ 952327/Muara Enim
Mrs. NUR/ 52 YO/ 1213407/ Ogan Ilir
Mrs. EMI/ 45 YO/ 1217518/ Palembang
Miss. YOS/ 33 YO/ 1217486/ Palembang
Miss. ELS/ 12 YO/ 1206262/ Muara Enim
Mrs. AND/ 56 YO/ 1199968/ Ogan Ilir
Miss. ALA/ 48 YO/ 1104499/ PALEMBANG
Miss. ANG/ 22 YO/ 1177593/ Musi Banyuasin
Mrs. ILU/ 26 YO/ 1205247
Mrs. LIN/ 31 YO/ 925008
Mrs. DID/ 69 yo/ 900468 PALEMBANG
Mrs. DIA / 30 YO/ 991742 / OGAN KOMERING
Mrs. MAI/ 45 YO/ 1202252/ Palembang
Mrs. YUL / 38 YO/ 922671
Mrs. NUR/ 45 YO/ 1203902/ Lahat
Mrs. ISA/ 47 YO/ 1199753/ Musi Rawas
Ms. MAR / 32 YO/ 1209004 / Banyuasin
Mrs. IYA/ 60 YO/ 1200511/ Palembang
Mrs. WAR / 26 YO/ 1208726 / Kayu Agung
Ms. NOV / 18 YO/ 1201726
Mrs. ISN/ 42 YO/ 1198477/ Palembang
Mrs. USP/ 28 YO/ 1213054/ Riau
Mrs. MUS/ 48 YO/ 1208724/ MARTAPURA
Ms. LUL/ 14 YO/ 1210182 / MUARA ENIM
Mrs. YUS/ 45 YO/ 1212194 / PRABUMULIH

Miss. DEL/ 24 YO/ 1192294/ Palembang


Mrs. NUR/ 51 Yo/ 1185601/ Palembang
Mrs. MAS/ 54 YO/ 1197749/ Palembang
Mrs. PAR/ 36 YO/ 1147653/ Palembang
Mrs. YUS/ 52 YO/ 1192268/ Bangka Belitung
Mrs. RUW/ 45 YO/ 1208994/ Palembang/
Mrs. AID/ 42 YO/ 1208935/ Palembang
Mrs. SUR/ 47 YO/ 1181958/ Prabumulih
Mrs. SUR/ 46 YO/ 1207410/ Muara Enim
Mrs. LEN/ 43 YO/ 1066709/ Palembang
Mrs. YUS/ 61 YO/ 1166473/ Palembang
Mrs. YUS/ 61 YO/ 1166473/ Palembang
Miss. SUR/ 22 YO/ 1210971/ Bangka Belitung
Mrs. DIL/ 47 YO/ 1217655/ Lahat
Mrs. SIT/ 71 YO/ 1216072/ Palembang
Mrs. TAT/ 45 YO/ 1208271/ Palembang/ P2A1/ OGL-IS
Mrs. VIN/ 36 YO/ 1200442/ Musi Banyuasin/ P3A0/ OGL-AT
Mrs. DEW/ 57 YO/ 1155825/ Muara Enim/ P4A0/ OGL-RS
Mrs. DEV/ 26 YO/ 1202633/ Palembang/ P2A0/ OGL-AT
Mrs. SUG/ 36 YO/ 1222461/ Ogan Komering Ilir/ P3A0/ OGL- IS
Mrs. WAR/ 48 YO/ 1208963/ Muara Enim/ P3A0/ INO-IS
Mrs. DAR/ 52 YO/ 1220806/ Palembang/ P6A0/ INO- RS
Mrs. SAU/ 59 YO/ 1204077/ Bangka Belitung/ P3A0/INO-IS
Mrs. MAS/ 51 YO/ 1203370/ Ogan Ilir/ P7A0/ INO-RS
Mrs. DAR/ 40 YO/ 1118874/ Pagar Alam/ P3A0/ INO-RS
Mrs. RUK/ 41 YO/ 1189789/ Prabumulih/ P2A0/INO-IS
Miss. HAM/ 21 YO/ 1190177/ Musi Rawas/ P0A0/INO-AT
Mrs. HAL/ 55 YO/ 1204580/ Muara Enim/ P0A0/ INO-IS
Mrs. SUG/ 55 YO/ 1212660/ Musi Rawas/ P2A0/INO-RS
Mrs. SRI/ 51 YO/ 1184907/ Palembang/ P3A0/ INO-RS
Mrs. DEW/ 57 YO/ 1155825/ Muara Enim/ P4A0/ INO-RS
Mrs. NUR/ 51 YO/ 1136980/ P3A1/ Palembang/ INO-RS
Mrs. SIN/ 22 Yo/ 1209157/ Palembang/ P1A0/ INO-AT
Miss. SEL/ 15 YO/ 1208246/ Muara Enim/P0A0/ INO-AT
Mrs. ERN/ 44 YO/ 1183682/ Palembang/ P4A0/ INO-IS
Miss. MAY/ 25 YO/ 1213439/ Palembang/ P0A0/ INO-AT
Mrs. NUR/ 45 YO/ 1203902/ Lahat/ P0A1/ INO-IS
Mrs. MEN/ 29 YO/ 1217491/ Palembang/ P4A0/ INO- IS
Mrs. NUR/ 52 YO/ 1213407/ Ogan Ilir/ P7A0/ INO-RS
Mrs. RIN / 70 YO/ 1210985/ Lubuk Linggau/ P4A1/ INO-RS
Miss. NIS/ 24 YO/ 1214111/ Lampung/ P0A0/ INO- AT
Miss. SUK/ 13 YO/ 1184905/ Palembang/ P0A0/ INO-IS
Mrs. SEP/ 29 YO/ 1212012/ Palembang/ P1A0/ INO-RS
Mrs. SAP/ 54 YO/ 1213929/ Palembang/ P3A0/ INO-RS
Mrs. YUL/ 36 YO/ 1194420/ Palembang/ P5A0/ OGL-AT
Mrs. SIS/ 48 YO/ 1179056/ Ogan Ilir/ P3A1/ INO-AT
Mrs. ANU/ 50 YO/ 1174361/ Palembang/ P4A1/ INO – IS
Mrs. ANA/ 51 YO/ 1209111/ Musi Rawas/ P5A0/ INO-AT
Mrs. MAI/ 70 YO/ 1215088/ Palembang/ P10A0/ INO-RS
Mrs. LIL/ 29 YO/ 1208424/ Ogan Ilir/ P2A0/ INO-NS
Mrs. AIN/ 28 YO/ 1202063/ OKU Selatan/ P0A2/ INO-IS
Mrs. SUS/ 46 YO/ 1207942/ Palembang/ P2A1/ INO-IS
Mrs. MUL/ 41 YO/ 519627/ Palembang/ P2A1/ INO-IS
Mrs. ISN/ 42 YO/ 1198477/ Palembang/ P3A0/ INO-AT
Mrs. ANA/ 51 YO/ 1209111/ Musi Rawas/ P5A0/ INO-AT
Mrs. SIS/ 48 YO/ 1179056/ Ogan Ilir/ P3A1/ INO-AT
Mrs. DID/ 67 YO/ 900468/ OganKomering Ilir P9A0/ INO-AT
Mrs. HIL/ 42 YO/ 1184822/ Palembang/ P0A0/ INO-IS
Mrs. MAR/ 57 YO/ 1208459/ OganKomering Ilir/ P2A0/ INO-RS
Mrs. AIN/ 28 YO/ 1202063/ OKU Selatan/ P0A2/ INO-IS
Mrs. LIL/ 29 YO/ 1208424/ Ogan Ilir/ P2A0/ INO-NS
Mrs. ASN/ 48 YO/ 1216210/ Musi Banyuasin/ P0A0/ INO-IS
Mrs. FIT/ 42 YO/ 1212052/ Palembang/ P3A0/ INO-RS
Mrs. BUD/ 50 YO/ 1215138/ LubukLinggau/ P3A1/INO-RS
Mrs. SUM/ 47 YO/ 1204412/ Ogan Komering Ilir/ P2A0/ INO-RS
Mrs. NUR/ 51 YO/ 1136980/ P3A1/ Palembang/ INO-RS
Mrs. ELI/ 50 YO/ 1209678/ Muara Enim/ P3A1/ INO-IS
Miss. YOS/ 33 YO/ 1217486/ Palembang/ P0A0/ INO-IS
Mrs. ERN/ 44 YO/ 1183682/ Palembang/ P4A0/ INO-IS
Mrs. KUS/ 33 YO/ 1220579/ OganKomering Ilir/ P3A1/ INO- IS
Mrs. SAU/ 59 YO/ 1204077/ Bangka Belitung/ P3A0/INO-IS
Mrs. ELI/ 44 YO/ 1208540/ OKU Timur/ P3A0/ INO-AT
Mrs. SUD/ 39 YO/ 1213052/ Dusun II/ P2A0/ INO-RS
Mrs. IND/ 56 YO/ 1072781/ Palembang/ P0A0/ INO-RS
Mrs. HUN/ 60 YO/ 887019/ Palembang/ P6A0/ INO-IS
Mrs. DAR/ 35 YO/ 232016/ Palembang/ P4A0/ OGL-RS
Mrs. AYU/ 25 YO/ 1198203/ Palembang/ P2A0/ INO-RS
Mrs. SUM/ 62 YO/ 1217724/ Lampung/ P2A0/ INO-AT
Mrs. EMA/ 55 YO/ 1184603/ Palembang/ INO-AT
Mrs. YUS/ 48 YO/ 1133600/ Palembang/ P4A0/ INO- IS
Mrs. ASN/ 48 YO/ 1216210/ Musi Banyuasin/ P0A0/ INO-IS
Mrs. MAI/ 70 YO/ 1215088/ Palembang/ P10A0/ INO-RS
Mrs. EMI/ 46 YO/ 1218487/ Palembang/ P1A1/ INO-IS
Mrs. SRI/ 49 YO/ 1218827/ Baturaja/ P2A1/ INO-IS
Miss. FIT/ 25 YO/ 1216218/ Bangka Belitung/ P0A0/ INO- IS
Mrs. HER/ 57 YO/ 1204279/ Palembang/ P4A0/INO-RS
Mrs. ONA/ 46 YO/ 1222182/ Palembang/ P3A0/ INO-AT
Mrs. ARM/ 67 YO/ 1195394/ Muara Enim/ P5A0/ INO-AT
Mrs. HUS/ 46 YO/ 485545/ Palembang/ P1A1/ INO-RS
Mrs. ROM/ 66 YO/ 1219793/ Palembang/ P5A0/ INO-AT
Mrs. DIL/ 47 YO/ 1217655/ Lahat/ P2A0/ INO-AT
Mrs. MAR/ 57 YO/ 1180539/ Palembang/ P5A0/ INO -IS
Mrs. SUR/ 57 YO/ 1211732/ LubukLinggau/ P0A0/ INO- RS
Mrs. ZUL/ 67 YO/ 1184014/ Sekayu/ P5A0/ INO-IS
Mrs. NET/ 40 YO/ 1198993/ Musi Banyuasin/ P3A2/ INO-IS
Mrs. BAS/ 41 YO/ 1203264/ OganKomering Ilir/ P4A1/ INO-RS
Mrs. SUH/ 48 YO/ 008415/ LubukLInggau/ P1A0/ INO-IS
Mrs. HUN/ 60 YO/ 887019/ Palembang/ P6A0/ INO-IS
Mrs. RIT/ 53 YO/ 1194677/ Palembang/ P3A0/ INO-RS
Mrs. SRI/ 38 YO/ 1211806/ Musi Banyuasin/ P2A2/ INO- RS
Mrs. MIA/ 25 YO/ 1204524/ Pagar Alam/ P2A1/ INO-AT
Mrs. SHE/ 29 YO/ 1102096/ Palembang/ P3A1/INO-AT
Mrs. HEL/ 53 YO/ 780971/ Banyuasin/ P1A0/ INO-RS
Mrs. DEW/ 40 YO/ 1219895/ OganIlir/P2A0/ OGL- AT
Mrs. TAS/ 19 YO/ 1209396/ Baturaja/ P0A1/ INO-RS
Mrs. SRI/ 27 YO/ 1203022/ Palembang/ P1A1/ INO-AT
Mrs. ELI/ 27 YO/ 1178008/ Palembang/ P4A0/ INO-RS
Mrs. FER/ 23 YO/ 1157950/ Musi Banyuasin/ P0A0/ INO-AT
Mrs. RAT/ 54 YO/ 1195946/ Palembang/ P1A0/ INO-IS
Mrs. IDA/ 52 YO/ 1218099/ Ogan Ilir/ P0A0/ INO-IS
Mrs. IDA/ 52 YO/ 1218099/ Ogan Ilir/ P0A0/ INO-IS

Mrs. IDA/ 52 YO/ 1218099/ Ogan Ilir/ P0A0/ INO-IS


Mrs. ZAH/ 56 YO/ 1203475/ Jambi/ P5A0/ OGL-RS
Mrs. FAR/ 58 YO/ 1126419/ OganKomering Ulu Selatan/ P5A1/ INO-AT
Mrs. REP/ 51 YO/ 1191495/ Palembang/ P3A0/ INO-RS
Mrs. FIT/ 43 YO/ 1108543/ Banyuasin/ P3A0/ INO-RS
Mrs. PAR/ 46 YO/ 1206656/ Banyuasin/ P4A0/ INO-RS
Mrs. ERN/ 55 YO/ 1204597/ Musi Banyuasin/ P5A0/ INO-IS
Mrs. HAR/ 50 YO/ 1111243/ Palembang/ P2A0/ INO-RS
Mrs. DIA/ 30 YO/ 991742/ OganKomering Ilir/ P0A0/ INO-RS
Mrs. YUS/ 48 YO/ 1133600/ Palembang/ P5A0/ INO-RS
Mrs. HEN/ 44 YO/ 1189670/ OganKomering Ulu Selatan/ P5A1/ INO-IS
Mrs. SUM/ 64 YO/ 1184894/ Palembang/ P3A0/ INO-RS
Mrs. ANU/ 51 YO/ 1174361/ Palembang/ P4A1/ INO-IS
Mrs. JUN/ 64 YO/ 1201580/ Palembang/ P3A0/ INO-RS
Mrs. MAY/ 25 YO/1213439/ Palembang/ P0A0/ INO-AT
Mrs. LIL/ 49 YO/1208424/ Palembang/ P2A0/ INO-AT
Mrs. YUS/ 48 YO/ 1133600/ Palembang/ P4A0/ INO-IS
Mrs. HEN/ 43 YO/ 1189670/ OganKomering Ilir/ P3A0/ INO-RS
Mrs. SUM/ 49 YO/ 118489/ Musi Rawas/ P3A0/ INO-RS
Mrs. ANU/ 50 YO/ 1174361/ Palembang/ P4A1/INO-IS
Mrs. JUN/ 64 YO/ 1201580/ Palembang/ P4A0/ INO-RS
Mrs. RIS/ 32 YO/ 1225296/ P1A1/ Palembang/ INO-IS
Mrs. MAY/ 25 YO/ 1213439/ Palembang/ P0A0/ INO-AT
Mrs. NUR/ 50 YO/ 885134/ Palembang/ P4A0/ INO-AT
Mrs. RUM/ 41 YO/ 1189719/ OKU Selatan/ P4A1/ INO-RS
Mrs. PON/ 50 YO/ 1193031/ Ogan Komering Ulu P4A0/ INO-AT
Mrs. PUR/ 41 YO/ 1220648/ Ogan Komering Ilir/ P4A0/ INO- RS
Mrs. ELI/ 50 YO/ 1209678/ Muara Enim/ P3A1/ INO-IS
Mrs. SIN/ 22 YO/ 1209157/ Palembang/ P1A0/ INO-AT
Mrs. TJO/ 69 YO/ 1190355/ Palembang/ P4A1/ INO-AT
Mrs. RIS/ 21 YO/ 1141398/ Palembang/ P0A1/ INO-RS
Mrs. END/ 41 YO/ 1121718/ Palembang/ INO-AT
Mrs. KOM/ 49 YO/ 1203021/ OKU timur/ P4A0/ INO-AT
Mrs. NUR/ 32 YO/ 1207648/ OKU Selatan/ P0A0/ INO-IS
Mrs. FIT/ 43 YO/ 1108543/ Banyuasin/ P3A0/ INO-RS
Mrs. WAR/ 48 YO/ 1208963/ Muara Enim/ P3A0/ INO-IS
Mrs. ERL/ 42 YO/ 1190734/ OganKomering Ilir/ P3A1/ INO-RS
Mrs. SEF/ 35 YO/ 1177430/ Palembang/ P2A0/ INO-IS
Mrs. DEW/ 41 YO/ 1223008/ Palembang/ INO-RS
Mrs. WAH/ 37 YO/ 1021518/ Palembang/ INO-RS
Mrs. ELN/ 46 YO/ 1051400/ Palembang/ INO-IS
Mrs. RIN / 70 YO/ 1210985/ LubukLinggau/ P4A1/ INO-RS
Mrs. TAT/ 45 YO/ 1208271/ Palembang/ P2A1/ INO-IS
Mrs. EST/ 40 YO/ 1208396/ Palembang/ P2A0/ INO-AT
Mrs. YUS/ 48 YO/ 1133600/ Palembang/ P4A0/ INO-IS
Mrs. MAR/ 57 YO/ 1208459/ OganKomering Ilir/ P2A0/ INO-RS
Mrs. PAR/ 49 YO/ 1208374/ Ogan Ilir/ P5A0/ INO-AT
Mrs. SUY/ 61 YO/ 1175649/ Palembang/ P2A4/ INO-AT
Mrs. HER/ 26 YO/ 1153242/ Palembang/ P0A2/ OGL-IS
Mrs. CIN/ 35 YO/ 1225001/ Palembang/ P3A0/ INO-RS
Mrs. ARY/ 58 YO/ 1225834/ Sekayu/ P9A0/ INO-RS
Mrs. MEL/ 61 YO/ 1115269/ Palembang/ P4A0/ INO-RS
Mrs. TAT/ 45 YO/ 1208271/ Palembang/ P2A1/ INO-IS
Mrs. IDA/ 50 YO/ 1208732/ Palembang/ P8A0/ INO-AT
Mrs. RIN / 70 YO/ 1210985/ LubukLinggau/ P4A1/ INO-RS
Mrs. MIN/ 58 YO/ 1225861/ Palembang/ P3A0/ INO-AT
Mrs. ANG/ 36 YO/ 1048776/ Palembang/ P0A0/ INO-RS
Mrs. DEW/ 41 YO/ 1223008/ Palembang/ INO-RS
Mrs. KHO/ 64 YO/ 1226330/ Palembang/ P9A0/ INO-RS
Mrs. CIN/ 35 YO/ 1225001/ Palembang/ P3A0/ RAM-RS
Mrs. ASN/ 48 YO/ 1216210/ Musi Banyuasin/ P0A0/ RAM-IS
Mrs. YUL/ 36 YO/ 1194420/ Palembang/ P5A0/RAM-AT
Mrs. SRI/ 49 YO/ 1218827/ Baturaja/ P2A1/ RAM-IS
Mrs. ERI/ 48 YO/ 1227394/ Palembang/ P3A0/ RAM-IS
Mrs. NUR/ 56 YO/ 1207296/ Palembang/ P0A0/ RAM-RS
Mrs. SUR/ 46 YO/ 1207410/ Muara Enim/ P0A0/ RAM-RS
Mrs. FAR/ 55 YO/ 1189543/ Bangka Belitung/ P5A0/ RAM-RS
Mrs. ROH/ 51 YO/ 1225202/ Lahat/ P3A0/ RAM-RS
Mrs. ROH/ 51 YO/ 1225202/ Lahat/ P3A0/ RAM-RS

Mrs. ROH/ 51 YO/ 1225202/ Lahat/ P3A0/ RAM-RS


Mrs. RUS/ 58 YO/ 1225493/ Ogan Ilir/ P3A1/ INO-AT
Mrs. FIT/ 42 YO/ 1212052/ Palembang/ P3A0/ INO-RS
Mrs. DAR/ 52 YO/ 1220806/ Palembang/ P6A0/ INO- RS
Mrs. MEN/ 29 YO/ 1217491/ Palembang/ P4A0/ INO- IS
Mrs. NUR/60 YO/ 1198314/ Palembang/ P0A0/ INO- IS
Miss. NIS/ 24 YO/ 1214111/ Lampung/ P0A0/ INO- AT
Mrs. MAI/ 70 YO/ 1215088/ Palembang/ P10A0/ INO-RS
Mrs. SUM/ 62 YO/ 1217724/ Lampung/ P2A0/ INO-AT
Mrs. FIR/ 47 YO/ 1225461/ Palembang/ P2A0/ KOM-RS
Mrs. ROS/ 51 YO/ 1197016/ Palembang/ P3A0/ KOM-AT
Mrs. HAL/ 55 YO/ 1204580/ Muara Enim/ P0A0/ KOM-IS
Mrs. FIT/ 29 YO/ 1162227/ Palembang/ P2A0/ KOM-
Miss. SAN/ 22 YO/ 1222855/ Palembang/ P0A0/ KOM-IS
Mrs. JAI/ 45 YO/ 1208266/ OganKomering Ilir/ P2A0/ KOM-IS
Mrs. SHE/ 29 YO/ 1102096/ Palembang/ P3A1/KOM-AT
Mrs. MAR/ 48 YO/ 1223615/ Banyuasin/ P4A0/ KOM-RS
Mrs. SIS/ 35 YO/ 1227408/ Palembang/ KOM-AT
Mrs. WAI/ 53 YO/ 1221808/ Palembang/ P3A0/ KOM-IS
Mrs. RIN/ 51 YO/ 1227770/ Palembang/ ZAN-RS
Mrs. ERN/ 55 YO/ 1204597/ Musi Banyuasin/ P5A0/ ZAN-IS
Mrs. MEL/ 61 YO/ 1115269/ Palembang/ P4A0/ ZAN-RS
Mrs. ROM/ 66 YO/ 1219793/ Palembang/ P5A0/ ZAN- AT
Mrs. YUS/ 48 YO/ 1133600/ Palembang/ P4A0/ ZAN-IS
Mrs. ERN/ 56 YO/ 1176021/ Palembang/ P4A0/ ZAN-RS
Mrs. ELP 49 YO/ 1226031/ Palembang/ P4A1/ ZAN-IS
Mrs. MAR/ 48 YO/ 1223615/ Banyuasin/ P4A0/ KOM-RS
Identitas
Mrs.
HAY/ 44 YO/ 876278/ Palembang/ P2A0/ DID-RS

Mrs. MUR/ 69 YO/ 1206839/ Bangka Belitung/ P6A0/ STI-RS


Mrs. SUW/ 70 YO/ 1233153/ Palembang/ P2A0/ DID-AT
Mrs. SUP/ 53 YO/ 1234750/ Palembang/ P2A1/ DID-RS

KOS/ 64 YO/792025/ Banyuasin/


P4A0/ DID-RS

ROK/ 59 YO/ 1201586/ Banyuasin


/P2A0/
WAR/ 48DID-RS
YO/ 1208963/ Muara Enim/
P3A0/ DID-IS

Mrs. IND/ 56 YO/ 1072781/ Palembang/ P0A0/ DID-RS

Mrs. MAS/ 54 YO/ 1197749/ Palembang/ P2A2/ DID-IS


Mrs. NIN/
SUM/68
62YO/
YO/1235488/
1217724/Palembang/ DID-RS
Lampung/ P2A0/ DID-AT

Mrs. NIL/
TJO/ 47 12365432/
61 YO/ YO/ 1210137/ OKU Selatan/ P1A0/ DID-IS
Sekayu/
DID-IS
Miss. NOV/ 20 YO/ 1233712/ Palembang/ P0A0/ DID-AT
Mrs. NUR / 52 YO/ 1235534/ Bangka Belitung/ DID- IS
TEM/ 51 YO/ 1229788/ Muara Enim/
P3A0/ DID-AT
Mrs.
FIT/
Mrs. 42 YO/451212052/
TAT/ Palembang/
YO/ 1208271/ P3A0/P2A1/
Palembang/ DID-RS
DID-IS
Mrs.
TAR/AIS/
Mrs. 41 YO/ 1115243/
64 YO/ Palembang/
1235044/ P2A0/
Palembang/ DID-AT
DID- RS

Mrs. EKM/ 51YO/


PAR/ 60 YO/1235482/
1235586/Palembang/
Baturaja/ P3A1/ DID-IS
DID-AT
Mrs. RUM/ 68 YO/ 1234433/ Palembang/ P8A0/ DID-AT
Mrs. MIS/ 64 YO/ 838113/ Ogan Komering Ulur/ DID-IS

Mrs. RUS/ 53 YO/ 1234672/ Palembang/ DID-RS


TUN/4657YO/
Mrs. LIL/ YO/1235017/
1205597/Palembang/
Ogan Komering
P4A0/Ulu/ P4A0/DID-RS
DID-IS
Mrs. SEL/ 37 YO/ 1218814/ Bengkulu/ P0A0/ DID-RS
Mrs. ELI/ 44 YO/ 1207201/ Palembang/ P3A0/ DID-IS
Mrs.
DON/ 33 YO/
Mrs. ZER/ 1227765/
27 YO/ Palembang/
1205266/ P1A0/
Palembang/ KOM-HE-FU
P0A0/ KOM- KY- AW
Mrs. VER/ 30 YO/ 1201946/ Pagar Alam/ P0A1/ KOM- AW
Mrs.
ARI/ 45 YO/ KY
P2A0/RAM- 1204164/ Palembang/ P0A0/ RAM-KY
Mrs. MEL/ 25 YO/1218821/ Palembang/ P0A0 / RAM- KY
Mrs.
ADE/ 36 YO/ 1206135/ Palembang/P0A0/ KOM-AW- HE

Mrs. HER/ 33 YO/ 962193/ Muara Enim/ P0A0/ RAM-KY

Mrs. MIL/OKU/
1231697/ 37 YO/ 1208971/ Musi Banyuasin/ P0A0/ RAM-HE
P3A0/OGL/HD
12314253/ PALEMBANG/ P2A0/OGL/AF
Mrs.
MUD/ 53 YO/
1234890/
MUSI RAWAS/ P2A0/OGL/AF

1235502/ PRABUMULIH/ P3A0/OGL/RK


Mrs.
DIY/ 22 YO/
Prabumulih/
P0A0/OGL/AF
1235586/ Baturaja/ P3A0/OGL/AF
Mrs.
OLG/ 26 YO/ 1236100/ PagaralamP0A0/ JAY-AF
Diagnosa
Uterine Adenomyosis was suspected

abnormal uterine bleeding cb


Intramural uterine myom
Endometrial polyp was suspected

Post laparotomy salphyngoooforectomi dextra on indication c

Diagnosa
Abnormal uterine bleeding caused by MI was suspected
Abnormal uterine bleeding caused by uterine adenomyosis wa
left cystic ovarian neoplasm

Dermoid cyst was suspected

Diagnosa
Recurrent pregnancy loss
Endometriosis cyst was suspected
Dysmenorrhea caused by endometriosis cyst was suspected
Endometriosis cyst was suspected
Uterine adenomyosis diffuse type was suspected
Endometriosis grade III (ASRM Score 28 EFI Score 4)
Post laparoscopy myomectomv on indication uterine myoma Pos
Post salphingoraphy
Bilateral patent tube
Diagnosa
dysmenorrhea cb bilateral endometrial cyst was suspected
uterine Adenomyosis
internal genitalia organ adhesion
post leuprolide acetate injection 2nd series
Endometriosis grade III (ASRM Score 16)
post leuprolide acetate injection 5th series

Diagnosa
Right endometriosis cyst was suspected
Post multiple adenomyosis resection per laparoscopy

Diagnosa
Endometriosis ASRM grade IV ( ASRM score 120 + EFI Scor
Uterine adenomyosis
Bilateral patent tube
Endometriosis ASRM grade IV (ASRM Score 66 EFI score 7
Uterine adenomyosis
Post adhesiolysis oi Internal genitalia organ adhesion
Post bilateral salphingography
Patent tubes bilateral
Post leuprolide acetate 3.75 1st serie
Uterus myomatosus was suspected
Primary infertile 1 year
Diagnosa
Endometriosis ASRM grade IV
Post laparoscopy cystectomy bilateral
Post adhesiolysis bilateral as indication of internal genitalia organ adhesion
Tuba bilateral
Uterine adenomyosis
Subserous uterine myoma
Diagnosa
Cystocele grade III
Uterine prolapse grade IV
Rectocele grade III
Hypertension stage II
Diagnosa
Cystocele grade IV
Uterine prolapse grade IV
Rectocele grade II
Hypertension stage II
Polycystic right kidney
Diagnosa
Cervical cancer Stage IIA
Ovarian cancer Stage IIIC
Ovarian cancer Stage IIIC ( complete therapy complete respo
LGSIL
Solid ovarian neoplasm with malignancy was suspected
dd/ non-gynecology
Endometrial mass
cancer inadequate staging
Cervical cancer Stage IIIB
Cervical cancer Stage IIIB
Cervical cancer Stage IIIB
Stage IIIB was suspected AKI stage V was suspected
Moderate anemia
Ovarian cancer Stage IIIB
Endometriosis
GTN Stage I FIGO Score 2
GTN stage II FIGO Score 8
Endometrial cancer Stage IB ( endometrioid carcinoma FIGO
Endocervical polyp
Stage IIIB
Ovarian cancer Recurrent
Ovarian cancer Stage IC
Sage I FIGO Score 4
Stage IV FIGO Score 2
Left mucinous cystic ovarian neoplasm
Chronic hepatitis B

Stage IIIC1 was suspected


Stage IIIA
Stage IIIB
Moderate anemia

Stage IIIB
Recurrent
Moderate anemia

Stage I FIGO Score 1


Stage I FIGO Score 2

Stage IIA2
Stage IIIB.( complete therapy)
Severe anemia
Leukocytosis
AKI stage III was suspected
Hyponaremia
Hyperkalemia
Stage IIIB
Severe anemia
Hypoalbuminemia

Stage IIIB

Stage IIIB
Stage IIIB
Moderate anemia

Recurrent

Stage IA
Stage IC
Stage IIIC
Moderate anemia
Leucopenia

Stage I FIGO Score 4

Cervical cancer

Ovarian cancer

Endometrial cancer
GTN Stage I FIGO Score 1
ASCUS
Cystic ovarian neoplasm with solid part malignancy was suspected
Moderate anemia
GTN

Ascites on cystic ovarian neoplasm with solid part malignancy was suspected

Cystic ovarian neoplasm with solid part, malignancy was suspected

Cystic ovarian neoplasm with solid part, malignancy was suspected

Cervical cancer

Ovarian cancer
GTN

Multilocular cystic ovarian neoplasm permagna malignancy was suspected


Ovarian cancer

GTN
Solid ovarian neoplasm was suspected

Uterine myoma was suspected

Cervical cancer

Endometrial cancer

GTN
Bilateral solid ovarian neoplasm with malignancy was suspected
Ascites

Solid ovarian neoplasm dd/ non-gynecology intra-abdominal mass


Cystic ovarian neoplasm with solid part malignancy was suspected
Diabetes mellitus type II
Hypertension stage II

Intra-abdominal cystic mass was suspected dd/ mucinous cystic ovarian neoplasm was suspected

Cervical cancer

Ovarian cancer

Endometrial cancer

GTN
GTN

Cervical cancer

GTN
Solid ovarian neoplasm with malignancy was suspected ( C56)

Cervical cancer

Ovarian cancer

GTN
Cervical cancer

Ovarian cancer
GTN

Cystic ovarian neoplasm with malignancy was suspected ( C56)


Diabetes mellitus type II ( E11)
Moderate anemia
Cystic ovarian neoplasm with malignancy was suspected ( C56)
Ascites ( R18,8)
ILO
Moderate anemia ( D64.9)
Hypoalbumienmia ( E88.0)
Hypokalemia ( E87.6)
DLI (E86)
Diagnosa
Cervical cancer Stage IIIB ( C53.9)
Anemia cancer
Cervical ( D64.9)Stage IIIB Complete therapy complete respons ( C53.9)
Urinary tract
Cervical infection
cancer Stage (IIIB
N39.0)
( C53.9)
Ovarian cancer Stage IIIC ( C56)
CKD stage
Ovarian V onStage
cancer HD ( IIIC
Post( nephrostomy)
C56.9) (N18.5)
Ovarian cancer Recurrent ( C56.9)
Leucopenia ( D72.819)
GTN Stage I FIGO Score 2( O01.9)
GTN Stage I FIGO Score 7 ( O01.9)
Moderate
GTN anemia ( D64.9)
was suspected ( O01.9)
LGSIL ( R87.613)
Multilocular cystic ovarian neoplasm with malignancy was suspected ( C56)
Ascites (cancer
Cervical R18.8)stage IIIB ( C53.9)
Cervical cancer stage IVA (C53.9)
Cervical cancer Stage IIIC ( C56.9)
Moderate anemia
Hydatidiform mole (( O01.9)
D64.9)
Endometrial cancer Stage I was suspsected ( C54.1)
Uterine adenomyosis ( N80.0)
Atypical
Solid endometrial
ovarian hyperplasia
neoplasm ( N85) was suspected ( C56)
with malignancy
Ascites (cancer
Cervical R18.8)Recurrent ( C53.9)
Moderate
Ovarian anemia
cancer ( D64.9)
Stage IC (C56.9)
Moderate
Ovarian anemia
cancer ( D64.9)( C56.9)
Recurrent
Ovarian cancer Stage IC ( C56.9)
Leucopenia
GTN ( D72.819)
stage I FIGO Score 3 ( O01.9)
GTN Stage IV FIGO Score 2 (O01.9)
GTN Stage I FIGO Socre 6 ( O01.9)
Leucopenia
Right (D72.819)
cystic ovarian neoplasm ( N83.02)
Uterine
Cystic adenomyosis
ovarian ( N80.0)
neoplasm with malignancy was suspected ( C56.9)
Cervical cancer Stage IIB was suspected ( C53.9)
Left limbcancer
Cervical DVT was suspsected
Stage (I80.3)
IVA was suspected ( C53.9)
Hypertension
Cervical cancerstage II (IIIB
Stage I10)
( C53.9)
Moderate
Cervical anemia
cancer ( D64.9)
Stage IIIB ( C53.9)
Moderate
Ovarian anemia
cancer ( D64.9) staging ( C56)
inadequate
Ovarian cancer Recurrent ( C56)
GTN stage I FIGO Score 8 (O01.9)
GTN stage I FIGO Score 3 ( O01.9)
Recurrent vaginal cancer with buli metastases was suspected ( C51.9)
Gross ovarian
Cystic Hematuria ( R31.0)
neoplasm with solid part malignancy was suspected ( C56.9)
Ascites
AUB ( R18.8)
caused by coagulopathy was suspected (N93.9)
Secondary APS (D68.61)
Bilateral endometriosis cysts (N80.1)
Endometrial
•Multiple thickening
uterine myomacaused
(D25.9)by hyperplasia was suspected (N85.00)
•Uterine adenomyosis
•Abnormal (N80.0)
uterine bleeding caused by O1M1 ( N93.9)
Endometriosis ASRM grade III ( ASRM score 24) ( N80.9)
Post laparoscopy
Uterine cystectomy
adenomyosis (N80.0)
Bilateral
Cyst endometriosis
ovarian cysts (N80.1)
neoplasm (C56.9)
Primary infertilecaused
Dysmenorrhea 12 years
by (N97.9)
left endometriosis cyst (N80.1)
Uterine
Right adenomyosis
endometriosis (N80.0)
cyst (N80.1)
N82.0 vesicovaginal fistula (N73.6)
Internal genitalia adhesion
•Uterine(D25.1- Intramural leimyoma of uterus)
Ovarian cancer Stage IVA ( C56.9)
Severe anemia
Ovarian ( D64.9) staging ( C56.9
cancer inadequate
Ovarian cancer stage IIC complete therapy ( C56.9)
Ovarian cancer stage IC ( C56.9)
GTN Stage I FIGO Score 8 (O01.9)
GTN Stage I, FIGO Score 3 ( O01.9)
Diagnosa
Post menopause bleeding caused by malignancy was suspec
Intramural uterine myoma (D25.1)
Diabetes
Uterine mellitus type II (E11.0)
myoma
(D25.- leiomyoma
Uterine adenomyoma of uterus)
(D.25- leiomyoma of uterus)
Bilateral ovarian cyst neoplasm
Abnormal uterine bleeding caused (N.83- bilateral
by O1 ovarian cyst)
( N93.0)
Vulva-vaginitis (N77.1)
Urinary cancer
Cervical tract infection (N39.0)
Stage IIB ( C53.9) inadequate theapy
Moderate anemia (D64.9)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IVA ( C56.9)
Ovarian cancer Stage IA ( C56)
Ovarian cancer Recurrent ( C56)
Ovarian cancer Recurrent ( C56.9)
Moderate
Ovarian anemia
cancer ( D64.9)
Stage IIIC ( C56.9)
Ovarian cancer Stage IIIC ( C56.9)
Cystic ovarian neoplasm malignancy was suspected ( C56)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIIB ( C53.9) complete therapy comple
Ovarian cancer Stage IVB (C56.9)
Moderate
Ovarian anemia
cancer (D64.9)
Stage IC (C56.9) complete therapy complete
Ovarian cancer Progressive disease (C56.9)
Ovarian cancer Recurrent (C56.9)
Moderate
GTN Stage anemia
II FIGO (D64.9)
Score 9 ( O01.9)
Leucopenia ( D72.819)
GTN Stage I FIGO Score 2 complete therapy (O01.9)
Cystic ovarian neoplasm malignancy was suspected ( C56)
Atypical glandular cell ( R87.619)
•G4P2A1 39 weeks gestational age (Z3A.39)
•Prior CS35
•G1P0A0 1Xweeks
(O34.21)
gestational age (Z3A.35)
•Beta thalassemia intermediate (D56.1)
•P6A1 post SSTP oi Superimposed preeclampsia + PPHD NYHA IV (days 10th)
•Post post
•P1A0 tuba spontaneous
ligation (daysdelivery
10th) (O34.21)
with history of rupture of
•P3A0 post LSCS oi placentae previa with prior cs 1x (days 8th ) (O34.21)
•Post pomeroy tubectomy (days 8th)
Diagnosa
•Cystocele grade III (N81.1)
•Uterine prolapse
Endometrial cancergrade
stageIV (N81.2)
IIIA on brachytherapy (C54.1)
Burst vaginal stump (89.8)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIIB ( C53.9)
Cystic ovarian neoplasm with maligancny was suspected ( C5
Solid ovarian neoplasm with maligancny was suspected dd/ intra-abdominal mass ( C56)
Massive ascites Stage
Ovarian cancer ( R18.8)
IIIC ( C56.9)
Ovarian cancer Stage IIIB ( C56.9)
Leucopenia ( D72.819)
Ovarian cancer Stage IIC complete therapy ( C56.9)
Ovarian cancer Stage IIIC complete therapy
Dysmenorrhea
Death conceptusc.b(O36.4)
left endometriosis cyst was suspected (N80.1)

Solid ovarian neoplasm with cystic part, malignancy was sus


Pedunculated Myoma (D25.0)
Endometrial Hyperplasia
Dysmenorrhea (N85.0)
caused by right endometriosis cyst (N80.0)
Right tubal Endometriosis (N80.2)
Stage IIIB ( C53.9)
Moderate
Stage IIIB anemia
complete ( D64.9)
therapy complete response ( C53.9)
Hypoalbuminemia
•Intramural (E88.09)(D25.1)
uterine myoma
Cervical cancer III B
•Left cyst ovarian neoplasm (C56.9)
•Primary
Cystic infertile
ovarian
Thrombocytopenia 1,5
neoplasm years (N97.9)
with
( D69.6) solid part, permagna, malignan

Stage IIIB was suspected ( C53.9)


Moderate
AUB anemia
c.b M1 + A1( D64.9)
Multilocular cystic ovarian neoplasm (D27.9)
Right cystic ovarian neoplasm (D27.9)
Ovarian cancer Stage IIIB ( C56.9)
Ovarian cancer Stage IA ( C56.9)
Ovarian cancer Stage IIIC( C56.9)
Ovarian cancer Stage IA ( C56.9)
Moderate anemiaStage
Ovarian cancer ( D64.9)
IIC complete therapy ( C56.9)
Ovarian cancer Stage IIIB ( complete therapy) C53.9)
Ovarian Cancer Stage IIIB ( C53.9)
Mild anemia
Ovarian ( D64.9)
Cancer Stage IIIC ( C53.9)
Moderate anemia ( D64.9)
Ovarian cancer Stage IB2 ( C53.9
Ovarian cancer Stage IC ( C56.9)
Ovarian cancer Recurrent with liver metastases ( C56)
Moderate anemia
Ovarian cancer ( D64.9)
Stage IA complete therapy complete response
Ovarian cancer Stage IA complete therapy complete response
Ovarian cancer Stage IIC ( C56.9)
Ovarian cancer Inadequate staging ( C56.9)
Cystic ovarian neoplasm with malignancy was suspected ( C5
Cervical cancer (C53.9)

Ovarian cancer(C56.9)
GTN (O01.9)
Cervical cancer (C53.9)
Cervical cancer (C53.9)

Ovarian cancer (C56.9)

Endometrial cancer (C54.9)


Cervical cancer (C53.9)

Ovarian cancer (C56.9)


Endometrial cancer (C54.9)
GTN (O019)
Cervical cancer

Ovarian cancer

GTN
Cervical cancer

Ovarian cancer
GTN

Cervical cancer

Ovarian cancer

GTN

Cervical cancer
Cervical cancer

Ovarian cancer
Endometrial cancer
Cervical cancer

Ovarian cancer
Ovarian cancer

GTN
Post hydatidiform mole evacuation ( O01.9)
Endometrial cancer
Cervical cancer

Ovarian cancer

GTN

Cervical cancer

Ovarian cancer

Endometrial cancer
Cervical cancer
Ovarian cancer

Ovarian cancer

Endometrial cancer
GTN

Cervical cancer

GTN

Ovarian cancer
Ovarian cancer

Ovarian cancer

Cervical cancer

Cervical cancer
Ovarian cancer
Endometrial cancer
Cervical cancer

Ovarian cancer
GTN

Cervical cancer

Ovarian cancer
GTN

Cervical cancer

Ovarian cancer
Endometrial cancer
GTN
Cervical cancer

Cervicalcancer

Ovarian cancer
Endometrial cancer
GTN
Cervical cancer

Ovarian cancer

Endometrial cancer
GTN
Cervical cancer

Cervical cancer

Ovarian cancer

Endometrial cancer
Cervical cancer

GTN

Cystic ovarian neoplasm with malignancy was suspected ( C56.9)


Ovarian cancer

Ovarian cancer

Cervical cancer

Ovarian cancer

Endometrial cancer
Cervical cancer

Ovarian cancer
Ovarian cancer

Endometrial cancer
GTN
Uterine sarcoma was suspected ( C51.9) )
Cystic ovarian neoplasm with malignancy was suspected (C56)
Leimyosarcoma dd/ mesentrium tumor ( C56)
Cervical cancer

Ovarian cancers
Cystic ovarian neoplasm with maliganncywas suspected ( C56.9)
Uterine sarcoma was suspected ( C51.9)
AKI stage
Diagnosa
Ovarian II DD/Inadequate
cancer, acute on CKD stage
staging V (N13.02)
( C56.9)

Thrombocyotopenia ( D69.6)

Solid ovarian neoplasm with malignancy was suspected ( C56


Cystic ovarian neoplasm with malignancy was suspected ( C5
Pseudocyst dd/ rupture cystic ovarian neoplasm ( N83.02)
Right hydronephrosis ( N13.2)
Internal genitalia adhesion ( N73.6)
Ascites ( cancer,Stage
Cervical R18.8) IIIB complete therapy complete response ( C53.9)

Thrombocytopenia ( D69.6)

Ovarian cancer Stage IA complete therapy( C56.9)


Endometrial cancer,Was suspected ( C54.9)

Endometrial cancer,Recurrent (C54.,9)


Myoma intraligamen was suspected

Multilocular cystic ovarian neoplasm with malignancy was su


Cervical cancer Stage IIB ( C53.9)
Leucopenia ( D72.819)
Stage IIIB ( C53.9)

Vulvar cancer was suspected( C51.2)


Rectocele grade III ( N81.6)

Cystic ovarian neoplasm with malignancy was suspected ( C5


Cystic ovarian
Cervical cancerneoplasm
Stage IB1with solid part, malignancy was susp
( C53.9)

Stage IIIB was suspected ( C53.9)

Cervical myoma ( D25.9)


Uterine adenomyosis (N80.0)
Primay infertile 2 years (N97.9)
Primary infertile 3 years (N97.9)
Primary infertile 12 years

•Dysmenorrhea
Bilateral caused by bilateral endometriosis cyst was su
patent tube

•Post laparoscopy resection adenomyosis (N80.0)


•Post myomectomy o.i intramural uterine myoma (D25.9)
•Patent left tube (N97.1)
•Primary infertile 7 years (N97.9)
•Right hydrosalpinx
•Endometriosis ASRM grade IV ( ASRM Score 104; EFI Score 4)
•Latent syphilis
Primary infertileinfection
15 years was suspected
Cervical cancer stage IV A was suspected

Cervical cancersinistra
Labia mayora stage IV A was suspected
tumors

Rectocele grade II
Vagina Septum Incomplete

Rectocele grade III


(D64.1)
Prosedur
US Gynecology
Injection leuprolide acetate 37.5 mg 3th series
Gynecology ultrasonograpgy
Laboratory
rritation
Plan for histeroscopy polypectomi
Plan for consult to internal department and anesthesiology
Gynecology ultrasonograpgy
Education
Prosedur
Plan for laparoscopy hysterectomy
Plan for laparotomy hysterectomy
Ultasonography
Plan for laboratory examination
Plan for labpratory examination (Tumor Marker: AFP)

Prosedur
Laboratory examination
Plan for operative laparoscopy
Operative laparoscopy
Plan for operative laparoscopy

Leuprolide acetate injection 3,75 mg 2nd course


Control 1 month later

Prosedur
Inj. Leuprolide acetate 3.75 mg 3rd series
CaCo3 1tab/24 hours
Re-evaluation after 3rd series

Injection of leuprolide acetate 37.5 mg 6th series


CaCo3 1tab/24 hours
Re-evaluation next month
Prosedur
Sperm analysis
Leuprolide acetate injection 3,75 mg
(5th course)
Prosedur
CIE
Sulfas ferrous /24 hours
Plan for leuprolide acetate 2nd series

Laparotomy myomectomy

Prosedur
Inj. leuprolide acetate 3.75 mg 2nd series

genitalia organ adhesion

Inj. leuprolide acetate 3.75 mg 2nd series

Prosedur
Laboratory examination
US confirmation
Consult internal medicine and anesthesiology department
Plan for total vaginal hysterectomy, colporrhaphy anterior and posterior
Prosedur
US confirmation
Consult to urology department
Consult internal medicine and anesthesiology department
Plan for total vaginal hysterectomy, colporrhaphy anterior and posterior

Prosedur
Plan for laparotomy radical hysterectomy
Chemotherapy paclitaxel-carboplatin 2nd course
Abdominal CT scan with contrast
Colposcopy
Internal medicine assessment
Abdominal CT scan with contrast
US gynecology
Chemotherapy paclitaxel-carboplatin 4th course
Chemotherapy paclitaxel-carboplatin 2nd course
radiotherapy paclitaxel-carboplatin
Plan for Chemotherapy
Plan for radiotherapy
Hospitalized
Internal
Plan for department assessment
Chemotherapy Paclitaxel-Carboplatin 2nd course
MR chemotherapy 4th course
MER chemotherapy 5th course
Plan for chemotherapy
Hysteroscopy DnC
Chemotherapy paclitaxel-carboplatin 3rd course
Plan for radiotherapy (March, 21st 2021)

diagnosis

C53.9 – malignant neoplasm of uterine cervix


C53.9 – malignant neoplasm of uterine cervix
C53.9 – malignant neoplasm of uterine cervix
D64.9 – moderate anemia

C56 – malignant neoplasm of ovary


C56 – malignant neoplasm of ovary
D64.9 – anemia

C56 – malignant neoplasm of ovary


O01.9 – gestational trophoblastic disease
O01.9 – gestational trophoblastic disease

O01.9 – gestational trophoblastic disease


C54.9 – malignant neoplasm of uterine corpus
D64.9 – anemia
D72.819 – decreased of white blood cells

N83.2 – unspecified ovarian cyst


N17.9 – hydronphrosis
E87.6 – hypokalemia

C53.9 – malignant neoplasm of uterine cervix


C53.9 – malignant neoplasm of uterine cervix
D64.9 – anemia
288.60 – leukocytosis
N13.9 – AKI
E87.1- hyponatremia
E87.5.- hyperkalemia
C53.9 – malignant neoplasm of uterine cervix
D64.9 – anemia
E88.1 – hypoalbuminemia

C53.9 – malignant neoplasm of uterine cervix

C53.9 – malignant neoplasm of uterine cervix


C53.9 – malignant neoplasm of uterine cervix
D64.9 – anemia

C56 – malignant neoplasm of ovary ( unspecified)

C56 – malignant neoplasm of ovary ( unspecified)


C56 – malignant neoplasm of ovary ( unspecified
C56 – malignant neoplasm of ovary ( unspecified) D64.9 – anemia
D72.819 – decreased of white blood cells

O01.9 – gestational throphoblastic disease

Stage IIIB
Moderate anemia

Stage IIIB
Leucopenia

Stage IC
Stage IC ( complete therapy)
Stage IIIC
Moderate anemia

Recurrent

Stage IB ( post laparotomy bilateral salpingo-oophorectomy + bilatera

y was suspected
Stage IC
Mild anemia
Inadeqaute staging
Leucopenia

Stage I FIGO Score 6


Stage I FIGO Score 3
Satge I FIGO Scre 3

malignancy was suspected

cy was suspected

cy was suspected

Stage IIIB
Mild anemia

Stage IIIC1 ( with pelvic lymph nodes invasion)

Stage IIIB
Recurrent
Severe anemia

Stage IC
Moderate anemia

Recurrent with liver metastases


Moderate anemia
Leukopenia
Thrombocytopenia

Stage I FIGO Score 6

alignancy was suspected

Stage IIIB ( complete therapy complete response)

Stage IVA
Stage IA

Stage IA
Stage IIIC
Cancer pain

Stage II FIGO Score 5


Stage IV FIGO Score 2

Stage IB2 was suspected


Stage IIIC
Mild anemia

Stage IIIB complete therapy


Stage IIIB
Mild anemia

Stage IC
Was suspected

Stage I FIGO Score 9


was suspected

abdominal mass
y was suspected

cinous cystic ovarian neoplasm was suspected

Stage IB2

Stage IIIC (complete therapy)

Stage IIIB complete therapy


Stage I FIGO Score 3
Stage I FIGO Score 2 (complete therapy)
Stage I FIGO Score 3

Stage IIIB ( C53.9)

Stage IIB was suspected ( C53.9)

Stage IB3 was suspected ( C53.9)


Progressive disease (C53.9(
Bilateral hydronephrosis ( N13.2)
CKD stage V on HD ( N18.5)
Hypertension stage I on therapy ( U10)
Post DJ Stent

Stage IIB ( post radical hysterectomy) ( C53.9)


Stage IIIA1 C56.9)

Stage I FIGO Score 7 ( O01.9)


d ( C56)

Stage IIIC ( C53.9)


Stage IIA2 (C53.9)
Recurrent ( C56)
Thrombocytopenia ( D69.6)

Stage IA ( C56)
Stage IA ( C56)
Thrombocytopenia ( D69.6)

Stage IIIC complete therapy ( C56)


Stage I FIGO score 3(O01.9)
Stage I FIGO Score 3 ( O01.9)
Stage I FIGO Score 3 ( O01.9)

Stage I FIGO Score 6 ( O01.9)


Recurrent ( C53.9)
GI tract metastases was suspected
Moderate anemia ( D64.9(
Thrombocytopenia ( D69.6(

Stage IIB was suspected ( C53.9)


Stage IIB ( C53.9 )
Post radical hysterectomy
Recurrent ( C56)
Moderate anemia ( D64.9)
Hypokalemia ( E87.6)
Hypoalbuminemia ( E88.0)
Stage IA ( C56)
Leukopenia ( D72.819(
Mild anemia ( D64.9)
Thrombocytopenia ( D69.6(
Stage IIC Complete therapy ( C56)
Stage I FIGO Score 6 ( O01,9)
Stage I FIGO Score 8 ( O01.9)
Moderate anemia ( D64.9)
Leuocpenia ( D72,819)

pected ( C56)

pected ( C56)

Prosedur
PRC transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin 1st course ( 99.25)
Pap Smear’s Evaluation
Cefixime 200 mg/12 hours ( 99.1)
Chemotherapy pactliaxel-carboplatin1st course ( 99.25)
US gynecology ( March, 19th 2021)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Hospitalized
Leucogen injection ( 99.21)
MR Chemotherapy 1st course ( 99.25)
Hospitalized
Leucogen
US injection
gynecology ( 99.21)
( March, 19th 2021)
Planning for LEEP ( 67.32)
Planning for Laparotomy frozen section ( April, 05th 2021)
Plan for radiotherapy ( March, 18th 2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Plan for radiotherapy ( 92.29)
PRC Transfusion ( 99.04)
BEP Chemotherapy 4th course ( 99.25)
Hospitalized
Laboratoryexamination
Laboratory examination((V72.62)
V72.62)
Chest-X-Raysurgical
Laparotomy ( 87.4) staging ( 54.29)
Laparotomy TAHBSO ( 54.2)
Hospitalized
Leucogen inj ( 99.21)
PRC Transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin
Leucogen injection ( 99.21) 3rd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
MR chemotherapy 11th course ( 99.25)
Hospitalized
MER chemotherapy 9th course ( 99.25)
Hospitalized
MER chemotherapy 3rd course ( 99.25)
Hospitalized
Internal medicine
Laparotomy assessment ( 89.09)
VC ( 54.1)
Clinical staging
Urogynecology consultation ( 89.09)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Medicinalis ( 99.21)
Plan for radiotherapy (April, 28th 2021) ( 92.29)
PRC Transfusion ( 99.04)
Leucogen injection ( 99.21)
Laparotomy surgical staging ( 54.1)
Chemotherapy paclitaxel-carboplatin 3 course ( 99.25)
Laboratory examination ( V72.62)
US gynecology ( 88.79)
MR Chemotherapy 3rd course
Abdominal US examination ( 88.01)
Urology consult
Laparotomy VC (( 54.1)
89.09)
Sperm analysis (DNA fragmentation) (V26.21)
US examination during menstruation day 10th (88.7)
Plan for laparotomy total abdominal hysterectomy + bilateral salpingo-oophorectomy (68.49)
•Leuprolide acetate injection 3 more cycles (99.2)
•Sperm 2x5
Provera analysis
mg ( (V26.21)
14 days) ( 99.24)
Control ( when
Dienogest 2 mg/patient menstruation)
24 hours for 6 months ( 99.24)
US gynecology ( after 6 months therapy) ( 88.79)
Plan for diagnostic hysteroscopy operative laparoscopy
Plan for laparoscopy cystectomy ( 57.7)
•Plan for diagnostic hysteroscopy operative laparoscopy
Plan for diagnostic hysteroscopy operative laparoscopy
·Plan for Repair fistula
•Plan for laparotomy myomectomy (68.29- uterine myomectomy)
Hospitlized
Chemotherapy
PRC transfusionpaclitaxel-carboplatin
( 99.04) 1st course ( 99.25)
Plan for laparotomy surgical staging ( 99.25)
Tumor marker evaluation ( August, 09th 2021) (V72.16)
US evaluation ( 88.79)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
ß-HCG evaluation ( April, 12th 2021) ( V72.4)
Chemotherapy MR 7th course ( 99.25)
Prosedur
Hysteroscopy DnC ( 68.12)
Internal medicine assessment à for DM treatment ( 89.09)
Laparotomy
Plan myomectomy
for laparotomy ( 68.29)
myomectomy
(68.29-
Plan uterine myomectomy)
for laparotomy hysterectomy bilateral salphingo-oophorectomy (68.29- uterine myomectomy)
Plan for PRC transfusion (99- transfusion of blood and blood component)
Laboratory examination (V72.62)
Medicinalis ( 99.2)
•Cortimoxasol 60 mg / 12 hours
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy ( July,
Plan for radiotherapy (92.29) 02nd 2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
BEP Chemotherapy 3rd course ( 99.25)
Hospitalized
PRC transfusion
Chemotherapy ( 99.04)
paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Laparotomy VC ( 54.1)
Chemotherapy pacliltaxel-carboplatin 2nd course ( 99.25)
Pap’s smear ( V72.32)
Hospitalized
PRC transfusion
Tumor ( 99.04)(V72.4)
marker evaluation
Laboratory examination (V72.62)
Plan for CIM Chemotherapy ( 99.25)
Hospitalized
BEP chemotherapy 1st course ( 99.25)
Hosptialized
Leucogen
ß-HCG injection
evaluation ( 99.21)
(V72.3)
Plan laparotomy VC (54.1)
Plan for LEEP (68.12)
•Hospitalized
•Plan for
•Control inelective
1 week cesarean section (20.04.2021)
•Education
•CIE(E94.2)
•CIE
•Plan for consult Internal Medicine department
•CIE(E94.2)
•Antibiotic
•CIE
Prosedur
•Total vaginal hysterectomy (68.59)
•Anterior
•Repair of colporrhaphy
vaginal stump(70.51)
(70)

Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)


Hospitalized
General condition improvement
Hospiralized
PRC transfusion
Plan for ( 99.04)
laparotomy FS ( 54.1)
Plan for abdominal CT Scan ( 88.01)
Hospitalized
BEP chemotherapy 2nd course ( 99.25)
Hospitalized
Leucogen injection
Tumor marker ( 99.21)
evaluation ( V72.16
Tumor marker evaluation ( V72.16
Hysteroscopy (68.12), Chromotubation (66.29), Cystectomy (65.2), Adhesiolysis (614.6)
Laboratory examination ( V72.62)
Plan for DnC Biopsy
•Laparotomy ( 69.02)(54.23)
•Cytology of(68.29)
-Extirpation Ascites
-Curettage (69)
-Laparotomy Total Abdominal Hysterectomy (68.4)
-Cystectomy (656)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
Pap’s smearmyomectomy
Laparotomy evaluation ( V27.4)
(68.29)
-
Cervical cancer
Laparotomy cystectomy (65.1)
Chromotubation
Laparotomy
Chemotherapy (66.95)
Salpingo-Oophorectomy
paclitaxel-carboplatin Dextra
3rd (65.4)
course ( 99.25)
-
Plan for radiotherapy ( October, 05th 2021)
Hospitalized
PRC transfusion
Hysteroscopy DnC ( 99.04)
(68.12)
Laparotomy right Salpingo-oophorectomy (656)
•Laparotomy bilateral Salpingo-oophorectomy (656)
•Adhesiolysis
TC transfusion (65.8)
( 99.05)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Plan for radiotherapy ( October, 05th 2021)
Hosptialized
PRC
Tumor transfusion ( 99.04) ( V72.41)
marker evaluation
Pap’s smear evaluation ( September, 06th 2021)
Hospitalized
Leucogen injection ( 99.2)
Hospitalized
PRC transfusion
Cystoscopy ( 99.04)
( 57.21)
Chemotherapy paclitaxel-carboplatin (2nd 99.25)
course ( 99.25)
Hospitalized
PRC
Tumor transfusion
marker evaluation ( February, 18th 2021) ( V72.4)
Tumor marker evaluation ( February, 18th 2021) ( V72.4)
Hospitalized
BEP Chemotherapy
Laparotomy surgical(staging
99.25) ( 54.1)
Laparotomy FS ( 54.1) )
Stage IIB
Stage IIIB
Severe anemia
Stage IIIB ( D64.9)
complete therapy
Stage IIIC (C56.9)
Moderate anemia
Stage I FIGO Score( D64.9)
2
Stage IIIB
Stage IIIB
Stage IIIB
Thrombocytopenia
Stage IIIB ( D69.6)
Moderate
Stage IVBanemia ( D64.9)
Severe
Stage ICanemia ( D64.9)
complete therapy complete response
Stage IIA complete therapy complete response
Stage IC
Stage IVB
Stage IIIB complete therapy
Stage IIIB complete therapy
Stage IIIB complete therapy complete reponse
Stage IIIB
Stage IIA
Stage IIIA complete therapy
Stage I FIGO score 2
Stage IIIB ( C53.9)
Severe anemia
Stage IIIA1 ( D64.9)
( C53.9)
Moderate
Stage IIB (anemia
C53.9)( D64.9)
Stage IIIB ( C53.9)
Stage IC ( C56)
Moderate
Stage IA (anemia
C56.9) ( D64.9)
Stage IA ( C56.9)
Stage IC ( C56.9)
Stage I FIGO score 3 ( O01.9)
Stage IIB complete therapy complete response ( C53.9)
Stage IB2 complete therapy complete response ( C53.9)
Stage IIIA (C53.9)
Moderate
Stage IIICanemia
( C56.9)( D64.9)
Stage I FIGO Score 2 ( O01.9)
Stage I FIGO Score 4 ( O01.9)
Stage I FIGO Score 2 ( O01.9)
Stage IB2 ( C53.9) complete therapy complete response
Stage IIIB ( C53.9)
Stage IIIA (C53.9)
Moderate anemia (D64.9)
Stage IIB complete therapy complete response (C53.9)
Stage IVB ( C56.9)
Thrombocytopenia (D69.6)complete response ( C56.9)
Stage IA complete therapy
Stage IIIA C53.9)
Stage I FIGO Score 4 (O01.9)
Stage I FIGO Score 2 (O01.9)
Stage IIIB (C 53.9)
Stage IIIB (C53.9)
Stage IIIC ( C53.9)
Moderate
Stage IIIBanemia
( C53.9)( D64.9)
Severe anemia ( D64.9)
Stage IIIB complete therapy complete reponse( C53.9)
Stage IIIB was suspected ( C53.9)
Severe anemia
Stage IVB ( D64.9)
( C56.9)
Stage IIIA ( C54.9) complete therapy complete response
Stage IIB ( C53.9)
Moderate
Stage IIIBanemia
( C53.9)( D64.9)
Stage IIIB ( C53.9)
Diabetes
Stage IC (mellitus
C56.9) type II (E11)
Recurrent
Stage IA ( C56.9)
Stage I FIGO Score 3 ( O01.9)

Stage IVA ( C54.9)


Stage IIIB Progressive disease ( C53.9)
Rectum mass
Stage IIIB was suspected metastaseprocess was suspected
( C53.9)
Stage IIIB (C 53.9)
Stage IIIC ( C56.9)
Stage IA ( C56.9)
Stage I FIGO Score 2 ( O01.9)
Stage I FIGO Score 4 ( O01.9)
Stage IIIB ( C53.9)
Moderate
Stage IIIBanemia ( D64.9)
( C53.9)
Stage IIIA ( C53.9)
Stage IVB ( C53.9)
Stage IIIA ( C53.9)
Stage IB ( C56.9)
Recurrent
Moderate
Stage IIICanemia ( D64.9)
( C54.9)
Stage IIIB ( C53.9)
Moderate
Stage IA (anemia
C56.9) ( D64.9)
Stage IC ( C56.9)
Stage IIIC ( C53.9)
Moderate
Stage IA (anemia
C56.9) ( D64.9)
Stage IIIC Complete therapy complete respon (C56.9)
Stage IC ( c54.9)
Moderate anemia
Stage I FIGO ( D64.9)
Score 1 ( O01.9)
Stage II FIGO Score 6 ( O01.9)
Stage IVA ( C53.(0
Moderate
Stage IB2 anemia
( C53.9)( D64.9)
Stage I FIGO Score 1 ( O01.9)
GTN stage I FIGO Score 4 ( O01.9)
Stage IIIC ( C56.9)
Stage IC complete therapy complete response ( C56.9)
Stage IIIC ( C56.9)
Stage IC ( clinically) (C56.9)

Stage IC ( clinically) (C56.9)


Stage IIIB ( C53.9)
Moderate
Stage IIIBanemia
( C53.9)( D64.9)
complete therapy
Stage IIB ( C53.9)
Stage IIIB complete therapy
Complete
Stage IVBresponse
( C53.9) (Diabetes
C53.9) mellitus type II ( E11)
Stage IIIB ( C53.9)
Recurrent ( C56.9)
Stage IA ( C54.9)
Stage IIIB ( C53.9)
Stage IIIB ( C53.9) complete therapy
Stage IIIB ( C53.9)
Stage IB2 complete therapy
Complete
Stage IA (response
C56.9) ( C53.9)
Stage I FIGO score 4 ( C54.9)
Stage I FIGO score 2 ( C54.9)
Stage IIIB ( C53.9)
Stage IIIB complete therapy complete reponse ( C53.9)
Stage IIIB complete therapy complete reponse ( C53.9)
Stage IB2 ( C53.9)
Stage IA
Stage I FIGO Score 4 ( O01.9)
Moderate anemia
Stage I FIGO ( D64.9)
Score 2 ( O01.9)
Stage IIB complete therapy ( C53.9)
Stage IIIB complete therapy ( C53.9)
Stage IIIB ( C53.9) complete therapy
Stage IIIB ( C53.9)
Stage IIIB (C53.9)
Stage IIC ( C56.9)
Leucopenia ( D72.819)
Stage IA ( C54.9)
Stage I FIGO Score 2 ( O01.9)
Recurrent ( C53.9)
Stage IIIB ( C53.9)
Stage IB2 ( C53.9)
Stage IIIB complete therapy ( C53.9)
Stage IIIB ( C53.9)
Thrombocytopenia
Stage IIIB ( C53.9) ( D69.6)
Stage IIIC complete therapy complete response ( C53.9)
Stage IIIC ( C56.9)
Stage IIIC ( C54.9)
Stage I FIGO Score 2 ( O01.9)
Stage IIIB ( C53.9)
Moderate
Stage IIB (anemia
C53.9)( D64.9)
Moderate
Stage IIIA2anemia ( D64.9)
( C53.9)
Stage IIIB ( C53.9)
Stage IIIA (C56.9)
Stage IIB ( C56.9)
Leucopenia ( D72.819)
Stage IB complete response complete therapy ( C54.9)
Stage I FIGO Score 2 ( O01.9)
Stage IIIB (C53.9)
Stage IIB ( C53.9)
Moderate
Stage IIIBanemia (D64.9)
complete therapy complete response (C53.9)
Stage IIB ( C53.9)
Moderate
Stage IIIAanemia ( D64.9)
( C53.9)
Mild anemia
Stage ( D64.9)
IIIB ( C53.9)
Moderate
Inadequate staging( D64.9)
anemia
Stage IA ( C56.9)
Stage IIIC ( C56.9)
Stage IC was suspected (C54.9)
Stage IIIB ( C53.9)
Stage IIIB (C 53.9)
Moderate anemia
Stage I FIGO ( D64.9)
Score 3 ( O01.9)
Stage I FIGO Score 2 ( O01.9)
pected ( C56.9)
Stage IIIC ( C56.9)
Stage IC ( C56.9)
Leucopenia
Stage IIIC ( (C56.9)
D72.819)
Inadequate staging
( C56.9)

Inadequate staging
( C56.9)
Stage IIIB was suspected ( C53.9)
AKI
Stage IIIA (IIIC53.9)
Stage caused by uropathy obstructive ( N13.2)
Stage IVB ( C53.9)
Stage IIIB ( C53.9)
Stage IC (C56)
Leucopenia ( D72.819)
Stage IC ( C56)
Stage IIIC ( C56.9)
Stage IVA ( C54.9)
Stage IIIB ( C53.9)
Stage IIIC ( C53.9)
Complete
Stage IC ( therapy
C56.9)
Stage IVA ( C56.9) complete therapy
Stage IC ( C56.9)
Stage IC ( C54.9)
Stage II FIGO Score 6 ( O01.9)

pected (C56)

Stage IIIB was suspected ( C53.9)


Stage IIIB ( C53.9)
Moderate
Stage IIIBanemia ( D64.9)
complete therapy complete response ( C53.9)
Stage IIIA (C53.9)
Stage IIIB ( C53.9)
Recurrent ( C56.9) complete therapy complete response
pected ( C56.9)

Prosedure
Laparotomy FS ( 54.1)

Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)


Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)

Pap’s smear evaluation ( V72.32)

Pap’s smear evaluation ( V72.32)

Chemotherapy weekly ( 99.25)

Hospitalized
TC Transfusion ( 99.05)
Chemotherapy pactliaxel-carboplatin 4th course ( 99.25)
Tumor marker evaluation ( V72.32)
Hysteroscopy D&C ( 69.02)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Laparoscopy hysterectomy ( 68.12)
Laparotomy FS (54.1)
Clinical staging
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Plan for radiotherapy ( 92.29)
CIM Chemotherapy 5th course ( 99.25)
Biopsy ( 70.24)
Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)
Radical hysterectomy ( 68.4)
Chemoradiation
Plan for branchytherapy ( 92.29)
Radical Hysterectomy
Chemotherapy paclitaxel-carboplatin 5th course
Labia mayor tumor resection ( 70)
Plan for husband’s sperm analysis
Control at menstruation
Re control at menstruation
Plan for HDLO
Plan for laparoscopy cystectomy
CaCO3 500mg/12 hours PO
Plan for SIS

DV assessment

04; EFI Score 4)


Leuprolide acetate injection 3,75 mg 6th course
Plan for Clinical Staging
Plan for Clinical Staging

•Laboratory examination
•MRI
•Chest X-ray
•Planfor
Plan forColphokleisis
Excision
Controlled when patient get menstruation

Plan for TVH, Colphorapy anterior, colphoraphy posterior after laparotomy VC


Laparotomy exploration
nd posterior

nd posterior
iagnosis
ingo-oophorectomy (68.49)
orectomy (68.29- uterine myomectomy)
od component)
(65.2), Adhesiolysis (614.6)

Chemotherapy paclitaxel-carboplatin 3rd course (NAC) (99.25)


Plan for radical hysterectomy
Hospitalized
PRC
Pap’stransfusion ( 99.04)( V76.49)
smear evaluation
Hospitalized
PRC Transfusion ( 99.04)
MR Chemotherapy 1st course (99.25)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Plan for radiotherapy ( November, 05th 2021)
Laboratory examination ( V72.62)
Chemotherapy
Hospitalized paclitaxel-carboplatin 1stcourse ( 99.25)
TC transfusion ( 99.05)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC
Tumortransfusion ( 99.04)
marker evaluation
Tumor marker evaluation
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Plan
Pap’sfor radiotherapy
smear ( 92.29)
evaluation.(V76.49)
Pap’s smear evaluation ( V76.49)
Pap’s smear evaluation ( V76.49)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Plan for radiotherapy ( 92.29)
Hospitalized
BEP
Pap’sChemotherapy
smear evaluation 2nd( course
V76.49)( 99.25)
MR chemotherapy 1st course ( 99.25)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusionpaclitaxel-carboplatin
Chemotherapy ( 99.04) 4th course ( 99.25)
Plan for radical hysterectomy ( 68.4)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Plan for radiotherapy ( November, 11th 2021)
Hospitalized
PRC
TumorTransfusion ( 99.04) ( December, 29th 2021)
marker evaluation
Tumor marker evaluation ( 1 months later)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
MR chemotherapy 6th course ( 99.25)
Pap’s smear evaluation ( V76.49)
Pap’s smear evaluation ( V76.49)
Hospitalized
PRC transfusion
Laboratory ( 99.04)( V72.62)
examination
Chemotherapy
MR chemotherapy paclitaxel-carboplatin
8th course ( 99.25)1st course ( 99.25)
ß-HCG evaluation ( 99.25)
Consolidation chemotherapy 1stcourse ( 99.25)
Pap’s smear evaluation ( V76.49)
Plan for radiotherapy (October, 05th 2021)
Hospitalized
PRC
Pap’stransfusion (99.04)(V76.49)
smear evaluation
Hospitalized
TC transfusion
Tumor (99.05) (January, 04th 2021)
marker evaluation
Chemotherapy paclitaxel-carboplatin 5th course (99.25)
ß-HCG evaluation (99.25)
MR chemotherapy 8th course (99.25)
Chemotherapy paclitaxel-carboplatin 1st course (99.25)
Plan for radiotherapy
Chemotherapy (November, 23rd
paclitaxel-carboplatin 4th2021)
course ( 99.25)
Plan for radiotherapy (November, 11th 2021)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusion (99.04)
Pap’s smear evaluation ( V76.49)
Hospitalized
PRC transfusionpaclitaxel-carboplatin
Chemotherapy ( 99.04) 2nd course ( 99.25)
Pap’s smear evaluation ( V76.49)
Hospitalized
PRC transfusion
Continued external radiotherapy ( 92.29)
Hospitalized
PRC transfusion (99.04)
Hospitalized
BEP Chemotherapy
Chemotherapy 2nd course ( 99.25)
paclitaxel-carboplatin 3 course ( 99.25)
Plan for Laparotomy secondary
Tumor marker evaluation ( V72.62) debulking (54.1) after 3 course of chemotherapy
Hospitalized
MER
ß-HCG chemotherapy 2nd course ( 99.25)
evaluation ( V72.3)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Digestive surgery consult
Plan for Abdominal
Chemotherapy weeklyct-scan and colonoscopy
( 99,25)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy
Chemotherapy ( November, 23rd
paclitaxel-carboplatin 1st2021)
course ( 99.25)
Tumor marker evaluation ( V72.32)
MR chemotherapy 1st course ( 99.250
MR Chemotherapy 5th course ( 99.25)
Hospitalized
PRC transufisonpaclitaxel-carboplatin
Chemotherapy ( 99.04) 6 course ( 99.25)
Plan for radiotherapy ( 92.29)
Laboratory examination ( V72.62)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Laboratory examination ( V72.62)
Chemotherapy cisplatin weekly ( 40 mg)
paclitaxel-carboplatin ( 99.25)
1st course ( 99.25)
Hospitalized
Leucogen
Chemotherapyinjection ( 99.2)
paclitaxel-carboplatin 2nd course ( 99.25)
Hospitalized
PRC
Tumortransfusion ( 99.04) ( V72.3)
marker evaluation
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Hospitalized
Chemotherapy paclitaxel-carboplatin
Tumor marker evaluation ( V72.62) 6th course
Tumor marker evaluation ( V72.3)
Hospitalized
Chemotherapy
MR chemotherapy paclitaxel-carboplatin 3rd course
1st course ( consolidation) ( 99.25)
MR chemotherapy 7th course (99.25)
Hospitalized
PRC
NACtransfusion
Chemotherapy ( 99.05)
2nd course ( 99.25)
Plan
ß-HCG evaluation (V72.3) hysterectomy ( 68.4)
for laparotomy radical
ß-HCG evaluation ( V72.3)
Laboratory examination ( V72.62)
Chemotherapy paclitaxel-carboplatin
Tumor marker evaluation ( V76.0) 6 course ( 99.25)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Laboratory examination ( V72.62)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)

Laboratory examination ( V72.62)


Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Hospitalized
PRC
Pap’stransfusion ( 99.04)( V72.32)
smear evaluation
Pap’s smear evaluation ( V72.32)
Pap’s smear evaluation ( V72.32)
Plan for radiotherapy ( 92.29)
Laboratory examination ( V72.62)
Plangynecology
US for radiotherapy ( 92.29)
( V72.62)
CT-Scan Abdomen
Chemotherapy ( 92.29)
paclitaxel-carboplatin 4th course ( 99.25)
Chemotherapy weekly. Cysplatin( 99.25)
Pap’s smear evaluation ( V72.32)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Pap’s smear evaluation ( V72.32)
Tumor Marker evaluation ( V72.32)
Chemotherapy Methotrexate - Rescovulin 2th course ( 99.25)
Chemotherapy Methotrexate - Rescovulin 9th course ( 99.25)
Cysplatin chemotherapy (weekly) (99.25)
Pap’s smear evaluation ( V72.32)
Pap’s smear evaluation ( V72.32)
Pap’s smear evaluation ( V72.32)
Tumor marker evaluation ( V72.6)
Hospitalized
PRC transfusion ( 99.04)
MR Chemotherapy 2nd course ( 99.25)
Pap’s smear evaluation ( V72.6)
Pap’s smear evaluation ( V72.6)
Pap’s smear evaluation
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 1st course
Hospitalized
Leucogen
Pap’s smear injection ( 99.2)
evaluation ( V72.6)
ß-HCG evaluation ( V72.32)
Laboratory examination ( V72.62)
Pap’s smear evaluation
Chemohterapy ( V72.32) 5th course ( 99.25)
paclitaxel-carboplatin
Pap’s smear evaluation ( V72.32)
Pap’s smear evaluation ( V72.32)
Hospitalized
TC transfusion paclitaxel-carboplatin
Chemotherapy ( 99.05) 5th course ( 99.25)
Pap’s smear evaluation ( October, 05th 2021)
Chemotherapy paclitaxel-carboplatin 1st course
Laboratory
Pap’s smearexamination
evaluation ((V72.32)
V72.62)
Hospitalized
MER chemotherapy 1st course ( 99.25)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusion ( 99.04)
paclitaxel-carboplatin 6th course ( 99.25)
Plan for radiotherapy
Cysplatin chemotherapy ( November, 04th 2021)
40 mg ( weekly) ( 92.29)
( 99.25)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
Hospitalized
Leucogen
Pap’s smearinjection ( 99.21)
( October, 13th 2021) ( V72.32)
ß-HCG evaluation ( V72.32)
Chemotherapy cisplatin weekly( 99.25)
Plan for radiotherapy (Ocotber, 29th 2021)
Hospitalized
PRC
Pap’stransfusion ( 99.04)( V72.32)
smear evaluation
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC transfusion ( 99.04)
Hospitalized
PRC
NACtransfusion ( 99.04)
chemotherapy 3 course ( (99.25)
Laparotomy surgical
Tumor marker evaluation staging ( 54.1)
( V76.49)
US evaluation (V72.62)
Chemotherapy paclitaxel-carboplatin 1st course (99.25)
Plan for Laparotomy
Chemotherapy surgical staging 1st course ( 99.25)
paclitaxel-carboplatin
Plan for radiotherapy
Hospitalized
PRC transfusion ( 99.04)
MR chemotherapy 7th course ( 99.25)
MR chemotherapy 2nd course ( 99.250
Plan for Laparotomy FS
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Hospitalized
Leucogen injection
Chemotherapy ( 99.2)
paclitaxel-carboplatin 2nd course ( 99.25)
NAC chemotherapy 3 course ( (99.25)
Plan for Laparotomy secondary debulking

NAC chemotherapy 3 course ( (99.25)


Plan for Laparotomy secondary debulking
Hospitalized
Join care with Internal
Chemotherapy medicine Department
paclitaxel-carboplatin (89.09)
4th course ( 99.25)
Plan for radiotherapy
Chemotherapy ( November, 11th
paclitaxel-carboplatin 5th2021)
course( (92.29)
99.25)
Plan for radiotherapy ( December, 17th 2021)
Hospitalized
CIM Chemotherapy 23rd course ( 99.25)
Hospitalized
Leucogen injection
Chemotherapy ( 99.2)
paclitaxel-carboplatin 4th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Chemotherapy cyplatine weekly ( 99.25)
Plan
PAP for RadiotheraphyNovember
smear evaluation (91.46) 3rd 2021
Tumor marker evaluation ( V72.3)
Tumor marker evaluation ( V72.3)
BEP Chemotherapy 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Plan for Brchytheraphy
MR chemotherapy ( 92.29)consolidation) ( 99.25)
2nd course
Plan for Laparotomy surgical staging ( 54.1)
Plan for Laparotomy FS ( 54.1)
Plan for Laparotomy surgical staging ( 54.1)
Digestive surgery consult ( 89.09)
Clinical staging
Hospitalized
PRC
Pap’stransfusion ( 99.04)( V72.32)
smear evaluation
Laboratory examination ( V72.62)
Chemotherapy cysplatin weekly ( 99.25)
weekly cysplatin5th course ( 99.25)
Tumor marker evaluation (V72.32)
US examination
Tumor ( 88.79) ( V72.32)
marker evaluation
Hospitalized
PRC transfusion ( 99.04)
fter laparotomy VC
procedure

Cystoscopy
Clinical staging
Chemotherapy paclitaxel-carboplatin 2nd course
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin3rd course
Plan for radiotherapy (March, 22nd2020)
Chemotherapy paclitaxel-carboplatin 3rd course
Hospitalized
PRC transfusion

Tumor marker evaluation ( 1 month later)


ß-HCG evaluation ( 1 monht later)
MR Chemotherapy 2nd course
Hospitalized
US gynecology
Internal medicine assessment
Laboratory examination
Plan for hysterectomy per laparotomy
Hospitalized
PRC transfusion
Leucogen injection
VAC Chemotherapy 3rd course

Plan for Laparotomy surgical

Chemotherapy paclitaxel-carboplatin 1st course


Plan for radical hysterectomy ( after NAC chemotherapy 3 cour
Hospitalized
PRC Transfusion
Internal medicine assessment
Cefriaxone 1 gram/12 hours

Hospitalized
PRC Transfusion
Chemotherapy paclitaxel-carboplatin 3rd course
Cefriaxone 1 gram/12 hours
Albumin 1 flash/24 hours
Plan for radiation ( 03rd March 2020)
Plan for radiation ( 03rd March 2020)

Chemotherapy paclitaxel-carb
Hospitalized
PRC Transfusion
Chemotherapy paclitaxel-carboplatin 3rd course

Chemotherapy paclitaxel-carb

Chemotherapy paclitaxel-car
BEP Chemohterapy 5th course
Hospitalized
PRC Transfusion
Leuocgen injection
Chemotherapy paclitaxel-carboplatin 3rd course
MER Chemotherapy 3rd course
Hospitalized
PRC transfusion
Radiotherapy
Hospitalized
Leucogen injection
Chemotherapy pactlixel-carboplatin 3rdcourse
Plan for radiotherapy ( March, 18th 2021)
Chemotherapy pactliaxel-carboplatin 5thcourse
Tumor marker evaluation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 2ndcourse
Laboratory examination
CIM Chemotherapy 1st course

Brachytherapy adjuvant 3x
Radiotherapy consult

MR Chemotherapy1st course
Colposcopy
Hospitalized
PRC transfusion
Plan Laparotomy surgical staging
Chemotherapy paclitaxel-car
Hospitalized
Leucogen injection
BEP 1st course
Plan for laparotomy surgical satging
MR chemotherapy 9th course
MR chemotherapy 9th course
MR Chemotherapy 1st course

Laparotomy surgical staging


Laparotomy VC
Abdominal CT Scan
Laparotomy VC
Abdominal CT Scan
Digestive surgery consult

Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Plan for radiotherapy ( March, 21st2021)
Chemotherapy paclitaxel-carboplatin 6 course
Plan for radiotherapy
Chemotherapy paclitaxel-carboplatin 3rd course
Plan for radiotherapy ( March, 18th2021)
Hospitalized
PRC transfusion
Plan for radiotherapy simulation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 5th course
Hospitalized
PRC transfusion
TC transfusion
Leucogen injection
Chemotherapy paclitaxel-carboplatin 4th course
MR Chemotherapy 4th course

Laboratory examination La
Clinical staging

Pap’s smear
Chemotherapy paclitaxel- carboplatin 6 course
Plan for radiotherapy ( April, 27th2021)
Tumour marker evaluation

Tumour marker evaluation


Hospitalized
Pronalges supp 3x1
US examination
MR chemotherapy 3rd course
MER chemotherapy 1st course ( consolidation)
Laparotomy surgical staging

Laparotomy myomectomy
Laboratory examination
Chest-X-Ray
BNO-IVP
US gynecology
Hospitalized
PRC transfusion
Plan for radiotherapy Chemotherapy paclitaxel-carboplatin 6 co
Pap’s smear evaluation
Hospitalized
PRC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Plan for radiotherapy ( 09th February 2020)
Chemotherapy pacliraxel-carboplatin 3rd course
Laparoscopy surgical staging
Hospitalized
MER chemotherapy 3rd course

Laparotomy VC
Laparotomy VC
Abdominal CT Scan

Endocrinology division consu

Laparotomy VC

Laparotomy radical hysterectomy

Tumour marker evaluation


Pap’s smear evaluation
US gynecology
MR Chemotherapy 2nd course
ß-HCG evaluation
MR Chemotherapy 11th

Hospitalized
CIM chemotherapy 4th course ( 99.25)
BNO-IVP ( 87.79)
Chest-X-Ray ( 87.4)
Clinical staging
BNO-IVP ( 87.79)
Chest-X-Ray ( 87.4)
Clinical staging
Laboratory examination ( V72.62)
Plan for radiotherapy ( 92.29)

Control ( May, 20th 2021)


Pap’s smear ) V72.4)
Chemotherapy paclitaxel-carboplatin 2ndcourse ( 99.25)
Hospitalized
MER chemotherapy 1st course ( 99.25)
Laparotomy surgical staging ( 54.1)

Chemotherapy
aclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy ( April. 19th 2021)
Chemotherapy paclitaxel-carboplatin 2ndcourse ( 99.25)
Hospitalized
Chemotherapy paclitaxel-carboplatin 2ndcourse ( 99.25)
TC transfusion ( 99.05)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
Laboratory examination.( V72.62)
Hospitalized
Chemotherapy paclitaxel-carboplatin 3rdcourse ( 99.25)
TC transfusion ( 99.05)
Tumor marker evaluation ( V72.4)
MR chemotherapy 2nd course ( 99.25
MR chemotherapy 11th course ( 99.25)
MR chemotherapy 10th course ( 99.25)
Hospitalized
MER chemotherapy 2nd course ( 99.25)
5)
r 3 course of chemotherapy
clitaxel-carboplatin 2nd course

clitaxel-carboplatin3rd course
apy (March, 22nd2020)
clitaxel-carboplatin 3rd course

aluation ( 1 month later)


n ( 1 monht later)
py 2nd course

assessment

omy per laparotomy

apy 3rd course

clitaxel-carboplatin 1st course


ysterectomy ( after NAC chemotherapy 3 course)

assessment
clitaxel-carboplatin 3rd course

( 03rd March 2020)


( 03rd March 2020)

clitaxel-carboplatin 3rd course

py 5th course

clitaxel-carboplatin 3rd course


apy 3rd course

ctlixel-carboplatin 3rdcourse
apy ( March, 18th 2021)
ctliaxel-carboplatin 5thcourse

clitaxel-carboplatin 2ndcourse

py 1st course

py1st course

surgical staging
my surgical satging
y 9th course
y 9th course
py 1st course

clitaxel-carboplatin 4th course


apy ( March, 21st2021)
clitaxel-carboplatin 6 course

clitaxel-carboplatin 3rd course


apy ( March, 18th2021)

apy simulation

clitaxel-carboplatin 5th course

clitaxel-carboplatin 4th course


py 4th course

clitaxel- carboplatin 6 course


apy ( April, 27th2021)
y 3rd course
py 1st course ( consolidation)
ical staging

apy Chemotherapy paclitaxel-carboplatin 6 course

clitaxel-carboplatin 4th course


apy ( 09th February 2020)
cliraxel-carboplatin 3rd course
gical staging

py 3rd course

al hysterectomy

py 2nd course
py 4th course ( 99.25)

nation ( V72.62)
apy ( 92.29)

litaxel-carboplatin 2ndcourse ( 99.25)

y 1st course ( 99.25)


al staging ( 54.1)

n 2nd course ( 99.25)


py ( April. 19th 2021)
litaxel-carboplatin 2ndcourse ( 99.25)

litaxel-carboplatin 2ndcourse ( 99.25)

litaxel-carboplatin 6 course ( 99.25)


ation.( V72.62)

litaxel-carboplatin 3rdcourse ( 99.25)

uation ( V72.4)
2nd course ( 99.25
11th course ( 99.25)
10th course ( 99.25)

y 2nd course ( 99.25)


No Bulan Tanggal
1 Januari 08 Januari 2021

2 08 Januari 2021

3 08 Januari 2021

4 08 Januari 2021

5 08 Januari 2021

6 08 Januari 2021

7 08 Januari 2021

No. Bulan Tanggal


1 Januari 11 Januari 2021

2 11 Januari 2021

3 11 Januari 2021

4 11 Januari 2021
5 11 Januari 2021
6 11 Januari 2021
7 11 Januari 2021

8 11 Januari 2021
9 11 Januari 2021
10 11 Januari 2021
No. Bulan Tanggal
1 Januari 12 Januari 2021

2 12 Januari 2021

3 12 Januari 2021

4 12 Januari 2021

5 12 Januari 2021
6 12 Januari 2021

7 12 Januari 2021
8 12 Januari 2021
No. Bulan Tanggal
1 Januari 13 Januari 2021

2 13 Januari 2021

3 13 Januari 2021
4 13 Januari 2021
5 13 Januari 2021

6 13 Januari 2021

7 13 Januari 2021
8 13 Januari 2021

9 13 Januari 2021

10 13 Januari 2021
11 13 Januari 2021
No. Bulan Tanggal
1 Januari 14 Januari 2021

2 14 Januari 2021

3 14 Januari 2021

4 14 Januari 2021

5 14 Januari 2021

GYNECOLOGY INPATIENT REPORT


1 January 08 Januari 2021

2 08 Januari 2021

3 08 Januari 2021

4 08 Januari 2021

5 08 Januari 2021

6 08 Januari 2021

7 08 Januari 2021

8 08 Januari 2021
1 Januari 09 Januari 2021

2 09 Januari 2021

3 09 Januari 2021

4 09 Januari 2021

1 Januari 10 Januari 2021

2 10 Januari 2021

3 10 Januari 2021

4 10 Januari 2021

5 10 Januari 2021

1 Januari 11 Januari 2021

2 11 Januari 2021

3 11 Januari 2021

4 11 Januari 2021
5 11 Januari 2021

6 11 Januari 2021

7 11 Januari 2021

8 11 Januari 2021
9 11 Januari 2021

1 Januari 12 Januari 2021

2 12 Januari 2021

3 12 Januari 2021

4 12 Januari 2021

5 12 Januari 2021

6 12 Januari 2021

7 12 Januari 2021

8 12 Januari 2021

1 Januari 13 Januari 2021


2 13 Januari 2021
1 Januari 14 Januari 2021
no bulan tanggal
Februari Monday, February 01st 2021
Februari Monday, February 01st 2021
Februari Monday, February 01st 2021
Februari Tuesday, February 02nd 2021
Februari Tuesday, February 02nd 2021
Februari Tuesday, February 02nd 2021
Februari Wednesday, February 03rd 2021
Februari Wednesday, February 03rd 2021
Februari Wednesday, February 03rd 2021
Februari Thursday, February 04th 2021
Februari Thursday, February 04th 2021

no bulan tanggal
1 Maret 12.03.2021
2 Maret 12.03.2021
3 Maret 16.03.2021
4 Maret 18.03.2021
5 Maret 12.03.2021
6 Maret 12.03.2021
7 Maret 12.03.2021
8 Maret 12.03.2021
9 Maret 12.03.2021
10 Maret 12.03.2021
11 Maret 12.03.2021
12 Maret 12.03.2021
13 Maret 15.03.2021
14 Maret 15.03.2021
15 Maret 15.03.2021
16 Maret 15.03.2021
17 Maret 15.03.2021
18 Maret 15.03.2021
19 Maret 15.03.2021
20 Maret 15.03.2021
21 Maret 15.03.2021
22 Maret 15.03.2021
23 Maret 15.03.2021
24 Maret 16.03.2021
25 Maret 16.03.2021
26 Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 16.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 17.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 18.03.2021
Maret 12.03.2021
Maret 12.03.2021
Maret
Maret 15.03.2021
Maret
Maret
Maret 16.03.2021
Maret
Maret
Maret 17.03.2021
Maret
Maret 18.03.2021
Maret
Maret 15.03.2021
Maret 16.03.2021
Maret
Maret 17.03.2021
Maret
Maret
Maret
Maret 18.03.2021
Maret
Maret 15.03.2021
Maret
Maret 16.03.2021
Maret
Maret 17.03.2021
Maret
Maret
Maret 18.03.2021
Maret
Maret 12.03.2021
Maret
Maret
Maret
Maret 13.03.2021
Maret
Maret
Maret
Maret
Maret
Maret
Maret 14.03.2021
Maret

15.03.2021

16.03.2021

17.03.2021

18.03.2021

12.03.2021

15.03.2021

16.03.2021

17.03.2021
18.03.2021

12.03.2021
15.03.2021

16.03.2021
17.03.2021
18.03.2021

05.03.2021

08.03.2021

09.03.2021

10.03.2021

05.03.2021

08.03.2021
09.03.2021

10.03.2021

09.03.2021
05.03.2021
10.03.2021
05.03.2021

06.03.2021

07.03.2021

08.03.2021

09.03.2021

10.03.2021

08.03.2021
09.03.2021

15.03.2021
05.03.2021
05.03.2021

08.03.2021

09.03.2021

10.03.2021

05.03.2021

08.03.2021
09.03.2021
10.03.2021

19.03.2021

22.03.2021
23.03.12

24.03.2021

25.03.2021

19.03.2021

22.03.2021
23.03.2021

24.03.2021

25.01.2021

19.03.2021

No Bulan Tanggal
1 April 03.04.21
2 April 03.04.21
3 April 03.04.21
4 April 03.04.21
5 April 03.04.21
6 April 04.04.21
7 April 04.04.21
8 April 04.04.21
9 April 04.04.21
10 April 04.04.21
11 April 05.04.21
12 April 05.04.21
13 April 05.04.21
14 April 05.04.21
15 April 05.04.21
16 April 05.04.21
17 April 05.04.21
18 April 05.04.21
19 April 05.04.21
20 April 05.04.21
21 April 05.04.21
22 April 05.04.21
23 April 05.04.21
24 April 05.04.21
25 April 05.04.21
26 April 05.04.21
27 April 05.04.21
28 April 05.04.21
29 April 05.04.21
30 April 05.04.21
31 April 05.04.21
32 April 05.04.21
33 April 05.04.21
34 April 05.04.21
35 April 06.04.21
36 April 06.04.21
37 April 06.04.21
38 April 06.04.21
39 April 06.04.21
40 April 06.04.21
41 April 06.04.21
42 April 06.04.21
43 April 06.04.21
44 April 06.04.21
45 April 06.04.21
46 April 06.04.21
47 April 06.04.21
48 April 06.04.21
49 April 06.04.21
50 April 06.04.21
51 April 06.04.21
52 April 06.04.21
53 April 06.04.21
54 April 06.04.21
55 April 06.04.21
56 April 06.04.21
57 April 06.04.21
58 April 07.04.21
59 April 07.04.21
60 April 07.04.21
61 April 07.04.21
62 April 07.04.21
63 April 07.04.21
64 April 07.04.21
65 April 07.04.21
66 April 07.04.21
67 April 07.04.21
68 April 07.04.21
69 April 07.04.21
70 April 07.04.21
71 April 07.04.21
72 April 07.04.21
73 April 07.04.21
74 April 07.04.21
75 April 07.04.21
76 April 07.04.21
77 April 07.04.21
78 April 07.04.21
79 April 07.04.21
80 April 07.04.21
81 April 07.04.21
82 April 07.04.21
83 April 08.04.21
84 April 08.04.21
85 April 08.04.21
86 April 08.04.21
87 April 08.04.21
88 April 08.04.21
89 April 08.04.21
90 April 08.04.21
91 April 08.04.21
92 April 08.04.21
93 April 08.04.21
94 April 08.04.21
95 April 08.04.21
96 April 08.04.21
97 April 08.04.21
98 April 08.04.21
99 April 08.04.21
100 April 08.04.21
101 April 08.04.21
102 April 08.04.21
103 April 08.04.21
104 April 08.04.21
105 April 09.04.21
106 April 09.04.21
107 April 09.04.21
108 April 09.04.21
109 April 09.04.21
110 April 09.04.21
111 April 09.04.21
112 April 09.04.21
113 April 09.04.21
114 April 09.04.21
115 April 09.04.21
116 April 09.04.21
117 April 09.04.21
118 April 09.04.21
119 April 12.04.21
120 April 12.04.21
121 April 12.04.21
122 April 12.04.21
123 April 12.04.21
124 April 12.04.21
125 April 12.04.21
126 April 12.04.21
127 April 12.04.21
128 April 12.04.21
129 April 12.04.21
130 April 12.04.21
131 April 12.04.21
132 April 12.04.21
133 April 12.04.21
134 April 12.04.21
135 April 12.04.21
136 April 12.04.21
137 April 13.04.21
138 April 13.04.21
139 April 13.04.21
140 April 13.04.21
141 April 13.04.21
142 April 13.04.21
143 April 13.04.21
144 April 13.04.21
145 April 13.04.21
146 April 13.04.21
147 April 13.04.21
148 April 13.04.21
149 April 13.04.21
150 April 13.04.21
151 April 14.04.21
152 April 14.04.21
153 April 14.04.21
154 April 14.04.21
155 April 14.04.21
156 April 14.04.21
157 April 14.04.21
158 April 14.04.21
159 April 14.04.21
160 April 14.04.21
161 April 14.04.21
162 April 15.04.21
163 April 15.04.21
164 April 15.04.21
165 April 15.04.21
166 April 15.04.21
167 April 15.04.21
168 April 15.04.21
169 April 15.04.21
170 April 15.04.21
171 April 15.04.21

No Bulan
1 Juni

2 Juni

3 Juni

4 Juni

5 Juni

6 Juni

7 Juni

8 Juni

9 Juni

10 Juni
11 Juni

12 Juni

13 Juni

14 Juni

15 Juni

16 Juni

17 Juni

18 Juni

19 Juni

20 Juni

21 Juni

22 Juni

23 Juni
24 Juni

25 Juni

26 Juni

27 Juni
1 Juli

No Bulan

1 September
2 September
3 September
4 September
5 September
6 September
7 September
8 September
9 September
10 September
11 September
12 September
13 September
14 September
15 September
16 September
17 September
18 September
19 September
20 September
21 September
22 September
Identitas
Mrs. IRA/ 40 YO/ 1193029/ BANGKA BELITUNG/ P2A1/ CYN-AT

Mrs. MUG/ 52 YO/ 1190193/ BANGKA BELITUNG/ P2A0/ CYN-IS

Mrs. YUS/ 52 YO/ 1192268/ BANGKA BELITUNG/ P3A0/ CYN-IS

Mrs. WAY/ 66 YO/ 1193666/ OKU TIMUR/ P2A0/ CYN-RS

Mrs. PAT/ 38 YO/ 1157081/ MUSI RAWAS/ P2A1/ CYN-AT

Mrs. FAR/ 55 YO/ 1189543/ BANGKA BELITUNG/ P5A0/ CYN-RS

Mrs. ERL/ 52 YO/ 1183529/ PALEMBANG/P1A3/ CYN-RS

Identitas
Mrs. WID/ 41 YO/ 1192742/ PALEMBANG/P4A1/ CYN-IS

Mrs. SUY/ 52 YO/ 1193576/ PALEMBANG/ P1A3/ CYN -RS

Mrs. IRN/ 49 YO/ 1188871/ PALEMBANG/P2A0/ CYN-AT

Mrs. FER/ 23 YO/ 1157950/ MUSI BANYUASIN/ P0A0/ CYN-AT


Mrs. AKH/ 51 YO/ 1187313/ OGAN ILIR/ P1A1/ CYN-IS
Mrs. YUS/ 44 YO/ 1181709/ BANGKA BELITUNG/ P1A0/ CYN-RS
Miss. MUS/ 56 YO/ 1186430/PALEMBANG/P0A0/ CYN-RS

Mrs. TJO/ 69 YO/ 1190355/ BANYUASIN/ P4A1/ CYN-AT


Mrs. DEW/ 20 YO/ 1190997/ MUSI BANYUASIN/ P0A1/ CYN-AT
Mrs. PAT/ 52 YO/ 1194375/ OGAN KOMERING ILIR/ P4A0/ CYN-RS
Identitas
Mrs. KOM/ 59 YO/ 1192544/ PALEMBANG/ P5A0/ CYN-IS

Miss. MAR/ 37 YO/ 1185891/ PALEMBANG/ P0A0/ CYN-AT

Mrs. ISN/ 42 YO/ 1194602/ JAMBI/ P0A0/ CYN-AT

Mrs. MAR/ 57 YO/ 1180539/ PALEMBANG/ P5A0/ CYN-IS

Mrs. PON/ 57 YO/ 1093449/ BANYUASIN/ CYN-IS


Mrs. HAS/ 34 YO/ 1186541/ PALEMBANG/ P2A1/ CYN-IS

Mrs. SRI/ 55 YO/ 1193590/ MUARA ENIM/P4A0/ CYN-AT


Mrs. HER/ 37 YO/ 1194544/ MUARA ENIM/ P1A0/ CYN- AT
Identitas
Mrs. YOH/ 56 YO/ 1108319/ PALEMBANG/ P4A1/ CYN-RS

Mrs. NAD/ 32 YO/ 1193722/ BANGKA BELITUNG/ P2A1/ CYN-RS

Mrs. NUR/ 50 YO/ 885134/ PALEMBANG/ P4A0/ CYN-AT


Mrs. AIS/ 33 YO/ 1184298/ MUARA ENIM/P3A0/ CYN-AT
Mrs. HAR/ 52 YO/ 1181109/ PALEMBANG/ P1A0/ CYN-IS

Mrs. SIT/ 50 YO/ 1182507/ PRABUMULIH/P2A0/ CYN-RS

Mrs. FAT/ 52 YO/ 1185932/ BANYUASIN/ P3A1/ CYN-AT


Miss. MAR/ 40 YO/ 1185109/ BENGKULU/ P0A0/ CYN-RS

Mrs. RIT/ 53 YO/ 1194677/ PALEMBANG/ P3A1/ CYN-RS

Miss. SRI/ 29 YO/ 1179841/ EMPAT LAWANG/ P0A0/ CYN-IS


Mrs. LIN/ 46 YO/ 1194693/ PALEMBANG/ P0A0/ CYN-AT
Identitas
Mrs. SEL/ 36 YO/ 1111743/ MUARA ENIM/ P2A0/ CYN-IS

Mrs. SAF/ 38 YO/ 1161822/ BENGKULU/ P2A0/ CYN-AT

Mrs. MAR/ 54 YO/ 1191949/ MUSI BANYUASIN/ P5A0/ CYN-RS

Mrs. SHE/ 29 YO/ 1192096/ PALEMBANG/ P3A1/ CYN-AT

Mrs. RIT/ 27 YO/ 1134363/ MUARA ENIM/ P0A1/ CYN-IS

Mrs. IRA/ 40 YO/ 1193029/ BANGKA BELITUNG/ P2A1/AT

Mrs. MUG/ 52 YO/ 1190193/ BANGKA BELITUNG/ P2A0/ CYN-IS

Mrs. YUS/ 52 YO/ 1192268/ BANGKA BELITUNG/ P3A0/IS

P2A1

VAI-TIA

Mrs. Kar/44yo/P1A0/
193490/Palembang/IS
TIA-VAI

IS

TIA-VAI
VAI-TIA

P3A0/ IS
VAI-TIA

TIA-VAI

VAI-TIA

TIA-VAI

VAI-TIA

TIA-VAI

VAI-TIA

TIA-VAI

TIA-VAI

VAI-TIA

VAI-TIA

Mrs. IRN/ 49 YO/ 1188871/ PALEMBANG/P2A0/ CYN-AT


TIA-VAI

VAI-TIA

TIA-VAI

Mrs. FIT/ 28 YO/ 1194286/ PALEMBANG/ P1A0/ IJA - IS


VAI-TIA
TIA-VAI

VAI-TIA

TIA-VAI

VAI-TIA

TIA-VAI

VAI-TIA

TIA-VAI

TIA-VAI

VAI-TIA

Miss. MAR/ 40 YO/ 1185109/ BENGKULU/ P0A0/ CYN-RS


VAI-TIA
Mrs. TRI/ 35 YO/ 821938/ PALEMBANG/ DEV-WAH/AB
TIA-VAI
Mrs. MAR/ 54 YO/ 1191949/ MUSI BANYUASIN/ P5A0/ CYN-RS
VAI-TIA
identitas
Mrs. WIL/ 41 YO/ 11093462/ PRABUMULIH/ DID-IAN/RS
Mrs. DEW/ 58 YO/ 117951/ BENGKULU/ DID-HUD/ RS
Mrs. UMM/ 46 YO/ 1196597/ OGAN ILIR/ DID-HUD/ RS
Mrs. SUP / 76 yo/ 1190695/ Prabumulih/AF-HIL
Mrs. SUL/ 41 YO / 1194321 / P3A0 / Baturaja/ RS/DES
Mrs. NUR / 25 YO / 1195982/P0A0/ Palembang/ KY/DAV/THR
Mrs. FER/ 38 yo/ 1193230 / PALEMBANG/ P0A0/HE/AT/WIS
Mrs. WEL / 37 YO / 1194801/P4A0/ Palembang/ HE
Ms. EMA / 47 YO /942605/P0A0/ Palembang/ AA
Ms. MAR / 52 YO / 589182/P3A0/ Palembang/ IS
Mrs. YEL/ 29 yo/ 1093186 / MUARA ENIM/ P0A0
Mrs. WIJ/ 55 YO/
BANYUASIN/ 1197506/
DID-HIL/ NS MUARA ENIM/ STI-WAH/ RS

DEV-OSP/

Mrs. APR/ 38 yo/ 1196035/ Palembang/ P1A0


P6A0
Palembang

Mrs. EMI / 39 YO / 1196412 / Bengkulu / AF – HD - THR


Palembang
OKU Timur

identitas
Mrs. HERDA
APRIYANI/ 37 YO/ 1194544/ MUARA ENIM/ P1A0/ STI-HAD/ AT
Mrs. FETRI
Miss. YENI/ 46
Ely Mulyani/ 49 YO/ 1200201/OGAN ILIR/ P5A0/ STI-HAD/ AT
1067226/ PALEMBANG/
STI-HAD-IS
Mrs. MIFTA PRATIWI/ 28 YO/ 1102433/ PALEMBANG/ STI-HAD/NS
Mrs. ELI/ 51 YO/ 1158879/ MUSI RAWAS/ P0A1/SAR-AT
Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ SAR-AT
Mrs. SAR/ 58 YO/ 1198813/ OKU TIMUR/ P0A1/ SAR-RS
Miss. ALA/ 48 YO/ 1104499/ PALEMBANG/ P0A0/ SAR-RS
Mrs. RUK/ 41 YO/ 1189789/ PRABUMULIIH/ P2A0/ IJA-IS
Mrs. LIN/ 48 YO/ 1190432/ PALEMBANG/ P2A0/ SAR-IS
Mrs. DEW/ 20 YO/ 1190997/ MUSI BANYUASIN/ P0A1/ SAR-AT
Mrs. NUR/ 64 YO/ 1102751/ PALEMBANG/ P5A2/ IJA-RS
Mrs. MUR/ 46 YO/ 1162745/ PALEMBANG/ P2A0/ MIQ-RS
Mrs. RUH/ 60 YO/ 1196750/ JAMBI/ P2A0/ MIQ-AT
Mrs. HAN/ 43 YO/ 1195022/ PRABUMULIIH/ P5A2/ MIQ-AT
Mrs. NUR/ 47 YO/ 11975921/ MUSI RAWAS/ P3A3/ MIQ-IS
Mrs. HAN/ 49 YO/ 1051669/ MUSI RAWAS/ P3A0/ MIQ-IS
Mrs. DEW/ 58 YO/ 1177951/ BENGKULU/P2A1/ MIQ-RS
Mrs. SHE/ 27 YO/ 1200079/ PALEMBANG/ P0A2/ MIQ-IS
Mrs. SUP/ 36 YO/ 1200078/ BANYUASIN/ P1A0/ MIQ-IS
Mrs. PAT/ 39 YO/ 1157081/ MUSI RAWAS/ P2A0/ MIQ-AT
Mrs. ELI/ 44 YO/ 1142806/ PALEMBANG/ P3A0/ MIQ-RS
Mrs. SUL/ 39 YO/ 1198965/ LAMPUNG/ P4A0/ MIQ-RS
Mrs. SUW/ 58 YO/ 116098/ OGAN KOMERING ILIR/ P4A0/ MIQ-RS
Mrs. MUL/ 49 YO/ 1200391/ EMPAT LAWANG/ P3A0/ MIQ-AT
Mrs. AGU/ 43 YO/ 1186285/ BANGKA BELITUNG/ P3A1/ MIQ-RS
Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ MIQ-IS
Mrs. HIL/ 42 YO/ 1184822/ PALEMBANG/ P0A0/ MIQ-IS
Mrs. ERN/ 43 YO/ 1176021/ PALEMBANG/ P3A0/ MIQ-RS
Mrs. ANI/ 17 YO/ 174287/ PALEMBANG/ P0A1/MIQ-RS
Mrs. DAR/ 35 YO/ 232016/ PALEMBANG/ P4A0/ MIQ-RS
Mrs. TIA/ 24 YO/ 1184535/ OGAN ILIR/ P0A1/ MIQ-IS
Mrs. CIK/ 61 YO/ 1199981/ MUARA ENIM/ P7A3/ MIQ-IS
Mrs. NUR/ 50 YO/ 1157496/ BANYUASIN/ P1A0/ MIQ-AT
Mrs. SIT/ 69 YO/ 1199680/ MUARA ENIM/ P2A0/ MIQ-IS
Mrs. ROS/ 62 YO/ 1186276/ PALEMBANG/ P6A0/ MIQ-AT
Mrs. LIN/ 40 YO/ 1140853/ LUBUK LINGGAU/ P2A0/ MIQ-IS
Mrs. MAS/ 44 YO/ 1198554/ BANYUASIN/ P4A0/ MIQ-AT
Mrs. GUS/ 48 YO/ 1182780/ PALEMBANG/ P3A0/ MIQ-IS
Mrs. SUS/ 32 YO/ 1200552/ MUARA ENIM/ P3A0/ MIQ-AT
Mrs. SHE/ 29 YO/ 1192096/ PALEMBANG/ MIQ-AT
Mrs. NOV/ 26 YO/ 1197552/ EMPAT LAWANG/ P2A0/ MIQ-AT
Mrs. ASN/ 56 YO/ 1200417/ PALEMBANG/ P4A0/ MIQ-IS
Mrs. MAR/ 57 YO/ 846749/ P1A0/ MIQ-AT
Mrs. NOR/ 55 YO/ 1198795/ JAMBI/ P5A0/ MIQ-AT
Mrs. RUM/ 42 YO/ 1189719/ PALEMBANG/ P4A1/ MIQ-RS
Mrs. TUR/ 56 YO/ 1199031/ PRABUMULIH/ P1A0/ MIQ-RS
Mrs. YUS/ 52 YO/ 1192268/ BANGKA BELITUNG/ P3A0/ MIQ-IS
Mrs. HER/ 52 YO/ 1074388/ PALEMBANG/ P3A0/ MIQ-RS
Miss. MAR/45
Mrs. TAR/ 24YO/
YO/1200069/
1200645/PALEMBANG/
PALEMBANG/P0A0/
P0A0/OSP-HE
MIQ-IS
Mrs. WHI/ 39 YO/ 1055047/ PALEMBANG/ P2A0/ OSP-HE
Mrs. NAD/36 YO/ 1199886/ Palembang/ P0A0/ OSP-HE
Mrs. KOM/ 33 YO/ 1200206/ Banyuasin/ P0A3/ OSP-MUG-AW
Mrs. END/ 38 YO/ 1200053/ Muara Enim/ P0A0/ OSP-MUG-HE
Mrs. IKA/ 33 YO/ 1185297/ OKU/ P2A0/ CYN-MUG-KY
Mrs. MAR/ 39 YO/ 1200339/ Palembang/ P0A0/ CYN-HE/FU
Mrs. ANI/35 YO/ 1191628/ Palembang/ P0A0/ CYN-IZ/FU
Mrs. Umi Kalsum/38 YO/ 1166910/ Muara Enim/ P1A0/ CYN-AA/FU
Mrs. ROS/ 38 YO/ 1200378/ Musi Rawas/ P1A0/ CYN-IZ/HE
Ms. YEN/29 YO/ 1158287/OKU/ P0A0/ CYN-AW/FU
Mrs. SIT/ 40 YO/ 1183209/ BANYUASIN/ P2A0/ OSP-AW
Mrs. YEN/ 33 YO/ 117989/ MUARA ENIM/ P0A0/ OSP-HE
Mrs. HAS/ 55 YO/ 1165582/ MUSI RAWAS/ P5A2/ HD –SAR – HIL
Mrs. TIN/ 17 YO/ 1170956/ Kertapati/ P0A0/ HD –SAR – HIL
Mrs. SUP/ 76 YO/ 1190695/ Prabumulih/ P7A0/ AF –SAR – HIL
Mrs. NUR/ 63 YO/ 1198547/ PALEMBANG/ P4A0/ RK-HIL-SAR
Mrs. RIH/ 54 YO/ 1194072/ Palembang/ P4A0/ RK- SAR - HIL
Miss RIA / 2 YO / 1200617 / Musi Banyuasin / HD – SAR – HIL
Mrs. Lia Sagita/ 36 YO/ 1200434/ PALEMBANG/ SAR-HD

Mrs.FET/
Miss. CHE46/ 9YO/
YO/1200201/OGAN
1170956/ Musi ILIR/
Rawas P5A0/AT-HD-SAR-HIL
/ P0A0 / FU- HD – SAR - HIL
MRS. EVI/ 39 YO/ 90908/ Palembang/ P4A0/ IZY-AA/ NS
MRS. YEN/ 40 YO/ 936444/ Palembang/ P1A0/ IZY-AT/ NS
Mrs. ELL/52 YO/ 722842/ Palembang/ P3A2/ IZY-IS/ HD
Mrs. MAL/ 53 YO/ 1199130/ Banyuasin/ P4A0/ WIS-RS/ HD
Mrs. NUR/ 41 YO/ 1168304/ Palembang/ P1A0/ IZY-IS/ RS
Mrs. ELI/ 33 YO/ 1200538/ Palembang/ P2A0/ IZY-HD/ RS
Mrs. NAN/ 48 YO/ 1200425/ Palembang/ P5A1/ IZY-NS/ RS
Mrs.Ros/70YO/1200853/Lubuk-linggau/STI-ARM/ RS

Mrs.Neli
Mrs. Openi/46YO/
WIL/41 1200842/STI-ARM/RS
YO/1193462/Prabumulih/P0A1
Mrs. DEW/21 YO/1197704/Muara Enim/P1A0
IZY/ AT-HE
Miss. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ SAR-AT
Mrs.EMI/40YO/1184667/STI-HIL/IS
Mrs.ITA/29YO/
1200256/Ogan-ilir/STI-HIL/AT
Mrs.ROG/63YO/139064/Ogan Ilir/STI-HIL/
Mrs. MEL/40 YO/355585/Palembang/P1A0
Mrs. EMI/39 YO/1196412/Bengkulu/P2A0/AF-HD
HIL-SAR
Mrs. REN/ 49 YO/ 948571 / Banyuasin/ P3A1 / MUG-IS
Mrs. RUS/ 38 YO/ 1194105 / Banyuasin/ P0A0 / MUG-KY
Mrs. FEB/ 30 YO/ PALEMBANG/ DID-UFA/ AB
Mrs. LIL/ 32 YO/ PALEMBANG/ DID-UFA/ AT

Mrs. NIT/ 29 YO/ 1179068/ JAMBI/ DEV- IZY/ NS


Mrs. MAR/34 YO/1196863/Banyuasin
Mrs. SAN/43 YO/1195363/Banyuasin
SAR
UTI
Mrs. DEW/ 58 YO/ 1177951/ BENGKULU/P2A1/ MIQ-RS
Mrs. NUR /17 Y0/ 1200439/ PALEMBANG/STI-OSP/FY
Mrs. LIA/ 36 YO/ 1200434/ Palembang/ STI-OSP/ HD
Mrs. Sri / 51 YO/ 1184907/ PALEMBANG/ OSP-STI/RS
Mrs. Ven/ 36 YO/ 1200442/ Banyuasin/OSP-STI/AT

Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ MIQ-IS


HIL/ 42
Mrs. ERN/ 43YO/
YO/1184822/
1176021/PALEMBANG/
PALEMBANG/P0A0/
P3A0/MIQ-IS
MIQ-RS
Mrs. Wiji/ 55 YO/ 1197506/ MUARA ENIM/ DEV-HIL/ RS
Mrs. Lia/ 36 YO/ 1200434/ PALEMBANG/ SAR-HD
Mrs. IIA/ 26 YO/ 1189411/ PALEMBANG/ DID-WIS/NS
Mrs. NIK 30 YO/ 931197/ PAGAR ALAM/ DID-WIS/AB
Mrs. DET/ 24 YO/ 1200710/ PALEMBANG/ DID-WIS/KY
Mrs. Herlina Binti Hamdani / 31 YO/ 1200725/ PALEMBANG/ DID-WIS/ AF
 
 
TIA
IZY/ IS

Mrs. NUR/ 50 YO/ 1157496/ BANYUASIN/ P1A0/ MIQ-AT


Mrs. ROS/ 62 YO/ 1186276/ PALEMBANG/ P6A0/ MIQ-AT
Mrs. LIN/ 40 YO/ 1140853/ LUBUK LINGGAU/ P2A0/ MIQ-IS
Mrs. GUS/ 48 YO/ 1182780/ PALEMBANG/ P3A0/ MIQ-IS
Mrs. NOV/ 26 YO/ 1197552/ EMPAT LAWANG/ P2A0/ MIQ-AT
Mrs. NOR/ 55 YO/ 1198795/ JAMBI/ P5A0/ MIQ-AT
Mrs. HER/ 52 YO/ 1074388/ PALEMBANG/ P3A0/ MIQ-RS
PALI
Mrs. ROS/ 43 YO/ 850321/ PALEMBANG/ FU
IZY
IJA
VAI
Mrs. MAR / 51 YO/ 1180150/ PALEMBANG/ STI-UFA/ RS
Mrs. SIM_x000B_50 YO_x000B_1198196_x000B_Banyuasin_x000B_STI-WIS_x000B_AT_x000B_P1A0
Mrs. IND/ 45 YO/ 1169046/ PALEMBANG/ DID-OGL/ IS
UTI
UTI
IJA
HIL-SAR
VAI
VAI
SAR
IJA
IJA
TIA
IZY
IJA
VAI
IZY/ AT-HE
 
Mrs. RUS/ 38 YO/ 1194105 / Banyuasin/ P0A0 / MUG-KY
UTI
IZY/ IS
 
THR
P2A0

Mrs. LEN/ 32 YO/ 1185134/ MUSI RAWAS/ P2A1/ SAR-RS


Mrs. HAT/ 74 YO/ 1050372/ PALEMBANG/ P6A6/ IJA-RS
Mrs. RAT/ 41 YO/ 1197693/ OGAN KOMERING ILIR/ P3A2/ IJA-RS
Mrs. ELM/ 47 YO/ 980694/ BANGKA BELITUNG/ P1A0/ SAR-IS
Mrs. FAR/ 55 YO/ 1189543/ BANGKA BELITUNG/ P5A0/ SAR-RS
Miss. SIT/ 13 YO/ 1160300/ PALEMBANG/ P0A0/ IJA-AT
Mrs. JUM/ 27 YO/ 1199252/ PALEMBANG/ P2A1/ SAR-RS
Mrs. HER/ 52 YO/ 1196302/ EMPAT LAWANG/ P3A0/ SAR-IS
Mrs. AYU/ 25 YO/ 1198203/ PALEMBANG/ P0A2/ IJA-IS
Mrs. YUL/ 36 YO/ 874601/ PALEMBANG/ P2A0/ SAR-RS
Mrs. MAR/48 YO/ 1198959/ LAHAT/ P0A0/ IJA-IS
Mrs PON/ 50 YO/ 1193031/ LAHAT/ P4A0/ IJA-AT
Mrs. NOR/ 55 YO/ 1198795/ JAMBI/ P3A0/ IJA-AT
Mrs. MAH/ 46 YO/ 1186648/ BANGKA BELITUNG/ P2A1/ IJA-AT
Mrs. WAI/ 38 YO/ 1199757/ BANYUASIN/ P2A0/ SAR-RS
Mrs. ETI/ 36 YO/ 1199627/ PALEMBANG/ P1A0/ SAR-IS
Mrs. NUR/ 48 YO/ 1199485/ PALEMBANG/ P1A1/ SAR-RS
Mrs. CIK/ 61 YO/ 1199325/ MUSI RAWAS/ P4A1/IJA-RS
Mrs. MIS/ 58 YO/ 1103440/ PALEMBANG/ P3A0/ SAR-AT
Mrs. NUR/ 53 YO/ 1180434/ PALEMBANG/ P2A0/ IJA-IS
Mrs. SUJ/ 56 YO/ 985389/ PALEMBANG/ P7A0/ IJA-RS
Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/ P0A0/ IJA-IS
Mrs. KUR/ 39 YO/ 1179808/ PALEMBANG/ P1A1/ SAR-IS
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ SAR-IS
Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ IJA-AT
Mrs. SAN/ 43 YO/ 1195363/ BANYUASIN/ P3A0/ IJA-RS
Mrs. SUT/ 44 YO/ 1197080/ OGAN KOMERING ILIR/ P1A1/ SAR-IS
Mrs. ISA/ 47 YO/ 1199753/ MUSI RAWAS/ P2A0/ SAR-IS
Mrs. NUR/ 63 YO/ 1198547/ PALEMBANG/ P4A2/ IJA-AT
Mrs. SRI/ 53 YO/ 1197302/ RIAU/ P3A0/ IJA-RS
Mrs. SUM/ 48 YO/ 1184894/ MUSI RAWAS/ P3A0/ SAR-RS
Mrs. PON/ 53 YO/ 1199899/ PALEMBANG/ P4A1/ SAR-AT
Mrs. END/ 50 YO/ 1174789/ PALEMBANG/ IJA-RS
Mrs. LIN/ 48 YO/ 1190432/ PALEMBANG/ P2A0/ SAR-IS
Mrs. SUK/ 18 YO/ 1196600/ PALEMBANG/ P0A1/ DES-AT
Mrs. NUR/ 64 YO/ 1102751/ PALEMBANG/ P5A2/ IJA-RS
SIT/ 25
Mrs. IND/ 30 YO/
YO/ 1082767/
1194937/ PAGAR ALAM/
Banyuasin/ IJA-RS
P0A3/ CYN-FU/ AC
Mrs. END/ 49 YO/ 702775/ Palembang/ P4A3/ CYN-RS/AC
Mrs. DES/ 40 YO/ 1143159/ Palembang/ P0A0/ CYN-KY/AC
 
Miss. SIT/ 22 YO/ 733958/ PALEMBANG/ P0A0/ OSP-AA
Mrs. YUN/22 YO/ 1199481/ OKI/ P0A0/ CYN-AC/ KY
Mrs. ETI/ 44 YO/ 1199749/ Ogan Komering Ilir/ P0A0/ OSP-AW/KY
Mrs. NAD/36 YO/ 1199886/ Palembang/ P0A0/ CYN-HE/HE
Mrs. Siti Aina bt M. Rum/ 33 YO/ 1199903/ Palembang/ P0A0/ CYN-HE/HE
Mrs. Irmawati Binti Agin/ 46 YO/ 1183676/ MUARA ENIM/ RK-THR
Ms. FAU/ 34 YO/ 890677/ Palembnag/ P0A0/ IZY-AT/ HI
Mrs. SEI/ 71 YO/ 1199743/ Palembang/ P3A0/ IZY-AA/ AT
P3A0
Mrs. RIH_x000B_54 YO_x000B_1194072_x000B_Palembang_x000B_P4A0_x000B_RK-THR
Miss. TIN/ 17 YO/ 1170956/ PALEMBANG/ HD-THR/ P0A0
Mrs. USW/ 33 YO/ 1185834/ Palembang/ P0A0/ AW
Mrs. DIA/ 26 YO/ 1199489/ OGAN ILIR/ AW
FES
 
Miss. REG 23 YO/ 1199114/ PALEMBANG/ IJA-IS

Mrs. LEN/ 32 YO/ 1185134/ MUSI RAWAS/ P2A1/ SAR-RS


Miss. SIT/ 13 YO/ 1160300/ PALEMBANG/ P0A0/ IJA-AT
Mrs. HER/
KHO/ 52
45 YO/ 1196302/
1196882/ EMPAT LAWANG/
PALEMBANG/ P3A0/
P2A1/ SAR-IS
STI-DAV-MUT/AT
 

Mrs. ROM/ 60 YO/ 1167298/ PALEMBANG/


Mrs.MEL/40th/355585/Palembang/RS/ P0A0ZAN-UFA/ IS
Mrs. NUR/ 68 YO/ 1184931/ EMPAT LAWANG/ DID – OSP/ IS
Mrs. EVI 36 YO/ 1158028/ PALEMBANG/ P0A0/ -WIS/ RS
Mrs. KIK/ 24 YO/ 1199689/ Palembang/ STI-HAD/ AA
Mrs. HOL/ 52 YO/ 1196156/ Talang UBI/DEV-IZY/ IS
Mrs. SIT/ 28 YO/ 1031158/ Palembang/ P0A0/ OSP-KY

Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ IJA-AT


Mrs. WAI/ 38 YO/ 1199757/ BANYUASIN/ P2A0/ SAR-RS
Mrs. ISN/ 50 YO/ 1072884/P5A0/ OKI
 Mrs. PAR/ 36 YO/ 1147653/P3A0/ Palembang
Mrs. TIE/ 67 YO/ 1148495/ PALEMBANG/ STI-ARM/

Mrs. MIS/ 56 YO/ 1103440/ PALEMBANG/ P3A0/ SAR-IS


Mrs. NUR/ 53 YO/ 1180434/ PALEMBANG/ P2A0/ SAR-IS
Miss. IDA/ 38 YO/ 1185408/ PALEMBANG/P0A0/ IJA-IS
Mrs. ROD/ 33 YO/ 1185094/ RIAU/ P2A1/ SAR-IS
Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ IJA-AT
SAN/ 42
Mrs. VER/ 43 YO/ 1197277/
1195363/ Banyuasin/
BANYUASIN/ P3A0/
P0A0/ IJA-RS
CYN-IS
URI
Empat Lawang
Mrs. SIS/ 30 YO/ 863969/ OKU Selatan/ P0A0/ CYN-KY
UTI

Mrs. DES/ 22 YO/ 1200089/ Palembang/ DEV-SAR/ HD

Mrs. SRI/ 53 YO/ 1197302/ RIAU/ P3A0/ IJA-RS


SUM/6248YO/
Mrs. SIT/ YO/1199689/
1184894/Muara
MUSIEnim/
RAWAS/ P3A0/AT
JAY-IJA/ SAR-RS

Mrs. HOL/
ROM/52
60YO/
YO/1196156/
1167298/PALEMBANG/DEV-IZY/
PALEMBANG/ ZAN-UFA/ ISIS
Mrs. RUS/ 38 YO/ 1194105 / Banyuasin/ P0A0 / MUG-KY
Miss. REG 23 YO/ 1199114/ PALEMBANG/ IJA-IS
UTI
WIS-TIA
Mrs. RIH_x000B_54 YO_x000B_1194072_x000B_Palembang_x000B_P4A0_x000B_RK-THR
UTI
VAI
UTI
VAI
UTI
VAI
URI
TIA
UTI
TIA
WIS
AT HE
UTI
TIA
VAI USW/ 33 YO/ 1185834/ Palembang/ P0A0/ CYN-AW
Mrs.
FES
 
Mrs. VER/ 42 YO/ 1197277/ Banyuasin/ P0A0/ CYN-IS
 

Mrs.
IJA SOF/ 38 YO/ 1199843/ PALEMBANG/MIQ-INO-ZAN/ AF
AF-HD
SAR-HIL
RK-HD
SAR-HIL/TIA
VAI
IJA
KY-AT
IJA
VAI
IJA
VAI
IJA
VAI
IJA
TIA
IZY
IJA
Digestive division
FB
IZY
RS
UTI
Mrs. DEW/ 32 YO/ 1199652/ Palembang/ CYN-RS
Mrs. SIT/ 33 YO/ 1199903/P0A0 Palembang/ HE-AT
Mrs. BEL/ 28 YO/ 1199666/ Palembang/ RS
Mrs. SAH/ 42 YO/ 1199710/ Palembang/ CYN-IS
Mrs. END/ 38 YO/ 1200053/ Muara Enim/ HE-AT
Mrs. ROS/ 38 YO/ 1200378/ Palembang/ AW-AA
Mrs.
WIS KOR/ 29 YO/ 1200818/ Palembang/ CYN-IS
THR
FB
 WIS
AF-HD
SAR-HIL
RK-HD
SAR-HIL
FB
IZY
RS
UTI

Identitas
Mrs.OVI/22 YO/1202426/ PALEMBANG/ DEV-HIL/ FY
Mrs. MAR/ 39 YO/ 1200339/ Palembang/ AT-HE
Mrs. EFE/ 40 YO/ 1113077/ Palembang/ RK-AC
Mrs. MAR/ 61 YO/ 1201232/ Muara Enim/ P3A0/ AF-HD/ ARM
Mrs. MAY/ 51 YO/ 1200336/ Bangka Belitung/ P2A0/ AT-HE/ MUT
Mrs. HAB/ 31 YO/ 1202444/ PALEMBANG/API-UFA/ HE

Mrs. RES/ 27from


Assessment YO/ internal
895412/departement
PALEMBANG/API-UFA/ HE
Ms. BEL/19 YO/1197781/Muara Enim/P0A0/MUT-IJA/IS

Mrs. YUL/43
YOH/ 32YO/1154499/Palembang/P2A0/
YO/ 1202574/P2A2 PALEMBANG/IJA-KOM/RS
STI-TIA/ AB
Mrs. RIS/ 38 YO/ 1201546/ Palembang/ P0A0/ IS/ MUT- IJA
Ms. PUS/ 49 YO/ 1195265/ Ogan Komering Ilir/ P1A0
Mrs. DWI 48 Y/ 1202529/ Palembang/ P2A0 / RS/ MUT-IJA
Mrs. DAN/ 33 YO/ 880133/ Palembang/ NAL-AW-AT

Mrs.MAY/51
Mrs. MAR/61YO/1200336/Bangka
YO/1201232/ Muara Belitung/P2A0/MUT/AT-HE
Enim/P3A0/AF-HD/ARM

Mrs. DIA/ 53 YO/ 1197151/ PALEMBANG/ P3A0/ OSP/ KY

Mrs. SRI/ 53 YO/ 1197302/ RIAU/ P3A0/ MIQ-RS


Mrs. TEN/ 43 YO/ 1201570/ BANYUASIN/ P4A0/ MIQ-RS
Mrs. RUH/ 60 YO/ 1196750/ JAMBI/ P2A0/ MIQ-AT
Mrs. NUR/ 55 YO/ 1150147/ PALEMBANG/ P4A1/ MIQ-AT
Mrs. HIL/
ARD/4262YO/
YO/1184822/ PALEMBANG/
963036/ LUBUK P0A0/
LINGGAU/ MIQ-IS
P4A0/ MIQ-RS
Mrs. PAT/ 39 YO/ 1157081/ MUSI RAWAS/ P2A0/ MIQ-AT
Mrs. FER/ 34 YO/ 1191054/ PRABUMULIH/ P1A2/ MIQ-AT
Mrs. SUR/ 34 YO/ 1185061/ PAGAR ALAM/ P4A1/ MIQ-RS
Mrs. MAI/ 45 YO/ 1202252/_x000B_PALEMBANG/P0A2/MIQ-IS

EMY/ 49
Mrs. HER/ 35 YO/ 1195510/
1202580/ PALEMBANG/
OGAN ILIR/P2A0/ MIQ-RS
P5A2/ MIQ-IS
Mrs. LIS/ 33 YO/ 1184883/ Banyuasin/ CYN-IS/AW
Mrs. ROS/ 38 YO/ 1200378/ P1A0/ Musi Rawas/ CYN-AW/AW
Mrs. UMI/ 38 YO/ 1166910/ Muara Enim/ AW-AA
Mrs. IND/ 30 YO/ 1194937/ Banyuasin/ P0A3/ CYN-FU/ FU
Mrs. Sri/ 28 YO/ 1202560/ Palembang/ P4A0/ CYN-KY/ KY

Mrs. SIT/ 69 YO/ 1199680/ MUARA ENIM/ P2A0/ MIQ-IS


Mrs. AGU/ 43 YO/ 1186285/ BANGKA BELITUNG/ P3A1/ MIQ-RS
Mrs. SIT/ 48 YO/ 1202051/ MUSI BANYUASIN/ P3A0/ MIQ-AT
Mrs. NEL/ 42 YO/ 1175389/ OGAN KOMERING ILIR/ P2A0/MIQ-RS
Miss. SIT/ 13 YO/ 1160300/ PALEMBANG/ P0A0/ MIQ-AT
Mrs. RUK/ 41 YO/ 1189789/ PRABUMULIH/ P2A0/ MIQ-IS
Mrs. ERN/ 44 YO/ 1183682/ PALEMBANG/ P4A0/ MIQ-IS
Mrs. NUR/ 31 YO/ 1183942/ OGAN ILIR/ P0A1/ MIQ-IS
Mrs. NOV/ 26 YO/ 1197552/ EMPAT LAWANG/ P2A0/ MIQ-AT
Mrs. RIS/ 28 YO/ 1201006/ PALEMBANG/ P1A1/ MIQ-AT
REF/ 34
Mrs. MAR/ 51 YO/
YO/ 1193968/
1202135/ PALEMBANG/ P3A0/
Musi Rawas/ P3A0 MIQ-IS
/ THR/ AT
Ms. BEL/19 YO/1197781/Muara Enim/P0A0/MUT-IJA/IS

Mrs. YUL/43
YOH/ 32YO/1154499/Palembang/P2A0/ IJA-KOM/RS
YO/ 1202574/P2A2 PALEMBANG/ STI-TIA-VAI/ AB
Mrs. ROH/ 66 YO/ 1201232/ OKU TIMUR/ P3A0/ RK-SAR-ARM
Mrs. ASM/48 YO/ 921541/ Palembang/ P2A0/ HD/ SAR-ARM
Mrs. MAR/ 29 YO/ 1194662/ Palembang/ P1A0/ RK/ SAR-ARM
Mrs. RIT/ 44 YO/ 865235/ BANYUASIN/ P2A1/ OSP-RS
KAR/ 23 YO/ OGAN KOMERING ILIR/ INO - CYN / AF - RK 

Miss. LIL/
MRS. YUL/3943YO/
YO/1201331/
1202309/Palembang/
Palembang/P0A0/
P2A0/HE
HE– –HIL
HIL
Mrs. MAR/ 64 YO/ 1202790/ BETUNG/ P5A0/ HD / SAR-ARM
Mrs. EMI/ 43 YO/ 942357/ Lahat/ P3A0/ AF/ SAR-ARM
Mrs. MUR/ 41 YO/ 1202831/ Sekayu/ P2A0/ HD/ SAR-ARM
Mrs. DAN/ 33 YO/ 880133/ Palembang/ NAL-AW-AT
Mrs. RIS/ 38
Ms. PUS/ 49 YO/ 1201546/
1195265/ Palembang/ P0A0/
Ogan Komering Ilir/MUT-IJA/ IS
P1A0 / MUT-IJA/ RS
Mrs. DWI / 48 YO/ 1202529/ Palembang/ P2A0 / MUT-IJA/ RS

Mrs. RUM/ 42 YO/ 1189719/ PALEMBANG/ P4A1/ MIQ-RS


Mrs. ERM/ 45 YO/ 1201908/ MUARA ENIM/ P4A0/ MIQ-IS
Mrs. SUG/ 62 YO/ 1200400/ MUSI RAWAS/ P3A1/ MIQ-AT
Mrs. ERN/ 43 YO/ 1176021/ PALEMBANG/ P3A0/ MIQ-RS
Mrs. DAR/ 48 YO/ 1195327/ OGAN ILIR/ P4A1/ MIQ-RS
Mrs. MEL/ 28 YO/ 1202554/ PRABUMULIH/ P0A1/ MIQ-AT
Mrs. SUS/ 32 YO/ 1200552/ MUARA ENIM/ P3A0/ MIQ-AT
Mrs. TET/ 48 YO/ 1201336/ PALEMBANG/ P2A0/ MIQ-RS
Mrs. MAU/ 48 YO/ 1200992/ PALEMBANG/ P2A0/ MIQ-AT
Mrs. DEV/ 26 YO/ 1202633/ PALEMBANG/ P2A0/ MIQ-AT
ROM/29
Mrs. DES/ 62YO/
YO/1158791/
1202361/PALEMBANG/
PALEMBANG/NAL-AA
P9A0/ MIQ-AT
Mrs. IIN/ 37 YO/ 1124575/ PALEMBANG/ P2A0/ NAL- RS
Miss. TES/ 40 YO/ 579793/ PALEMBANG/ P0A0/ NAL- IS
Mrs. NUR/ 34 YO/ 1202710/ LAMPUNG/ P1A0/ NAL-HE
Miss. REV/ 13 YO/ 1202900/ MUARA ENIM/ DID-OSP/ AF
Mrs. DEN/ 44 YO/ 1202766/ PALEMBANG/ P2A0/ NAL-KY
Mrs. ERD/ 42 YO/ 1198804/ PALEMBANG/ P1A0/ NAL-HE

Mrs. SRI/ 40 YO/ 1197776/ MUSI RAWAS/ P4A0/ MIQ-IS


Mrs. NUR/ 60 YO/ 1186065/ MUSI RAWAS/ P2A1/ MIQ- IS
Mrs. NUR/ 57 YO/ 1160481/ MUARA ENIM/ P3A0/ MIQ-RS
Mrs. HEN/ 67 YO/ 881475/ MUSI BANYUASIN/ P1A1/MIQ-AT
Mrs. DES/ 29 YO/ 1158791/ PALEMBANG/ P0A0/ MIQ-AT
Mrs. YUL/
MRS. 36 YO/ 1194420/
SRI AGUSTINA/ PALEMBANG/
27 YO/ P5A1/ MIQ-AT
1203022/ PALEMBANG/ P1A0/ STI-TIA-VAI/AT

Mrs. HES/ 36 YO/ Banyuasin/ P2A0 / MUT/ AT-AW


Ms. PRI/ 41 YO/ 868451/ Palembang / P2A2 / MUT-IJA/ RS
Mrs. SAR/ 56 YO/ 110753 / Pagar Alam / P3A1/ MUT-IJA/ IS

Mrs.
KAR/RIS/ 33 YO/
23 YO/ OGAN1200607/ Palembang/
KOMERING AT-HE
ILIR/ INO - CYN / AF - RK 
Mrs. NIS/ 57 YO/ 1202985/ OKU/ P5A0/ RK / SAR-ARM
Mrs. IRM/ 46 YO/ 1183676/ Muara Enim/ P3A0/ AF-RK/ SAR-ARM
Miss. DIA/ 17 YO/ 1134439/ PALEMBANG/ HIL-PM
Miss. ZAH/ 32 YO/ 1090862/ PALEMBANG/ HIL-RS

LANASARI BINTI
Mrs. MUDRIKAH BINTISYAFIK/
ASNAWI/3435YO/
YO/OGAN
MUSIILIR/ KOM/ PMKOM/AB
BANYUASIN/

Mrs. NAI/ 59 YO/ 1202861/ PALEMBANG/ P6A0/ MIQ-IS


Mrs. SUG/ 62 YO/ 1185872/ OKU TIMUR/ P3A0/ MIQ-AT
Mrs. ERM/ 45 YO/ 1201908/ MUARA ENIM/ P4A0/ MIQ-IS
Mrs. DEW/ 48 YO/ 1135664/ PAGAR ALAM/P0A0/ MIQ-IS
Mrs. GUS/ 48 YO/ 1182780/ PALEMBANG/ P3A0/ MIQ-IS
Mrs. SRI/ 67 YO/ 1176549/ OGAN KOMERING ULU/ P8A1 MIQ-IS
Mrs. DES/ 29 YO/ 1158791/ PALEMBANG/ P0A0/ MIQ-AT
Mrs. KUR/ 38 YO/ 1179808/ PALEMBANG/ P1A1/ MIQ-IS
Mrs. WIW/ 34 YO/ 835176/ PALEMBANG/ P2A2/ MIQ-AT
Mrs. HEL/
MAR/5429YO/
YO/31527/ PALEMBANG/
1194662/ Palembang/ P1A2/
P1A0/ MIQ-IS
ARM-RK
Mrs. RIA, MD / 58 YO/ 965064/ Palembang/ P1A0/ MUT-IJA/ IS-AT
Ms. FIT/ 42 YO/ 1197774/ PALEMBANG / P1A0 / IS/ MUT-IJA-JAY
Mrs. LUT/ 26 YO/ 1202002/ Palembang/ NAL-KY-AT

Mrs. NUR/50 YO/ 1157496/ BANYUASIN/P1A0/ ZAN-AT


Mrs. ROS/ 62 YO/ 1186276/ PALEMBANG/ P6A0/UTI-AT
Mrs. JUA/76 YO/ 1164997/ OGAN KOMERING ULU/ P8A0/UTI-IS
Mrs. HER/54 YO/ 1074388/ PALEMBANG/ P3A0/ UTI-RS
Mrs. SUR/21 YO/ 1191656/ BANGKA BELITUNG/ P1A0/ ZAN-RS
Mrs. RIT/53 YO/ 1194677/ PALEMBANG/ P3A1/ UTI-RS
Mrs. ROG/61 YO/ 1139064/ OGAN ILIR/ P5A1/ UTI-RS
Mrs. FAT/52 YO/ 11859832/ BATURAJA/ P3A1/ ZAN-AT
Mrs. LIN/47 YO/ 1190432/ PALEMBANG/ P2A0/ ZAN-IS
Mrs. NUR/25 YO/ 1077069/ PALEMBANG/ P0A1/ UTI-RS
Mrs. SUK/18 YO/ 1196600/ PALEMBANG/ P0A1/ ZAN-AT
HER/52
Mrs. DEN/ 43YO/
YO/1196302/
1202766/PALEMBANG/
Palembang/ KYP3A0/UTI-IS

Mrs. ROI/
Miss. FIT/ 34
46 YO/
YO/ 1202550/P3A0/ Palembang/ AT-HE
1203312/OKU TIMUR/JAY-API-VAI-TIA/ AT
Mrs. DAR / 38 YO/ 1197642/ Palembang/ P0A0/ AT-HE/ MUT-RAM
Ms. UNA/ 43 YO/ 1002161/ PALEMBANG / P1A0 / RS/ FES-RAM
Mrs. EMI/43 YO/942357 / Lahat/ P3A0/ AF-MIQ
Mrs. DER/ 33 YO/ 805564/ Palembang/ NAL-HE-AT
Mrs. SIT/ 43 YO/ 1201694/ OKU TIMUR/ P0A0/ KY-AT/ MUT-RAM
Ms. KAI/ 18 YO/ 1198667/ BENGKULU/ P0A0/ AA-AT/ MUT

Mrs. NIL/ 47 YO/ 1197176/ PALEMBANG/ P3A0/ UTI-RS


Mrs. SAM/ 50 YO/ 1187369/ OGAN ILIR/ P0A0/ ZAN-IS
Mrs. NUR/ 50 YO/ 1198314/ PALEMBANG/ P0A0/ UTI-IS
Mrs. ISN/ 42 YO/ 1194602/ JAMBI/ P0A0/ UTI-AT
Mrs. TRI/ 43 YO/ 1203130/ PALEMBANG/ P3A2/ UTI-IS
Mrs. EMM/ 47 YO/ 1203286/ BANGKA BELITUNG/ P1A0/ UTI-IS
Miss. DEL/ 24 YO/ 1192294/ PALEMBANG/ P0A0/ ZAN-IS
Mrs. HAM/ 21 YO/ 1190177/ MUSI RAWAS/ P0A0/ ZAN-AT
Mrs. KOM/ 47 YO/ 1203439/ BANYUASIN/ P5A0/ UTI-RS
Miss. ELY/ 50 YO/ 1067226/ PALEMBANG/ P0A0/ UTI-IS
Mrs. ERN/65 YO/ 1202849/ PALEMBANG/ P0A0/ UTI-AT

Mrs. RIT/ 54 YO/ 1175933/ MUSI RAWAS/ P5A0/ UTI-RS


Mrs. MUL/ 49 YO/ 1200391/ EMPAT LAWANG/ P3A0/ZAN-AT
Mrs. YEN/ 45 YO/1 201410/ PALEMBANG/ P4A0/ ZAN-RS
Miss. SRI/ 47 YO/ 1190702/ PALEMBANG/ P0A0/ ZAN-IS
Mrs. HEN/ 67 YO/ 881475/ MUSI BANYUASIN/ P1A0/ ZAN-RS
Miss. BIN/ 48 YO/ 1042820/ PALEMBANG/ P0A0/ UTI-RS
Mrs. FAR/ 55 YO/ 1189543/ BANGKA BELITUNG/ P5A0/ UTI-RS
Mrs. PAR/ 36 YO/ 1147653/ PALEMBANG/ P3A0/ UTI-RS
Miss.VER/
Mrs. RAN/3034YO/
YO/1201946/
1203488/Pagar
PALEMBANG/ P0A0/
Alam/ P0A1/ ZAN-RS
AW-AT/ RAM
Mrs. MAS / 54 YO/ 1197749/ PALEMBANG/ IS/ MUT-RAM
Mrs. KAM/ 48 YO/ 1181897/ Palembang/ P2A3/ AT-HE/ IJA-INO

Mrs. KOM/ 49 YO/ 1203021/ OGAN KOMERING ULUR TIMUR/ P4A0/ ZAN-AT
Mrs. VIN/ 36 YO/ 1200442/ MUSI BANYUASIN/ P3A0/ ZAN-AT
Mrs. ZAH/ 56 YO/ 1203475/ JAMBI/ P5A0/ ZAN-RS
Mrs. NIN/ 46 YO/ 1181583/ PALEMBANG/ P2A0/ UTI-IS
Miss. KHA/ 24 YO/ 1200690/ LAMPUNG/ P0A0/ UTI-IS
Mrs. SUG/ 61 YO/ 1193704/ PALEMBANG/ P1A0/ MIQ-RS
Mrs. YUL 43 YO/ 1203585/ OGAN KOMERING ILIR/ UTI-RS

Tanggal
02.06.21

03.06.21

04.06.21

04.06.21

10.06.21

10.06.21

10.06.21

11.06.21

04.06.21

04.06.21
07.06.21

09.06.21

10.06.21

08.06.21

08.06.21

10.06.21

11.06.21

11.06.21

11.06.21

11.06.21

11.06.21

11.06.21

11.06.21
11.06.21

12.06.21

13.06.21

14.06.21

Tanggal

27.08.21

28.08.22
29.08.22

30.08.22
31.08.22

01.09.22
Diagnosa
Cervival Cancer

Ovarian Cancer

Endometrial cancer

Diagnosa
Cervical Cancer

Ovarian Cancer
Endometrial cancer

GTN
Left mature teratoma was suspected
Diagnosa
Cervical Cancer

Ovarian Cancer

Endometrial cancer
Post laparotomy total hysterectomy on indication GTN Stage I FIGO Score 6
Thrombocytosis
Right pleural effusion
Cystic ovarian neoplasm with solid part malignancy was suspected
Diagnosa
Cervical Cancer

Ovarian Cancer

GTN
Uterine sarcoma FIGO grade I

Right adnexa mass dd/ non gynecology mass


Ascites
Bilateral pleural effusion dd/ metastases process
Hypoalbuminemia
Solid ovarian neoplasm dd/ dermoid cyst
Right solid ovarian neoplasm with maligancny was suspected
Left cystic ovarian neoplasm with solid part maligancny was suspected
Ascites
Diagnosa
Cervical cancer

GTN

Cervical cancer

Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis

Post operative diagnosis

Pre-operative diagnosis

Post operative diagnosis

· Blighted Ovum
· COVID-19 was suspected (Ig G reactive)

Incomplete abortion
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis

Pre-operative diagnosis

Post operative diagnosis

Pre-operative diagnosis
Post operative diagnosis

- Solid ovarian neoplasm was suspected


- Urinary retention

Pre-operative diagnosis

Post operative diagnosis

Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis

Post operative diagnosis

· Death conceptus
· Covid-19 was suspected ( IgG and IgM reactive)
Cervical cancer

Ovarian cancer stage IIIC


Moderate anemia
Thrombocytopenia
Endometrial cancer Stage IVB
Leucopenia

Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis
Post operative diagnosis

Abnormal uterine bleeding caused by polyp endometrial was suspected


Pre-operative diagnosis
Post operative diagnosis

· Incomplete abortion
· Covid-19 was suspected
Ovarian cancer

Cervical cancer

Ovarian cancer Inadequate staging


Severe anemia
Leucoepenia
Hypoalbuminemia

Pre-operative diagnosis
Post operative diagnosis
Pre-operative diagnosis

Post operative diagnosis


· G1P0A0 5 weeks gestational age with Threatened abortion
· Confirmed COVID -19
Pre-operative diagnosis

Post operative diagnosis

Uterine sarcoma urinary


· Asymptomatic FIGO grade I
tract infection
· Single
Stomatitislife fetus intrauterine
Thrombocytopenia
diagnosa
Abdominal ascites
Cervical malignancy mass
cystic ovarian neoplasm was suspected

myometrium, endometrium
Unspecified ovarian cyst
endometriosis of fallopian tube
Malignant neoplasm ovary
Intramural leiomyoma of uterus
Intramural leiomyoma of uterus
hypoplasia
• Grossofhematuria
uterus caused by infiltration mass was suspected
• AKI Stage III
• Moderate anemia
• hypoalbuminemia
Bilateral endometriosis cyst

Mucinous cyst ovarian neoplasm


Cystic ovarian neoplasm with solid part malignancy was suspec
Vesicovaginal
• fistula dd
Primary infertile uterovesical fistula was suspected
5 years

Cystic ovarian neoplasm with solid part malignancy was suspec


•diagnosa
Covid -19 was suspected (U07.2)
• Severe anemia (D64.9)
• Moderate anemia (D64.9)
• Single life fetus intrauterine
Ovarian cancer stage IIA ( C56.9)
Stomatitis apthosa (K12.0)

inadequate
Ovarian cancer stage staging therapy
IIC complete ( C56.9 ( C56.9)
Ovarian cancer stage IC ( C56.9)
GTN Stage I FIGO Score 8 (O01.9)
GTN Stage I, FIGO Score 3 ( O01.9)
Leukocytosis ( 288.19)
Cervical cancer Stage IIB ( Complete therapy) (C53.9 )
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIA2 (C53.9)
Cervical cancer Stage IIIB complete therapy ( C53.9)

Cervical cancer
Leucopenia Recurrent ( C53.9)
( D72.819)
Cervical cancer Stage IIA was suspected ( C53.9)

Ovarian
Post cancer Inadequate staging ( C56)
DJ Stent
Controlled hypertension (I10)
Hematuria c.b bladder tumor was suspected (C67.9)

Cervical cancer stage IIIB complete therapy ( C53.9)


Cervical cancer stage IIIB was suspected ( C53.9)
Cervical cancer stage
Thrombocytopenia IIB ( C53.9) post radical hysterectomy
( D69.6)
Thrombocytopenia ( D69.6)
Hypokalemia ( E87.6)

GTN stage I FIGO Score 4 ( O01.9)


GTN was suspected ( O01.9)
GTN stage
Cervical I FIGO
cancer Score
Stage IB26was
( O01.9)
suspected ( C53.9)
Severe anemia ( D64.9)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IIIC ( C53.9)
D64.9
Moderate anemia ( D64.9)
Ovarian cancer Stage IIIC ( C56.9)
Thrombocytopenia ( D69.6)
Ovarian cancer Was suspected ( O01.9)
GTN Stage II FIGO Score 5 ( O01.9)
Leukopenia ( D72.819)
Cyst Ovarian Neoplasm Permagna, malignancy was suspected (C56)
Ascites ( R18.8)
Chronic tract
Urinary cervicitis (with( ASCUS)
infection N39.0)

Cervical cancer stage IIIA ( C53.9)


Cervical cancer stage IIIB ( C53.9)
Cervical
Mild cancer
anemia stage IIIB ( C53.9)
( D64.9)
Bilateral hydronephrosis ( N32.0)

Intramural
Secondaryuterine
infertilemyoma
1 year (dd/ adenomyoma ( D25.1
N97.9)
Infetile primer 8 years ( N97.9)
Moderate anemia (
Primary infertile7 years ( N97.9)
Endometriosis ASRM Grade III (ASRM Score 32, EFI Score 8) (N80.1)
Primary infertile 3 years (N97.9)
Primary infertile 10 years (N97.9)
Internal genitalia adhesion (N97.9)
Secondary infertile 12 years (N97.9)
Chronic disease

Endometriosis ASRM grade IV ( outside) (N80.1)


Primary amenorrhea
Haemorrhoids (K64) ( N91.0)
Post laparotomy total hysterectomy on indication cervical agenesis
Rectocele grade III
 
Rectocele grade IV
Vaginal synechiae (Q52.2)
Bartholini abcess (N75.1)
Endometrial cancer was suspected (C54.1)
Vaginal septal was suspected dd imperforate hymen(Q52.2)
(N80.0 – endometriosis of uterus)
Bilateral hydronephrosis (N13.2 hydronephrosis with renal and ureteral obstruction
Bilateral pelvic congestive
Uterine adenomyosis (N80.0- endometriosis of uterus)
Uterine adenomyosis (N80.0- Endometriosis of uterus)
AUB-P1 was suspected (N93.9- abnormal uterine bleeding)
(C54.1- malignant neoplasm of uterus)
Bilateral hydronephrosis (N13.2)
Ileus paralytic was suspected with ascites
Post adhesiolysis on indication internal genital adhesion
Post laparotomy right salpingo-oophorectomy on indication right dermoid cyst
Carcinoma of corpus uterine was suspected (C54.9- malignant neoplasm of corpus uteri, unspecified)
Stomatitis apthosa (K12.0)
Moderate anemia ( D64.9 )
Post Hydatidiform mole evacuation
Hyperthyroid
 

- Post bladder repair on indication vesico fistula


Post adhesiolysis on indication internal genitalia adhesion
Post myomectomy oi subserous uterine myoma
Moderate Anemia Hypochromic Microcytic (D64.9)
Cancer pain (G89.3)
Covid-19 was suspected (IgG IgM reactive)  (U07.2
Twin life fetus intrauterine (O30)
Post laparotomy surgical staging
Post stab wound drain
-Post fistuloraphy on indication Vesicovaginal fistula
Post laparoscopic surgical staging
Leucopenia ( D72.819)
Post curettage on indication incomplete abortion
 
Covid 19 was suspected (U07.2)
Moderate anemia(D64.9)
Thrombocytopenia ( D69.6)
Thrombocytopenia ( D69.6)
Hypokalemia ( E87.6)
Urine retention
Post incision & drainage and Masupialization oi Bartholin abcess
Hydrops fetalis P 56.9
Single life fetus intrauterine O00.01
COVID-19 was suspected ( U072 )
 
 
 
C56.9 Malignant neoplasm of right ovary
Post laparoscopy total hysterectomy bilateral salpingoophorectomy + Post adhesiolysis (o.i uterus myomatous + Uterine adeno
Urinary tract infection ( N39.0)
Moderate anemia ( D64.9)
Moderate anemia ( D64.9)
Thrombocytopenia ( D69.6)
Leukopenia ( D72.819)

Cervical cancer
Ovarian cancer
Bilateral salpingo-oophorectomy
Post adhesiolisis o.i adhesion with omentum, peritoneum, intestine
Post laparotomy right cystectomy on indication right tubo ovarian abcess.
Post left salpingo-oophorectomy on indication left cyst ovarian
Solid ovarian neoplasm with malignancy was suspected dd/ intra-abdominal mass non-gynecology
Icteric caused by hepatobilier obstruction ; liver metastases  
Left hydronephrosis
Thrombocytopenia
Post adhesiolysis on indication internal genital adhesion

Solid ovarian
-Cystic neoplasm
ovarian (D27.9
neoplasm with solid part papillary, malignancy was suspected

Cystic ovarian neoplasm malignancy was suspected


Uterine adenomyosis
-Post fistuloraphy on indication Vesicovaginal fistula
Cystic ovarian neoplasm with solid part, malignancy was suspected
Incisional hernia
Cystic ovarian neoplasm with solid part
Post laparotomy right cystectomy on indication right tubo ovarian abcess.
Post left salpingo-oophorectomy on indication left cyst ovarian
Solid ovarian neoplasm with malignancy was suspected dd/ intra-abdominal mass non-gynecology
Carcinoma of corpus uterine was suspected (C54.9- malignant neoplasm of corpus uteri, unspecified)
Post adhesiolysis on indication internal genitalia adhesion
Post myomectomy oi subserous uterine myoma
Ovarian cancer inadequate staging
Post laparoscopy total hysterectomy bilateral salpingoophorectomy + Post adhesiolysis (o.i uterus myomatous + Uterine adeno
Post adhesiolisis o.i adhesion with omentum, peritoneum, intestine
Bilateral salpingo-oophorectomy
Post IUD extraction on indication IUD dislocation (T83.32)
Anemia ( D64.9)
Moderate anemia (D64.9)
Cervical cancer Stage IIIB ( C53.9)
Adnexa mass ( R19.0)
Ovarian cancer Stage IIIC ( C56.9)
Leucopenia ( D72.819)

Leukopenia ( D72.819)
GTN was suspected ( O01.9)

LGSIL ( genital
Internal R87.613)
adhesion ( N73.6)

Cervical cancer stage IIIB ( C53.9)


Cervical
Moderatecancer
anemiastage IVA (C53.9)
( D64.9)
Hydatidiform mole ( O01.9)
Endometrial cancer Stage I was suspsected ( C54.1)
Atypical endometrial hyperplasia ( N85)
Ascites ( R18.8)
Moderate anemia ( D64.9)
Leucopenia ( D72.819)
Ovarian cancer Recurrent ( C56.9)
Leucopenia ( D72.819)

GTN stage I FIGO Score 3 ( O01.9)


GTN Stage
Hernia IV FIGO
Incisional wasScore 2 (O01.9)
suspected ( K43.2)
Hypokalemia ( E87.6)
Cystic ovarian neoplasm with malignancy was suspected ( C56.9)
Left limb DVT was suspsected (I80.3)
Hypertension stage II ( I10)
Moderate anemia ( D64.9)
Leucopenia ( D72.819)

Ovarian cancer inadequate staging ( C56)


Ovarian cancer Recurrent ( C56)
GTN stage I FIGO Score 8 (O01.9)
GTN stage I FIGO
Leukocytosis Score 3 ( O01.9)
( 288.19)
Ascites ( R18.8)
Recurrent pregnancy loss (N96)
Endometrial thickening caused by hyperplasia was suspected (N85.00)
•Uterine adenomyosis (N80.0)
•Primary infertile 12 years (N97.9)
•Abnormal uterine bleeding caused by O1M1 ( N93.9)
Post laparoscopy cystectomy
Epilepsygenitalia
Internal idiophatic on therapy
adhesion ( G40)
(N73.6)
Secondary amenorrhea (N91.2)
Intramural uterine myoma (D25,9)
Primary genitalia
Internal infertile 8adhesion
years (N97.9)
(N73.6)
Primary infertile 3 years (N97.9)
N82.0 vesicovaginal fistula
•Uterine(D25.1-
Solid ovarian mass Intramural leimyoma subserous
dd/ pendiculated of uterus) myoma ( D25.2)
Ascites
Post ( R18.8) surgical staging
laparotomy
Rectocele grade IV
Uterine prolapse grade
·Post laparotomy IV + Post Myomectomy
total Hysterctomy on indication Intramural
+ Right Salphingooforectomy + Left Uterine Myoma on indication Hematometra + Hemato
Salphingectomy
·Post adhesiolysis
Endometriosis ASRM on indication
grade I (ASRMinternal genitalia
score 2 EFIadhesion
score 7) (N80.1)
Non patent
·Post bilateral
curettage tubes
on indication incomplete abortion
·Urinary tract infection
·Hyperkalemia (E87.5)
·Hypoalbuminemia
•Post (E88.0) debulking
laparotomy suboptimal
•Post stab
Cervical wound
cancer drain
stage ( Z97
IIIB )
( C53.9)
Anemia ( D64.9)
Recurrent ovarian cancer ( C56.9)
Leucopenia
Moderate anemia ( D72.819)
( D64.9)
Leukopenia (with D72.819)
high risk neutropenia febrile (D72.819)
Trombositopenia
·Leucopenia (D69.6)
(D72.819)
 ·Thromobcytopenia ( D69.6)
 
Post wound rehecting on indication burst abdomen
 
Post Curretage o.i death conceptus

Post Hysteroscopy DnC o.i endometrial polyp


( K43.2)
Hydatidiform mole ( O01.9)

Uterine adenomyosis (N80.0)


Ovarian cancer inadequate staging (C56.9)
Cystic ovarian neoplasm with solid part permagna malignancy
Cervical cancer complete
reccurent(therapy
C53.9) complete response ( C53.9)
Moderate anemia ( D64.9)
Leucopenia
Ovarian ( D72.819)
cancer Stage IC ( C56.9)
Leucopenia ( D72.819)
GTN Stage IV(D72.819)
Leucopenia FIGO Score 2 (O01.9)
Hernia Incisional(was
Thrombocytosis suspected ( K43.2)
D47.3)
Hypokalemia ( ASRM
Endometriosis E87.6) grade IV post laparoscopy total hysterectomy bilateral salphingo-oophorectomy
adhesiolysis
Post operative on indication internal genitalia adhesion
diagnosis
Post laparotomy
operative diagnosis salpingo-oophorectomy on indication benign ovarian neoplasm
unilateral
Post laparotomy unilateral
Post hysteroscopy D&C on salpingo-oophorectomy on indication benign ovarian neoplasm
indication endometrial hyperplasia

Post laparotomy myomectomy on indication multiple uterine myoma


 
 
Stage IIIB ( C53.9)
Moderate anemia ( D64.9)
Leucopenia ( D72.819)
Meteorismus
AKI stage I
 Hypoalbuminemia
Post adhesiolysis on indication internal genitalia adhesion
Ovarian Cancert clinically Stage IIIC Post laparotomy suboptimal debulking
Single life fetus cephalic presentation
Ovarian cancer advanced stage inadequate therapy
Uterine prolapse grade IV + Post Myomectomy on indication Intramural Uterine Myoma

Uterine adenomyosis
Ovarian cancer inadequate staging
Cervical cancer stage IB2
Multilocular cystic ovarian neoplasm (D27.9)
•Solid ovarian neoplasm
•Adenocarcinoma withbladder
recti with solid part dd/ dermoid
metastasis cyst
(C21.8)
•Single life fetus cephalic presentation
Ovarian cancer
•Multiple uterineinadequate
myoma (D25.9) staging (C56.9)
•Primary infertility
Endometriosis ASRM14 years
grade(N97.9)
I (ASRM score 2 EFI score 7) (N80.1)
Non stage
CKD patentVbilateral
on HD tubes
Recent diagnosis:
Post Hysteroscopy
Endometriosis ASRM DnC o.i endometrial
grade polyp
IV post laparoscopy total hysterectomy left salphingo-oophorectomy
Post adhesiolysis
Postoperative on indication internal genitalia adhesion
diagnosis:
Post hysteroscopy D&C on indication endometrial hyperplasia
Post Minilaparatomy Interval Tubectomy Pomeroy
Cystic ovarian neoplasm mucinous type (C56.9)
Vesicovaginal
Uterine prolapse fistula
grade(N82.0)
III (N81.2 )
Hypertension stage II (I15.9
Endometrial
Multiple carcinoma
uterine myom (D26) stage IB was suspected
Hepatitisadenomyosis
Uterine B (18.1) (N80.0)
Ascites
Solid (R18)neoplasm malignancy was suspected (C56.9)
ovarian
Ascites (R18)
Solid ovarian
Uterine myoma neoplasm
(D25) malignancy was suspected (C56.9)
Endometrial Polyp (N84.0)
Ovarian cancer
Endometrial inadequate
Polyp (D27.9) therapy with metastase abdominal w
Benign neoplasm of ovary
Low grade squamous
Intramural uterine myoma intraepithelial
(D25.9) lesion (LGSIL) (R87.612)
Secondary
Internal infertile
genitalia 5 years (D25.9)
adhesion (N97.9)
Primary
Left infertile
ovarian PCO3 years (N97.9)
Right endometriosis
Preoperative diagnosis: cyst (N80.1)
Subserous uterine myoma
Uterine adenomyoma (N80.0) (D25.9)
Primary infertile 4 years
Right hydrosalpinx (N70.1) (N97.9)
Secondary Infertile 12
Right endometriosis years
cyst N97.9)
(N80.1)
Left cystic ovarian neoplasm (D27.9)
Cystic ovarian neoplasm with solid part, malignancy was suspe
•(N80.0)
•Endometriosis
ICD 10 of uterus
C56.9operative
Post Malignant neoplasm of right ovary
diagnosis
Post Fistuloraphy
Uterine prolapse gradeon indication
III Vesicovaginal fistula
+ Hipertensi stage II
Post left salphingo-oophorectomy o.i Left cystic ovarian neoplasm
Post adhesiolysis o.i internal genitalia adhesion
operative diagnosis
Post LEEP on indication LGSIL

Diagnosa
Recent Diagnosis
Post
Postdilatation andadhesiolysis
laparoscopy curettage onon indication death
indication conceptus
internal genitalia adhesion
Bilateral
Post patent tubes
laparoscopy rectovaginal nodule resection
Post laparoscopy
Rectocele grade IIadhesiolysis
Uterine
Post prolapse
operative grade II
diagnosis
•Cervical cancer
Recent diagnose: stage IIIC1
Post curratage on indication
COVID -19 was suspected ( U07.2) incomplete abortion
Single lifedd/
·Gastritis fetus intrauterine
HEGdd/ ( Z3A.37)
cholelithiasis (K25.9)
·Single life fetus intrauterine
•Post right salpingectomy on indication right tubo ovarian abscess
•Posttotal
Post stababdominal
wound drain hysterectomy – bilateral salpingoooforectomy on indication adenomyosis and bilateral endometriosis cyst
Endometriosis
Post Laparatomy grade IVsalpingoraphy
right ( ASRM scoreoi96) right tubal abortion
Moderate
•Post rightanemia
cystectomy on indication endometriosis cyst
•Endometriosis cyst grade I (ASRM scor3 4 EFI score
Post operative diagnosis
hysterectomy
Post left total – bilateral
salpingoooforectomy salpingoooforectomy
on indication on indication
left endometriosis cyst subserous uterine myom
Endometriosis
Post grade II (ASRM score
right salpingo-oophorectomy 11) endometriosis cyst + right hydrosalpinx
oi right
Postop
Post stab wound drain
diagnosis: Cervical cancer stage IIA (C53)
Rectocele grade II
Uterine prolapse grade II
Post menopause
Bilateral bleeding caused by malignancy was suspecte
patent tubes
Post laparoscopy adhesiolysis
Moderate anemia ( C64.9)

Hernia ventralis ( K43.9)

Endometrial Cancer Stage IB


COVID – 19 was suspected
Vaginal cancer ( C51.9)
Secondary infertile 6 years (N97.9)
Secondary infertile 12 years (N97.9)
Bilateral patent tubes
Secondary APS (D68.61)
Recurrent pregnancy loss (N96)
Cervical Cancer Stage IIIB ( C53.9)
Moderate anemia ( D64.9)
Cervical Cancer Stage IIB ( C53.9)
Cervical Cancer ( Stage
Severe anemia D64.9)IB2 ( C53.9)
CKD on HD ( N18.5)
Ovarian Cancer Recurrent ( C56.9)
Ovarian Cancer Stage IC (C56.9)
Endometrial Cancer Stage IIIA ( C54.9) complete therapy
GTN Stageanemia
Moderate I FIGO (Score
D64.9) 2 ( O01.9)
Leucopenia ( D72.819)
Hydatidiform
Solid ovarian mole ( postwith
neoplasm curettage) (O01.9)
cystic part maligancny was suspected ( C56.9)
Hepatitis cirrhosis
Postoperative ( K74.60)
diagnosis:
Cervical
Post rightCancer Stage 1b2
salpingectomy onwas Suspected
indication right tubo ovarian abscess
Post stab wound drain
total abdominal hysterectomy – bilateral salpingooophorectomy on indication adenomyosis and bilateral endometriosis cys
Endometriosis
Moderate anemia grade IV (ASRM score 96)
Rectocele grade III (N. 81.6)
on indication Vesicovaginal fistula (N82.0)
Preoperative Diagnosis: Perineovaginal fistula (N82.3)
Intramural uterine myoma (D25.1)
Diabetes mellitus
Postoperative type II (E11.0)
diagnosis:
Post Laparascopy
(D25.- leiomyoma ofsalpingectomy
uterus) on right tube on indication ectopic pregnancy on right tube
Stage II ovarian
Bilateral hypertension (I10- essential
cyst neoplasm (N.83-hypertension)
bilateral ovarian cyst)
Moderate anemia (D.25 Anemia)
Uterine prolapse grade IV (N81.2)
Rectocele grade IV (N. 81.6)
Labia minora
Cystocele hypertrophy
grade I (N81.1)(N90.6)
Rectocele grade I (N. 81.6)
Post stab wound drain
Post right cystectomy on indication endometriosis cyst
Endometriosis cyst grade I (ASRM score 4 EFI score 7)
Post op diagnosis:
Post hysterectomy
Endometriosis total
grade – bilateral
II (ASRM salpingoooforectomy
score 11) on indication subserous uterine myom
Cervical Cancer Stage IIIA ( C53.9)
Moderate anemia ( D64.9)
Cervical Cancer Stage IIIB ( C53.9)
Cervical cancer Stage
Thrombocytopenia IVB ( C53.9)
( D69,6)
Hyperkalemia ( E87.6)
Ovarian
GTN Stagecancer Stage
I FIGO IA (6C56.9)
Score (O01.9)
GTN Stage I FIGO Score 2 (O01.9)
Vaginal cancer stage III
Cystic ovarian neoplasm with solid part malignancy was suspected ( C56.9)
Cystic ovarian neoplasm dd/ pseudomyxoma peritonii ( C56)
Hepatitis B (B19.8)
Primary infertile 4,5 years ( N97.9)

Uterine adenomyosis
Intramural uterine myoma( N80.0)
( D25.1)
Right endometriosis cyst ( N80.1)
Right endometriosis cyst (N80.1)
Left lateral vaginal wall laceration (O70.0)
Bilateral endometriosis
Right cystic cyst ( N80.1)
ovarian neoplasm (N83.02)
Secondary infertile 7 years ( N97.9)
Cervical Cancer Stage IIIB ( C53.9)
Mild anemia ( D64.9)
Ovarian Cancer Recurrent (C56.9)
Ovarian Cancer Recurrent ( C56.9)
Ovarian Cancer Inadequate staging ( C56.9)
GTNanemia
Mild Stage I FIGO Score 3 ( O01.9)
Recent diagnosis:
• Post curettage
Recent diagnosis:oi Incomplete abortion
• Postlaparotomy
post curettage oi Death conceptus
conservative surgical staging
Post right cystectomy on indication ovarian cyst
adhesiolisis
Post liver biopsy
Post adhesiolysis on indication internal genitalia adhesion
Bilateral patent tubes
Post laparascopy right salpingectomy on indication ectopic pregnancy on right tube
Vaginal Stumps prolapse grade IV (N81.2)
Rectocele grade IV (N. 81.6)
Post Fistuloraphy (57.84) on indication Vesicovaginal fistula (N
Abnormal uterine
Urinary tract bleeding
infection caused by O1 ( N93.0)
(N39.0)
Endocervical
Recent polyp + subserous penduculated myoma ( N84.)
Diagnosis
death conceptus
Post curettage on indication Incomplete Abortion

Cervical Cancer Stage IIIB was suspected


( C53.9) ( C53.9)
on radiotherapy
Moderate anemia ( D64.9)
Cervical Cancer Stage IIIB ( C53.9)
Moderate anemia ( D64.9)
Cervical Cancer
Ovarian Cancer Stage
Stage IIIC
IIIB ( C56.9)
C53.9) complete therapy complete response
Ovarian Cancer Stage IIIC ( C56.9) complete therapy complete response

GTN Stage
Right I FIGO neoplasm
solid ovarian Score 3 ( O01.9)
( C56)
Left cystic ovarian neoplasm ( N83.02)
Cystic ovarian neoplasm with malignancy was suspected ( C56
Perineovaginal
Ovarian carcinomafistula (N82.3)stage IC
clinically
Ovarian cancer clinically stage IB
Bilateral patent tubes

Cervical Cancer Recurrent (C53.9)


Cervical
Complete Cancer Stage IIIC1 ( C53.9)
therapy
Partial response
Ovarian cancer Stage IVA (C56.9)
Moderate anemia ( D64.9)
Ovarian cancer Stage IIIC (C56.9)
Moderate anemia (D64.9)
Endometrial Stage II (C54.9)
GTN Stage I FIGO Score 6 (O01.9)
GTN Stage I FIGO Score 8 (O01.9)
GTN Stage I FIGO Score 2 (O01.9)
GTN Stage I FIGO Score 7 3 (O01.9)
(O1.90
Leukopenia
Post ( D72.819)
IUD extraction
Postoperative diagnosis:
Post laparoscopy
Left cystic ovarianleft salpingo-oophorectomy on indication cystic ovarian torsion
neoplasm
Endometrial hyperplasia
Primary Infertile 18 years

Post Operative Diagnosis:


Postlaparotomy
Post labia minoraleft
excision o.i right labia minora
salpingo-oophorectomy hypertrophy
oi left (N90.6)
endometriosis cyst
Post Operative Diagnosis:
Ovariancancer
Ovarian cancerstage
stageIIIC
IIC

Cervical cancer Stage IIB ( C53.9)


Ovarian cancer Stage IC ( C56)
Ovarian cancer Stage ICIVB( C56)
( C56)
Moderate anemia ( D64.9)
Ovarian cancer Stage IIIC ( C56)
Inadequate
Ovarian cancer Stage staging ( C56)
IA ( C56)
Leucopenia ( C72.819)
Ovarian cancer Stage IVA ( C56)
Hydatidiform mole was suspected ( O01.9)
Post appendectomy
Wound scar infection (T81.49XA
Cystic ovarian
Post left neoplasm with malignancy
salpingoophorectomy was
on indication leftsuspected ( C56
cyst ovarian serous neoplasm
Breast cancer post right mastectomy on chemotherapy (C50- malignant neoplasm of breast)
Cervical cancer Stage IIB ( C53.9) inadequate theapy
Moderate anemia (D64.9)
Cervical cancer Stage IIIB ( C53.9)
Cervical cancer Stage IVA ( C56.9)
Ovarian cancer Stage IA ( C56)
Ovarian cancer
Moderate anemiaRecurrent
( D64.9) ( C56)
Ovarian cancer Stage IIIC ( C56.9)
Ovarian cancer Stage IIIC ( C56.9)

Cysticadenomyosis
Post ovarian neoplasm malignancy
resection was suspected
on indication ( C56)
uterine adenomyosis
adhesiolysis
Post Operative on indication internal genitalia adhesion
Diagnosis:
Ovarian cancer
Diabetes clinically
Mellitus type II stage IIIC
Cervical cancer Stage IIIB ( C53.9)
Moderate anemia ( d64.9)
Cervical cancer Stage IIIB ( C53.9) was suspected
Thrombocytopenia ( D69.6)
Moderate anemia (D64.9)
Endometrial cancer Stage IIIA ( C54.1)
Thrombocytopenia ( D69.6)
Multiloculare cystic ovarian neoplasm with malignancy was suspected ( C56)

Identitas
IRT, 31 tahun, Banyuasin

EKA, 27 tahun, Palembang

MEI, 26 tahun, Banyuasin

MAR, 38 tahun, Ogan Ilir

EST, 40 tahun, Palembang

SER, 27 tahun, Palembang

DAL, 45 tahun, Ogan Ilir

ROS, 64 tahun, Lahat

SRI, 39 tahun, Palembang

JUL, 29 tahun, Palembang


Mei, 30 tahun, Palembang

IND, 31 tahun, Palembang

KUR, 42 tahun, Palembang

ALD, 36 tahun, Palembang

IND, 21 tahun, Palembang

SIT, 25 tahun, Palembang

EMI, 32 tahun, Palembang

DWI, 23 tahun

VIN, 36 tahun, Musi Banyuasin

NUR, 51 tahun, Palembang

ORI, 27 tahun, Palembang

FIT, 25 tahun, Muara Enim

NUR, 18 tahun, Palembang


MIR, 24 tahun, Palembang

IKA, 23 tahun, Palembang

ERL, 41 tahun, Palembang

SAS, 52 tahun, Palembang

Identitas

Mrs. FAR/ 55 YO/1218387/BANGKA BELITUNG /P5A0


Internal genitalia adhesion
Mrs. ANG/ 30 YO/ 1217915/ Palembang
Mrs. SIN/ 22 Yo/ 1209157/ Palembang
Mrs. SRI/ 46 YO/ 1125525/ Palembang
Miss. ELS/ 12 YO/ 1206262/ Muara Enim
Miss. IND/ 22 YO/ 1086226/ Ogan Ilir
Mrs. SUM/ 46 YO/ 1140766/ Palembang/ P0A0
Mrs. SAK/ 4YO /1219185 /BANYUASIN
Mrs.TAN/ 43 YO/ 1143949/ LUBUK LINGGAU
Mrs. EMI/ 69YO/1181384/BANYUASIN
Mrs. RIK/ 37 YO/ 1141940/ P0A0/ PALEMBANG
Miss. YOS/ 33 YO/1217486/PALEMBANG
Mrs. YAN/ 31 YO/1183800/Ogan Komering Ilir
Mrs. SUK/ 46 YO/1183800/Banyuasin
Mrs. Hol/ 34 YO/ 1196564/ Palembang
Mrs. AMR/ 42 YO/1207382 /Muara Enim
Mrs. ROM/ 66 YO/ 1219793/ PALEMBANG
MRS. TATU BT SALIM / 69 YO/ 1198420/OGAN ILIR
Mrs. TAT/ 45 YO/ 1208271/ Palembang
Mrs. YUL/ 35 YO/ 1191511/ Ogan Komering Ilir
Mrs. ITA/ 39 YO/1214734/Musi Rawas
Mrs. DWI/ 28 YO/554401/Palembang
Prosedur
Stage IIIA Hospitalized
Moderate anemia PRC transfusion
Hypoalbuminemia Internal medicine assessment
Hypokalemia Tranexamic acid 500 mg/8 hours
Chemotherapy Paclitaxel-Carboplatin 1st course
Plan for radiotherapy
Stage IIIB Hospitalized
Moderate anemia PRC transfusion
Chemotherapy Paclitaxel-Carboplatin 2nd course
Plan for radiotherapy (March, 22nd 2020)
Stage IIIB Hospitalized
Moderate anemia PRC transfusion
Chemotherapy Paclitaxel-Carboplatin 2nd course
Stage IIIC Chemotherapy Paclitaxel-Carboplatin 6 course
Hypertension Plan for radiotherapy
AKI stage I Internal medicine assessment
Stage IIIB Digestive surgery assessment
Endometriosis TUG-US (January, 21st 2021)
Post laparotomy suboptimal debulking Chemotherapy Paclitaxel-Carboplatin 6 course
Post colostomy transversal colon
Post DJ stent
Stage IIIC IHC Examination
Chemotherapy Paclitaxel-Carboplatin 6 course
Stage IIIA Chemotherapy Paclitaxel-Carboplatin 4th course
Plan for radiation (2nd February 2020)
Prosedur
Stage IVA Hospitalized
Gross hematuria IVFD RL
Moderate anemia (clinically) Tranexamic acid 500 mg/8 hours
Cancer pain Pronalgess supp 3x1
Laboratory examination
Cystoscopy
Chemotherapy paclitaxel-carboplatin 6 course
Plan for radiotherapy
Stage IVA Chemotherapy paclitaxel-carboplatin 6 course
Plan for radiotherapy
Stage IIIC Hospitalized
Moderate anemia PRC Transfusion
Thrombocytopenai TC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Stage IA ( complete therapy complete response) Tumor marker evaluation (April, 2021)
Stage IIIA1 Chemotherapy paclitaxel-carboplatin 3 course
Radiotherapy 25x
Chemotherapy paclitaxel-carboplatin 3 course
Stage IIIC Chemotherapy paclitaxel-carboplatin 4th course
Stage IVB Hospitalized
Leucopenia Leucogen injection
Chemotherapy paclitaxel-carbopltin 3rd course
Plan for radiotherapy (February, 15th 2021)
Stage IA ( post laparoscopy surgical staging) Tumor marker evaluation (every 3 months)
Stage I FIGO Score 3 MR Chemotherapy 3rd course
Laparotomy surgical staging
Prosedur
Stage IIIB Hospitalized
Hypertension stage II Internal medicine and urology assessment
AKI stage II Laboratory examination
TUG- US examination
Candersatan 1x8 mg PO
Chemotherapy paclitaxel-carboplatin 1st course
Plan for radiotherapy ( April, 14th 2021)
Stage IC (clinically) Tumor marker evaluation ( 3 months later)
Post laparotomy conservative surgical staging
nadequate staging Hospitalized
Severe anemia US Gynecology
Leucoepenia Abdominal CT scan with contrast
Hypoalbuminemia PRC transfusion
Digestive surgery assessment
Stage III C Laboratory examination
Chemotherapy paclitaxel-carboplatin 6 course
Stage IIIC ( compete therapy complete response) Pap’s smear
TN Stage I FIGO Score 6 MR Chemotherapy 1st course ( consolidation)

Tumor marker evaluation


was suspected Laparotomy surgical staging
Prosedur
Recurrent with left coli lymph nodes metastases Plan for radiotherapy
Hypertension stage II
Stage IIIB Chemotherapy paclitaxel-carboplatin 6 course
Plan for radiotherapy
Stage IIB good response Laparotomy radical hysterectomy
Stage IB1 Laparotomy radical hysterectomy
Stage IIIC (complete therapy complete response) US gynecology
Left pleural effusion caused by malignancy was suspected
Mild anemia
Stage IC Chemotherapy paclitaxel-carboplatin 4th course
Mild anemia
Stage I FIGO Score 6 MR Chemotherapy 2nd course
Hospitalized
VAC chemotherapy 2nd course
Abdominal CT Scan with contrast
Laparotomy surgical staging

Laparotomy conservative surgical staging


Laparotomy surgical staging
ncny was suspected

Prosedur
Recurrent with rectal metastases Abdominal CT Scan
Digestive surgery assessment
Stage IIIB ( Complete therapy complete response) Pap’s smear 1 month later

Stage III FIGO Score 7 Hospitalized


Severe anemia PRC transfusion
Leucopenia Leucogen inj
Hyponatremia IVFD NaCl 0,9% drips xx/minute
Stomatitis Aloclair gel 4x/day
Thrombocytopenia MER Chemohterapy 3rd course
Stage II FIGO Score 5 MR chemotherapy 1st couse
Hypertension stage II Amlodipin 1x10 mg
Stage I FIGO Score 2 Β-HCG Evaluation

Stage IIIA Hospitalized


Moderate anemia PRC transfusion
Hypoalbuminemia Internal medicine assessment
Hypokalemia Tranexamic acid 500 mg/8 hours
Chemotherapy Paclitaxel-Carboplatin 1st course
Plan for radiotherapy (April, 5th 2020)
Stage IIIB Hospitalized
Moderate anemia PRC transfusion
Chemotherapy Paclitaxel-Carboplatin 2nd course
Plan for radiotherapy (March, 22nd 2020)
Stage IIIB Hospitalized
Moderate anemia PRC transfusion
Chemotherapy Paclitaxel-Carboplatin 2nd course
Plan for radiotherapy (March, 29th 2020)
Ovarian cancer inadequate staging Laparotomy optimal debulking (total omentectomy, appendecto
Post laparotomy optimal debulking (total omentectomy) on indication peritoneal carcinoma was suspected stage IIIc
Adenomyosis uterine Laparoscopy operative:
Paraovarian endocyst - salphingoraphy
Primary infertile 6 years - Adhesiolysis
Post laparoscopic adhesiolysis oi internal genitalia adhesion - Chromotubation
Post bilateral salphyngoraphy o.i bilateral Hydrosalphing
Bilateral Patent tube
Dysmenorrhea caused by bilateral endometriosis cyst was suspOperative laparoscopy:
Uterine adenomyosis Total abdominal hysterectomy
Internal genitalia organ adhesion Bilateral Salphingooophorectomy
Adhesiolysis Stab wound drain
- Endometriosis ASRM Grade IV (ASRM score 96)
- Post total histerectomy– salphingooophorectomy bilateral perlaparoscopy a/i uterine adenomyosis and bilateral endometriosis
- Post adhesiolysis oi internal genital adhesion
- Post stab wound drain
· Laboratory examination Chest X-ray
· Anesthesia assessment
· EID assessment
· Curettage
Laboratory examination
Anesthesia assessment
Curettage
Ovarian cancer stage IIIC - Laparotomy secondary debulking + Adhesiolysis + stab woun
Ovarian cancer stage IIIC + post laparotomy secondary debulking + stab wound drain
Endometrial carcinoma stage IB was suspected - Laparotomy radical surgical staging (HTSOS, omentectomy, l
- Endometrial carcinoma clinically stage IB - adhesiolysis
- Post laparotomy surgical staging (HTSOS, omentectomy, lym - Post stab wound drain
- adhesiolisis
- Post stab wound drain
- Dysmenorrhea caused by endometriosis cyst was suspected Laparoscopy operative:
- Primary infertile 2 years - Salphingoraphy
- Endometriosis grade IV (ASRM score 96 EFI score 4) - Adhesiolysis
- Post adhesiolysis oi internal genitalia adhesion - Cystectomy
- Post bilateral salphingoraphy - Chromotubation
- Patent tube bilateral
- Cystic ovarian neoplasm with solid part was suspected Operative laparoscopy:
- Endometriosis ASRM Grade IV (ASRM score 46) - Bilateral cystectomy
- Post adhesiolysis oi internal genital adhesion - Adhesiolysis
· Urinary catheter
· Analgesic
· Laboratory examination
· US gynecology
· MRI
Seromural uterine myoma dd/ intraligamenter uterine myoma + Myomectomy
Urine retention Total hysterectomy
Post laparotomy myomectomy + total hysterectomy on indicationAdhesiolysis
Stab wound drain
Cystic ovarian neoplasm with solid part malignancy was suspec - Laparotomy salphyngooforectomy sinistra + omentectomy + s
Post laparotomy salphyngooforectomy sinistra + omentectomy + stab wound drain
Ovarian cancer stage IIIC complete therapy - Laparotomy insision
Ovarian cancer stage IIIC complete therapy
- Adenomyosis uterine Laparoscopy operative
- Dysmenorrhea cb bilateral endometriosis cyst was suspected - Bilateral cystectomy
- Primary infertile 3 years - Adhesiolysis
- Endometriosis ASRM Grade IV (ASRM score 48 EFI score 8) - Chromotubation
- Post adhesiolysis oi internal genital adhesion - Stab wound drain
- Bilateral patent tubes
- Post stab wound drain
- Primary infertile 3 years
Curettage
Plan for Swab PCR
Stage IIIB · Laboratory examination
Hypoalbuminemia · Internal medicine assessment
AKI stage II · Plan for clinical staging
· US confirmation
Stage IVA Hospitalized
Gross hematuria IVFD RL drips xx/minute
Moderate anemia (clinically) Tranexamic acid 500 mg/8 hours
Cancer pain Pronalgess supp 3x1
Laboratory examination
Cystoscopy
Chemotherapy paclitaxel-carboplatin 6 course
Hospitalized
PRC Transfusion
TC transfusion
Chemotherapy paclitaxel-carboplatin 4th course
Plan for radiotherapy
Hospitalized
Leucogen injection
Chemotherapy paclitaxel-carbopltin 3rd course
Plan for radiotherapy ( February, 15th 2021)
Recurrent ovarian cancer laparotomy secondary debulking + stab wound drain
Recurrent ovarian cancer Post laparotomy secondary debulking + stab wound drain
submucous uterine myoma Myomectomy
Post laparotomy myomectomy + total hysterectomy with left sal Total hysterectomy with left salphingooforectomy
Adhesiolysis
etrial was suspected •- Hysteroscopy DnC
Laparatomy operative
· Primary amenorrhea c.b MRKH Syndrome (Mayer–Rokitansky
Post neovaginal on indication MRKH syndrome - Open the peritoneum
- Create the vaginal cuff
• Neovaginal (davydov procedure)
EID assessment
Curettage
Std IIIB · Observation of vital sign
Post laparotomy suboptimal debulking · IVFD RL drips xx/minute
Colostomy · Laboratory examination
Post Dj Stent insertion · Assessment digestive and Urology department
Stage IIIB Hospitalized
Hypertension stage II Internal medicine and urology assessment
AKI stage II Laboratory examination
TUG- US examination
Candersatan 1x8 mg (PO
Plan for radiotherapy April, 14th 2021)

Hospitalized
US Gynecology
Abdominal CT scan with contrast
PRC transfusion
Digestive surgery assessment
Cervical cancer stage IIB ( post NAC Chemotherapy) Laparotomy radical hysterectomy + lymphadenectomy + stab w
Cervical cancer stage IIB post radical hysterectomy + stab wound drain
Uterine adenomyosis Total hysterectomy with right salphingooforectomy
Bilateral endometriosis cyst Adhesiolysis
Internal genitalia adhesion Stab wound drain
Post laparotomy total hysterectomy with right salphingooforectomy _ stab wound drain
Plan for Laparoscopy diagnostic

- Endometrial polyp Hysteroscopy


- Hydrosalpinx Laparoscopy operative
- Primary infertile 15 years - chromotubation
- Post curettage oi endometrial polyp - Adhesiolysis
- Post adhesiolysis oi internal genital adhesion
- Bilateral non patent tubes
- Turner syndrome anomaly
- Primary infertile 15 years Hospitalized
VAC chemotherapy 2nd course
Laboratory
Aloclair gel examination
4x/day
MER Chemohterapy 3rd course
procedure
pap’s smear
infusion of cancer chemotherapeutic substance
Pronalgess supp

dilatation and curettage


Laparoscopic of ovarian cyst
laparoscopic
Laparoscopic unilateral oophorectomy
total abdominal hysterectomy
total abdominal hysterectomy
laparascopy
· procedure haven’t been performed
US confirmation
• Hemodialysis
• Hysteroscopy DnC ( February, 17th 2021)
• US gynecology confirmation  haven’t been performed ( waiting for swab result)
- Stab wound drain
• Frozen section
- Omentectomy

Hysteroscopy
• diagnostic
Adhesiolysis
- Ascites fluid sampling

•procedure
Laparotomy surgical staging (54.1)
Cervical Biopsy (67.12)
· Laparotomy (54.1)
• Medicinalis
Plan for simulation radiotherapy ( April, 14th 2021)
BEP Chemotherapy 2nd course (. 99.25)
Plan for laparotomy surgical staging ( 99.25)
US evaluation ( 88.79)
Chemotherapy paclitaxel-carboplatin 6 course ( 99.25)
ß-HCG evaluation ( April, 12th 2021) ( V72.4)

Chemotherapy
Vaginal biopsy (MR 7th course ( 99.25)
70.24)
Pap’s smear evaluation ( V72.4)
Plan for radiotherapy ( 92.29)
Radical hysterectomy( 68.4)
Pap’s smear evaluation ( V72.4)
Cervical biopsy ( 67.12)
TC transfusion ( 99.05)
BNO-IVP (87.79)
Laparotomy surgical staging ( 54.1)
Chemotherapy paclitaxel-carboplatin 4th course
Plan for laparotomy after 3rd course ( 54.1)
Abdominal CT Scan with contrast ( 88.01)
Pap’s smear ( V72.4)
Clinical staging
 
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
CaCO3 500 mg/8 hours ( 99.21)

MER chemotherapy 6th course ( 99.25)


Laparotomy total hysterectomy ( 68.41)
MR
Planchemotherapy 11th course ( 99.25)
for Clinical Staging
Albumin flash ( 99.21)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)

Chemotherapy
PRC Transfusion paclitaxel-carboplatin
( 99.04) 1st course ( 99.25
Chemotherapy
Plan for Clinicalpaclitaxel-carboplatin
Staging 6th course ( 99.25)
MR chemotherapy 5th course ( 99.25)
MER chemotherapy 3rd course
Laparotomy VC ( 54.1)
Medicinalis ( 99.21)
Chemotherapy paclitaxel-carboplatin ( 99.25)
Plan for radiotherapy ( April, 12th 2021)
Chemotherapy paclitaxel-carboplatin 1st course _x000B_Plan for radiotherapy ( June, 21st 2021)
Chemotherapy paclitaxel-carboplatin 5th course
Chemohterapy CIM 4th course
Laparotomy VC ( 54.1)
Leuprolide acetate injection 1,88 mg 1 course ( 99.24)
Laparotomy
Control whenmyomectomy ( 68.29
patient had blood spotting
Infetile primer 8 years ( N97.9)
Anesthesia assessment
Anesthesia assessment
USG folicle at 2nd/ 3rd day of menstrual cycle

Plan for D
Vitamin sperm
PO analysis (V26.21
Leuprolide acetate 3.75 mg injection (IM) (99.2)
Plan for sperm analysis (V26.21)
Examine FSH, E2, prolactin (V72.62)
Evaluation ( 3 months)
HDLO ( 68.12)

Education
Analgetic
  
Medication (V0.79)
Topical estrogen cream (968.5)
Hospitalized
  
At this time there is no treatment from urogynecology division
(68.4- total abdominal hysterectomy)
Consult to urology departemtn
Continue euprolid acetate injection up to 6 courses
Plan for hysteroscopy D&C
Leuprolid acetate injection 3 courses
Plan for polypectomy and curettage (69.01- excusion or destruction of lesion or tissue of uterus and supporting structure; 69.09
Pathology anatomy examination

Tumor marker examination


Patien was discharged
Patient was discharged
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
BEP Chemotherapy 2nd course (99.25)
Consult to urology department
Dilatation and Curettage ( 69.09)
Plan for laparotomy surgical staging ( 54.19 )
Adhesiolysis ( 54.55)
Bladder repair (57.)
Resection adenomyosis
 cromotubation
Curettage (69.59
EID and internal medicine assessment
Treated at isolation ward and plan for Swab PCR  patient refused hospitalization
Medicinalis (99.21)
Sampling of Peritoneum Paracolic dextra and sinistra ( 54.22)
Stab wound drain( 998.89) Peritoneal washing ( 54.25)

Fistuloraphy
Excision (K62.89
of lymph node (40.24)
TC transfusion ( 99.05
Stable in ward
Patient was discharged
Treated at non isolation ward and plan for Swab PCR
Plan for Clinical Staging
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
CaCO3 500 mg/8 hours ( 99.21)
PRC tranfussion
Incision and drainage
Marsupialisasi
US confirmation 88.78
General condition improvement
Patient was discharged at her own request
Discharge --> plan for control to urogynecology policlinic
65.4 Unilateral salpingo-oophorectomy
54.5 Lysis of peritoneal C53.61 Open incisional hernia repair with graft or prothesis.
54.5 Lysis of peritoneal C53.61 Open incisional hernia repair with graft or prothesis.
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
Albumin flash ( 99.21)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
MER chemotherapy 3rd course
Urinary tract infection ( N39.0)
Mild anemia ( D64.9)
65.6 Bilateral salpingo-oophorectomy
Adhesiolysis (54.5)
Right Cystectomy
Left Salpingoooforectomy
Bilateral salpingo-oophorectomy
Passed away ( Tuesday, March 16th 2021; 05.30 PM)
Passed away march 17th 2021 at 09.30 AM
DNR

Patient was discharged


Adhesiolysis
Bladder repair (57.)
Sampling of Peritoneum Paracolic dextra and sinistra
Peritoneal washing

65.4 Unilateral salpingo-oophorectomy


With mesh
Right salpingo oophorectomy

Bilateral salpingo-oophorectomy
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
 
 
Excision of lymph node (40.24)
- Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)
 
65.6 Bilateral salpingo-oophorectomy
IUD extraction (99.71)
Chemotherapy paclitaxel-carboplatin 1st course ( 99.25)
FeSO4 1 tab/24 hours ( 99.21)
Chemotherapy pactliaxel-carboplatin1st course ( 99.25)
US gynecology ( March, 19th 2021)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
BEP Chemotherapy 3rd course ( 99.25)
MR Chemotherapy 1st course ( 99.25)
MER chemotherapy 2nd course ( 99.25)

US gynecology ( March, 19th 2021)


Planning for LEEP ( 67.32)
Planning
Plan for Laparotomy
for radiotherapy frozen18th
( March, section ( April,
2021) 05th 2021)
( 92.29)
Plan for radiotherapy ( 92.29)
 
US gynecology (88.79)
US Gynecology ( 88.79)

Laparotomy surgical staging ( 54.29)


Laparotomy
Ranitidine TAHBSO
2x1 ( 54.2)
amp ( 99.21)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
MR chemotherapy 11th course ( 99.25)
MER chemotherapy 9th course ( 99.25)
Digestive surgery assessment ( 89.09)
CaCO3 3x1 tab ( 99.21)
Laparotomy VC ( 54.1)

Clinical staging consultation ( 89.09)


Urogynecology
Medicinalis
Chemotherapy ( 99.21)
paclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy
PRC Transfusion ( 99.04)(April, 28th 2021) ( 92.29)
Leucogen injection ( 99.21)
Laparotomy surgical
Chemotherapy staging ( 54.1) 3 course ( 99.25)
paclitaxel-carboplatin
Laboratory examination ( V72.62)
US gynecology ( 88.79)
MR Chemotherapy
Urology 3rd course
consult ( 89.09)
Vaginal biopsy ( 70.24)
Laparotomy VC ( 54.1)

•Leuprolide acetate injection 3 more cycles (99.2)


•Sperm 2x5
Provera analysis
mg ( (V26.21)
14 days) ( 99.24)
Control ( when patient menstruation)
Dienogest 2 mg/ 24 hours for 6 months ( 99.24)
US gynecology
Plan ( after
for diagnostic 6 months therapy)
hysteroscopy operative( laparoscopy
88.79)

•Plan for diagnostic hysteroscopy operative laparoscopy


Plan for diagnostic hysteroscopy operative laparoscopy
·Plan for Repair fistula
•Plan
Chestfor laparotomy
X-Ray ( 87.4) myomectomy (68.29- uterine myomectomy)
Plan for lymphadenectomy
Bilateral laparotomy ( 54.1) (40.24)
Anterior and posterior colporrhapy
Myomectomy
Left Salphingectomy
Adhesiolysis endometriosis ablation (65.25)
Laparoscopy
Chromotubation
Sondage (628.2) anteflexed uterus 7 cm
was performed,
Curettage was performed, there were tissue and blood for 50 cc
Hysteroscopy DnC( (99.04)
·PRC transfusion 68.12
·Internal
Plan medicine assessment
for Laparotomy Suboptimal( 89.09)
debulking( 54.2 )
Post stab
PRC wound (drain
transfusion ( 54.91 )
99.04)
Chemotherapy
Leucogen injectionpaclitaxel-carboplatin
( 99.21) 1st course ( 99.25)
BEP Chemotherapy
PRC transfusion ( 99.04)3rd course ( 99.25)
MER chemotherapy
PRC Transfusion 2nd course ( 99.25)
( 99.04)
MERgynecology
·US chemotherapy 2nd course
confirmation ( 99.25)
(88.79)
-·Other
routinetherapy from
urinalysis internal medicine department
examination

Rehecting

 
 
Mole Evacuation

Laparotomy
•Omentectomy Hysterectomy
•Stab wound
Laboratory drain
examination ( V72.62)
US confirmation ( 88.79)
US confirmation
Plan ( 88.79)
for radiotherapy ( 92.29)
Ranitidine 2x1 amp
Leucogen inj ( 99.21) ( 99.21)
Chemotherapy
Leucogen injectionpaclitaxel-carboplatin
( 99.21) 6th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Hospitalized
MER chemotherapy
Leucogen injection ( 9th course ( 99.25)
99.21)
Digestive
PRC surgery( assessment
transfusion 99.04) ( 89.09)
CaCO3 3x1 tab ( 99.21)
Adhesiolysis
Laparotomy unilateral salpingo-oophorectomy (65.4)
Laparotomy unilateral salpingo-oophorectomy (65.4)
Consult to nutritionist
Laparotomy surgical staging (ascites fluid sampling, omentum mass biopsy, peritoneal mass biopsy, mesocolon mass biopsy) (
Laparotomy myomectomy (68.29)
Stable in ward
PRC Transfusion 600 cc ( 99.04)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Plan for
PRC radiotherapy
Transfusion (April, 28th 2021) ( 92.29)
( 99.04)
Leucogen
Passed awayinjection ( 99.21)
( March, 09th 2021 on 00.45 AM
Outcomes
Passedaway
Passed away((March,
March, 11th 2021;
2021 ;05.00
03.15PM)
AM)
 
Laparotomy Suboptimal Debulking : unilateral salphingo –oophorectomy, omentectomy ( C56.9)
Exploratory laparotomy (54.11)
Bilateral lymphadenectomy
Myomectomy
•Total abdominal hysterectomy
••Stab wound drain
••Stab wound drain

Post laparotomy right salpingo-oophorectomy on indication benign ovarian neoplasm
Laparotomy left salpingo-oophorectomy (65.4)
Transurethral resection of bladder tumor  (57)
Laparotomy surgical staging (ascites fluid sampling, omentum mass biopsy, peritoneal mass biopsy, mesocolon mass biopsy)

Laparotomy myomectomy
Chromotubation (628.2) (68.29)

Hysterescopy D&C (69.09)


Hysteroscopy
Adhesiolysis
Consult to nutritionist
Tubectomy Pomeroy
-Peritoneal washing (54.25)
-Stab wound drain (998.89)
Fistuloraphy (57.84) (57240 )
Anterior Colporrhapy
Posterior
•Stab Colporrhapy
wound (57250 )
drain (998.89)

·Laparotomy myomectomy (68.2)
·Salpingostomy
•Stab wound drainbilateral(66.73)
(998.89)
••Stab wound drain (998.89)

Laparotomy myomectomy oi multiple uterine myoma (D25.9)
•-Left salipingoooforectomy (65.6)
-Right Cystectomy
-Abdominal Flap (65.1)
--Appendectomy
Adhesiolysis (54.51- laparoscopic adhesiolysis of peritoneal adhesion)

Loop electrosurgical excision procedure (LEEP) (67.32)


Adhesiolysis
Chromotubation (628.2)
Adhesiolysis
Chromotubation (628.2)
Adhesiolysis
Laparoscopy left ovarian drilling (65.99)
Laparoscopy
Adhesiolysis myomectomy (54.21)
Chromotubation
Adhesiolysis (628.2)
Chromotubation (628.2)
Adhesiolysis (54.51)
Stab wound
•Stab wounddrain
drain (998.89)

(54.42 – polypectomy)
•40.24 Excision of inguinal lymph node
•998.89 stab wound drain
Fistuloraphy (57.84) (57240 )
Anterior Colporrhapy
Posterior Colporrhapy (57250
Post left salphingo-oophorectomy o.i Left cystic ovarian neoplasm
Post adhesiolysis o.i internal genitalia adhesion
Loop electrosurgical excision procedure (LEEP) (67.32)

Procedure
Antibiotic
Adhesiolysis (54.51)
Chromotubation
Rectovaginal (66.0)
nodule resection
Adhesiolysis
Anterior (54.51) (70.8)
Colporrhaphy
PosteriorofColporrhaphy
-Biopsy bilateral pelvic(70.8)
lymph node (40.11)
-Omentectomy (54.4)
04.04.2021 (04.30 PM)
there were tissue and blood for 100 cc from curratage
Antimimetic
Discharged bypatient
·Laboratory examination request
( V72.62)
·If there is no contraindication à ondansentron 2x1 amp IV ( 99.21)
-Right salpingectomy (54.4)
-Stab wound(54.5)
Adhesiolisis drain (998.89)
•Anesthesia assessment
•Laparotomymyomectomy
·Laparotomy exploration (68.29)
-·Cystectomy
Hysterectomy (65.12)
(68.4)
- Bilateral salpingoooforectomy
Adhesiolisis(54.5) Hysterectomy(65.6)
(68.4)
Left salpingoooforectomy
stab wound drain (65.1)
(66.0)
Omentectomy (54.4)
Posterior Colporrhaphy (70.8)

Hysteroscopy
Chromotubation DnC ( 68.12)
(66.0)
Adhesiolysis (54.51)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Plan for radiotherapy ( 92.29)
Pap Smear Evaluation ( V72.3)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Tumor marker evaluation ( V72.3)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Digestive surgery consult ( 89.09)
Control 1 month later
Plan for radiotherapy ( 92.29)
Gynecology US Examination ( 88.79)
Plan for resection of vaginal mass after NAC
Sperm analysis (V26.21)
CaCO3 500 mg/ 8 hours PO
CaCO3 500 mg/ 8 hours PO
Control
Vitamin next month
E 1 tab/ 24 hours PO
Laboratory
Sperm examination
analysis (V26.21)(V72.62)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)

Laparotomy
Internal radical
medicine hysterectomy
consult ( 89.09) ( 68.4)

Plan for laparotomy second look ( 54.1)


Chemotherapy paclitaxel-carbiplatin 2nd course ( 99.25)
Control 3 months
Contol 1 month
Leucogen injection (99.21)
MER chemotherapy 4th course ( 99.25)
ß-HCG evaluation ( V62.4)
Laparotomy
Cervical VC (67.12)
Biopsy ( 54.1)
Stab wound drain (998.89)
Adhesiolisis (54.5)
Laparotomy exploration
Education
Education
Chest X ray (87.44)
Plan for medicine
Internal fistuloraphy (K62.89) à for DM treatment ( 89.09)
assessment
Laparotomy myomectomy ( 68.29)
Operative
Plan laparoscopy:
for laparotomy Salpingectomy right tube (65.1)
myomectomy
(68.29-
Plan foruterine myomectomy)
laparotomy hysterectomy bilateral salphingo-oophorectomy (68.29- uterine myomectomy)
Plan for PRC
·Anterior transfusion
colporrhaphy (99- transfusion of blood and blood component)
(70.51)
·Posterior colporrhaphy
·US Examination (88.7) (618.04)
·Plan Forcolporrhaphy
·Anterior exicion (86.) (70.51)
·Posterior colporrhaphy (618.04)
Stab wound drain (66.0)
Cystectomy (65.12)
- Bilateral salpingoooforectomy (65.6)
Left salpingoooforectomy (65.1)
Plan for radiotherapy (April, 12th 2021)
( 92.29)
Plan for radiotherapy (August 8,2021)
( 92.29)
Plan for radiotherapy (August 8,2021)
( 92.29)
TC transfusion ( 99.05)
Chemotherapy paclitaxel-carboplatin 4th course ( 99.25)
Tumor marker evaluation ( V72.4)
MR chemotherapy 1st course ( 99.25)
MR chemotherapy
Chemotherapy 2nd course ( 99.25)
paclitaxel-carboplatin 1s course ( 99.25)
Plan for radiotherapy (August, 13th 2021) ( 92.29)
Laparotomy VC ( 54.1)
Consult
Consultto toDigestive
PA for FNACSurgery Division Laparotomy VC ( 54.1)
Laparotomy
Consult VC ( 54.1)department ( 89.09)
with oncology

Leuprolide acetate injection 3,75 mg 3 ( 3course ( 99.24)


course) ( 99.24)
US evaluation ( after 3 course leuprolide acetate
Leuprolide acetate injection 3,75 mg 3 course ( 99.24) injection) ( 88.79)
CaCO3 500 mg/8
NaCl compress 2x1 ( 99)hours ( 99.21)
Laboratory examination ( V72.62)
HDLO ( 68.12)
Ovulation stimulation à clomifen citrate 50 mg/ 24 hours for 5 days ( started in 3nd of menstrual cycle) ( 99.21)
Vitamin E 1x1 paclitaxel carboplatin 3rd course 9 99.25)
Chemotherapy
Plan for
PRC radiotherapy
transfusion ( May, 01st 2021) ( 92.29)
( 99.04)
Plan for internal radiation ( 92.29)
Secondary debulking (54.1) à patient refused
BEP Chemotherapy 2nd course ( 99.25)
Laparoscopy conservative surgical staging ( 54.21)
MR confirmation
US chemotherapy 5th course ( 99.25)
• Curratage
• Dilatation & Curettage
Peritoneal washing (54.5)
- Right cystectomy (65.12)
Consult to digestive division -> liver biopsy
Chromotubation (628.2)
Operative laparoscopy right salpingectomy (65.1)
·US Examination (88.7)
·Plan Forurine
Catether colpocleisys (68.)
Education
Laboratory
•Cortimoxasolexamination
60 mg / 12 (V72.62)
hours
•Paracetamol
Dilatation 500 mg/8 hours
& Curettage

Curettage
Plan
PRCfor Clinical staging
transfusion ( 99.04)
Radiotherapy
Chemotherapy( 92.29)
paclitaxel-carboplatin 1st course ( 99.25)
Plan for radiotherapy
Chemotherapy ( August, 19th 2021)
paclitaxel-carboplatin ( 92.29)
1st course ( 99.25)
Plan for radiotherapy ( June, 29th 2021) ( 92.29)
Tumor marker evaluation ( V72.4)
Laparoscopy conservative surgical staging ( 54.21)

MR Chemotherapy 14th course ( 99.25)


Laparotomy VC ( 54.1)
Laparotomy VC ( 54.1)
Fistuloraphy (K62.89)
Post stab wound drain (998.89)
Post stab wound drain (998.89)
Chromotubation (628.2)
Laboratory examination ( V72.62)
US examination ( 88.79)
Paclitaxel-carboplatin chemotherapy 4th course (99.25)
Plan for radiotherapy (92.29)
Pap’s smear evaluation
PRC transfusion (99.04)(July, 2021) (V62.4)
CIM chemotherapy
Laboratory 5th course
examination (99.21) (99.25)
Plan for
PRC chemotherapy
transfusion (99.04)paclitaxel-carboplatin 6 course (99.25)
Chemotherapy paclitaxel-carboplatin 3rd course (99.25)
Plan for radiotherapy ( 92.29)
ß-HCG evaluation (V72.3)
ß-HCG evaluation (V72.3)
MR Chemotherapy 1st course (99.25)
MR chemotherapy
Leucogen injection2nd course (consolidation) (99.25)
(99.21)
MER
IUD chemotherapy
extraction (97.71)4th course (99.25)
Laparoscopy left salpingo-oophorectomy (65.41)
US confirmation ( 88,79)
Plan for laparotomy myomectomy ( 68.29)
Bilateral salpingo-oophorectomy(65.6)

Labia minora
laparotomy Excision (7109)
salpingo-oophorectomy  
Resection of the left ovarian mass
Ascites cytology

NAC Chemotherapy 3rd course ( 99.25)


Chemotherapy paclitaxel-carboplatin 6 1stcourse
course( 99.25)
( 99.25)
Plan for radiotherapy
PRC transfusion ( (99.04) ( 92.29)
CIM Chemotherapy 1st course ( 99.25)
Chemotherapy paclitaxel-carboplatin 1st course ( 99.25)
Laparotomy surgical( staging
Leucogen injection 99.21) ( 54.1)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
BEP Chemotherapy
US Confirmation 2nd course ( 99.25)
( 88.79)
Internal
Pus medicine assessment ( 89.09)
culture
Antibiotic (99.21)
Laparotomy VC ( 54.1)
Peritoneal washing cytology
Hysteroscopy D & C (68.12- hysteroscopy)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Plan for radiotherapy
Chemotherapy ( June, 09th 2021)
paclitaxel-carboplatin 2nd (course
92.29) ( 99.25)
Plan for radiotherapy ( July, 02nd 2021) ( 92.29)
Plan for radiotherapy (92.29)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
BEP
PRCChemotherapy 3rd course ( 99.25)
transfusion ( 99.04)
CIM chemotherapy 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 5th course ( 99.25)
Chemotherapy paclitaxel-carboplatin 2nd course ( 99.25)
Laparotomy VC ( 54.1)
Adhesiolysis
Omentectomy
Laparoscopy total Hysterectomy (68.41)
Bilateral
Plan salpingoooforectomy
for radiotherapy ( 92.29) (65.6)
Plan for radiotherapy ( 92.29)
Plan for clinical staging
Chemotherapy paclitaxel-carboplatin 6th course ( 99.25)
BEP chemotherapy 1st course ( 99.25)
Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Laparotomy VC ( 54.1)

Diagnosa Procedure
G4P2A1 12 weeks gestational age (Z3A.12) Control in 4 weeks
Single life fetus intrauterine (Z37.0) Medication
Folic acid 1x400mcg
CaCO3 tab 3x500mg
sulfas ferrous 1 x 1 tab
P3A1 post LSCS on indication Prior CS 2x Wound toilet
nephrotic syndrome (Z37.A) Antibiotic
Post tubectomy pomeroy (V26.51) Analgetic
Incomplete abortion (O03.4)
Recent diagnosis Curettage ( 69.02)
Post curettage oi incomplete abortion
Outcomes :
there were tissue and blood for 60 cc
G3P2A0 16 weeks gestational age not in labor (Z3A.16) Joint care with interna department
Recurrence case of pulmonary TB dd/ covid-19 was suspected (Conservative management
Single life fetus intrauterine ( Z37.0) GeneXpert
Medicinalis
Cervical cancer was suspected (C53.9) Cervical biopsy (67.12)
Moderate anemia (D64.9) Vaginal tamponade (75.8)
Chest-X-Ray ( 87.4)
US confirmation ( 88.79)
BNO-IVP ( 87.79)
PRC transfusion ( 99.04)
Clinical staging
Uterine adenomyosis ( N80.0) Analgetic ( 99.2)
Moderate anemia (D64.9) PRC Tranfusion (99.0)
P/ Adenomyosis resection (68.2)
AUB cause by M1 was suspected (N93.9) Observation of vital sign, bleeding
Left endometriosis cyst was suspected ( N80.1) General condition improvement
Moderate anemia (D64.9) US gynecology
Syphilis infection latent (A52.8) Re-check HIV in 2 weeks
HIV infection was suspected
Decreased of consciousness Observation of vital sign
Generalized onset motor tonic seizure c.b Non-hemorrhagic stroP1 care 🡪 after stabilization🡪 P2 OBGYN care
Joint care with Neurology, internal medicine
DD/ haemorrhagic stroke
SOL intracranial metastases

Cystic ovarian neoplasm malignancy was suspected (D27.9)


DM type 2 (E11)
AKI stage II (N.17.9)
G4P3A0 6 weeks gestational age Control in 2 weeks
Chronic Myeloid Leukemia Medications :
Single life fetus intrauterine - CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
Sulfas ferrous 1 tab/24 hours (PO)
Imatinib Mesilate 1 tab/24 hours (PO)
G1P0A0 17 weeks gestational age (Z3A.12) Control in 4 weeks
SLE arthrititis manifestation (M32.9) Methylprednisolon 4 mg/ 24 hours (PO)
Single life fetus intrauterine (Z37.0) Imoran 50 mg/ 24 hours (PO)
Mulitivitamin
- CaCO3 500mg/ 8 hours (PO)
- Folid acid 400mg/24 hours (PO)
G2P1A0 6 weeks gestational age TORCH Screening
History Toxoplasma infection
Single life fetus intrauterine
G2P1A0 19 weeks gestational age Control on the next 4 weeks
Prior sc 1 x Medications
Hepatitis B infection (B19.10) -CaCO3 500mg/ 8 hours (PO)
Single life fetus intrauterine - Folid acid 400mg/24 hours (PO)
Sulfas ferrous 1 tab/24 hours (PO)
Ricovir 200 mg/24 hours (PO)
Post curettage on indication incomplete abortion (2 days ago) Observation vital sign
Post minilaparatomy tubectomy Minilaparatomy tubectomy
P2A0 post LSCS on indication Prior CS 1x (Z37.A) Days 4 Wound toilet
Antibiotic
Analgetic
High protein diet
P3A0 post LSCS on indication prior cs 2x + history covid-19 (Z3Contraceptive counselling
Wound care
High protein diet
P2A0 post LSCS on indication Prior CS 1x (Z37.A) Days 8 Wound toilet
Antibiotic
Analgetic
High protein diet
G4P2A1 16 weeks gestational age with second trimester bleedinObservation of vital sign, contraction and FHR , bleeding
Single life fetus intrauterine (O10.0) Laboratorium examination
Conservative management
US confirmation
Vulnus laceratum et regio labio mayor caused by blunt trauma Observation of vital sign, bleeding
Recent diagnosis Laboratory examination
Post wound suturing on indication vulnus laceratum et regio lab Wound suturing
Cervical cancer stage IIIB ospitalized
Moderate anemia PRC transfusion
Chemotherapy paclitaxel-carboplatin 2nd oucrse
Plan for radiotherapy
Curcuma 3x1
Ovarian cancer stage IIIC Hospitalized
Leukopenia Leucogen injection
Chemotherapy paclitaxel-carboplatin 1st course ( after radiothe
Pre Op Diagnosis Loop electrosurgical excision procedure (LEEP) (67.32)
Chronic cervicitis (N72) Endocervical curettage (69.0)
AGC NOS (R87.619)
Post Op Diagnosis
Post LEEP + endocervical curettage on indication AGC
Preoperative diagnosis: Cystectomy
Dysmenorrhea caused by bilateral endometriosis cyst was suspWedge resection
Adhesiolysis
Postoperative diagnosis:
Endometriosis ASRM grade IV (ASRM score 57 EFI score 6)
Post laparoscopy cystectomy on indication bilateral endometriosis cyst
Post left ovarian wedge resection
Post adhesiolysis o.i internal genitalia adhesion
PREOP DIAGNOSIS Laparotomy exploration
Endometriosis cyst (N80.9) - Hysterectomy (68.4)
Uterine adenomyosis (N80.0) right salpingoooforectomy (65.6)
POST OP DIAGNOSIS Adhesiolisis (54.5)
Endometriosisis ASRM grade 4
(ASRM score 116 EFI score 4)
Post hysterectomy on indication Uterine adenomyosis
Post adhesiolisis
PREOP DIAGNOSIS Laparotomy myomectomy oi multiple uterine myoma (D25.9)
Intramural uterine myoma (D25.9)
POST OP DIAGNOSIS
Post laparotomy myomectomy oi multiple uterine myoma
G2P1A0 12 weeks gestational age Laboratory examination (V72.62)
Threatened abortion Total bedrest
Placenta covering OUI Medicinalis
Subchorionic bleeding Vaginal swab
Single life fetus intrauterine
Recent Condition
Stable in Ward
Carsinoma cerviks stadium II was suspected (D06. 9) Observation of vital sign, tenderness, and rigid
Hipokalemia ( E87.6 ) Laboratory examination
Severe Anemia (D63.8) Solid tampon vagina 24 hours
Tranecsamat acid
PRC transfusion
Plan for BNO
Plan for US gynecology
Plan for surgical staging
PREOP DIAGNOSIS Laparotomy
Pedunculated Myoma (D26.7) Total hysterectomy (68.4)
POST OP DIAGNOSIS bilateral salpingoooforectomy (65.6)
Post total hysterectomy on indication pedunculated myoma
Diagnosa Procedure

Internal genitalia adhesion Stab wound drain


Moderate anemia (D64.9) Curettage ( 69.02)
Thromobocytopenia ( D69.6) TC transfusion ( 99.05)
Chronic hepatitis B ( B19,8) Chemotherapy
Hospitalized paclitaxel-carboplatin 3rd course ( 99.25)
CIM Chemotherapy 4th course
Hospitalized
Ovarian cancer stage IIIC ( C56.9) BEP chemotherapy 2nd course ( 99.25)
Hospitalized
Ovarian
Right cancer
pleural stage (IAJ18)
effusion ( C56.9) BEP chemotherapy
Chemotherapy 1st course ( 99.25)
paclitaxel-carboplatin 6 course ( 99.25)
1/3 proximal femur fracture (S72.0) Antibiotic
Ascites (R18) US gynecology
Left hydronefrosis
Moderate (N13. 30)
anemia (D64.9) Joint care with Internal medicine
Controlled hyperthyroidism Plan to Adenomyosis resection
Asictes colostomy

GTN stage I FIGO Score 3 Laparotomy


Adhesiolysistotal hysterectomy
Cystic ovarian neoplasm with solid part malignancy was suspec (68.12)
Abnormal uterine bleeding ec endometrial hyperplasia dd/ endo
Internal genital adhesion
HHD DD/ CAD Laparotomy
Cardiologist total hysterectomy salphyngooforectomy bilateral
assessment
Moderate anemia (D64.9) Plan laparotomy FS after General condition improvement
Moderate anemia ( D64.9) Chemotherapy paclitaxel-carboplatin 3rd course ( 99.25)
Severe anemia Plan for radiotherapy
Cervical biopsy ( November, 17th 2021) ( 92.29)
Cystectomy Sinistra
Endometriosis
Urinary cyst dd/ cyst ovarian neoplasm was suspected
tract infection Stab Wound drain
in 1st course

in 2nd course

in 2nd course

in 4th course

n 4th course
n 4th course

n 1st course

n 4th course
in 1st course

in 2nd course

in 2nd course

omentectomy, appendectomy) + adhesiolysis


pected stage IIIc

and bilateral endometriosis cysts


+ Adhesiolysis + stab wound drain

g (HTSOS, omentectomy, lymphadenectomy)

sinistra + omentectomy + stab wound drain


n 4th course

stab wound drain

gooforectomy

y department

021)

lymphadenectomy + stab wound drain

ngooforectomy
supporting structure; 69.09- other dilatation and curettage)
, mesocolon mass biopsy) ( 54.1)
, mesocolon mass biopsy)
n and FHR , bleeding

n 2nd oucrse

n 1st course ( after radiotherapy)


dure (LEEP) (67.32)
e uterine myoma (D25.9)

n 3rd course ( 99.25)

n 6 course ( 99.25)
hyngooforectomy bilateral
condition improvement
n 3rd course ( 99.25)
17th 2021) ( 92.29)

Anda mungkin juga menyukai